<SUBMISSION>
<ACCESSION-NUMBER>0001096906-18-000055
<TYPE>10-Q
<PUBLIC-DOCUMENT-COUNT>79
<PERIOD>20170630
<FILING-DATE>20180131
<DATE-OF-FILING-DATE-CHANGE>20180131
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ACTIVECARE, INC.
<CIK>0001429896
<ASSIGNED-SIC>3669
<IRS-NUMBER>870578125
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>0930
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>10-Q
<ACT>34
<FILE-NUMBER>000-53570
<FILM-NUMBER>18563889
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1365 WEST BUSINESS PARK DRIVE, SUITE 100
<CITY>OREM
<STATE>UT
<ZIP>84058
<PHONE>877-219-6050
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1365 WEST BUSINESS PARK DRIVE, SUITE 100
<CITY>OREM
<STATE>UT
<ZIP>84058
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>Volu-Sol Reagents CORP
<DATE-CHANGED>20080317
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>activecare.htm
<DESCRIPTION>10Q
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.1
    Copyright 1995 - 2018 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a name="_GoBack"><!--Anchor--></a><font style="FONT-SIZE: 14pt">UNITED STATES</font></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Washington, D.C. 20549</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FORM 10-Q</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9746;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"> QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">For the quarterly period ended:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"> June 30, 2017</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">OR</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">For the transition period from __________ to __________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Commission File No. </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>000-53570</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="COLOR: #000000; TEXT-ALIGN: center; FONT: bold 18pt/1.25 'Times New Roman', Times, serif"><u>ACTIVECARE, INC.</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Exact name of registrant as specified in its charter)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z27b55eb44daa4a398f8487de13646e2f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; COLOR: #000000; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>Delaware</u></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>87-0578125</u></div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(State or other jurisdiction of incorporation)</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(IRS Employer Identification No.)</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">1365 West Business Park Drive, Suite 100</div>

<div style="COLOR: #000000; TEXT-ALIGN: center; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>Orem, UT 84058</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Address of principal executive offices)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>(877) 219-6050</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;(Registrant's telephone number, including area code)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 29.7pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9745;</font>&#160;&#160;No <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 29.7pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files. Yes <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9745;</font>&#160;&#160;No <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 29.7pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 29.7pt">&#160;</div>

<table id="zd70e124e04854cfebe9819bb5d3e6b84" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 33.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Large accelerated filer</div>
</td>
<td style="WIDTH: 16.55%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="WIDTH: 33.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accelerated filer</div>
</td>
<td style="WIDTH: 17.23%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 33.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Non-accelerated filer</div>
</td>
<td style="WIDTH: 16.55%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="WIDTH: 33.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Smaller reporting company</div>
</td>
<td style="WIDTH: 17.23%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9745;</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 29.7pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">&#9744;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font>&#160;&#160;No <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9745;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 432pt"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">As of January 30, 2018, the registrant had 239,100 shares of common stock outstanding.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<!--PROfilePageNumberReset%Num%2%%%-->
<div id="DSPFPageFooter"></div>

<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ActiveCare, Inc.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quarterly Report on Form 10-Q</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Table of Contents</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z4e8e332c8a4a41ad8b580db805f0dfb5" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Page</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PART I &#8211; FINANCIAL INFORMATION</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 1.&#160; Financial Statements</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; LINE-HEIGHT: 1.25">Condensed Consolidated Balance Sheets (Unaudited)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; LINE-HEIGHT: 1.25">Condensed Consolidated Statements of Operations (Unaudited)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">5</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; LINE-HEIGHT: 1.25">Condensed Consolidated Statements of Cash Flows (Unaudited)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">6</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; LINE-HEIGHT: 1.25">Notes to Condensed Consolidated Financial Statements (Unaudited)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">8</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 2.&#160; Management's Discussion and Analysis of Financial Condition and Results of&#160;Operations</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">38</div>
</td>
</tr>

<tr style="HEIGHT: 19px">
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 3.&#160; Quantitative and Qualitative Disclosures About Market Risk</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">53</div>
</td>
</tr>

<tr style="HEIGHT: 21px">
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 4.&#160; Controls and Procedures</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">53</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="LINE-HEIGHT: 1.25">PART II &#8211; OTHER INFORMATION</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">53</div>
</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 1.&#160; Legal Proceedings</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">53</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">Item 1A.&#160; Risk Factors</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">53</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 2.&#160; Unregistered Sales of Equity Securities and Use of Proceeds</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">53</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 3.&#160; Defaults Upon Senior Securities</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">54</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 4.&#160; Mine Safety Disclosures</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">54</div>
</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 5.&#160; Other Information</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">54</div>
</td>
</tr>

<tr style="HEIGHT: 13px">
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 6.&#160; Exhibits</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">54</div>
</td>
</tr>

<tr style="HEIGHT: 13px">
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr style="HEIGHT: 20px">
<td style="WIDTH: 95%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">SIGNATURES</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">55</div>
</td>
</tr>
</table>

<div id="DSPFPageHeader"></div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">2</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<!--PROfilePageNumberReset%Num%3%%%-->
<div>PART I &#8211; FINANCIAL INFORMATION</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 1.&#160;&#160;Financial Statements</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ActiveCare, Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Condensed Consolidated Balance Sheets (Unaudited)</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
<br style="LINE-HEIGHT: 1.25">
</div>

<div style="MARGIN-BOTTOM: 10pt; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z247b4dbe99c7445c8190ceb8d18266fa" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: bold; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Assets</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Current assets:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Cash</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">114,440</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">167,737</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Accounts receivable, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">643,857</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">487,001</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Inventory</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">501,769</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">204,736</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Note receivable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">500,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Prepaid expenses and other</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,555</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">644,857</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Total current assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,816,621</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,504,331</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,445</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">86,734</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Deposits and other assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,970</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,846</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Domain name, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,759</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,295</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Total assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,894,795</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,618,206</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-TOP: 10pt; CLEAR: both; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">See accompanying notes to condensed consolidated financial statements.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ActiveCare, Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Condensed Consolidated Balance Sheets (Unaudited) (<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">continued</font>)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"></div>

<div>&#160;</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<table id="z54ef066741a140fbbfc44e12eec601f3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: bold; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Liabilities and Stockholders' Deficit</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Current liabilities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Accounts payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,453,795</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,700,448</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Accounts payable, related party</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">242,568</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">291,753</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Accrued expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,765,437</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,101,711</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Contingent liabilities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">750,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Current portion of notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,501,544</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,722,899</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Notes payable, related party</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,869,683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,898,124</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Dividends payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">733,880</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">606,545</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Derivatives liability</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,231,983</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,054,071</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Total current liabilities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,548,890</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,375,551</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Notes payable, net of current portion</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,889,170</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,353,856</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Total liabilities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">36,438,060</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,729,407</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stockholders' deficit:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Preferred stock, $.00001 par value: 10,000,000 shares authorized; 45,000 shares of Series D; 70,070 shares of Series E; and 43,220 and 0 shares of Series G issued and outstanding, respectively</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Common stock, $.00001 par value: 200,000,000 shares authorized; 239,100 and 232,100 shares outstanding, respectively</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Additional paid-in capital, common and preferred</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">88,786,513</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">88,067,410</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 28pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -10pt">Accumulated deficit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(123,329,782</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(108,178,614</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Total stockholders' deficit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(34,543,265</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(20,111,201</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Total liabilities and stockholders' deficit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,894,795</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,618,206</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div id="DSPFPageFooter" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; CLEAR: both; LINE-HEIGHT: 1.25"></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">See accompanying notes to condensed consolidated financial statements.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">4</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ActiveCare, Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Condensed Consolidated Statements of Operations (Unaudited)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="z004d51bc657d49a2809c19750dabf839" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Nine Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Revenues:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Chronic illness monitoring supplies revenues</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,037,179</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,858,926</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,311,955</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,972,196</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Chronic illness monitoring fee revenues</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">159,025</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">317,156</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">599,339</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">888,453</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 54pt">Total Chronic illness monitoring revenues</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,196,204</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,176,082</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,911,294</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,860,649</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cost of revenues:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 34.25pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -14.2pt">Chronic illness monitoring supplies cost of revenues</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">733,143</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,269,828</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,054,086</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,878,972</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 34.25pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -14.2pt">Chronic illness monitoring fee cost of revenues</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">114,954</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">112,486</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">319,184</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">358,436</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 34.25pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 3.8pt">Total Chronic illness monitoring cost of revenues</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">848,097</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,382,314</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,373,270</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,237,408</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Gross profit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">348,107</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">793,768</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,538,024</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,623,241</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Operating expenses:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 34.25pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -14.2pt">Selling, general and administrative (including $1,461,457, $1,004,211, $2,101,037 and $3,257,614, respectively, of stock-based compensation)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,225,054</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,169,603</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,382,027</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,944,098</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Research and development</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,191</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">57,611</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">307,137</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">139,023</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Total operating expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,281,245</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,227,214</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,689,164</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,083,121</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Loss from operations</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,933,138</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,433,446</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,151,140</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,459,880</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other income (expense):</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Interest expense, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,198,631</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(813,517</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,856,258</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,935,486</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Loss on settlement</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(750,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(750,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Gain on derivatives liability</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">64,145</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,603,411</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">230,163</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,796,542</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Loss on extinguishment of debt</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(15,393</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,499,212</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,058,809</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Gain on disposal of property and equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">245</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Gain on liability settlements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,859</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">295,099</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Loss on induced conversions of debt</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(379,132</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Other income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,614</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,614</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Total other income (expense)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,881,872</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,783,360</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(9,872,693</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,281,541</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net income (loss)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,815,010</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,349,914</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(15,023,833</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(7,741,421</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 17.85pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -17.85pt">Deemed dividends on redemption of preferred stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,484,236</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dividends on preferred stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(58,978</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(45,781</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(127,335</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(699,250</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 61.55pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -25.55pt">Net loss attributable to common stockholders</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,873,988</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,304,133</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(15,151,168</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(14,924,907</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss per common share - basic</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24.77</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15.18</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(64.81</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(81.57</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss per common share - diluted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24.77</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3.78</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(64.81</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(82.78</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Weighted average common shares outstanding &#8211; basic</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">237,100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">217,595</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">233,767</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">182,979</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Weighted average common shares outstanding &#8211; diluted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">237,100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">260,266</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">233,767</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">201,928</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageFooter" style="CLEAR: both">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;&#160;&#160;

<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">See accompanying notes to condensed consolidated financial statements.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">5</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ActiveCare, Inc.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Condensed Consolidated Statements of Cash Flows (Unaudited)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="z839d2d582cf84b3db3a9472ab64733ca" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Nine Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash flows from operating activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Net loss</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(15,023,833</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(7,741,421</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Adjustments to reconcile net loss to net cash used in operating activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Amortization of debt discounts</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,081,912</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">904,115</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Loss on extinguishment of debt</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,499,212</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,058,809</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Stock-based compensation expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,705,975</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,801,432</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Loss on settlement</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">750,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Stock and warrants issued and accrued for services</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">395,062</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">456,182</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Increase in note payable principal recorded as interest expense to&#160;convert accounts payable into notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">482,500</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Stock accrued for interest expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">144,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Depreciation and amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">33,643</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,353</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Gain on derivatives liability</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(230,163</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,796,542</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Gain on disposal of property and equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(245</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Loss on induced conversions of debt</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">379,132</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Gain on liability settlements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(295,099</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Changes in operating assets and liabilities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Accounts receivable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(241,844</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(44,459</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Inventory</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(297,033</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">414,110</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Prepaid expenses and other</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">815,799</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(178,053</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Accounts payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,470,310</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(732,265</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 30pt">Accrued expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,796,360</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">931,492</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 40pt">Net cash used in operating activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(618,100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,803,459</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash flows from investing activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Proceeds from sale of property and equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">600</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Purchases of property and equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,818</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,004</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Investment in contingent note receivable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(500,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 40pt">Net cash used in investing activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(502,818</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,404</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash flows from financing activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Proceeds from issuance of notes payable, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,421,489</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,709,287</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Proceeds from issuance of related-party notes payable, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">250,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Proceeds from issuance of warrants in connection with notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,967</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Principal payments on related-party notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(28,441</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(7,795</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Principal payments on notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,325,427</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,175,603</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 40pt">Net cash provided by financing activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,067,621</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,778,856</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net decrease in cash</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(53,297</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(29,007</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash, beginning of the period</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">167,737</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">172,436</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash, end of the period</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">114,440</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">143,429</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageFooter" style="CLEAR: both"></div>

<br style="LINE-HEIGHT: 1.25">
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">See accompanying notes to condensed consolidated financial statements.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">6</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageFooter" style="FONT-WEIGHT: bold; TEXT-ALIGN: center">ActiveCare, Inc.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Condensed Consolidated Statements of Cash Flows (Unaudited) (<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">continued</font>)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="zdfc1f3293a55413e9ba566e1a00d5c1a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Nine Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Supplemental Cash Flow Information:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Cash paid for interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">379,589</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">191,943</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Non-Cash Investing and Financing Activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Issuance of warrants to purchase shares of common stock for loan origination fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,103,341</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">201,058</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Accrual of a liability to issue warrants to purchase shares of common&#160;stock for loan forbearance fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">148,677</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Accrual of a liability to issue shares of common stock for loan&#160;origination fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">125,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Dividends on preferred stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">127,335</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">699,250</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Accrual of a liability to issue shares of common stock for loan&#160;forbearance fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">60,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Deemed dividend on the redemption of preferred stock and&#160;accrued dividends for notes payable, common stock and exchange&#160;of warrants</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,484,236</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Conversion of accounts payable and accrued liabilities to&#160;notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,555,189</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Assignment of related-party notes payable to an unrelated third party</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">263,082</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Issuance of shares of common stock for consulting services</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">227,500</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Accrual of a liability to issue warrants to purchase shares of common&#160;stock for loan origination fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">130,246</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Cancellation and reissuance of shares of common stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">121,250</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Conversion of related-party accounts payable and accrued liabilities to&#160;related-party notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">84,404</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Issuance of shares of common stock for related-party loan origination fee</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">70,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Issuance of shares of common stock for loan extension fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">31,250</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Accrual of a liability to issue shares of common stock for loan amendment fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28,500</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Issuance of shares of common stock for dividends</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,434</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 5pt">Accrual of a liability to issue shares of common stock for services</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,600</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageFooter" style="CLEAR: both"></div>
</div>

<div style="TEXT-ALIGN: center; CLEAR: both; LINE-HEIGHT: 1.25">See accompanying notes to condensed consolidated financial statements.</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">7</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageFooter" style="FONT-WEIGHT: bold; TEXT-ALIGN: center">ActiveCare, Inc.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Notes to Condensed Consolidated Financial Statements (Unaudited)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">1.&#160;&#160; Basis of Presentation</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The unaudited interim condensed consolidated financial statements of ActiveCare, Inc. (the "Company" or "ActiveCare") have been prepared in accordance with Article 8 of Regulation S-X, promulgated by the Securities and Exchange Commission.&#160;&#160;Certain information and disclosures normally included in financial statements prepared in accordance with US generally accepted accounting principles ("US GAAP") have been condensed or omitted pursuant to such rules and regulations.&#160;&#160;In the opinion of management, the accompanying interim condensed consolidated financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the Company's financial position as of June 30, 2017 and September 30, 2016, and the results of its operations for the three and nine months ended June 30, 2017 and 2016 and its cash flows for the nine months ended June 30, 2017 and 2016.&#160;&#160;These financial statements should be read in conjunction with the annual consolidated financial statements and notes thereto that are included in the Company's Annual Report on Form 10-K for the year ended September 30, 2016.&#160;&#160;The results of operations for the three and nine months ended June 30, 2017 may not be indicative of the results for the full fiscal year ending September 30, 2017.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Going Concern</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">The Company continues to incur negative cash flows from operating activities and net losses.&#160; The Company had minimal cash, negative working capital and negative total equity as of June 30, 2017 and September 30, 2016.&#160; In addition, the Company is in technical default on certain notes payable although the lenders in each case are working with the Company to resolve the defaults.&#160; These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In order for the Company to eliminate substantial doubt about its ability to continue as a going concern, it must achieve profitability, generate positive cash flows from operating activities and obtain the necessary debt or equity funding to meet its projected capital investment requirements.&#160; Management's plans with respect to this uncertainty consist of raising additional capital by issuing debt or equity securities and increasing the sales of the Company's services and products.&#160; There can be no assurance that the Company will be able to raise sufficient additional capital or that revenues will increase rapidly enough to achieve operating profits.&#160; If the Company is unable to increase revenues or obtain additional financing, it will be unable to continue the development of its products and services and may have to cease operations.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Use of Estimates in the Preparation of Financial Statements</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the reporting periods. Actual results could differ from these estimates.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Fair Value of Financial Instruments</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The Company measures the fair values of its assets and liabilities using the US GAAP hierarchy.&#160; The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts receivable, accounts payable, and accrued liabilities approximate fair values due to the short-term nature of these financial instruments. Derivative financial instruments are recorded at fair value based on current market pricing models. The carrying amounts reported for notes payable approximate fair values because the underlying instruments are at interest rates which approximate current market rates.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Reclassifications</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Certain prior year amounts have been reclassified to conform to the current period's presentation. The reclassifications had no effect on the previously reported net loss.</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">2.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Net Loss per Common Share</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 5pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 5pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 5pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 5pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Basic net loss per common share (<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">"</font>Basic EPS<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">") </font>is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 5pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 5pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Diluted net loss per common share (<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">"</font>Diluted EPS<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">") </font>is computed by dividing net loss available to common stockholders by the sum of the weighted average number of common shares outstanding and the weighted-average dilutive potential common shares outstanding.&#160; The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 5pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 5pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">8</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Potential common shares consist of shares issuable upon the exercise of common stock warrants, shares issuable from restricted stock grants, and shares issuable pursuant to convertible notes and convertible Series D and Series E preferred stock.&#160; The following table reflects the calculation of basic and diluted net loss per common share for the periods indicated:</div>

<div id="DSPFPageFooter"></div>

<br style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="z4702f74a59834e15a31f53e465a4156e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three Months Ended</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Nine Months Ended</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Numerator:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Net loss attributable to common stockholders</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,873,988</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,304,133</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(15,151,168</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(14,924,907</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Effect of dilutive securities on net loss:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Common stock warrants</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,427,640</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Convertible debt</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,860,373</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,790,407</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Total net loss for purpose of&#160;calculating diluted net loss&#160;per common share</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5,873,988</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(983,880</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(15,151,168</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(16,715,314</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Number of shares used in per common share&#160;calculations:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Total shares for purposes of calculating basic&#160;net loss per common share</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">237,100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">217,595</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">233,767</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">182,979</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Weighted-average effect of dilutive securities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Common stock warrants</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,337</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20pt">Convertible debt</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,334</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,949</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Total shares for purpose of calculating diluted&#160;net loss per common share</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">237,100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">260,266</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">233,767</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">201,928</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss per common share:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Basic</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24.77</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15.18</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(64.81</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(81.57</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Diluted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24.77</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3.78</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(64.81</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(82.78</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
</table>

<div id="DSPFPageFooter" style="CLEAR: both"></div>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The effect of dilutive securities on the numerator for purposes of calculating diluted loss per common share is related to the convertible debt and related warrants due to the reduction of the gain on derivatives liability for warrants that were in the money.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">As of June 30, 2017 and 2016, there were certain outstanding potential common shares that were not included in the computation of Diluted EPS as their effect would be anti-dilutive for the three and nine months then ended.&#160; The potential common shares outstanding consist of the following:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageHeader" style="CLEAR: both; LINE-HEIGHT: 1.25"></div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">
<table id="z6f66f1dcc3ee473799b8916788779a15" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Three Months Ended</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Nine Months Ended</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Common stock warrants</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">109,174</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,346</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">109,174</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">42,378</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Series D convertible preferred stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">450</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">450</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">450</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">450</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Series E convertible preferred stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Convertible debt</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">158,798</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">95,799</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">158,798</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">95,799</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Restricted shares of common stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Liability to issue common stock and warrants</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">358,097</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,246</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">358,097</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,246</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 20.2pt">Total common stock equivalents</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">627,495</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">117,817</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">627,495</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">141,849</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div id="DSPFPageFooter" style="CLEAR: both; LINE-HEIGHT: 1.25"></div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">3.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Recent Accounting Pronouncements</font></div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In May 2014, August 2015 and May 2016, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue from Contracts with Customers</font>, ASU 2015-14 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue from Contracts with Customers, Deferral of the Effective Date</font>, ASU 2016-12 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue from Contracts with Customers, Narrow-Scope Improvements and Practical Expedients</font>, ASU 2017-13 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue Recognition, Revenue from Contracts with Customers, Leases, and Leases: Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments</font>, and ASU 2017-14 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Income Statement&#8212;Reporting Comprehensive Income, Revenue Recognition, and Revenue from Contracts with Customers</font>, respectively, which implement ASC Topic 606. ASC Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance under US GAAP, including industry-specific guidance. It also requires entities to disclose both quantitative and qualitative information that enable financial statements users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amendments in these ASUs are effective for annual periods beginning after December 15, 2017, and interim periods therein, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted for annual periods beginning after December 15, 2016. These ASUs may be applied retrospectively to all prior periods presented, or retrospectively with a cumulative adjustment to retained earnings in the year of adoption. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">9</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageFooter" style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">In August 2014, the FASB issued ASU 2014-15, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern</font>. This standard sets forth management's responsibility to evaluate, each reporting period, whether there is substantial doubt about the Company's ability to continue as a going concern, and if so, to provide related disclosures. ASU 2014-15 is effective for annual reporting periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its evaluation of going concern.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In July 2015, the FASB issued ASU 2015-11, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Inventory: Simplifying the Measurement of Inventory</font>. The purpose of ASU 2015-11 is to more closely align the measurement of inventory in US GAAP with the measurement of inventory in International Financial Reporting Standards. ASU 2015-11 requires entities to measure most inventory at the "lower of cost or net realizable value." Additionally, some of the amendments are designed to more clearly articulate the requirements for the measurement and disclosure of inventory. ASU 2015-11 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In February 2016, the FASB issued ASU 2016-02, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Leases</font>.&#160; The purpose of ASU 2016-02 is to establish the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. This guidance results in a more faithful representation of the rights and obligations arising from operating and capital leases by requiring lessees to recognize the lease assets and lease liabilities that arise from leases in the statement of financial position and to disclose qualitative and quantitative information about lease transactions, such as information about variable lease payments and options to renew and terminate leases. ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In March 2016, the FASB issued ASU 2016-09, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Stock Compensation: Improvements to Employee Share-Based Payment Accounting</font>.&#160; The purpose of ASU 2016-09 is to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equities or liabilities, and classification of amounts in the statement of cash flows.&#160; ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017.&#160; The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In August 2016, the FASB issued ASU 2016-15, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments</font>. The amendments in this update provided guidance on eight specific cash flow issues. This update is to provide specific guidance on each of the eight issues, thereby reducing the diversity in practice in how certain transactions are classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In May 2017, the FASB issued ASU 2017-09, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Stock Compensation: Scope of Modification Accounting</font>. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. ASU 2017-09 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">10</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">In July 2017, the FASB issued ASU 2017-11, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivative and Hedging (Topic 815)</font>. The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down-round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down-round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity's own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down-round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share ("EPS") in accordance with Topic 260 to recognize the effect of the down-round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down-round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt-Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Accounting Standards Codification, to a scope exception. Those amendments do not have an accounting effect. ASU 2017-11 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160; </div>

<div id="DSPFPageFooter"></div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">4.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accounts Receivable</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts.&#160; Specific reserves are estimated by management based on certain assumptions and variables, including the customer's financial condition, age of the customer's receivables and changes in payment histories.&#160; Accounts receivable are written off when management determines the likelihood of collection is remote.&#160; A receivable is considered to be past due if any portion of the receivable balance has not been received by the contractual payment date.&#160; Interest is not charged on accounts receivable that are past due.&#160; The Company recorded an allowance for doubtful accounts of $25,468 and $75,161 as of June 30, 2017 and September 30, 2016, respectively.&#160; During the three months ended June 30, 2017, the Company wrote off approximately $103,000 of accounts receivable that were previously allowed against.</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">5.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Inventory</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Inventory is recorded at the lower of cost or market value, cost being determined using the first-in, first-out ("FIFO") method. Inventory consists of diabetic supplies.&#160; Inventory held by distributors is reported as inventory until the supplies are shipped to the end user by the distributor.&#160; The Company estimates an inventory reserve for obsolescence and excessive quantities.&#160; Due to competitive pressures and technological innovation, it is possible that estimates of net realizable values could change in the near term.&#160; Inventory consists of the following as of:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<table id="zcc119388048546708950a7f13367812a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Finished goods</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">503,477</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">206,444</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Inventory reserve</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,708</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,708</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt; TEXT-INDENT: 10pt">Net inventory</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">501,769</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">204,736</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; CLEAR: both; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">6.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Prepaid Expenses and Other Current Assets</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Prepaid expenses and other current assets consisted of the following as of:</div>

<table id="zf7e576b0111a49ae9648f5a5a21a7ad2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;Prepaid information technology services</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">38,081</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">57,073</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;Other</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,249</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">112,117</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;Prepaid insurance</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,225</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,602</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;Prepaid legal and professional fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">333,741</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;Research and development</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">96,346</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;Line of credit acquisition fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,978</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt; TEXT-INDENT: 10pt">Total prepaid expenses and&#160;other current assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,555</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">644,857</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">11</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; CLEAR: both; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">7.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Property and Equipment</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Property and equipment are stated at cost, less accumulated depreciation and amortization.&#160; Depreciation and amortization are determined using the straight-line method over the estimated useful lives of the assets, which range between 3 and 7 years.&#160; Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the terms of the lease.&#160; Expenditures for maintenance and repairs are expensed as incurred.&#160; Upon the sale or disposal of property and equipment, any gains or losses are included in operations.&#160; Property and equipment consisted of the following as of:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<table id="zb324003c577c431a85e3710a90024b0b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30, </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Software</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">47,974</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">47,974</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Leasehold improvements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">98,023</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">98,023</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Furniture</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68,758</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68,758</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">47,191</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49,772</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Total property and equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">261,946</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">264,527</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accumulated depreciation and amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(205,501</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(177,793</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Property and equipment, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,445</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">86,734</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Assets to be disposed of are reported at the lower of the carrying amounts or fair values, less the estimated costs to sell or dispose.&#160; During the nine months ended June 30, 2016, the Company recorded a gain on the disposal of property and equipment of $245.&#160; Depreciation expense for the nine months ended June 30, 2017 and 2016, was $33,107 and $38,817, respectively.</div>

<div id="DSPFPageFooter"></div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">8.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accrued Expenses</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Accrued expenses consisted of the following as of:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<table id="z8dc511fc37da4b5d98a979995cdcad94" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30, </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,694,545</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,206,387</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Liability to issue warrants for the purchase&#160;shares of common stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,081,254</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Liability to issue common stock</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,000,933</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">240,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Finance fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">333,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Payroll expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">329,615</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">207,052</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Other</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">141,394</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">89,828</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Deferred revenue</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">85,399</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">111,803</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Warranty liability</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58,300</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">134,330</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Commissions and fees</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">40,997</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">52,311</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Severance</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">60,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 10pt">Total accrued expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,765,437</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,101,711</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageFooter" style="CLEAR: both"></div>
</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">12</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">9.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Notes Payable</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The Company had the following notes payable outstanding as of:&#160; </div>

<table id="z821d6e097bf84b23b3aee6eaa0145040" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured notes payable with interest at 10% per annum, due November 2018.&#160; The notes may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; Some of the notes are currently in technical default. However, as of the time of this report, the lenders have informally agreed to work with the Company until such time as the note can be repaid.&#160; In February 2016, the Company redeemed all 5,361 shares of its Series F Convertible Preferred Stock ("Series F preferred") plus accrued dividends of $673,948 for 20,005 shares of common stock with a fair value of $1,600,000 containing certain temporary restrictions, and $5,900,000 of notes payable. Payments on the notes are partially or fully convertible at the Company's option at the lesser of (i) 80% of the per share price of the common stock to be offered in the proposed offering that is described in the Form S-1 filed on July 19, 2016 (the "Offering"), (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering to a maximum of 39,334 shares of common stock.&#160; The conversion rate is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&#160; A note may only be converted if the holder owns less than 4.99% of the Company's common stock after conversion.&#160; The Company recorded a derivative liability of $2,461,899 related to the conversion feature of the notes.&#160; In connection with the redemption of the Series F preferred stock, the Company issued new warrants in exchange for warrants held by the Series F preferred stockholders for the purchase of 11,070 shares of common stock at an exercise price of the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering, adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&#160; The Company is also required to issue additional warrants for the purchase of up to 16,000 shares of common stock exercisable at $0.50 per share, also adjustable, that vest upon certain events of default.&#160; On December 11, 2017, the Company entered into Securities Purchase Agreements that adjusted the conversion rate to exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in a contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the "Private Placement") (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment (see Note 18).&#160; The fair value of $1,344,608 related to the new warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value of the stock, conversion feature, warrants and $25,000 of fees, in excess of the carrying value of the Series F preferred stock were recorded as a deemed dividend of $6,484,236.&#160; During the three months ended March 31, 2017, the Company entered into letter agreements related to the note to convert the outstanding principal and interest into shares of common stock contingent upon the Offering, which also removes the maximum share limitation conversion, which have expired (see Note 17).&#160; Subsequent to June 30, 2017, the Company received letters related to the notes wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 (see Note 18).&#160; In December 2017, the Company entered into those certain forbearance and lock up letter agreements with four of the eight debtors, with principal balances in the aggregate amount of $1,134,658, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of Common Stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more.&#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&#160; In addition, two of the five debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity (see Note 18).&#160; On January 12, 2018, the Company received letters from four of the debtors where the debtors forbear against any historical and future events of default and remedies through February 15, 2018. Further, the maturity date was extended through February 15, 2018.&#160; As part of the letters, the Company agreed not to initiate any new financing arrangements without the consent of the debtors. (see Note 18).&#160; On December 11, 2017, the Company borrowed an aggregate additional $300,000 from two of the lenders under new note payable agreements (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,900,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,900,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">13</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="z01e9b4a8cba842f9b29bb13ab9448848" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a name="_Hlk499725324"><!--Anchor--></a>Secured borrowings from a third party that purchased $3,257,600 of customer receivables for $2,100,000, with due dates ranging from January 2018 to October 2018, and payable in daily payments ranging from $5,000 to $13,000.&#160; The $1,157,600 difference between the customer receivables and cash received is being amortized to interest expense over the term of the respective notes.&#160; The secured borrowings are guaranteed by a former chief executive officer of the Company and are subordinated to other notes payable. On April 17, 2017, the Company entered into a factoring agreement which provides for an advance of $1,794,000, comprised of $1,000,000 in cash and the consolidation of $794,000 from four prior factoring agreements into the amounts owed under the factoring agreement (collectively, the "Funds"). In consideration for the Funds, the Company sold to the lender all future receipts until the total amount of $2,511,601 has been paid. The factoring agreement requires payment of the minimum daily amount of $12,999.99 for 193 days. The $2,511,601 can be reduced if repayment occurs more quickly. Repayment of the amounts owing is with recourse and secured by all accounts, chattel paper, documents, equipment, general intangibles, instruments, and inventory of the Company and subordinated to other notes payable.&#160; In June 2017, the lender verbally agreed to reduce the minimum daily amount to $5,000 and, in November 2017, verbally agreed to further reduce the minimum daily amount to $2,600 through January 7, 2018, after which the daily amount would return to $13,000.&#160; Subsequent to June 30, 2017, the Company entered into similar secured borrowings and related verbal or written reductions in the daily amounts.&#160; On January 5, 2018, the Company further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018 (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,974,602</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">689,318</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<table id="z36612d7a29184954b3bfb1e54ee48b72" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured note payable with a vendor with interest at 0.65% per annum payable at the end of each calendar year, due January 2018, issued in March 2016 upon the conversion of $2,523,937 in accounts payable to the vendor.&#160; The note requires payments of $50,000 per month in April 2016 through December 2016, $100,000 per month in January 2017 through December 2017 and the remaining balance due in January 2018.&#160; In September 2017, the Company entered into agreements with the vendor which supersedes the unsecured note payable agreement and provides new terms (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,773,937</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,223,937</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">14</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="z998356ea4fce4db69b14f0d142b01703" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div id="DSPFPageHeader" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured note payable with a third party with no interest, was due the earlier of November 2016 or the third business day after the closing of a proposed Offering.&#160;The note is currently in technical default. However, as of the time of this report, the lender has provided bridge capital since going in default&#160;and has informally agreed to work with the Company until such time as the note can be repaid.&#160; Pursuant to the note, the Company may borrow up to $1,500,000 upon meeting certain milestones and may be converted into shares of common stock upon default.&#160; The note required a payment of common stock on the 5th trading day after the pricing of the proposed Offering, but no later than December 15, 2016.&#160; The number of common shares will equal $200,000 divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the common shares or during&#160; the ten days prior to the date of the Purchase Agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price of the Offering, or (iv) the exercise price of any warrants issued in the Offering.&#160; The estimated fair value of $240,000 of the stock is included in accrued liabilities and is being amortized to interest expense over the life of the note.&#160; In connection with the issuance of the note, the Company also issued 20,000 warrants to purchase shares of common stock at an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock in the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering, or (iv) the exercise price of any warrants issued in the Offering and the number of shares will reset upon the closing of the Offering.&#160; The warrants may only be exercised to the extent the holder would own a maximum of 9.99% of the Company's common stock after exercise.&#160; The fair value of $493,590 related to the replacement warrants was recorded as a derivative (see Notes 12 and 15).&#160; Of this fair value amount, $220,000 was recorded as a debt discount and is being amortized over the life of the note and the remaining $273,590 was recorded as a loss on derivative liability.&#160; In the event of borrowing in excess of an initial $500,000, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to the initial warrants issued.&#160; In November 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $286,171 related to the November 2016 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; In November 2016, the Company amended the note to extend the maturity date to the earlier of January 31, 2017 or the third business day after the closing of the Offering.&#160; In addition, the amendment adjusted the origination shares to equal 20% of the note divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the shares or during the ten days prior to the date of the agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Offering.&#160; In December 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $349,819 related to the December 2016 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; On January 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $567,753 related to the January 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note. On January 30, 2017, the Company amended the note to extend the maturity date to the earlier of March 15, 2017 or the third business day after the closing of the Offering. Also on January 30, 2017. the Company borrowed the remaining $300,000 on the note and issued an additional warrant for the purchase of 12,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $899,598 related to the January 30, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; On March 3, 2017, the Company amended the note to increase the maximum sum from $1,500,000 to $2,000,000. Also on March 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $407,947 related to the March 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The Company recorded a loss on extinguishment of debt of $501,969 related to the March 3, 2017 amendment and additional borrowing. Effective March 27, 2017, the Company amended the note to extend the maturity date to the earlier of April 15, 2017 or the third business day after the closing of the Offering. Additionally, the lender agreed to enter into a lock up prohibiting the sale or other transfer of all securities of the Company owned by them for a period of 6 months. In consideration for entering into the lock-up agreement the Company has agreed to pay a $340,000 fee, payable in&#160;shares of common stock at a rate of the lowest of (i) 80% of the common stock Offering price of the Offering, (ii) 80% of the unit price Offering price of the Offering (if applicable), or (iii) 80% of the exercise price of any warrants issued in the Offering.&#160; The lock-up agreement was signed during April 2017, which has expired. Effective April 19, 2017, the Company amended the note to extend the maturity date to the earlier of May 20, 2017 or the third business day after the closing of the Offering. On December 11, 2017, the Company borrowed an additional $250,000 from the lender under a new note payable agreement (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,700,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">500,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">15</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="z66ed90cab5154ca4b3345bd41650263e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Secured note payable to a third party with interest at 12.75% per annum, due February 2019, in default.&#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; The Company entered into the note payable agreement in conjunction with a line of credit.&#160; The Company initially borrowed $1,500,000 and may borrow additional amounts under the note payable agreement up to a total balance of $3,000,000 as the Company meets certain milestones.&#160; The interest rate may also reduce to 11.25% per annum as the Company meets certain milestones.&#160; In conjunction with the note and related line of credit, the Company issued warrants to the lender to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&#160; The Company has recorded discounts of $1,500,000, which are being amortized to interest expense over the term of the note.&#160; In April 2016, the Company borrowed an additional $500,000 on the note and incurred additional fees of $25,000, which are being amortized to interest expense over the remaining term of the note.&#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issue the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the "November Forbearance Agreement"). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the "November Forbearance") with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company's Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company's Series G Preferred Stock to certain affiliates of the Company.&#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the "December Forbearance"). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $15,470 on the note payable.</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,152,778</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,652,778</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">16</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="zf0d0d0153d8a4b9f988ba44d3ec0ef3b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: justify">Secured line of credit with a third party with interest at 12.25% per annum, due February 2018, in default.&#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; The Company entered into the line of credit agreement in conjunction with a note payable.&#160; The Company may draw up to the lesser of 80% of certain accounts receivable or $1,500,000 and increase the maximum it may borrow under the agreement up to a total balance of $3,000,000 at $500,000 per increase as the Company meets certain milestones.&#160; The interest rate may also reduce to 10.75% per annum as the Company meets certain milestones.&#160; In conjunction with the line of credit and related note, the Company issued warrants to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&#160; The Company has recorded prepaid expenses of $44,665, which are being amortized to interest expense over the term of the line of credit.&#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issuance of the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the "November Forbearance Agreement"). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the "November Forbearance") with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company's Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company's Series G Preferred Stock to certain affiliates of the Company.&#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the "December Forbearance"). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $16,997 on the note payable.</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,259,007</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">929,518</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">17</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="z9c3bdd9ea0b649079c7257f8629d13da" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; BACKGROUND-COLOR: #cceeff" valign="bottom">Unsecured note payable with interest at 18% per annum, with no maturity date.&#160; The note payable is from a verbal agreement with the lender which converted $617,500 of advances into $1,100,000 of principal on the note payable.&#160; The additional $482,500 of principal plus agreed upon fees of $95,226 have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company's common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">1,100,000</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">-</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; BACKGROUND-COLOR: #cceeff" valign="bottom">Unsecured note payable with interest at 2.8% of total revenue per annum, with no maturity date.&#160; The note payable is from a verbal agreement with the lender which converted a $350,000 advance into the note payable.&#160; Agreed upon fees of $143,987 and a future payoff fee of 20%, or $70,000, have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to where the Company is required to pay any outstanding interest at the end of the first month following a quarter end, the lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and to become convertible into shares of the Company's common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">350,000</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">-</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 240px">
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Note payable previously secured by CareServices customer contracts.&#160; In January 2015, the note was amended to reduce the outstanding principal to $375,000, interest at 9% per annum, and payable in 15 monthly installments beginning in February 2015.&#160; The amendment released the collateralized customer contracts and the note payable is guaranteed by both a former Executive Chairman of the Board of Directors and a member of the Board of Directors.&#160; A gain on the extinguishment of the old note of $769,449 was recorded in other income.&#160; In December 2015, the note was amended to extend maturity to January 2018 payable in monthly installments beginning in July 2016, convert $31,252 from accrued interest into principal, interest at 10% per annum, and provide that the note is convertible into common stock at its fair value per share.&#160; The Company recorded a derivative in connection with the convertible feature of the note (see Note 12) and is amortizing the initial $302,690 fair value of the derivative liability over the life of the note.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016.&#160; In July 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or November 2016 and included additional default penalties and payment terms.&#160; In October 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or December 31, 2016 and included additional default penalties and payment terms. In October 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or December 31, 2016 and included additional default penalties and payment terms.&#160; In December 2016, February 2017 and March 2017, the note was further amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or February 15, 2017, March 31, 2017, and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">334,464</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">334,464</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured note payable with interest at 12% per annum, due February 2016, convertible into common stock at $150 per share.&#160; In connection with the issuance of the note, the Company repriced previously issued warrants to purchase shares of common stock.&#160; The $22,397 increase in relative fair value of the warrants was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&#160; The note also required a payment of 6,000 shares of common stock.&#160; The fair value of $780,000 was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&#160; The maturity date was subsequently extended on two occasions for a total of 500 shares of common stock and the note was due May 2016.&#160; The $31,250 fair value of these shares was being amortized over the extension period.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company's common stock on the date of the amendment.&#160; The note may only be converted if the holder owns less than 9.99% of the Company's common stock after conversion.&#160; The Company recorded the value of the beneficial conversion feature of $381,299 to loss on termination of debt as a result of the modification.&#160; In May 2016, the note was amended to extend the maturity date to the earlier of an equity raise of $10,000,000 or October 2016 which required a payment of 600 shares of common stock.&#160; The $28,500 fair value of these shares has been included in accrued liabilities and was amortized over the extension period.&#160; During September 2017, the Board of Directors granted 200 shares of Series H Preferred Stock for extension fees. In October 2016, the Company extended the maturity date of the note month-by-month through no later than April 30, 2017 for a fee of $5,000 per month extended.&#160; In October 2017, the Company entered into a settlement agreement related to the note where the Company borrowed an additional $200,000 and modified the terms of the note payable to become secured by inventory owned by the Company, requires issuance of 3,000 shares of Series H Preferred Stock, which were authorized for grant by the Board of Directors on September 5, 2017 and are required to be able to convert the lender's shares into 300,000 shares of the Company's common stock, and requires payments of $8,600 for 72 consecutive weeks.&#160; If any payment is late, the Company is required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&#160; The fair value of the shares will be amortized over the life of the amended note.&#160; The note terms are adjustable for any terms subsequently provided to other investors (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">300,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">300,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">18</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="z50e4d16948294cea8dd33178d845433a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Secured note payable with interest at 12.25% per annum, due May 2017, in default. The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note. The Company entered into the agreement in conjunction with a modification to another note payable and line of credit. The note requires payment of a $3,000 modification fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&#160; The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $4,050 on the note payable..</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">300,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured note payable with interest at 12.75% per annum, due June 2017, in default, subordinated to other notes payable. The note requires payment of a $3,000 closing fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&#160; The $3,000 closing fee is being amortized to interest expense over the remaining term of the note and the $50,000 fees are being accrued as incurred.&#160; On January 12, 2018, the lender forbore against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">300,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Unsecured note payable with interest at 12% per annum, due September 2016, in default, subordinated to other notes payable.&#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&#160; The $100,000 fair value of the stock was amortized to interest expense over the term of the note.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). On January 12, 2018, the lender forbore against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">250,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">250,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; BACKGROUND-COLOR: #cceeff" valign="bottom">Unsecured cash advance with fees at $1,000 per day for the first 15 days and $1,500 per day thereafter, with no maturity date.&#160; The terms of the advance are verbal. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company's common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">100,000</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">-</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Unsecured notes with interest at 18% per annum, due April 2013, in default.&#160; The Company issued 20,000 shares of Series D preferred stock as loan origination fees.&#160; The $195,000 fair value of the preferred stock was amortized over the original term of the note.&#160;&#160; Principal of $50,000 and accrued interest of $13,333 were converted to common stock in December 2013.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17).</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">64,261</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">64,261</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Secured note payable to a third party with interest at 18% per annum, due June 2017.&#160; The note was secured by shares of the Company's common stock held by, and other assets of an entity controlled by, a former Executive Chairman of the Board of Directors.&#160; The note was guaranteed by a former Executive Chairman of the Board of Directors and his related entity and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; Payments on the note were convertible at the holder's option into common stock at 75% of its fair value if not paid by its respective due date, which is subject to a 20 trading day true-up and is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of other certain raises.&#160; The Company recognized a derivative liability related to the conversion feature with a fair value of $181,670, which was recognized as a loss on termination of debt.&#160; In June 2016, $13,713 of principal and $11,287 of accrued interest converted into 953 shares of common stock, pursuant to the terms of the note.&#160; In August 2016, $64,654 of principal and $10,346 of accrued interest converted into 9,203 shares of common stock, pursuant to the terms of the note.&#160; This note was terminated by paying the remaining principal and accrued interest in cash with no additional consideration.</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">162,539</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">19</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="z4893e31ede814caab1099ef45ff2e307" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;&#160;Total notes payable before discount</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,859,049</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,006,815</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;&#160;&#160;&#160;&#160;Less discount</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,468,335</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,930,060</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;&#160;Total notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,390,714</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,076,755</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;&#160;&#160;&#160;&#160;Less current portion</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(9,501,544</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,722,899</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;Notes payable, net of current portion</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,889,170</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,353,856</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">10.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Related-Party Notes Payable</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The Company had the following related-party notes payable outstanding as of:</div>

<table id="z205ec7c3ec8b4f0489a50e085797b6b1" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Secured borrowings from entities controlled by an officer who purchased a $2,813,175 customer receivable for $1,710,500.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; The Company repurchased the receivable for $1,950,000 less cash received by the entities through March 2015.&#160; The $239,500 difference between the buyback and cash received plus $253,500 of loan origination fees was amortized to interest expense through March 2015.&#160; In September 2015, the note was modified to extend the maturity date to January 2017, with interest at 18% per annum.&#160; The Company added $81,600 of extension fees and issued 6,000 shares of common stock to a lender as part of the modification.&#160; The note is convertible into common stock at $150 per share.&#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lenders.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lenders, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,721,100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,721,100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">20</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="zabfc9c3720a34a8886d986e480cae716" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due January 2017, convertible into common stock at $150 per share.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; The Company issued 6,000 shares of common stock to a lender as loan origination fees.&#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and reduced the conversion price to $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lender.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lender, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,303,135</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,303,135</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured note payable to an entity controlled by a former Executive Chairman of the Board of Directors with interest at 18% per annum, due January 2017.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In February 2016, notes payable to the same entity, with outstanding balances of $511,005 plus accrued interest of $30,999 combined into this note.&#160;&#160; The note is subordinated to notes payable to unrelated parties and is convertible into shares of common stock at $30 per share, which was below the fair value of the Company's stock on the date of the agreement.&#160; The conversion of the note is limited to a maximum of 18,500 common shares.&#160; The Company recorded the value of the beneficial conversion feature of $632,339 to loss on termination of debt.&#160; The note has a default penalty of 1,469 shares of common stock if not paid by maturity. The note may only be converted if the holder owns less than 4.99% of the Company's common stock after conversion.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">542,004</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">542,004</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured note payable to an entity controlled by an officer with interest at 12% per annum, due September 2016, subordinated to other third party notes payable.&#160;The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&#160; The $70,000 fair value of the stock is being amortized to interest expense over the term of the note.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">250,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">250,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Unsecured note payable to a former officer with interest at 12% per annum, due September 2013.&#160; This note is in default and is convertible into common stock at $375 per share.</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,721</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,721</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">21</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="zac833aba3f6d4883a174198ae9f932f2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due on demand.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In February 2016, the note was amended to subordinate the note to other notes payable also issued during February 2016.&#160; The note is convertible into shares of common stock at $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the entity.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the entity, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; In January 2017 and February 2017, the note was amended to extend the maturity date to February 15, 2017 and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</div>
</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,463</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,463</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Unsecured note payable to a former officer with interest at 15% per annum, due June 2012, in default.&#160; The note included a $3,000 loan origination fee added to the principal and is convertible into common stock at $250 per share.</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,260</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,227</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Unsecured note payable to a former officer with interest at 12% per annum, due on demand.</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,474</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;&#160;Total notes payable, related-party</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,869,683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,898,124</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;&#160;&#160;&#160;&#160;Less current portion</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,869,683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,898,124</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;&#160;Notes payable, related-party, net of current portion</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">11.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Fair Value Measurements</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The Company measures the fair values of its assets and liabilities using the US GAAP hierarchy levels as follows:<br style="LINE-HEIGHT: 1.25">
 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>

<table id="z6345780f5fd0435ebd4a6d1614c2dc16" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 9.21%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #dbeef3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Level 1</div>
</td>
<td style="WIDTH: 90.79%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #dbeef3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The Company does not have any Level 1 inputs available to measure its assets.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Level 2</div>
</td>
<td style="WIDTH: 90.79%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Certain of the Company's embedded derivative liabilities are measured on a recurring basis using Level 2 inputs.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9.21%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #dbeef3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Level 3</div>
</td>
<td style="WIDTH: 90.79%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #dbeef3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Certain of the Company's embedded derivative liabilities are measured on a recurring basis using Level 3 inputs.</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Items measured at fair value on a recurring basis include embedded derivatives related to the Company's warrants and notes payable. During the nine months ended June 30, 2017, the Company has not changed the manner in which it values liabilities that are measured at fair value using Level 3 inputs. The following fair value hierarchy table presents information about the Company's financial liabilities measured at fair value on a recurring basis:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<table id="z927b800702c1498ab6a7c222e2a5c31a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quoted Prices in Active Markets for Identical Items </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Level 1)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Significant Other Observable Inputs (Level 2)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Significant Unobservable Inputs (Level 3)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt; TEXT-INDENT: 20pt">Derivatives liability</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">269,427</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,962,556</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,231,983</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">September 30, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt; TEXT-INDENT: 20pt">Derivatives liability</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">281,613</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,772,458</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,054,071</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">22</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The following is a reconciliation of the opening and closing balances for the derivatives liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended June 30, 2017:</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z3dc36f9ce03d4798a71c2febc6a37385" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Derivatives Liability</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Balance, September 30, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,772,458</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt; TEXT-INDENT: 10pt">Issuance of warrants recorded as derivatives</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,511,288</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt; TEXT-INDENT: 10pt">Gain on termination of debt resulting from&#160;payments on notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(103,213</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt; TEXT-INDENT: 10pt">Loss on derivatives liability resulting&#160;from changes in fair value</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(217,977</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">)&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Balance, June 30, 2017</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,962,556</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The Company's embedded derivative liabilities are re-measured to fair value as of each reporting date.&#160; See Note 12 for more information about the valuation methods of derivatives and the inputs used for calculating fair value.</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">12.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Derivatives Liability</font></div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The derivatives liability as of June 30, 2017 and September 30, 2016, was $4,231,983 and $2,054,071, respectively. The derivatives liability as of June 30, 2017 and September 30, 2016 is related to a variable conversion price adjustment on outstanding notes payable and warrants.&#160; All of the derivatives outstanding as of September 30, 2015, were eliminated during February 2016, due to the conversion of notes payable into shares of common stock.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During the nine months ended June 30, 2017, the Company estimated the fair value of some of the embedded derivatives upon issuance at the end of each reporting period using a binomial option-pricing model with the following assumptions, according to the instrument: exercise price of $8 to $15 per share; risk free interest rate of 0.85% to 1.14%; expected life of 0.53 to 1.03 years; expected dividends of 0%; volatility factor of 260.57% to 282.07%; and stock price of $8 to $15.&#160; During the nine months ended June 30, 2017, the Company estimated the fair value of the remaining embedded derivatives upon issuance and at the end of each reporting period using a Monte Carlo valuation model with the following assumptions: exercise prices ranging from $2.50 to $25.00 per share; risk free interest rates ranging from 0.44% to 1.99%; expected lives ranging from 0.09 to 4.93 years; expected dividends of 0%; volatility factors of 128% - 194%; and stock prices ranging from $2.50 to $25.00.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During fiscal year 2016, the Company estimated the fair value of some of the embedded derivatives upon issuance, at the end of each reporting period and prior to their conversion and elimination using a binomial option-pricing model with the following assumptions, according to the instrument: exercise prices ranging from $14.50 to $46.75 per share; risk free interest rates ranging from 0.16% to 1.06%; expected lives ranging from 0.05 to 2.09 years; expected dividends of 0%; volatility factors ranging from 125.33% to 510.03%; and stock prices ranging from $15 to $70. During fiscal 2016, the Company estimated the fair value of the remaining embedded derivatives upon issuance and at the end of each reporting period using a Monte Carlo valuation model with the following assumptions: exercise prices ranging from $20 to $125 per share; risk free interest rates ranging from 0.18% to 1.44%; expected lives ranging from 0.04 to 6.40 years; expected dividends of 0%; volatility factors of 129% to 140%; and stock prices ranging from $20 to $475 per share.&#160; The expected lives of the instruments were equal to the average term of the conversion option or expected exercise period of the warrants.&#160; The expected volatility is based on the historical price volatility of the Company's common stock.&#160; The risk-free interest rate represents the US Treasury constant maturities rate for the expected life of the related conversion option. The dividend yield represents anticipated cash dividends to be paid over the expected life of the conversion option.&#160; The Company recognized a gain on derivatives liability for the three months ended June 30, 2017 of $64,145 and a gain on derivatives liability for the three months ended June 30, 2016 of $5,603,411.&#160; The Company recognized a gain on derivatives liability for the nine months ended June 30, 2017 of $230,163 and a gain on derivatives liability for the nine months ended June 30, 2016 of $2,796,542.</div>

<div id="DSPFPageFooter"></div>

<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">13.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Preferred Stock</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The Company is authorized to issue 10,000,000 shares of preferred stock, with a par value of $0.00001 per share.&#160; Pursuant to the Company's Certificate of Incorporation, the Board of Directors has the authority to amend the Company's Certificate of Incorporation, without further stockholder approval, to designate and determine the preferences, limitations and relative rights of the preferred stock before any issuance of the preferred stock and to create one or more series of preferred stock, fix the number of shares of each such series, and determine the preferences, limitations and relative rights of each series of preferred stock, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, and liquidation preferences.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">23</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><u>Series D Convertible Preferred Stock</u></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div id="DSPFPageHeader" style="LINE-HEIGHT: 1.25"></div>

<div style="LINE-HEIGHT: 1.25">The Board of Directors has designated 1,000,000 shares of preferred stock as Series D Convertible Preferred Stock ("Series D Preferred ").&#160; The Series D Preferred votes on an as-converted basis.&#160; The Series D Preferred has a dividend rate of 8%, payable quarterly.&#160; The Company may redeem the Series D Preferred at a redemption price equal to 120% of the original purchase price with 15 days<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">'</font> notice. During the nine months ended June 30, 2017 and 2016, the Company accrued $24,800 and $18,617 of dividends on Series D preferred stock, respectively, and settled $0 and $12,434 of accrued dividends, respectively, by issuing 0 and 455 shares of common stock, respectively.</div>

<div style="LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>

<div style="LINE-HEIGHT: 1.25"><u>Series E Convertible Preferred Stock</u></div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During fiscal year 2013, the Board of Directors designated shares of preferred stock as Series E Convertible Preferred Stock ("Series E Preferred"), convertible into common stock at $500 per share, adjustable if there are distributions of common stock or stock splits by the Company.&#160; The Series E Preferred is non-voting and receives a monthly dividend of 3.322% for 25 to 32 months.&#160; In addition, the convertibility and the redemption price of the Series E Preferred is gradually reduced by dividend payments over 25 to 32 months.&#160; After the dividend payment term, the redemption price of Series E Preferred is $0, the Series E Preferred has no convertibility to common stock and the holders are entitled to receive a pro-rata share of cumulative royalties totaling 4% of the Company's gross profits payable quarterly for a two-year period.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During the three months ended June 30, 2017 and 2016, the Company accrued dividends of $34,178 and $39,598, respectively, payable to Series E Preferred.&#160; During the nine months ended June 30, 2017 and 2016, the Company accrued dividends of $102,535 and $185,485, respectively, payable to Series E Preferred.&#160; As of June 30, 2017 and September 30, 2016, the aggregate redemption price for the Series E Preferred was $477,829.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">24</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><u>Series F Convertible Preferred Stock</u></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">During fiscal year 2014, the Board of Directors designated 7,803 shares of preferred stock as Series F Convertible Preferred Stock ("Series F Preferred").&#160; In April 2014, the Company increased the authorized shares of Series F Preferred to 10,000.&#160; Series F Preferred is non-voting, has a stated value of $1,000 per share and is convertible into common stock at $166.85 per share (see Note 12).&#160; Series F Preferred has a dividend rate, payable quarterly, of 8% until April 30, 2015, 16% from May 1, 2015 to July 31, 2015, 20% from August 1, 2015 to October 31, 2015, and 25% thereafter.&#160; In February 2016, the Company redeemed all 5,361 outstanding shares and $673,848 of accrued dividends for 20,005 shares of common stock, $5,900,000 of notes payable and exchanged warrants for the purchase of 11,070 shares of common stock held by Series F Preferred stockholders for new warrants with new terms for the purchase of the same number of shares (see Note 15).&#160; The Company recorded a deemed dividend of $6,484,236 as a result of the transactions.</div>

<div style="LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160; </div>

<div id="DSPFPageFooter"></div>

During the three and nine months ended June 30, 2016, the Company accrued dividends of $0 and $495,148, respectively, payable to Series F Preferred stockholders.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><u>Series G Convertible Preferred Stock</u></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">During January 2017, the Board of Directors designated 43,220 shares of preferred stock as Series G Convertible Preferred Stock ("Series F Preferred").&#160; Series G Preferred votes on an as-converted basis, has a stated value of $500 per share. The Series G Preferred will automatically convert the stated value of such shares into fully paid and non-assessable shares of common stock <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(Series G Conversion Shares") </font>of the Company upon (i) the Company's receipt of $50,000,000 or more in gross revenue in a single fiscal year, (ii) the sale of the Company via asset purchase, stock sale, merger or other business combination in which the Company and/or its stockholders receive aggregate gross proceeds of $25,000,000 or more, or (iii) the closing of an underwritten <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">offering </font>by the Company pursuant to which the Company receives aggregate gross proceeds of at least $10,000,000 in consideration of the purchase of shares of common stock and/or which results in the listing of the Company's common stock on the Nasdaq National Market, the Nasdaq Capital Market, the New York Stock Exchange, or the NYSE MKT. The number of Series G Conversion Shares issuable upon conversion shall equal the stated value divided by the conversion price then in effect. The conversion price of the Series G Preferred is $22.50. Upon the trigger of an automatic conversion, all of the shares of Series G Preferred owned by such <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">holders </font>will convert into common stock at the conversion price then in effect.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">On January 31, 2017, the Company issued 32,415 shares of Series G Preferred to an entity affiliated with one of the Company's former Chief Executive Officers and 10,805 shares of Series G Preferred to a different former Chief Executive Officer and consultant to the Company. The consideration for such issuance relates to services rendered to the Company. Each of the two recipients of the Series G Preferred stock have entered into lock-up agreements, as amended, prohibiting the sale or other transfer of the Common Shares issued pursuant to the conversion of the Series G Preferred securities of the Company owned by each of them for the longer of (i) 18 months or (ii) the date the Company first has annual gross revenues in an amount of at least $20,000,000.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>The lock-up agreements initially expired if the Offering was not completed by February 15, 2017, whose expirations were extended to March 31, 2017 with new agreements signed during February 2017.&#160; As of June 30, 2017, the agreements have expired.&#160; On September 5, 2017, the Board of Directors of the Company <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">agreed to </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">modify </font>the terms of the Series G Convertible Preferred stock to remove the 18-month lock-up period<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">, however, no such </font>amendment <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">to the Series G Preferred </font>has not been filed with the State of Delaware as of the date of this filing.</div>

<div id="DSPFPageFooter"></div>

<div id="DSPFPageFooter"></div>

<u>Liquidation Preference</u></div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Upon any liquidation, dissolution or winding up of the Company, before any distribution or payment may be made to the holders of the common stock, the holders of the Series D Preferred, Series E Preferred, and Series F Preferred are entitled to be paid out of the assets an amount equal to $1.00 per share plus all accrued but unpaid dividends.&#160; If the assets of the Company are insufficient to make payment in full to all holders of preferred stock, then the assets shall be distributed among the holders of preferred stock ratably in proportion to the full amounts to which they would otherwise be entitled.</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">14.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Common Stock</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In April 2014, the Company amended its Certificate of Incorporation increasing the total number of authorized shares of common stock from 50,000,000 shares to 200,000,000 shares.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">On January 27, 2017, the Company effected a 1-for-500 reverse stock split of its outstanding common stock, which caused the then outstanding common stock to decrease from 115,112,802 to 232,100 while keeping the authorized capitalization unchanged.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During the nine months ended June 30, 2017, the Company issued 7,000 shares of common stock<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> (post reverse stock split)</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>for services provided by an independent consultant; the value on the date of grant was $70,000.</div>

<div id="DSPFPageFooter"></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">25</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">15.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Common Stock Options and Warrants</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The fair value of each stock option or warrant is estimated on the date of grant using a binomial option-pricing model or the Monte Carlo valuation model.&#160; The expected life of stock options or warrants represents the period of time that the stock options or warrants are expected to be outstanding, based on the simplified method.&#160; Expected volatilities are based on historical volatility of the Company's common stock, among other factors.&#160; The Company uses the simplified method within the binomial option-pricing valuation model due to the Company's short trading history.&#160; The risk-free rate related to the expected term of the stock options or warrants is based on the US Treasury yield curve in effect at the time of grant.&#160; The dividend yield is zero.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During fiscal 2016, the Company granted warrants to purchase 24,032 common shares with an exercise price of $32.50 per share in connection with the acquisition of a note payable and line of credit; warrants for the purchase of 14,786 shares vested immediately, 3,696 vested upon the disbursement of the second tranche of the related note payable, and 5,550 vest evenly in the event of three available increases on the related line of credit (see Note 9). The warrants expire in February 2023, may be exercised via cashless exercise and are puttable upon expiration or liquidation for the greater of $500,000 or up to 6.5% of the equity value of the Company, depending on the number of warrants vested. The fair value of the warrants upon grant of $3,731,969 was recorded as a derivative and the Company received cash of $2,967 upon issuance of the warrants. The Company recognized $1,419,541 as debt discount for the portion allocated to the note payable and the debt discount is being amortized over the life of the note payable to interest expense. During September 2016, the Company entered into a conditionally effective warrant cancellation agreement with the warrant holders, which has expired (see Note 17).</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During February 2016, the Company exchanged warrants held by the holders of its Series F Preferred for the purchase of 11,070 shares of common stock in connection with the redemption of Series F Preferred for new warrants for the purchase of the same number of shares on different terms. The new warrants were initially exercisable for $150 per share, adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises. During September 2016, the Company issued warrants for the purchase of common stock that adjusted the warrants to have an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering. On December 11, 2017, the Company entered into Securities Purchase Agreements that adjusted the conversion rate to exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in a contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the "Private Placement") (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment (see Note 18). The new warrants expire in February 2021, and may be exercised via cashless exercise. Additional warrants for the purchase of 16,000 shares of common stock may be issued in the event of default on the related notes payable, exercisable at $0.50 per share, with 25% issuable upon the first event of default, 37.5% upon the second event, and 37.5% upon the third event. The warrants issuable upon default expire in February 2026 (if issued), may be exercised via cashless exercise, and are puttable upon expiration or liquidation with the primary warrants. The new warrants may only be exercised to the extent the respective holder would own a maximum of 4.99% of the Company's common stock after exercise, but the holders may elect to increase the maximum to 9.99%. The Company recognized a deemed dividend of $6,484,236 as a result of the exchange and related redemption of Series F Preferred.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageFooter"></div>

During September 2016, the Company granted warrants to purchase 20,000 shares in connection with the acquisition of a note payable at an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering. Upon the closing of the Offering, the number of shares issuable under the warrant will reset to an amount of shares equal to the aggregate exercise amount of the warrants (as defined therein) divided by the exercise price then in effect. The warrants expire in September 2021, and may be exercised via cashless exercise. The warrants may only be exercised to the extent the holder would own a maximum of 9.99% of the Company's common stock after exercise. The Company recognized $220,000 of the $493,590 fair value of the warrants as a debt discount, which is being amortized over the life of the borrowing, and recognized the remaining $273,590 as a loss on derivatives liability. In the event the Company borrows additional amounts above the initial $500,000 under the note payable, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to warrants issued as part of the initial borrowing. During the nine months ended June 30, 2017, the Company borrowed an additional $1,000,000 on the note and issued warrants for the purchase of 40,000 shares of common stock with the same terms as the initial warrants. The Company recognized the $2,103,341 fair value of the warrants as debt discounts, which are being amortized over the remaining life of the borrowing. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>Effective March 3, 2017, the note was amended to increase the maximum principal sum from $1,500,000 to $2,000,000 under which the Company borrowed an additional $200,000 in consideration and issued the lender a warrant to purchase up to 8,000 shares of common stock with the same terms as the warrants previously issued under the previous terms of the note.&#160; The Company recognized the $407,947 fair value of the warrants as part of the total on extinguishment of debt of $501,969.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">26</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During the nine months ended June 30, 2017, the Company measured the fair value of warrants classified as liabilities on the date of issuance and on each re-measurement date using the Monte Carlo valuation model. For this liability, the Company and specialist developed their own assumptions that do not have observable inputs or available market data to support the fair value. This method of valuation involves using inputs such as the fair value of the Company's common stock, stock price volatility, the contractual term of the warrants, risk&#8211;free interest rates and dividend yields. Due to the nature of these inputs, the valuation of the warrants uses Level 3 measurements. The following assumptions were used:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<table id="z9f1153f81fc846f8b870e9cabee4a20e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Exercise price</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.50 - $25.00</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Expected term (years)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.21 - 4.93</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Volatility</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">128% - 194</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Risk-free rate</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.49% - 1.99</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Dividend rate</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Common stock price</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.50 - $25.00</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="MARGIN-TOP: 6pt; CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The following table summarizes information about stock options and warrants outstanding as of June 30, 2017:</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z856a2bf4db0f4cb58c5d2f8f3ed8b551" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Options and Warrants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Number of Options and Warrants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Weighted-</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Average</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Exercise</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Price</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Outstanding as of October 1, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65,045</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">35.06</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Granted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">48,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25.00</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Forfeited</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,871</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">357.84</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Outstanding as of June 30, 2017</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">109,174</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">37.12</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Exercisable as of June 30, 2017</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">102,225</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">34.46</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageHeader" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">As of June 30, 2017, the outstanding warrants have an aggregate intrinsic value of $0 and the weighted average remaining term of the warrants was 4.52 years. The total compensation cost related to unvested awards not yet recognized (warrants and shares) was $38,468.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">27</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageFooter" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">16.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Related-Party Transactions Not Otherwise Disclosed</font><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">In February 2016, the Company amended a consulting agreement dated September 2015, with an entity controlled by a former Executive Chairman of the Board of Directors, effective January 2016.&#160; The amendment extended the agreement through December 2016, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">which</font> automatic<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">ally</font> renew<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">s on a monthly basis until otherwise cancelled in accordance with the terms therein</font>, changing the monthly compensation of $6,000 to an hourly rate of $250 per hour, and eliminated the previously included bonus structure.&#160; During May 2017, the Company granted 1,719 shares of common stock, with a value of $17,207 on the date of grant, to the consultant as a bonus for services performed.&#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&#160; On September 5, 2017, the Company granted 1,500 shares of the Company's Series H Preferred stock to an entity controlled by a former Executive Chairman of the Board of Directors for past services rendered in addition to amounts earned under an existing consulting agreement.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; On November 13, 2017, the former Executive Chairman of the Board of Directors terminated the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">consulting </font>agreement.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">In July 2016, the Company entered into a Consulting Agreement with a former Executive Chairman and Chief Executive Officer of the Company.&#160; This Consulting Agreement is for an initial period of one year, and shall automatically renew for consecutive one month periods unless terminated by the Company or the former Executive Chairman and Chief Executive Officer. As consideration for the services <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">to be performed thereunder</font>, the Company shall pay the former Executive Chairman and Chief Executive Officer at the rate of $250 per hour, but such compensation may not exceed $20,000 during any calendar month.&#160; During May 2017, the Company granted 10,324 shares of common stock, with a value of $103,343 on the date of grant, to the consultant as a bonus for services performed.&#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&#160; On September 5, 2017, the agreement was replaced with a new agreement for an initial period of one year, and shall automatically renew for consecutive one month periods unless terminated by the Company or the former Executive Chairman and Chief Executive Officer.&#160; As consideration for the services, the Company shall pay the former Executive Chairman and Chief Executive Officer at the rate of $250 per hour, but such compensation may not exceed $20,000 during any calendar month, plus 1,500 shares of the Company's Series H Preferred stock.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">In August 2016, the Company received a cash advance for $135,000 from a former Executive Chairman and Chief Executive Officer of the Company.&#160; During the nine months ended June 30, 2017, the Company repaid the advance.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During May 2017, the Company granted 96,275 shares of common stock, with a value of $963,713 on the date of grant, to a former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, as a bonus for services performed.&#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&#160; On September 5, 2017, the Board of Directors of the Company granted 963 shares of Series H Preferred stock to the former Executive Chairman and Chief Executive Officer of the Company in lieu of the 96,275 shares of previously granted common stock.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; The Series H Preferred shares have not yet been issued.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">In September 2017, the Company entered into an employment agreement with the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, for a period of two years for services as the Executive Chairman and Chief Executive Officer of the Company.&#160; The initial term of the agreement is for two years and shall automatically renew on a year to year basis, unless terminated sooner.&#160; The base compensation is $360,000 per year plus 1,500 shares of the Company's Series H Preferred stock.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; An additional cash or stock bonus may be awarded, subject to the attainment of such individual <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">of certain</font> objectives as the Board of Directors of the Company shall establish from time to time.&#160; Upon certain termination conditions <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">contained in</font> the agreement, the Company may be required to pay severance of twice the base compensation at its highest point during the five-year period prior to termination.&#160; Effective October 12, 2017, the former Executive Chairman and Chief Executive Officer has waived any constructive termination in relation to changes in title, working conditions or duties such that his powers are diminished, reduced or otherwise changed to include powers, duties, or working conditions which are note materially consistent with title, continuing after written notice and 10 days to cure.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">28</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageFooter"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">17.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Commitments and Contingencies</font></div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During the nine months ended June 30, 2017, the Company leased office space under a non-cancelable operating lease.&#160; In February 2015, the Company entered into a sublease agreement for part of the office space under the non-cancelable operating lease through the end of the original lease period.&#160; Payments under the sublease were made by the sublessee directly to the Company's landlord.&#160; The non-cancelable operating lease was terminated during June 2015.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During June 2015, the Company entered into a new non-cancelable operating lease for its existing office space, excluding the previously subleased space, with payments beginning in July 2015.&#160; Future minimum rental payments under the non-cancelable operating lease as of June 30, 2017, were as follows:</div>

<table id="zc9bfd83d1bc2405a9eff0aacaadeed12" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Years Ending September 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">2017</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">32,908</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">2018</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">111,340</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">144,248</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">The Company's rent expense under the new non-cancelable operating lease for nine months ended June 30, 2017 and 2016, was approximately $97,000 and $94,000, respectively.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During February 2016, the Company entered into an agreement with one if its vendors to purchase a minimum of $200,000 of inventory per quarter through January 2018.&#160; The agreement was cancelled subsequent to June 30, 2017.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During February 2016, the Company redeemed all of its Series F preferred stock in exchange for 20,005 shares of common stock and $5,900,000 of notes payable (see Note 9).&#160; As part of the redemption, the Company exchanged warrants held by the Series F Preferred stockholders for the purchase of 11,070 shares of common stock for new warrants to purchase the same number of shares with different terms.&#160; As part of the redemption, the Company may be required to issue additional warrants for the purchase of up to 16,000 shares of common stock upon three events of default on the notes payable (see Note 15).</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During February 2016, the Company converted notes payable and accrued interest payable to an entity controlled by a former Executive Chairman of the Board of Directors into a convertible note payable (see Note 10).&#160; The Company may be required to issue 1,469 shares of common stock if the note is not paid by maturity.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During February 2016, the Company amended notes payable to an entity controlled by an officer of the Company to subordinate to notes payable also issued during February 2016, reduced the conversion price per share to $30 per share and limited the shares into which it is convertible (see Note 10).&#160; The Company may be required to issue 8,407 shares of common stock if the note is not paid by maturity.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During September 2016, the Company issued a note payable to a third party for up to $1,500,000.&#160; The Company initially borrowed $500,000 under the note and may borrow up to $1,500,000 upon meeting certain milestones.&#160; The Company subsequently drew an additional $1,000,000 under the note and issued additional warrants for the purchase of 40,000 shares of common stock at similar terms to warrants issued as part of the initial borrowing.&#160; During March 2017, the note was amended to increase the maximum principal sum from $1,500,000 to $2,000,000 under which the Company borrowed an additional $200,000 in consideration and issued the lender a warrant to purchase up to 8,000 shares of common stock with the same terms as the warrants previously issued under the previous terms of the note.&#160; In the event the Company borrows any part of the remaining $300,000 available, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to warrants issued as part of the initial borrowing.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">29</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">During September 2016, the Company entered into a conditionally effective warrant cancellation agreement (the "Warrant Cancellation Agreement") with certain warrant holders who were issued the warrants in connection with a secured note payable and line of credit. Pursuant to the terms of the Warrant Cancellation Agreement, upon the Company's consummation of an equity financing of at least $15,000,000, the warrant holders agree to terminate and cancel the warrants they currently hold. As an inducement to enter into the Warrant Cancellation Agreement, the warrant holders will receive upon termination and cancelation of the warrants an aggregate of 10,800 shares of the Company's common stock, which will be subject to a 6-month lock-up agreement. Additionally, if the warrant holders terminate and cancel the warrants, the Company will issue the related note holder a new unsecured promissory note with an initial principal amount of $180,000, no cash interest, and a three-year term. In lieu of cash interest, the principal of the note will increase in the amount $3,333 each month not to exceed a maximum of $300,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Effective November 1, 2016, the Board approved the 2016 Incentive Stock Option plan providing for the issuance of options to purchase up to 377,250 shares.&#160; No shares have been approved under the Plan as of June 30, 2017.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">On April 17, 2017 the Company entered into a Joint Venture Agreement, effective March 31, 2017 (the "JV Agreement") with Colorado Choice Health Plans ("CCHP"), a customer. Under the JV Agreement: (i) CCHP is providing various services to the Company to improve the Company's diabetes programs, (ii) the Company loaned CCHP $500,000 under a debenture note (recorded as a note receivable in the accompanying consolidated condensed balance sheets), and (iii) the JV Agreement will terminate upon the later of (a) repayment of the debenture note or (b) the one year anniversary of the JV Agreement. The debenture note: (i) bears interest at the rate of five percent per annum, (ii) is subordinated to the rights of CCHP policyholders, claimants and beneficiary claims and all other classes of CCHP creditors other than subordinated debenture holders, (iii) does not become a liability of CCHP until and unless the Commissioner of the Colorado Department of Regulatory Agencies, Division of Insurance ("Division of Insurance") authorizes repayment of the debenture agreement, and shall be treated by CCHP as surplus until the time of such approval, (iv) is only repayable from available funds in excess of CCHP's minimum net surplus required to be maintained by the Division of Insurance, and (v) is otherwise repayable on March 31, 2018, assuming approval by the Division of Insurance.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">On May 28, 2015, an investor of the Company filed a lawsuit claiming damages of $1,000,000 exclusive of interest and costs against the Company, a former Executive Chairman, an entity controlled by another former Executive Chairman, and 4G Biometrics, a wholly owned subsidiary of the Company, for breach of contract. The Company has engaged legal counsel regarding the matter.&#160; The Company has assessed a high probability of settling the matter for $750,000 in cash, equity, or a combination thereof.&#160; The Company has accrued a contingent liability of $750,000 and loss on settlement as of June 30, 2017.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">On November 4, 2015, the Company received a demand for payment of $275,000 from a former employee of the Company and former principal of 4G Biometrics whose employment was terminated for cause.&#160; On December 4, 2015, the Company filed a complaint against the former owners of 4G Biometrics, including this former employee, seeking damages in excess of $300,000 related to alleged misrepresentations made to induce the Company to acquire 4G Biometrics.&#160; Between February 4, 2016 and February 8, 2016, the Company settled the complaint with each of the former owners of 4G Biometrics and all parties released each other from all outstanding claims, including any current monetary obligations to each party, excluding one former owner of 4G Biometrics who continues to be employed by the Company.&#160; A Stipulation for Order of Dismissal with Prejudice of all Claims and Counterclaims has been filed and is in the process of being approved.&#160; The settlement resulted in the termination of $39,863 of related-party accounts payable.</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">30</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">18.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Subsequent Events</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Subsequent to June 30, 2017, the Company entered into the following agreements and transactions:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<table id="z8a28ab4a8cd84cf89d83bce4b6dcb469" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(1)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 2, 2017, the Company received a cash advance from a third party in the amount of $100,000, which incurs fees of $1,500 per day until repaid.&#160; During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company's common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(2)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 7, 2017, the Company received a cash advance from a third party in the amount of $50,000, which incurs fees of $750 per day until repaid. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company's common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(3)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During August 2017, the Company received letters related to unsecured notes payable with third parties with principal balances totaling $5,900,000 as of June 30, 2017 where the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(4)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During August 2017, the Company received a letter related to an unsecured note payable with a third party with a principal balance of $334,464 as of June 30, 2017 wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(5)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During August 2017, the Company received a letter related to secured and unsecured notes payable with entities controlled by the Company's former chief executive officer and Executive Chairman of the Board of Directors, who was in office at the time, with principal balances of $1,721,100, $1,303,135, $250,000 and $25,463 as of June 30, 2017, wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through January 12, 2018 and extended maturity date was extended through January 12, 2018.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(6)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During August 2017, the Company received a letter related to an unsecured note payable with a former Executive Chairman of the Board of Directors with a principal balance of $542,004 as of June 30, 2017 wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through January 12, 2018 and extended maturity date was extended through January 12, 2018.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(7)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During July 2017, the Company granted 1,562 shares of common stock, with a value of $12,496 on the date of grant, to the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, as a bonus for services performed during the three months ended June 30, 2017.&#160; The value of the shares has been included in accrued expenses as of June 30, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(8)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 16, 2017, the Company sold $248,500 of future customer receipts to a third party for $175,000 in cash.&#160; The $73,500 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company's former Executive Chairman and Chief Executive Officer, who was in office at the time.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">31</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<table id="zef57157ad22b4976958cc8d828b73df1" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(9)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During July 2017, the Company granted 50,000 shares of common stock, with a value of $400,000 on the date of grant, to a third party as part of a one-year consulting agreement.&#160; The value of the shares will be amortized to selling, general and administrative expenses evenly over the service period.&#160; On September 5, 2017, the Board of Directors granted the issuance of 500 shares of Series H Preferred stock in lieu of the 50,000 shares of common stock, to which the third party has verbally agreed.&#160; The Series H Preferred shares have not yet been issued.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(10)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During July 2017, the Company granted 3,937 shares of common stock to employees for bonuses.&#160; The $31,500 fair value of the shares has been included in accrued expenses as of June 30, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(11)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 28, 2017, the Company sold $224,850 of future customer receipts to a third party for $150,000 in cash.&#160; The $74,850 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company's former Executive Chairman and Chief Executive Officer, who was in office at the time.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(12)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 31, 2017, the Company sold $119,920 of future customer receipts to a third party for $80,000 in cash.&#160; The $39,920 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company's former Executive Chairman and Chief Executive Officer, who was in office at the time.</div>
</td>
</tr>

<tr style="HEIGHT: 13px">
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(13)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, the Board of Directors of the Company modified the terms of the Series G Convertible Preferred stock to remove the 18-month lock-up period.&#160; The amendment has not been filed with the State of Delaware as of the date of this filing.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(14)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, the Board of Directors of the Company ratified a change to the Series H Preferred stock, previously contemplated and approved by the Board of Directors, to where each share of the Series H Preferred stock is convertible into 100 shares of the Company's common stock, is limited to a total ownership of 4.99% of the outstanding common stock at the time of conversion, is to be non-voting stock, does not bear interest or dividends, and is transferable with the same terms.&#160; The Certificate of Designation for the Series H Preferred stock has not been filed with the State of Delaware as of the time of this filing and no shares had been issued prior to September 5, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(15)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, the Company entered into a consulting agreement with a former Executive Chairman and Chief Executive Officer of the Company, which replaced and existing consulting agreement, for certain consulting services to the Company including, but not limited to (i) developing business plans, (ii) making introductions to potential customers and/or suppliers, (iii) identifying qualified employees and other service providers, (iv) sales, marketing, manufacturing and other operating activities, and (v) meeting with the Company's and its affiliates' respective managers, officers, employees, agents, and other service providers regarding the business, prospects and affairs of the Company and its affiliates. The former officer may not engage in and shall not be entitled to any fees or consideration for (i) negotiating the purchase and/or sale of Company securities, (ii) making recommendations regarding transactions involving Company securities, (iii) or any other matters involving transactions of Company securities.&#160; The agreement is for one year and includes compensation of $250.00 per hour, but such compensation may not exceed $20,000 during any calendar month, plus 1,500 shares of the Company's Series H Preferred stock.&#160; The shares of Series H Preferred stock have not been issued at the time of this filing.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(16)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, the Company renewed an existing license and royalty agreement with an entity controlled by a former Executive Chairman and Chief Executive Officer of the Company (the "licensee").&#160; Under the agreement, the licensee receives the right to make, sell and use products related to the Company's intellectual property regarding diabetics, cellular, GPS and CareCenter arena and generally characterized as the CareCenter Technology in a certain region.&#160; The Company shall receive a royalty of 15% of the licensee's gross sales price for the product.&#160; The initial term is for three years whereby the licensee must achieve a minimum royalty of $10,000 per month to maintain the agreement, whereby the agreement will be extended for one addition year unless terminated.&#160; If the minimum monthly royalty is not maintained, the licensee may pay a sum to bring the total payment up to $360,000 within 60 days of the end of the three-year term to extend the agreement for one additional year.&#160; The Company may terminate the agreement if the licensee does not commence to manufacture, distribute and sell product within a 6-month period after the execution of the agreement.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(17)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, the Company granted 1,500 shares of the Company's Series H Preferred stock to an entity controlled by a former Executive Chairman of the Board of Directors for past services rendered in addition to amounts earned under an existing consulting agreement.&#160; The shares of Series H Preferred stock have not been issued at the time of this filing.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">32</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<table id="za881a5e2ad9d4e91ba76dd6e6ba3ad37" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(18)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, the Company entered into an employment agreement with the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, for a period of two years for services as the Executive Chairman and Chief Executive Officer of the Company.&#160; The initial term of the agreement is for two years and shall automatically renew on a year to year basis, unless terminated sooner.&#160; The base compensation is $360,000 per year plus 1,500 shares of the Company's Series H Preferred stock.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; An additional cash or stock bonus may be awarded, subject to the attainment of such individual and ActiveCare objectives as the Board of Directors of the Company shall establish from time to time as determined by the Board of Directors of the Company.&#160; Upon certain termination conditions upon termination of the agreement, the Company may be required to pay severance of twice the base compensation of the <a name="_Hlk502674916"><!--Anchor--></a>former Executive Chairman and Chief Executive Officer at its highest point during the five-year period prior to termination. In addition, the Board of Directors approved compensation at a level of $360,000 per year retroactive from July 2017, when the former Executive Chairman and Chief Executive Officer was appointed, until the employment agreement was signed. Effective October 12, 2017, the agreement was amended to waive any constructive termination in relation to changes in title, working conditions or duties such that his powers are diminished, reduced or otherwise changed to include powers, duties, or working conditions which are note materially consistent with title, continuing after written notice and 10 days to cure.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(19)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, the Board of Directors granted 963 shares of Series H Preferred stock to the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, in lieu of 96,275 shares of previously granted common stock as a bonus for services performed.&#160; The Series H Preferred shares have not yet been issued.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(20)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, the Board of Directors granted 200 shares of Series H Preferred stock to the holder of an unsecured note payable with a balance of $300,000 as of June 30, 2017 for the extension of the note payable.&#160; The Series H Preferred shares have not yet been issued.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(21)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">From September 21, 2017 through December 1, 2017, the Company received cash advances totaling $230,000 from an entity controlled by the Company's former Executive Chairman and Chief Executive Officer, who was in office at the time, and repaid $10,000 plus the reimbursement of bank fees of $200.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(22)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 25, 2017, the Company entered into agreements with its primary product vendor that supersedes all prior agreements with the vendor.&#160; Under the agreements, the vendor will provide all products and services to the Company's service members as they are assigned to the vendor.&#160; In return, the vendor will pay the Company a fee for services rendered to the vendor and to the members for monitoring and reporting.&#160; The Company also earns commissions on all members assigned under the agreement to be paid upon completion of certain milestones met with each individual member.&#160; The agreements also modify the terms of an existing note payable to the vendor.&#160; The note accrues interest at 0.65% per annum, is reduced by the amount of commissions earned by the Company under the agreements and matures on September 25, 2019.&#160; The agreements also add interest fees on existing accounts payable at 0.65% per annum and the accounts payable are reduced by the amount of commissions earned by the Company under the agreements for a minimum of 24 months.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">33</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<table id="zbee147ba9dbb4ec3b7fab326b127f3e1" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="HEIGHT: 20px">
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(23)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 27, 2017, the Company received a cash advance from a third party in the amount of $40,000, which incurs fees of $600 per day until repaid.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(24)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">In October 2017, the Company entered into a settlement agreement related to an unsecured note payable with a principal balance of $300,000 as of June 30, 2017.&#160; As part of the agreement, the lender lent the Company an additional $200,000 which has been added to the principal balance of the note payable.&#160; The agreement modified the terms of the note payable to become secured by inventory owned by the Company, requires issuance of 3,000 shares of Series H Preferred Stock, which were granted by the Board of Directors on September 5, 2017 and are required to be able to convert the lender's shares into 300,000 shares of the Company's common stock, and requires payments of $8,600 for 72 consecutive weeks.&#160; If any payment is late, the Company is required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&#160; The fair value of the shares will be amortized over the life of the amended note.&#160; The note terms are adjustable for any terms subsequently provided to other investors.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(25)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 7, 2017, the Company entered into individual agreements related to secured borrowings from four different parties that each previously purchased customer receivables that require daily payments.&#160; The agreements modified each agreement to reduce the amount of the respective daily payment to approximately half of the amount previously drawn through January 7, 2018, whereafter the amount of the payment returns to the payment required under the respective agreement plus an additional amount equal to the amount shorted during the period of lower payments divided by the number of remaining payments remaining on the original term of the respective note payable.&#160; Three of the four agreements are verbal.&#160; On January 5, 2018, the Company further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018.&#160; Three of the four agreements are verbal.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(26)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 13, 2017, an entity controlled by a former Executive Chairman of the Board of Directors, with whom we contracted for consulting, terminated the existing consulting arrangement.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(27)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 13, 2017, the Company entered into a sales broker agreement with an entity controlled by a former Executive Chairman of the Board (the "Sales Broker").&#160; Under the Sales Broker agreement, the Company will provide services to certain customers referred to the Company and the Sales Broker will receive administration fees in the amount of 15% of gross revenues, as defined by the Sales Broker agreement, as long as the Company services the respective customer even in the event the Sales Broker agreement is terminated.&#160; The Sales Broker will promote the Company, its services and products, and introduce potential customers to the Company as a sales representative.&#160; The initial term of the Sales Broker agreement is one year, which automatically renews for additional one-year periods until cancelled by either party.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(28)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 30, 2017, the Company signed a letter of understanding with a former consultant where the Company agreed to convert $100,000 of past consulting fees owed into an equivalent value of equity in the Company upon a qualifying capital raise.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(29)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 10, 2017, the Company signed a formal agreement replacing a former verbal agreement with an unsecured note holder, with principal due of $350,000 as of June 30, 2017.&#160; The new agreement memorialized previously agreed upon terms whereby the lender converted a $350,000 advance into an unsecured note payable, with interest at 2.8% of revenues, for $143,987 in fees and a future payoff fee of 20% of the principal, or $70,000, which are included in accrued liabilities and interest expense as of June 30, 2017.&#160; The written agreement adjusted the verbal agreement to where the Company is required to pay any outstanding interest at the end of the first month following a quarter end. The lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and the written agreement includes a most favored nations clause in relation to conversion features.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>
<div id="DSPFPageHeader"></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">34</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div>&#160;</div>

<table id="zfb1f0f9df6a74290ab54cc0102a684a4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(30)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 27, 2017, the Company signed a formal agreement memorializing previous agreements with the holder of an unsecured note and cash advance, with aggregate principal due of $1,200,000 as of June 30, 2017, as well as additional advances with aggregate principal of $190,000 that were received subsequent to June 30, 2017.&#160; The new agreement memorialized the terms of the note payable whereby the lender converted $617,500 in advances into a $1,100,000 unsecured note payable, with interest at 18% per annum for $95,226 in fees, which have been included in accrued liabilities and interest expense as of June 30, 2017.&#160; In addition, the new agreement allows for advances to incur fees at 1.5% of the advance principal per calendar day until paid in full.&#160; The written agreement adjusted the verbal agreements to where the note payable and advance balances and fees may be called by the lender at any time and are due by May 30, 2018, and the new agreement includes a most favored nations clause in relation to conversion features on the note payable and advances.&#160; The new agreement also assigned $2,000,000 of note payable principal held by an entity controlled by an officer of the Company to the lender.&#160; All interest accrued on the assigned balance is payable to the officer.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(31)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On December 6, 2017 the Company entered into those certain forbearance and lock up letter agreements with three (3) debtors which held convertible debentures in the aggregate principal amount of $1,109,345 at the time of the agreements, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more.&#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&#160; In addition, two (2) of the debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(32)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">Effective December 11, 2017, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") with four accredited investors, including the Company's new Chief Executive Officer in connection with the closing of a bridge financing (the "Bridge Financing") in the gross amount of $600,000. The three remaining accredited investors hold notes payable with an aggregate principal balance of $3,865,865 as of June 30, 2017. Pursuant to the Purchase Agreements, the Investors purchased from the Company (i) Promissory Notes in the aggregate principal amount of $631,578.06 (the "Notes") due and payable six months from the Effective Date and (ii) Common Stock Purchase Warrants (the "Warrant"), exercisable for five years from the date of issuance, to purchase up that certain amount of shares with an aggregate exercise amount equal to $600,000 at an exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in the companies contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the "Private Placement") (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment hereunder (the "Exercise Price"). The Notes were issued in favor of the Investors with an original issue discount equal to five percent (5%). Additionally, pursuant to the Purchase Agreement, the Company will issue the investors common stock (the "Origination Shares") worth 30% of the purchase price paid by each investor (the "Origination Dollar Amount") on the 5th trading day after the pricing of the Private Placement, but in no event later than six months from the Effective Date. The Origination Dollar amount will divided by the lowest of (i) $3.00 (subject to adjustment for stock splits), (ii) 80% of the common stock offering price in the Private Placement, (iii) 80% of the offering price of the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement.&#160; At the closing of the Private Placement the Note shall automatically convert into a subscription into the Private Placement in an amount equal to 125% of the Note balance, subject to certain conditions as outlined therein. If the Company fails to repay the balance due under the Note on its Maturity the Investors have the right, at any time, at their election, to convert all or part of the outstanding and unpaid principal sum and accrued interest (and any other fees) into shares of fully paid and non-assessable shares of common stock of the Company pursuant to the following conversion formula: number of shares receivable upon conversion equals the dollar amount being converted divided by the Conversion Price. The Conversion Price is the lesser of $3.00 (subject to adjustment for stock splits) or 60% of the lowest trade price in the 25 trading days. Further, in the event of any default, the outstanding principal amount of the Notes, plus accrued but unpaid interest, liquidated damages, fees and other amounts owing in respect thereof through the date of acceleration (the "Note Balance"), shall become, at the Investor's election, immediately due and payable in cash at the Mandatory Default Amount. The Mandatory Default Amount means the investor's choice of (this choice may be made at any time without presentment, demand, or notice of any kind): (i) the Note Balance divided by the Conversion Price on the date of the default multiplied by the closing price on the date of the default; or (ii) the Note Balance divided by the Conversion Price on the date the Mandatory Default Amount is either (a) demanded or (b) paid in full, whichever has a lower Conversion Price, multiplied by the closing price on the date the Mandatory Default Amount is either (a) demanded or (b) paid in full, whichever has a higher closing price; or (iii) 150% of the Note Balance. If, at any time the Note is outstanding, the Company issues a Variable Security (as defined therein), then in such event the Investors shall have the right to convert all or any portion of the outstanding balance of the Notes into shares of Common Stock on the same terms as granted in any applicable Variable Security issued by the Company.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">35</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<table id="z83dd35225e5149de93521bc320f1043b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(33)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 17, 2017, the Company received cash advances from third parties totaling $60,000.&#160; On January 5, 2018, the advances converted into agreements with the same terms as the Bridge Financing entered into on December 11, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(34)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On December 11, 2017, Eric Robinson voluntarily resigned as Chief Financial Officer, Secretary and In-House Counsel, and all other positions with the Company to which he has been assigned regardless of whether he served in such capacity, effective immediately. On the same date, Jeffrey S. Peterson voluntarily resigned as Chairman of the Board of Directors, while acknowledging that he will continue to serve the Company as a Director and Executive Vice President.&#160; On the same date, Robert J. Welgos and Bradley Robinson voluntarily resigned as members of the Board of Directors and all other positions with the Company to which they may have been assigned, regardless of whether they served in such capacity, effective immediately.&#160; These resignations were not as a result of any disagreements with the Company.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(35)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On December 11, 2017, Isaac Onn was appointed as a member of the Company's board of Directors and Mark J. Rosenblum was appointed as the Company's Chairman of the Board of Directors and Chief Executive Officer in connection with the Bridge Financing.&#160; In connection with Mr. Rosenblum's appointment as the Company's Chief Executive Officer, on December 11, 2017, the Company and Mr. Rosenblum finalized the terms of his employment and entered into an employment agreement (the "Rosenblum Employment Agreement"). Mr. Rosenblum shall have such duties, responsibilities and authority which shall include, but not be limited to the responsibility for the overall management, direction and strategy of the Company. The Company shall pay Mr. Rosenblum a salary at a rate of Three Hundred Thousand and 00/100 Dollars ($300,000) per year (the "Initial Base Salary"). The Initial Base Salary shall increase to an annual rate of Three Hundred and Sixty Thousand Dollars ($360,000) (the "Base Salary") upon the Company closing a financing of at least Five Million Dollars ($5,000,000). Mr. Rosenblum shall be eligible for an annual performance-based cash bonus of up to 100% of the Base Salary (as further defined in the Rosenblum Employment Agreement"). The Rosenblum Employment Agreement is for a term of three (3) years and will be automatically renewed for one year periods, unless otherwise terminated by the Company or Mr. Rosenblum. Upon execution of the Rosenblum Employment Agreement the Company agreed to issue restricted shares equal to $300,000 valued at the offering price of the next equity offering of the Company ("RSU") and an option to purchase an aggregate $600,000 valued at the offering price of the next equity offering of the Company at an exercise price equal to the market price for the next equity offering of the Company (the "Options"). One-third of these Options shall vest immediately, another third on the first anniversary of the Rosenblum Employment Agreement, and the final third on the second anniversary of the Rosenblum Employment Agreement. The RSUs shall vest 50% immediately upon issuance and 25% on each of the first and second anniversaries of the Rosenblum Employment Agreement. If the Company terminates Mr. Rosenblum's employment without just cause or if Mr. Rosenblum's employment is terminated due to Disability (as defined therein), Mr. Rosenblum shall be entitled to receive, in addition to any accrued and unpaid Base Salary, plus any accrued but unused vacation time and unpaid expenses that have been earned as of the date of such termination, the following severance payments (the "Severance Payments"): (i) equal monthly installments at the applicable Base Salary rate then in effect, as determined on the first day of the calendar month immediately preceding the day of termination, to be paid beginning on the first day of the month following such termination and continuing until the later of (A) the expiration of the Term or (B) the expiration of (i) six (6) months following the effective termination date; provided, however, that if the Company terminates the Agreement without Just Cause (as defined in the Rosenblum Employment Agreement) within six (6) months of the effective date, then Mr. Rosenblum will only be entitled to three (3) months of severance instead of six (6) months; and (ii) during the Severance Period (as defined in the Rosenblum Employment Agreement), health and life insurance benefits substantially similar to those which Mr. Rosenblum was receiving or entitled to receive immediately prior to termination; provided, however, such insurance benefits shall be reduced to the extent comparable benefits during such period following Mr. Rosenblum's termination, and any benefits actually received shall be reported by Mr. Rosenblum to the Company.&#160; The Company will reimburse Mr. Rosenblum for any reasonably travel and relocation expenses.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(36)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During December 2017, the Company entered into those certain forbearance and lock up letter agreements with a debtor which holds convertible debentures in the principal amount of $25,312 as of December 5, 2017, whereby the debtor agreed that, without prior written consent of the Company, the debtor will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more. Additionally, the debtor agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the convertible debentures. The forbearance and lock up letter agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">36</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<table id="z46ca3616597c4fa094e71a89db935e4c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(37)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On January 12, 2018, the Company received letters from four (4) debtors which hold convertible debentures with principal balances totaling $3,162,955 as of June 30, 2017 where the debtors forbear against any historical and future events of default and remedies through February 15, 2018. Further, the maturity date was extended through February 15, 2018.&#160; As part of the letters, the Company agreed not to initiate any new financing arrangements without the consent of the debtors.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(38)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On January 12, 2018, the Company received a letter from a lender who holds two unsecured notes payable with principal balances totaling $550,000 as of June 30, 2017 where the lender forbears against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(39)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On December 22, 2017, the Company entered into a Services Agreement (the "Cleveland Clinic Agreement") with the Cleveland Clinic Foundation d.b.a. Cleveland Clinic, an Ohio nonprofit corporation ("Cleveland Clinic"). Pursuant to the Cleveland Clinic Agreement, the Company will be providing services to Cleveland Clinic as agreed to by the parties in any mutually agreed form pursuant to a "Statement of Work". Pursuant to the Statement of Work included in the Cleveland Clinic Agreement, the Company will provide monitoring services to Cleveland Clinic's expected beneficiary diabetic population within the Cleveland Clinic Medicare ACO. The initial term of the Cleveland Clinic Agreement is for three years and shall automatically renew after the term for a successive twelve (12) month period from year to year unless sooner terminated by either party in accordance with the terms of the Cleveland Clinic Agreement. As consideration for the Company's Services, the Company is to receive a fixed monthly fee per Covered Diabetic Patient (as defined in the Cleveland Clinic Agreement). In addition, at such time the Cleveland Clinic Accountable Care Organization ("CCACO") shall receive a shared savings payment from the Centers for Medicare and Medicaid Services, CCACO shall share such savings with the Company based on a formula defined in the Cleveland Clinic Agreement. Cleveland Clinic may, by written notice to the Company, terminate the Agreement, any purchase order or any portion of a purchase order if the Company (i) is in material breach of any of the terms and conditions of the Cleveland Clinic Agreement or any Purchase Order, which breach in not cured within thirty (30) days after notification of such breach, (ii) terminates or suspends its business, becomes insolvent, or becomes subject to any bankruptcy or insolvency proceeding under Federal or State law. Cleveland Clinic further may terminate the Cleveland Clinic Agreement, any Purchase Order or any portion of any Purchase Order for convenience upon ninety (90) days' prior written notice to Company ("Termination for Convenience"). In connection with any Termination for Convenience, Cleveland Clinic will reimburse Company for the actual cost reasonably incurred for work in process up to the time of cancellation, as well as any non-cancellable contract of Company, or non-cancellable purchase order to a third party, entered into for the benefit of Cleveland Clinic. The Cleveland Clinic Agreement is nonexclusive, and Cleveland Clinic may contract with others to perform similar services. Accordingly, the Company may also perform similar services for others.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">37</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Item 2.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Management's Discussion and Analysis of Financial Condition and Results of Operations</font></div>

<div style="PAGE-BREAK-AFTER: always">&#160;</div>

<div style="PAGE-BREAK-AFTER: always; TEXT-ALIGN: justify">This quarterly report on Form 10-Q and other reports filed by ActiveCare, Inc. (the "Company") from time to time with the SEC (collectively, the "Filings") contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company's management as well as estimates and assumptions made by Company's management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the Filings, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions as they relate to the Company or the Company's management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors, including the risks relating to the Company's business, industry, and the Company's operations and results of operations. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Our financial statements are prepared in accordance with accounting principles generally accepted in the United States ("US GAAP"). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by US GAAP and does not require management's judgment in its application. There are also areas in which management's judgment in selecting any available alternative would not produce a materially different result.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageFooter"></div>

<font style="FONT-STYLE: italic">The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A") is intended to assist in better understanding our operations and our present business environment.&#160; This MD&amp;A is provided as a supplement to, and should be read in conjunction with, our audited consolidated financial statements for the fiscal years ended September 30, 2016 and 2015, and the accompanying notes thereto, contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2016.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Overview</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">ActiveCare, Inc. is a Delaware corporation, formed March 5, 1998. Our fiscal year ends on September 30. Our focus is on the monitoring of individuals with diabetes. Diabetes is a pandemic that, as of 2014, affected approximately 9% of the U.S. population or 29 million Americans. Studies have shown that the annual cost of treating an individual with diabetes and the comorbidities associated with the disease is approximately $13,700 per year. This combination costs the U.S. health system up to $245 billion annually. A major driver of diabetic-related claims is the lack of adherence to regular glucose monitoring. It is estimated that less than 20% of diabetics monitor their blood glucose levels on a regular basis, despite physician recommendations. ActiveCare offers what it believes to be a unique approach to caring for chronic illnesses such as diabetes by adding a "human touch" and monitoring component to traditional disease management. To that end, ActiveCare has created a "CareCenter" where its highly trained staff reaches out to assist its members in real-time. Historically, disease management, such as diabetes has been reserved for only the extreme high risk and high claim members. However, the ActiveCare solution brings clarity and light to the diabetic population, identifying who needs help today. Knowing who to worry about allows for the necessary action to be taken today to avoid major and costly events in the future.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">38</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Going Concern</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We have financed operations primarily through the sale of equity securities, long-term debt and short-term debt. Until revenues are sufficient to meet our needs, we will continue to attempt to secure financing through equity or debt securities. We continue to incur negative cash flows from operating activities and net losses. We had minimal cash, negative working capital, and negative total equity as of June 30, 2017 and September 30, 2016.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> In addition, the Company is in technical default on certain notes payable although the lenders in each case are working with the Company to resolve the defaults.</font> These factors, among others, raise substantial doubt about our ability to continue as a going concern. The financial statements included in this report do not include any adjustments that might result from the outcome of this uncertainty.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In order for us to eliminate substantial doubt about our ability to continue as a going concern, we must achieve profitability, generate positive cash flows from operating activities and obtain the necessary debt or equity funding to meet our projected capital investment requirements. Our management's plans with respect to this uncertainty consist of raising additional capital by issuing debt or equity securities and increasing the sales of our products and services. If we are successful in completing the Offering, we believe the net proceeds of the Offering together with anticipated growth of the business will be sufficient to eliminate substantial doubt about our ability to continue as a going concern. There can be no assurance, however, that we will be able to complete the Offering, raise sufficient additional capital or that revenues will increase rapidly enough to offset operating losses. If we are unable to increase revenues or obtain additional financing, we will be unable to continue the development of our products and services and may have to cease operations.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Research and Development Program</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the three and nine months ended June 30, 2017, we spent approximately $56,000 and $307,000, respectively, compared to $58,000 and $139,000 during the same periods in 2016, on research and development related to chronic illness monitoring. The research and development program focuses on ongoing improvements to methods and systems along with new technologies for the capture and analysis of data, as well as scalable architectures to migrate to production applications and deployments.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Critical Accounting Policies</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Our condensed consolidated financial statements are prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (or US GAAP).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">This Management's Discussion and Analysis of Financial Condition and Results of Operations discusses our condensed consolidated financial statements, which have been prepared in accordance with US GAAP. The preparation of these condensed consolidated financial statements requires making estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported revenues and expenses for the reporting periods. On an ongoing basis, we evaluate such estimates and judgments. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ (perhaps significantly) from these estimates under different assumptions or conditions. The following summary includes accounting policies that we deem to be most critical to our business. Management considers an accounting estimate to be critical if:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<table id="z558dca41979441c194d05185b0aba883" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 8.26%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#8226;</div>
</td>
<td style="WIDTH: 91.74%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">It requires assumptions to be made that were uncertain at the time the estimate was made, and</div>
</td>
</tr>

<tr>
<td style="WIDTH: 8.26%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 91.74%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 8.26%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#8226;</div>
</td>
<td style="WIDTH: 91.74%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Changes in the estimate or different estimates that could have been selected could have a material impact on the consolidated results of operations or financial condition.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Our significant accounting policies are described in Note 2 to our audited consolidated financial statements appearing in our Annual Report on Form 10-K for the fiscal year ended September 30, 2016 and are hereby incorporated by reference.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">39</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Liability Related to Options and Warrants</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The fair value of each stock option or warrant is estimated on the date of grant using a binomial option-pricing model or the Monte Carlo valuation model. The expected life of stock options or warrants represents the period of time that the stock options or warrants are expected to be outstanding, based on the simplified method. Expected volatilities are based on historical volatility of the Company's common stock, among other factors. The Company uses the simplified method within the binomial option-pricing valuation model due to the Company's short trading history and limited history of exercises of stock options or warrants. The risk-free rate related to the expected term of the stock options or warrants is based on the US Treasury yield curve in effect at the time of grant. The dividend yield is zero.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the three and nine months ended June 30, 2017, the Company measured the fair value of warrants classified as liabilities on the date of issuance and on each re-measurement date using the Monte Carlo valuation model. For this liability, the Company and valuation specialists developed their own assumptions that do not have observable inputs or available market data to support the fair value. This method of valuation involves using inputs such as the fair value of the Company's common stock, stock price volatility, the contractual term of the warrants, risk&#8211;free interest rates and dividend yields. Due to the nature of these inputs, the valuation of the warrants uses Level 3 measurements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Fair Value of Financial Instruments</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We measure the fair values of our assets and liabilities using the US GAAP hierarchy. The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts receivable, accounts payable, and accrued liabilities approximate fair values due to the short-term nature and liquidity of these financial instruments. Derivative financial instruments are recorded at fair value based on current market pricing models. The carrying amounts reported for notes payable approximate fair value because the underlying instruments are at interest rates which approximate current market rates.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accounts Receivable</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. Specific reserves are estimated by management based on certain assumptions and variables, including the customer's financial condition, age of the customer's receivables and changes in payment histories. Accounts receivable are written off when management determines the likelihood of collection is remote. A&#160;receivable is considered to be past due if any portion of the receivable balance has not been received by the contractual payment date.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Inventory</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Inventory consists of glucometers and diabetic supplies and is recorded at the lower of cost or market, cost being determined using the first-in, first-out ("FIFO") method. Inventory held by distributors is reported as inventory until the supplies are shipped to the end user by the distributor. We estimate an inventory reserve for obsolescence and excessive quantities. Due to competitive pressures and technological innovation, it is possible that estimates of net realizable values could change in the near term.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Goodwill</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Goodwill is reviewed for impairment annually or more frequently when an event occurs or circumstances change that indicate that the carrying value may not be recoverable. Our annual testing date is September 30. The estimates of fair value are based on the best information available as of the date of the assessment, which primarily incorporates management assumptions about expected future cash flows and the Company's overall market capitalization. Future cash flows can be affected by changes in industry or market conditions. Goodwill was impaired by $826,000 as of September 30, 2015, due, in part, to a potentially long-term reduction in the market capitalization of the Company subsequent to September 30, 2015.&#160; As a result, the Company no longer presents goodwill as an asset in its balance sheets.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">40</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Impairment of Long-Lived Assets</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Purchased intangible assets with finite lives are amortized using the straight-line method over the estimated economic lives of the assets, which range from two to twenty years. Long-lived assets, including intangible assets with finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts of such assets may not be recoverable. Determination of recoverability is based on an estimate of undiscounted future cash flows resulting from the use of the asset and its eventual disposition. No long-lived assets were considered to be impaired as of June 30, 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Extinguishment of Debt</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We compare the cash flows of a modified note payable on the date of modification to the original terms of the note payable. The original note is derecognized and a gain or loss on the extinguishment is recognized if the present value of the cash outflows of the original note payable is 10% or more than the modified note payable.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Revenue Recognition</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the three and nine months ended June 30, 2017 and the comparable periods from 2016, revenues came from Chronic Illness Monitoring products and services. Information regarding revenue recognition policies relating to Chronic Illness Monitoring is contained in the following paragraphs.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Chronic Illness Monitoring</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Chronic Illness Monitoring revenues are recognized when persuasive evidence of an arrangement exists, delivery of the product or service to the end user has occurred, prices are fixed or determinable, and collection is reasonably assured.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">41</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We enter into agreements with insurance companies, disease management companies, third-party administrators, and self-insured companies (collectively, the customers) to lower medical expenses by distributing diabetic testing products and supplies to employees (end users) covered by their health plans or the health plans they manage. Cash is due from the customer or the end user's health plan as the products and supplies are deployed to the end user. We also monitor the end user's test results in real-time with our 24x7 CareCenter. Customers who are billed separately for monitoring are obligated to pay as the service is performed and revenue is recognized ratably over the period of the contract. The term of these contracts is generally one year and, unless terminated by either party, will automatically renew annually until terminated. Collection terms are net 30 days after claims are submitted. There is no contingent revenue in these contracts.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We also enter into agreements with distributors who take title to products and distribute those products to the end user. Delivery is considered to occur when the supplies are delivered by the distributor to the end user. Cash is due from the distributor, the customer or the end user's health plan as initial products are deployed to the end user. Subsequent sales (resupplies) are shipped directly from us to the end user and cash is due from the customer or the end user's health plan.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Shipping and handling fees are typically not charged to end users. The related freight costs and supplies directly associated with shipping products to end users are included as a component of cost of revenues.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Multiple-Element Arrangements</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Sales of Chronic Illness Monitoring products and services contain multiple elements.&#160; We evaluate each element in a multiple-element arrangement to determine whether it represents a separate unit of accounting. In order to account for elements in a multiple-element arrangement as separate units of accounting, the deliverables must have stand-alone value upon delivery. In determining whether monitoring services have stand-alone value, the nature of our monitoring services, whether we sell supplies to new customers without monitoring services, and availability of monitoring services from the other vendors are factors that are considered.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">When multiple elements included in an arrangement are separable into different units of accounting, the arrangement consideration is allocated to the identified separate units of accounting based on the relative selling prices. Multiple-element arrangements accounting guidance provides a hierarchy to use when determining the relative selling price for each unit of accounting. Vendor-specific objective evidence (VSOE) of selling price, based on the price at which the item is regularly sold by the vendor on a stand-alone basis, should be used if it exists. If VSOE of selling price is not available, third-party evidence (TPE) of selling price is used to establish the selling price if it exists. If VSOE of selling price and TPE of selling price are not available, then the best estimate of selling price is to be used. Total consideration under our multiple-element contracts is allocated to supplies and monitoring through application of the relative fair value method or selling price.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Stock-Based Compensation</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. That cost is recognized in the statement of operations over the period during which the employee is required to provide service in exchange for the award &#8212; the requisite service period. The grant-date fair values of the equity instruments are estimated using option-pricing models adjusted for the unique characteristics of those instruments.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Results of Operations</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Three Months Ended June 30, 2017 and 2016</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Revenues</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Revenues for the three months ended June 30, 2017 were $1,196,000 compared to $2,176,000 for the same period in 2016, a decrease of $980,000.&#160; The decrease is primarily due to the loss of significant customers during the nine months ended June 30, 2017.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Cost of Revenues</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Cost of revenues for the three months ended June 30, 2017 was $848,000, compared to $1,382,000 for the same period in 2016, a decrease of $534,000.&#160; The decrease in cost of revenues is primarily due to the loss of significant customers during the nine months ended June 30, 2017 and a decrease in the cost of supplies from our vendors.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Gross Profit</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">Gross profit for the three months ended June 30, 2017 was $348,000, compared to $794,000 for the same period in 2016, a decrease of $446,000 as a result of the decrease in revenues and cost of revenues.&#160; </div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">42</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Selling, General and Administrative Expenses</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">Selling, general and administrative expenses for the three months ended June 30, 2017 were $3,225,000, compared to $2,170,000 for the same period in 2016, an increase of $1,055,000.&#160; Included in selling, general and administrative expenses is $1,461,000 and $1,004,000 of stock-based compensation incurred during the three months ended June 30, 2017 and 2016, respectively.&#160; The increase in expenses incurred is due primarily to a write off of prepaid legal and professional fees related to an equity financing during the three months ended June 30, 2017 and increases in stock-based compensation expense and payroll and payroll tax expenses, offset, in part, by a decrease in other legal and professional fees.</div>

<div id="DSPFPageFooter">&#160;</div>

<div style="FONT-STYLE: italic">Research and Development Expenses</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Research and development expenses for the three months ended June 30, 2017 were $56,000, compared to $57,000 for the same period in 2016, a decrease of $1,000. We expect to continue invest into innovating new products as funds become available.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Gain on Derivatives Liability</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Gain on derivatives liability for the three months ended June 30, 2017 was $64,000, compared to $5,603,000 for the same period in 2016.&#160; The derivative liability recorded as of June 30, 2017 and 2016 relate to variable conversion price adjustments and put options on outstanding notes payable and warrants.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Interest Expense</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Interest expense for the three months ended June 30, 2017 was $2,199,000, compared to $814,000 for the same period in 2016, an increase of $1,385,000.&#160; The increase was primarily due to amortization of note payable discounts related to warrants, shares and other costs accrued, issued or paid in connection with notes payable agreements entered into and/or amended during the fiscal years 2017 and 2016 as well as fees and interest related to cash advances made during the fiscal years 2017 and 2016.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Loss on Settlement</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the three months ended June 30, 2017, we assessed the potential outcome of a lawsuit and recorded a contingent liability of $750,000 for a potential settlement.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Net Income (Loss)</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss for the three months ended June 30, 2017, was $5,815,000 compared to net income of $3,350,000 for the same period in 2016, for the reasons described above.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageFooter"></div>

<div id="DSPFPageFooter"></div>

<font style="FONT-STYLE: italic">Dividends on Preferred Stock</font></div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Dividends on preferred stock for the three months ended June 30, 2017, were $59,000, compared to $46,000 for the same period in 2016.&#160; The decrease was primarily due to the accretion of dividends payable for July 1, 2016 through March 31, 2017 related to the expiration of letter agreements that ceased dividends beginning July 1, 2016.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Nine Months Ended June 30, 2017 and 2016</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Revenues</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Revenues for the nine months ended June 30, 2017 were $4,911,000 compared to $5,861,000 for the same period in 2016, a decrease of $950,000.&#160; The decrease is primarily due to the loss of significant customers during the nine months ended June 30, 2017.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Cost of Revenues</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Cost of revenues for the nine months ended June 30, 2017 was $3,373,000, compared to $4,237,000 for the same period in 2016, a decrease of $864,000.&#160; The decrease in cost of revenues is primarily due to the loss of significant customers during the nine months ended June 30, 2017 and a decrease in the cost of supplies from our vendors.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Gross Profit</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Gross profit for the nine months ended June 30, 2017 was $1,538,000, compared to $1,623,000 for the same period in 2016, a decrease of $85,000 as a result of an increase in revenues and a reduction in the cost of revenues.&#160; </div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Selling, General and Administrative Expenses</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">Selling, general and administrative expenses for the nine months ended June 30, 2017 were $6,382,000, compared to $6,944,000 for the same period in 2016, a decrease of $562,000.&#160; Included in selling, general and administrative expenses is $2,101,000 and $3,258,000 of stock-based compensation incurred during the nine months ended June 30, 2017 and 2016, respectively.&#160; The decrease in expenses incurred is due primarily to decreases in stock-based compensation expense and legal and professional fees, offset, in part, by a write off of prepaid legal and professional fees related to an equity financing during the nine months ended June 30, 2017 and an increase in payroll and payroll tax expenses.</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">43</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Research and Development Expenses</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Research and development expenses for the nine months ended June 30, 2017 were $307,000, compared to $139,000 for the same period in 2016, an increase of $168,000. The increase was due to more intense investing in research and development as we continue to develop new products and platforms for Chronic Illness Monitoring.&#160; We expect to continue invest into innovating new products as funds become available.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Gain on Derivatives Liability</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Gain on derivatives liability for the nine months ended June 30, 2017 was $230,000, compared to $2,797,000 for the same period in 2016.&#160; The derivative liability recorded as of June 30, 2017 and 2016 relate to variable conversion price adjustments and put options on outstanding notes payable and warrants.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Interest Expense</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">Interest expense for the nine months ended June 30, 2017 was $6,856,000, compared to $1,935,000 for the same period in 2016, an increase of $4,921,000.&#160; The increase was primarily due to amortization of note payable discounts related to warrants, shares and other costs accrued, issued or paid in connection with notes payable agreements entered into and/or amended during the fiscal years 2017 and 2016 as well as fees and interest related to cash advances made during the fiscal years 2017 and 2016.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Loss on Settlement</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the&#160;nine months ended June 30, 2017, we assessed the potential outcome of a lawsuit and recorded a contingent liability of $750,000 for a potential settlement.</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; BACKGROUND-COLOR: #ffffff">Loss on Extinguishment of Debt</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the nine months ended June 30, 2017, in addition to the loss on extinguishment described below, we recognized a gain on extinguishment of debt of $40,000 on the partial extinguishment of a derivative on a note payable as payments were made.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During November 2016, we entered into a forbearance agreement related to a secured note payable and related line of credit which requires the issuance of a warrant for the purchase of 130,000 shares of common stock upon the closing of the offering, which resulted in a loss on extinguishment of debt of $2,044,000 related to the extinguishment of debt related to the forbearance agreement on a secured note payable and related line of credit.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During January 2017, we terminated a note payable to a third party for cash and incurred no additional fees.&#160; The note had an associated derivative that resulted in a gain on extinguishment of debt of $64,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During March 2017, we modified notes payable to third parties to add additional borrowing capabilities under existing note payable agreements.&#160; These modifications resulted in an aggregate loss on extinguishment of debt of $559,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During February 2016, we terminated notes payable to third parties with outstanding principal, net of discounts, of $697,000 and accrued interest of $39,000, for $1,123,000 in cash, and incurred fees of $50,000 to third parties and $75,000 to a related party, which resulted in a loss on extinguishment of debt of $512,000 in connection with these terminations.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During February 2016, we modified notes payable to related parties to subordinate to notes payable also issued during February 2016.&#160; The modifications also reduced the conversion price to $30.00 per common share, which was below the fair value of the stock on the date of the modifications, and limited conversion to a maximum of 58,500 shares of common stock, which was below the fair value of the stock on the date of the modifications.&#160; The modifications resulted in a loss on extinguishment of debt of $2,032,000. Also during February 2016, we modified a note payable to subordinate to notes payable also issued during February 2016, reducing the conversion price to $30.00 per common share, which resulted in a loss on extinguishment of debt of $381,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During February 2016, we modified a note payable to related parties to bifurcate the note into two notes payable.&#160; We assigned the majority bifurcated note and part of the smaller bifurcated note to a third party, which then converted the amounts into a convertible note payable.&#160; The fair value of the conversion feature was recorded as a derivative liability and resulted in a loss on extinguishment of debt of $182,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During February 2016, notes payable with outstanding principal balances totaling $350,000 plus accrued interest of $16,000 were converted into 18,576 shares of common stock, at $20.00 per common share, which was below the fair value of the stock on the date of conversion.&#160; The conversion resulted in a loss on induced conversion of debt of $148,000 and a gain on extinguishment of debt of $64,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During June 2016, $14,000 of principal and $11,000 of accrued interest converted into 953 shares of common stock, pursuant to the terms of a note payable, which resulted in a loss on extinguishment of debt of $15,000.</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">44</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<!--PROfilePageNumberReset%Num%44%%%-->
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Loss on Induced Conversions of Debt</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During February 2016, we converted notes payable with outstanding principal balances totaling $233,333 into 11,600 shares of common stock, at $20.00 per common share, which was below the fair value of the Company's stock on the date of conversion, which resulted in a loss on induced conversion of debt of $231,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During February 2016, we converted notes payable with outstanding principal balances totaling $350,000 plus accrued interest of $16,000 into 18,576 shares of common stock, at $20.00 per common share, which was below the fair value of the stock on the date of conversion.&#160; The conversion resulted in a loss on induced conversion of debt of $148,000 and a gain on extinguishment of debt of $64,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Gain on Liability Settlements</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the nine months ending June 30, 2016, we entered into agreements which settled payables due to third parties, which resulted in gains totaling $295,000.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Net Loss</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Net loss for the nine months ended June 30, 2017, was $15,024,000 compared to a net loss of $7,741,000 for the same period in 2016, for the reasons described above.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageFooter"></div>

<div id="DSPFPageFooter"></div>

<font style="FONT-STYLE: italic">Deemed Dividend on Preferred Stock</font></div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During February 2016, we redeemed all 5,361 outstanding shares of our Series F preferred stock and related accrued dividends in exchange for 20,005 shares of common stock and notes payable of $5,900,000.&#160; We also exchanged warrants held by Series F preferred stockholders for the purchase 11,070 shares of common stock for new warrants for the purchase of the same number of shares with new terms.&#160; We recorded a deemed dividend of $6,484,000 as a result of these transactions.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Dividends on Preferred Stock</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Dividends on preferred stock for the nine months ended June 30, 2017, were $127,000, compared to $699,000 for the same period in 2016.&#160; The decrease was primarily due to the conversion of Series F Preferred into convertible notes payable and common stock during February 2016 and the reduction in the Series E Preferred dividend rate.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Liquidity and Capital Resources</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">Our primary sources of liquidity are the proceeds from the sale of our equity securities and debt.&#160; We have not historically financed operations from cash flows from operating activities.&#160; We anticipate that we will continue to seek funding to supplement revenues from the sale of our products and services through the sale of equity and debt securities until we achieve positive cash flows from operating activities. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">There is no guarantee that we will be able to raise capital on terms to favorable to the Company or at all.</font></div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Our cash balance as of June 30, 2017, was $114,000.&#160; At that time, we had a working capital deficit of $28,732,000, compared to a working capital deficit of $12,871,000 as of September 30, 2016.&#160; The increase in working capital deficit is primarily due to additions to accounts payable, accrued expenses, notes payable, and derivatives liabilities related to the issuance of notes payable and related warrants and reduction of prepaid expenses and other current assets, offset, in part, by additions to inventory and contingent notes receivable.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Operating activities for the nine months ended June 30, 2017, used cash of $618,000, compared to $2,803,000 for the same period in 2016.&#160; The decrease in cash used in operating activities is primarily due to the increase in accounts payable and accrued expenses and decrease in prepaid expenses during the nine months ended June 30, 2017, compared to the same period in 2016, offset, in part, by the increase in <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; BACKGROUND-COLOR: #ffffff">net loss after adjustment for non-cash items</font> and increase in accounts receivable and inventory during the nine months ended June 30, 2017, compared to the increase in accounts receivable and inventory for the same period in 2016.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Investing activities for the nine months ended June 30, 2017, used cash of $503,000, compared to $4,000 for the same period in 2016. The decrease in cash used in investing activities is primarily due to the acquisition of a contingent note receivable during the nine months ended June 30, 2017 and decreased purchases of property and equipment during the nine months ended June 30, 2017, compared to the same period in 2016.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Financing activities for the nine months ended June 30, 2017, provided cash of $1,068,000, compared to $2,779,000 for the same period in 2016. The decrease in cash provided by financing activities is primarily due to a net decrease in proceeds from the issuance of notes payable to related and third parties and net increase in principal payments on notes payable during the nine months ended June 30, 2017, compared to the same period in fiscal year 2016.</div>
</div>

<div style="LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">45</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">We had an accumulated deficit as of June 30, 2017, of $123,330,000, compared to $108,179,000 as of September 30, 2016.&#160; Our total stockholders' deficit as of June 30, 2017, was $34,543,000 compared to $20,111,000 as of September 30, 2016.&#160; These changes were primarily due to our net loss and dividends accrued during the nine months ended June 30, 2017.<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">During April 2017, the Company received a letter from a significant customer dated April 25, 2017 notifying the Company of the termination its customer agreement effective July 1, 2017. This customer represented approximately 67% and 52% of revenues during the three and nine months ended June 30, 2017, respectively. If the Company is not able to replace the revenues generated by this customer, of which there can be no assurance, it will result in a material reduction in revenues beginning in July 2017. On December 22, 2017, the Company entered into a Services Agreement that is expected to significantly improve revenues during the fiscal year ended September 30, 2018.<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">As of the date of this report, notes payable due to unrelated parties with total principal amounts in the aggregate of $2,776,046, owing as of June 30, 2017, are past due, in default, and unpaid.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>In addition, notes payable due to related parties with total principal amounts of $27,980, as of June 30, 2017, are past due, in default and unpaid.&#160; These defaults include principal obligations owed to Partners for Growth, our secured lender, which are in excess of $2,700,000 and which are secured by substantially all assets of the Company.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160; Other notes are currently in technical default. However, as of the time of this report, the lenders have informally agreed to work with us until such time as the notes can be repaid and some of the lenders have provided bridge capital since going in default.</font><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageFooter"></div>

<div id="DSPFPageFooter"></div>

<font style="FONT-WEIGHT: bold">Recent Accounting Pronouncements</font><br style="LINE-HEIGHT: 1.25">
</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In May 2014, August 2015 and May 2016, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue from Contracts with Customers</font>, ASU 2015-14 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue from Contracts with Customers, Deferral of the Effective Date</font>, ASU 2016-12 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue from Contracts with Customers, Narrow-Scope Improvements and Practical Expedients</font>, ASU 2017-13 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Revenue Recognition, Revenue from Contracts with Customers, Leases, and Leases: Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments</font>, and ASU 2017-14 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Income Statement&#8212;Reporting Comprehensive Income, Revenue Recognition, and Revenue from Contracts with Customers</font>, respectively, which implement ASC Topic 606. ASC Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance under US GAAP, including industry-specific guidance. It also requires entities to disclose both quantitative and qualitative information that enable financial statements users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amendments in these ASUs are effective for annual periods beginning after December 15, 2017, and interim periods therein, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted for annual periods beginning after December 15, 2016. These ASUs may be applied retrospectively to all prior periods presented, or retrospectively with a cumulative adjustment to retained earnings in the year of adoption. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In August 2014, the FASB issued ASU 2014-15, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern</font>. This standard sets forth management's responsibility to evaluate, each reporting period, whether there is substantial doubt about the Company's ability to continue as a going concern, and if so, to provide related disclosures. ASU 2014-15 is effective for annual reporting periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its evaluation of going concern.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In July 2015, the FASB issued ASU 2015-11, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Inventory: Simplifying the Measurement of Inventory</font>. The purpose of ASU 2015-11 is to more closely align the measurement of inventory in US GAAP with the measurement of inventory in International Financial Reporting Standards. ASU 2015-11 requires entities to measure most inventory at the "lower of cost or net realizable value." Additionally, some of the amendments are designed to more clearly articulate the requirements for the measurement and disclosure of inventory. ASU 2015-11 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In February 2016, the FASB issued ASU 2016-02, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Leases</font>.&#160; The purpose of ASU 2016-02 is to establish the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. This guidance results in a more faithful representation of the rights and obligations arising from operating and capital leases by requiring lessees to recognize the lease assets and lease liabilities that arise from leases in the statement of financial position and to disclose qualitative and quantitative information about lease transactions, such as information about variable lease payments and options to renew and terminate leases. ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In March 2016, the FASB issued ASU 2016-09, Stock Compensation: Improvements to Employee Share-Based Payment Accounting.&#160; The purpose of ASU 2016-09 is to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equities or liabilities, and classification of amounts in the statement of cash flows.&#160; ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017.&#160; The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">46</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. The amendments in this update provided guidance on eight specific cash flow issues. This update is to provide specific guidance on each of the eight issues, thereby reducing the diversity in practice in how certain transactions are classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In May 2017, the FASB issued ASU 2017-09, Stock Compensation: Scope of Modification Accounting. The amendments in this ASU provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. ASU 2017-09 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivative and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down-round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down-round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity's own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down-round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share ("EPS") in accordance with Topic 260 to recognize the effect of the down-round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down-round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt-Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Accounting Standards Codification, to a scope exception. Those amendments do not have an accounting effect. ASU 2017-11 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Recent Developments</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">Subsequent to June 30, 2017, the Company entered into the following agreements and transactions:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">
<div id="DSPFPageHeader"></div>

<table id="z8a30daaf45cc4a77918c646bbcba2e45" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(1)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 2, 2017, we received a cash advance from a third party in the amount of $100,000, which incurs fees of $1,500 per day until repaid. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company's common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(2)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 7, 2017, we received a cash advance from a third party in the amount of $50,000, which incurs fees of $750 per day until repaid. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company's common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(3)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During August 2017, we received letters related to unsecured notes payable with third parties with principal balances totaling $5,900,000 as of June 30, 2017 where the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(4)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During August 2017, we received a letter related to an unsecured note payable with a third party with a principal balance of $334,464 as of June 30, 2017 wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(5)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During August 2017, we received a letter related to secured and unsecured notes payable with entities controlled by our former chief executive officer and Executive Chairman of the Board of Directors, who was in office at the time, with principal balances of $1,721,100, $1,303,135, $250,000 and $25,463 as of June 30, 2017, wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through January 12, 2018 and extended maturity date was extended through January 12, 2018.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(6)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During August 2017, we received a letter related to an unsecured note payable with a former Executive Chairman of the Board of Directors with a principal balance of $542,004 as of June 30, 2017 wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through January 12, 2018 and extended maturity date was extended through January 12, 2018.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(7)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During July 2017, we granted 1,562 shares of common stock, with a value of $12,496 on the date of grant, to the former Executive Chairman and Chief Executive Officer, who was in office at the time, as a bonus for services performed during the three months ended June 30, 2017.&#160; The value of the shares has been included in accrued expenses as of June 30, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(8)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 16, 2017, we sold $248,500 of future customer receipts to a third party for $175,000 in cash.&#160; The $73,500 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by our former Executive Chairman and Chief Executive Officer, who was in office at the time.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">47</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<table id="z254b0a9b460e4274952a4f1b90a1ca67" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(9)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During July 2017, we granted 50,000 shares of common stock, with a value of $400,000 on the date of grant, to a third party as part of a one-year consulting agreement.&#160; The value of the shares will be amortized to selling, general and administrative expenses evenly over the service period.&#160; On September 5, 2017, our Board of Directors granted the issuance of 500 shares of Series H Preferred stock in lieu of the 50,000 shares of common stock, to which the third party has verbally agreed.&#160; The Series H Preferred shares have not yet been issued.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(10)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During July 2017, we granted 3,937 shares of common stock to employees for bonuses.&#160; The $31,500 fair value of the shares has been included in accrued expenses as of June 30, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(11)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 28, 2017, we sold $224,850 of future customer receipts to a third party for $150,000 in cash.&#160; The $74,850 difference between the future customer receipts and cash received is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by our former Executive Chairman and Chief Executive Officer, who was in office at the time.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(12)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On August 31, 2017, we sold $119,920 of future customer receipts to a third party for $80,000 in cash.&#160; The $39,920 difference between the future customer receipts and cash received is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by our former Executive Chairman and Chief Executive Officer, who was in office at the time.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(13)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, our Board of Directors modified the terms of the Series G Convertible Preferred stock to remove the 18-month lock-up period.&#160; The amendment has not been filed with the State of Delaware as of the date of this filing.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(14)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, our Board of Directors ratified a change to the Series H Preferred stock, previously contemplated and approved by the Board of Directors, to where each share of the Series H Preferred stock is convertible into 100 shares of our common stock, is limited to a total ownership of 4.99% of the outstanding common stock at the time of conversion, is to be non-voting stock, does not bear interest or dividends, and is transferable with the same terms.&#160; The Certificate of Designation for the Series H Preferred stock has not been filed with the State of Delaware as of the time of this filing and no shares had been issued prior to September 5, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(15)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, we entered into a consulting agreement with a former Executive Chairman and Chief Executive Officer, which replaced and existing consulting agreement, for certain consulting services to us including, but not limited to (i) developing business plans, (ii) making introductions to potential customers and/or suppliers, (iii) identifying qualified employees and other service providers, (iv) sales, marketing, manufacturing and other operating activities, and (v) meeting with us and our affiliates' respective managers, officers, employees, agents, and other service providers regarding the business, prospects and our affairs and our affiliates. The former officer may not engage in and shall not be entitled to any fees or consideration for (i) negotiating the purchase and/or sale of our securities, (ii) making recommendations regarding transactions involving our securities, (iii) or any other matters involving transactions of our securities.&#160; The agreement is for one year and includes compensation of $250.00 per hour, but such compensation may not exceed $20,000 during any calendar month, plus 1,500 shares of our Series H Preferred stock.&#160; The shares of Series H Preferred stock have not been issued at the time of this filing.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(16)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, we renewed an existing license and royalty agreement with an entity controlled by a former Executive Chairman and Chief Executive Officer (the "licensee").&#160; Under the agreement, the licensee receives the right to make, sell and use products related to our intellectual property regarding diabetics, cellular, GPS and CareCenter arena and generally characterized as the CareCenter Technology in a certain region.&#160; We shall receive a royalty of 15% of the licensee's gross sales price for the product.&#160; The initial term is for three years whereby the licensee must achieve a minimum royalty of $10,000 per month to maintain the agreement, whereby the agreement will be extended for one addition year unless terminated.&#160; If the minimum monthly royalty is not maintained, the licensee may pay a sum to bring the total payment up to $360,000 within 60 days of the end of the three-year term to extend the agreement for one additional year.&#160; The Company may terminate the agreement if the licensee does not commence to manufacture, distribute and sell product within a 6-month period after the execution of the agreement.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(17)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, we granted 1,500 shares of our Series H Preferred stock to an entity controlled by a former Executive Chairman of the Board of Directors for past services rendered in addition to amounts earned under an existing consulting agreement.&#160; The shares of Series H Preferred stock have not been issued at the time of this filing.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">48</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<table id="z87b18d64053e48f3a22c0034f7c269d1" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(18)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, we entered into an employment agreement with our former Executive Chairman and Chief Executive Officer, who was in office at the time, for a period of two years for services as our Executive Chairman and Chief Executive Officer.&#160; The initial term of the agreement is for two years and shall automatically renew on a year to year basis, unless terminated sooner.&#160; The base compensation is $360,000 per year plus 1,500 shares of our Series H Preferred stock.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by our Board of Directors, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; An additional cash or stock bonus may be awarded, subject to the attainment of such individual and ActiveCare objectives as our Board of Directors shall establish from time to time as determined by our Board of Directors.&#160; Upon certain termination conditions upon termination of the agreement, we may be required to pay severance of twice the base compensation of the former Executive Chairman and Chief Executive Officer at its highest point during the five-year period prior to termination. In addition, our Board of Directors approved compensation at a level of $360,000 per year retroactive from July 2017, when the former Executive Chairman and Chief Executive Officer was appointed, until the employment agreement was signed. Effective October 12, 2017, the agreement was amended to waive any constructive termination in relation to changes in title, working conditions or duties such that his powers are diminished, reduced or otherwise changed to include powers, duties, or working conditions which are note materially consistent with title, continuing after written notice and 10 days to cure.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(19)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, our Board of Directors granted 963 shares of Series H Preferred stock to our former Executive Chairman and Chief Executive Officer, who was in office at the time, in lieu of 96,275 shares of previously granted common stock as a bonus for services performed.&#160; The Series H Preferred shares have not yet been issued.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(20)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 5, 2017, our Board of Directors granted 200 shares of Series H Preferred stock to the holder of an unsecured note payable with a balance of $300,000 as of June 30, 2017 for the extension of the note payable.&#160; The Series H Preferred shares have not yet been issued.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(21)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">From September 21, 2017 through December 1, 2017, we received cash advances totaling $230,000 from an entity controlled by our former Executive Chairman and Chief Executive Officer, who was in office at the time, and repaid $10,000 plus the reimbursement of bank fees of $200.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(22)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 25, 2017, we entered into agreements with its primary product vendor that supersedes all prior agreements with the vendor.&#160; Under the agreements, the vendor will provide all products and services to our service members as they are assigned to the vendor.&#160; In return, the vendor will pay us a fee for services rendered to the vendor and to the members for monitoring and reporting.&#160; We also earn commissions on all members assigned under the agreement to be paid upon completion of certain milestones met with each individual member.&#160; The agreements also modify the terms of an existing note payable to the vendor.&#160; The note accrues interest at 0.65% per annum, is reduced by the amount of commissions earned by us under the agreements and matures on September 25, 2019. The agreements also add interest fees on existing accounts payable at 0.65% per annum and the accounts payable are reduced by the amount of commissions earned by us under the agreements for a minimum of 24 months.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(23)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On September 27, 2017, we received a cash advance from a third party in the amount of $40,000, which incurs fees of $600 per day until repaid.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(24)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">In October 2017, we entered into a settlement agreement related to an unsecured note payable with a principal balance of $300,000 as of June 30, 2017.&#160; As part of the agreement, the lender lent us an additional $200,000 which has been added to the principal balance of the note payable.&#160; The agreement modified the terms of the note payable to become secured by inventory owned by us, requires issuance of 3,000 shares of Series H Preferred Stock, which were granted by our Board of Directors on September 5, 2017 and are required to be able to convert the lender's shares into 300,000 shares of the Company's common stock, and requires payments of $8,600 for 72 consecutive weeks.&#160; If any payment is late, we are required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&#160; The fair value of the shares will be amortized over the life of the amended note. The note terms are adjustable for any terms subsequently provided to other investors.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(25)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 7, 2017, we entered into individual agreements related to secured borrowings from four different parties that each previously purchased customer receivables that require daily payments.&#160; The agreements modified each agreement to reduce the amount of the respective daily payment to approximately half of the amount previously drawn through January 7, 2018, whereafter the amount of the payment returns to the payment required under the respective agreement plus an additional amount equal to the amount shorted during the period of lower payments divided by the number of remaining payments remaining on the original term of the respective note payable.&#160; Three of the four agreements are verbal.&#160; On January 5, 2018, we further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018.&#160; Three of the four agreements are verbal.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(26)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 13, 2017, an entity controlled by a former Executive Chairman of the Board of Directors, with whom we contracted for consulting, terminated the existing consulting arrangement.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">49</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<table id="z9753245d1fa14ee59c77fc5d2a0cc9d8" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(27)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 13, 2017, we entered into a sales broker agreement with an entity controlled by a former Executive Chairman of the Board (the "Sales Broker ").&#160; Under the Sales Broker agreement, the Company will provide services to certain customers referred to us and the Sales Broker will receive administration fees in the amount of 15% of gross revenues, as defined by the Sales Broker agreement, as long as the Company services the respective customer even in the event the Sales Broker agreement is terminated.&#160; The Sales Broker will promote the Company, its services and products, and introduce potential customers to us as a sales representative.&#160; The initial term of the Sales Broker agreement is one year, which automatically renews for additional one-year periods until cancelled by either party.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(28)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 30, 2017, we signed a letter of understanding with a former consultant where we agreed to convert $100,000 of past consulting fees owed into an equivalent value of our equity upon a qualifying capital raise.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(29)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 10, 2017, we signed a formal agreement replacing a former verbal agreement with an unsecured note holder, with principal due of $350,000 as of June 30, 2017.&#160; The new agreement memorialized previously agreed upon terms whereby the lender converted a $350,000 advance into an unsecured note payable, with interest at 2.8% of revenues, for $143,987 in fees and a future payoff fee of 20% of the principal, or $70,000, which are included in accrued liabilities and interest expense as of June 30, 2017.&#160; The written agreement adjusted the verbal agreement to where we are required to pay any outstanding interest at the end of the first month following a quarter end. The lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and the written agreement includes a most favored nations clause in relation to conversion features.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(30)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 27, 2017, we signed a formal agreement memorializing previous agreements with the holder of an unsecured note and cash advance, with aggregate principal due of $1,200,000 as of June 30, 2017, as well as additional advances with aggregate principal of $190,000 that were received subsequent to June 30, 2017.&#160; The new agreement memorialized the terms of the note payable whereby the lender converted $617,500 in advances into a $1,100,000 unsecured note payable, with interest at 18% per annum for $95,226 in fees, which have been included in accrued liabilities and interest expense as of June 30, 2017.&#160; In addition, the new agreement allows for advances to incur fees at 1.5% of the advance principal per calendar day until paid in full.&#160; The written agreement adjusted the verbal agreements to where the note payable and advance balances and fees may be called by the lender at any time and are due by May 30, 2018, and the new agreement includes a most favored nations clause in relation to conversion features on the note payable and advances.&#160; The new agreement also assigned $2,000,000 of note payable principal held by an entity controlled by an officer to the lender.&#160; All interest accrued on the assigned balance is payable to the officer.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(31)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On December 6, 2017, we entered into those certain forbearance and lock up letter agreements with three (3) debtors which held convertible debentures in the aggregate principal amount of $1,109,345 at the time of the agreements, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any of our other securities, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering of $3,000,000 or more.&#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&#160; In addition, two (2) of the debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">50</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="zbd5861f9c85b48c2b999ef342d9317c8" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(32)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">Effective December 11, 2017, we entered into a Securities Purchase Agreement (the "Purchase Agreement") with four accredited investors, including our new Chief Executive Officer in connection with the closing of a bridge financing (the "Bridge Financing") in the gross amount of $600,000. The three remaining accredited investors hold notes payable with an aggregate principal balance of $3,865,865 as of June 30, 2017. Pursuant to the Purchase Agreements, the Investors purchased from us (i) Promissory Notes in the aggregate principal amount of $631,578.06 (the "Notes") due and payable six months from the Effective Date and (ii) Common Stock Purchase Warrants (the "Warrant"), exercisable for five years from the date of issuance, to purchase up that certain amount of shares with an aggregate exercise amount equal to $600,000 at an exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in the companies contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the "Private Placement") (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment hereunder (the "Exercise Price"). The Notes were issued in favor of the Investors with an original issue discount equal to five percent (5%). Additionally, pursuant to the Purchase Agreement, we will issue the investors common stock (the "Origination Shares") worth 30% of the purchase price paid by each investor (the "Origination Dollar Amount") on the 5th trading day after the pricing of the Private Placement, but in no event later than six months from the Effective Date. The Origination Dollar amount will divided by the lowest of (i) $3.00 (subject to adjustment for stock splits), (ii) 80% of the common stock offering price in the Private Placement, (iii) 80% of the offering price of the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement.&#160; At the closing of the Private Placement the Note shall automatically convert into a subscription into the Private Placement in an amount equal to 125% of the Note balance, subject to certain conditions as outlined therein. If we fail to repay the balance due under the Note on its Maturity the Investors have the right, at any time, at their election, to convert all or part of the outstanding and unpaid principal sum and accrued interest (and any other fees) into shares of fully paid and non-assessable shares of our common stock pursuant to the following conversion formula: number of shares receivable upon conversion equals the dollar amount being converted divided by the Conversion Price. The Conversion Price is the lesser of $3.00 (subject to adjustment for stock splits) or 60% of the lowest trade price in the 25 trading days. Further, in the event of any default, the outstanding principal amount of the Notes, plus accrued but unpaid interest, liquidated damages, fees and other amounts owing in respect thereof through the date of acceleration (the "Note Balance"), shall become, at the Investor's election, immediately due and payable in cash at the Mandatory Default Amount. The Mandatory Default Amount means the investor's choice of (this choice may be made at any time without presentment, demand, or notice of any kind): (i) the Note Balance divided by the Conversion Price on the date of the default multiplied by the closing price on the date of the default; or (ii) the Note Balance divided by the Conversion Price on the date the Mandatory Default Amount is either (a) demanded or (b) paid in full, whichever has a lower Conversion Price, multiplied by the closing price on the date the Mandatory Default Amount is either (a) demanded or (b) paid in full, whichever has a higher closing price; or (iii) 150% of the Note Balance. If, at any time the Note is outstanding, we issue a Variable Security (as defined therein), then in such event the Investors shall have the right to convert all or any portion of the outstanding balance of the Notes into shares of Common Stock on the same terms as granted in any applicable Variable Security issued by the Company.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(33)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On November 17, 2017, we received cash advances from third parties totaling $60,000.&#160; On January 5, 2018, the advances converted into agreements with the same terms as the Bridge Financing entered into on December 11, 2017.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(34)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On December 11, 2017, Eric Robinson voluntarily resigned as Chief Financial Officer, Secretary and In-House Counsel, and all other positions with the Company to which he has been assigned regardless of whether he served in such capacity, effective immediately. On the same date, Jeffrey S. Peterson voluntarily resigned as Chairman of the Board of Directors, while acknowledging that he will continue to serve the Company as a Director and Executive Vice President.&#160; On the same date, Robert J. Welgos and Bradley Robinson voluntarily resigned as members of the Board of Directors and all other positions with us to which they may have been assigned, regardless of whether they served in such capacity, effective immediately.&#160; These resignations were not as a result of any disagreements with us.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(35)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On December 11, 2017, Isaac Onn was appointed as a member of our board of Directors and Mark J. Rosenblum was appointed as our Chairman of the Board of Directors and Chief Executive Officer in connection with the Bridge Financing.&#160; In connection with Mr. Rosenblum's appointment as our Chief Executive Officer, on December 11, 2017, we and Mr. Rosenblum finalized the terms of his employment and entered into an employment agreement (the "Rosenblum Employment Agreement"). Mr. Rosenblum shall have such duties, responsibilities and authority which shall include, but not be limited to the responsibility for the overall management, direction and strategy of the Company. We shall pay Mr. Rosenblum a salary at a rate of Three Hundred Thousand and 00/100 Dollars ($300,000) per year (the "Initial Base Salary"). The Initial Base Salary shall increase to an annual rate of Three Hundred and Sixty Thousand Dollars ($360,000) (the "Base Salary") upon our closing a financing of at least Five Million Dollars ($5,000,000). Mr. Rosenblum shall be eligible for an annual performance-based cash bonus of up to 100% of the Base Salary (as further defined in the Rosenblum Employment Agreement"). The Rosenblum Employment Agreement is for a term of three (3) years and will be automatically renewed for one year periods, unless otherwise terminated by us or Mr. Rosenblum. Upon execution of the Rosenblum Employment Agreement we agreed to issue restricted shares equal to $300,000 valued at the offering price of the next equity offering of the Company ("RSU") and an option to purchase an aggregate $600,000 valued at the offering price of our next equity offering at an exercise price equal to the market price for our next equity offering (the "Options"). One-third of these Options shall vest immediately, another third on the first anniversary of the Rosenblum Employment Agreement, and the final third on the second anniversary of the Rosenblum Employment Agreement. The RSUs shall vest 50% immediately upon issuance and 25% on each of the first and second anniversaries of the Rosenblum Employment Agreement. If the Company terminates Mr. Rosenblum's employment without just cause or if Mr. Rosenblum's employment is terminated due to Disability (as defined therein), Mr. Rosenblum shall be entitled to receive, in addition to any accrued and unpaid Base Salary, plus any accrued but unused vacation time and unpaid expenses that have been earned as of the date of such termination, the following severance payments (the "Severance Payments"): (i) equal monthly installments at the applicable Base Salary rate then in effect, as determined on the first day of the calendar month immediately preceding the day of termination, to be paid beginning on the first day of the month following such termination and continuing until the later of (A) the expiration of the Term or (B) the expiration of (i) six (6) months following the effective termination date; provided, however, that if we terminate the Agreement without Just Cause (as defined in the Rosenblum Employment Agreement) within six (6) months of the effective date, then Mr. Rosenblum will only be entitled to three (3) months of severance instead of six (6) months; and (ii) during the Severance Period (as defined in the Rosenblum Employment Agreement), health and life insurance benefits substantially similar to those which Mr. Rosenblum was receiving or entitled to receive immediately prior to termination; provided, however, such insurance benefits shall be reduced to the extent comparable benefits during such period following Mr. Rosenblum's termination, and any benefits actually received shall be reported by Mr. Rosenblum to us.&#160; We will reimburse Mr. Rosenblum for any reasonably travel and relocation expenses.</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">51</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="z9e538d4fe797404797e15ca162bd347e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(36)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">During December 2017, we entered into those certain forbearance and lock up letter agreements with a debtor which holds convertible debentures in the principal amount of $25,312 as of December 5, 2017, whereby the debtor agreed that, without our prior written consent, the debtor will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any of our other securities, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering of $3,000,000 or more. Additionally, the debtor agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the convertible debentures. The forbearance and lock up letter agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(37)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On January 12, 2018, we received letters from four (4) debtors which hold convertible debentures with principal balances totaling $3,162,955 as of June 30, 2017 where the debtors forbear against any historical and future events of default and remedies through February 15, 2018 and extended the maturity date through February 15, 2018. As part of the letters, we agreed not to initiate any new financing arrangements without the consent of the debtors.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(38)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On January 12, 2018, we received a letter from a lender who holds two unsecured notes payable with principal balances totaling $550,000 as of June 30, 2017 where the lender forbears against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">(39)</div>
</td>
<td style="WIDTH: 94.15%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.7pt">On December 22, 2017, we entered into a Services Agreement (the "Cleveland Clinic Agreement") with the Cleveland Clinic Foundation d.b.a. Cleveland Clinic, an Ohio nonprofit corporation ("Cleveland Clinic"). Pursuant to the Cleveland Clinic Agreement, we will be providing services to Cleveland Clinic as agreed to by the parties in any mutually agreed form pursuant to a "Statement of Work". Pursuant to the Statement of Work included in the Cleveland Clinic Agreement, we will provide monitoring services to Cleveland Clinic's expected beneficiary diabetic population within the Cleveland Clinic Medicare ACO. The initial term of the Cleveland Clinic Agreement is for three years and shall automatically renew after the term for a successive twelve (12) month period from year to year unless sooner terminated by either party in accordance with the terms of the Cleveland Clinic Agreement. As consideration for our Services, we are to receive a fixed monthly fee per Covered Diabetic Patient (as defined in the Cleveland Clinic Agreement). In addition, at such time the Cleveland Clinic Accountable Care Organization ("CCACO") shall receive a shared savings payment from the Centers for Medicare and Medicaid Services, CCACO shall share such savings with us based on a formula defined in the Cleveland Clinic Agreement. Cleveland Clinic may, by written notice to us, terminate the Agreement, any purchase order or any portion of a purchase order if we (i) are in material breach of any of the terms and conditions of the Cleveland Clinic Agreement or any Purchase Order, which breach in not cured within thirty (30) days after notification of such breach, (ii) terminate or suspend our business, become insolvent, or become subject to any bankruptcy or insolvency proceeding under Federal or State law. Cleveland Clinic further may terminate the Cleveland Clinic Agreement, any Purchase Order or any portion of any Purchase Order for convenience upon ninety (90) days' prior written notice to us ("Termination for Convenience"). In connection with any Termination for Convenience, Cleveland Clinic will reimburse Company for the actual cost reasonably incurred for work in process up to the time of cancellation, as well as any non-cancellable contract of Company, or non-cancellable purchase order to a third party, entered into for the benefit of Cleveland Clinic. The Cleveland Clinic Agreement is nonexclusive, and Cleveland Clinic may contract with others to perform similar services. Accordingly, the Company may also perform similar services for others.</div>
</td>
</tr>
</table>

<div id="DSPFPageFooter"></div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.9pt">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">52</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Item 3.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Quantitative and Qualitative Disclosures about Market Risk</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Information about our exposure to market risk was disclosed in our Annual Report on Form 10-K for the year ended September 30, 2016, which was filed with the Securities and Exchange Commission ("SEC") on January 13, 2017. There have been no material quantitative or qualitative changes in market risk exposure since the date of that filing.</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Item 4.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Controls and Procedures</font></div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">(a) &#160;Evaluation of Disclosure Controls and Procedures</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We maintain disclosure controls and procedures that are designed to ensure that information that is required to be disclosed in our reports under the Securities Exchange Act of 1934 ("Exchange Act") is recorded, processed, summarized, and reported within the time periods that are specified in the rules and forms of the SEC and that such information is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding any required disclosure.&#160; In designing and evaluating these disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.</div>

<div style="LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) under the Exchange Act). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2017, our disclosure controls and procedures were not effective, for the reasons discussed below.&#160;&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the audit process for the year ended September 30, 2016 and the review process for the nine months ended June 30, 2017, management identified ineffective controls over the accounting for 1) debt issuance costs and derivatives, and 2) debt extinguishments as material weaknesses in internal control over financial reporting.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We are in the process of improving our internal control over financial reporting in an effort to eliminate these material weaknesses through improved supervision and training of our staff. Our management, audit committee, and directors will continue to work to ensure that our controls and procedures become adequate and effective.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 18pt">(b)&#160; Changes in Internal Control over Financial Reporting&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 12pt; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">PART II &#8211; OTHER INFORMATION</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Item 1.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Legal Proceedings</font></div>

<a name="_DV_M398"><!--Anchor--></a>

<div id="DSPFPageHeader" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Except as set forth below, there are no material proceedings to which any director or officer, or any associate of any such director or officer, is a party that is adverse to our Company or any of our subsidiaries or has a material interest adverse to our Company or any of our subsidiaries. No director or executive officer has been a director or executive officer of any business which has filed a bankruptcy petition or had a bankruptcy petition filed against it during the past ten years.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 8pt; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">On May 28, 2015, an investor in the Company, filed a lawsuit against the Company, James Dalton, our former CEO and Chairman, ADP Management, an entity controlled by David Derrick, our former Executive Chairman, and 4G Biometrics, a wholly owned subsidiary of the Company in the District Court of Utah-Central Division (Case No. 2:15-CV-00373-BCW). The lawsuit alleges a breach of contract, breach of the implied covenant of good faith and fair dealing, fraud and conspiracy to commit fraud and seeks damages in excess of $1,000,000, exclusive of interest and costs. The Company has engaged legal counsel regarding the matter. The Company has assessed a high probability of settling the matter for $750,000 in cash, equity, or a combination thereof.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Item 1A. Risk Factors.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We believe there are no changes that constitute material changes from the risk factors previously disclosed in our Annual Report on Form 10-K, filed with the SEC on January 13, 2017.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Item 2.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Unregistered Sales of Equity Securities and Use of Proceeds</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the three months ended June 30, 2017, we issued 7,000 shares of common stock for services provided by an independent consultant, with a value on the date of grant of $70,000 <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">in reliance on an exemption from registration set forth in Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Regulation D promulgated thereunder.</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">There were no other unregistered sales of the Company's equity securities during the quarter ended June 30, 2017, that were not otherwise disclosed in a Current Report on Form 8-K.</div>

<div id="DSPFPageFooter"></div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">53</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageFooter" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Item 3.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Defaults Upon Senior Securities</font></div>

<!--PROfilePageNumberReset%Num%54%%%-->
<div id="DSPFPageHeader" style="PAGE-BREAK-AFTER: always"></div>

<div style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; PAGE-BREAK-AFTER: always; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">As of the date of this report, notes payable due to unrelated parties with total principal amounts of $2,776,046, owing as of June 30, 2017, are past due, in default, and unpaid.&#160; In addition, notes payable due to related parties with total principal amounts of $26,721, as of June 30, 2017, are past due, in default and unpaid.&#160; These defaults include obligations owed to Partners for Growth, our secured lender, which are in excess of $2,700,000 and are secured by substantially all assets of the Company.&#160; We intend to make payments on these notes payable as funds are available.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160; Other notes are currently in technical default. However, as of the time of this report, the lenders have informally agreed to work with us until such time as the notes can be repaid and some of the lenders have provided bridge capital since going in default.</font></div>

<div id="DSPFPageFooter" style="PAGE-BREAK-AFTER: always"></div>

<div id="DSPFPageFooter" style="PAGE-BREAK-AFTER: always"></div>

<div style="PAGE-BREAK-AFTER: always; FONT-WEIGHT: bold">Item 4. &#160;Mine Safety Disclosures.</div>

<div style="PAGE-BREAK-AFTER: always">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Not applicable.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="MARGIN-BOTTOM: 6pt; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Item 5.&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Other Information</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">There is no other information required to be disclosed under this item which was not previously disclosed.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Item 6. Exhibits</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="z457457cc103f4892a434e6364b88aa84" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;<strong><u>Exhibit Number</u></strong></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><strong><u>Description</u></strong></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">4.1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000121390017013222/f8k120617ex4-1_activecare.htm"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Form of Warrant</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> (</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017).</font></a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">10.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Form of employment agreement with former chief executive officer.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">10.2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000109690617000257/exh10_1.htm">Factoring Agreement by and between Complete Business Solutions Group, Inc. and ActiveCare, Inc. (incorporated by reference to Current Report on Form 8-K filed with the SEC on April 20, 2017).</a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">10.3</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000109690617000257/exh10_2.htm">Joint Venture Agreement by and between Colorado Choice Health Plans and ActiveCare, Inc. (incorporated by reference to Current Report on Form 8-K filed with the SEC on April 20, 2017).</a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">10.4</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000109690617000257/exh10_3.htm">Amendment # 5 to the Securities Purchase Agreement and the $2,000,000 Promissory Note dated September 19, 2016 (incorporated by reference to Current Report on Form 8-K filed with the SEC on April 20, 2017).</a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">10.5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000121390017013222/f8k120617ex10-1_activecare.htm">Form of Forbearance and Lock Up Agreement (incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017).</a></div>
</td>
</tr>

<tr style="HEIGHT: 12px">
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">10.6</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000121390017013222/f8k120617ex10-2_activecare.htm">Form of Securities Purchase Agreement (incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017).</a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">10.7</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000121390017013222/f8k120617ex10-3_activecare.htm">Form of Promissory Note (incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017).</a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">10.8</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000121390017013222/f8k120617ex10-4_activecare.htm">Employment Agreement by and Between Mark J. Rosenblum and ActiveCare, Inc. (incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017).</a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">17.1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000121390017013222/f8k120617ex17-1_activecare.htm">Letter of Resignation from Bradley Robinson (incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017).</a></div>
</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">17.2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000121390017013222/f8k120617ex17-3_activecare.htm">Letter of Resignation from Eric Robinson (incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017).</a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr style="HEIGHT: 15px">
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">17.3</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/1429896/000121390017013222/f8k120617ex17-3_activecare.htm">Letter of Resignation from Jeffrey S. Peterson (incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017).</a></div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">31.1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Certification by the Principal Executive Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)). *</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">31.2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Certification by the Principal Financial Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)). *</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">32</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 90%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Certification pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *</div>
</td>
</tr>
</table>

<div id="DSPFPageFooter"></div>

<font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 216pt; DISPLAY: inline-block">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">* Filed herewith</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">*&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The XBRL related information in Exhibit 101 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.</font></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">54</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SIGNATURES</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z797edabda41b46afb4eea6326fd0e633" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 31.01%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 68.99%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ActiveCare, Inc.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 31.01%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 68.99%; VERTICAL-ALIGN: bottom">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 31.01%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 68.99%; VERTICAL-ALIGN: middle">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 31.01%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 68.99%; VERTICAL-ALIGN: middle">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 31.01%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Date: January 31, 2018</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 68.99%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: bold; FONT-STYLE: normal"><u>&#160;/s/Mark J. Rosenblum </u></td>
</tr>

<tr>
<td style="WIDTH: 31.01%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 68.99%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark J. Rosenblum</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Executive Officer</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Principal Executive Officer)</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z6a4d4fb036af4490901cae82a4a6940e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 31%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Date:&#160;January 31, 2018&#160;</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 69%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: bold; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: "><u>&#160;/s/Jeffrey S. Peterson</u></td>
</tr>

<tr>
<td style="WIDTH: 31%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 69%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: left; FONT: bold 10pt/1.25 'Times New Roman', Times, serif">Jeffrey S. Peterson</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Executive Vice President</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Principal Financial and Accounting Officer)</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">55</font></div>

<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh10_1.htm
<DESCRIPTION>SPARTAN SECURITIES AGREEMENT
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.1
    Copyright 1995 - 2018 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<!--PROfilePageNumberReset%Num%1%%%-->
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 10.1</font><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div>&#160;</div>

<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EMPLOYMENT AGREEMENT</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">THIS EMPLOYMENT AGREEMENT (the "Agreement") is effective as of the 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup> day of September, 2017, between Jeffrey Peterson, an individual ("Executive"), and <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">ACTIVECARE, INC., a Delaware corporation </font>("ActiveCare"). Executive and ActiveCare are sometimes collectively referred to herein as the "parties."</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>RECITALS</u></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">WHEREAS, ActiveCare is a corporation engaged in the business of monitoring individuals with diabetes; and</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">WHEREAS, Executive desires to obtain from ActiveCare certain benefits as set forth in this Agreement and ActiveCare desires to obtain from Executive a commitment to render services to ActiveCare and to provide various covenants relating to non-competition, intellectual property, non-disclosure and non-solicitation on the terms and conditions set forth in this Agreement, and Executive wishes to be employed by ActiveCare on such terms and conditions.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>AGREEMENT</u></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">NOW, THEREFORE,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>in consideration of the mutual promises and covenants contained herein, the parties agree as follows:</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Employment</u></font>.&#160; ActiveCare hereby employs Executive in the position of Chief Executive Officer.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Term</u></font>. The term of Executive's employment shall commence on the effective date of this Agreement and continue for an initial term of 2 year, unless sooner terminated as provided herein. Upon expiration of the initial term, the term of Executive's employment shall automatically renew on a year-to-year basis, unless and until terminated as provided herein.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Executive's Duties and Responsibilities</u></font>.</font></div>

<div>
<table id="zfcbcb11e0cf6482192d3a0eef5cbe56b" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">3.1</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Services with ActiveCare</u></font>. During the term of Executive's employment, Executive shall be appointed as Chief Executive Officer and shall perform such duties as are commensurate with his position as Chief Executive Officer. The Executive may be asked to also serve as a director of ActiveCare during all or part of the Term of this Agreement. Executive shall not receive any additional compensation for serving on the Board of Directors (the "Board"). Executive shall abide by the rules, regulations, and practices as adopted or modified from time to time by ActiveCare, in its discretion.&#160; Further, shall Executive's duties, responsibilities, or title change, said agreement shall remain in full force and effect in its entirety, and specifically including Sections 4 and 7 of said agreement herein.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zfbee3cd947f14d50b58dc2f4401cf725" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">3.2</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Performance of Duties</u></font>. Executive agrees to serve ActiveCare faithfully and to the best of Executive's ability. Executive will spend his full-time effort performing his duties for ActiveCare.&#160; Executive may set his own schedule, and is not required to be present for any set hours per day, week or month.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z9e83d31f81034e3ca1647bd915f472a5" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">3.3</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>No Conflict</u></font>.&#160; Executive hereby confirms that he is under no contractual commitments inconsistent with Executive's obligations set forth in this Agreement and that during the term of this Agreement, Executive will not render or perform services for any other corporation, firm, entity or person which are inconsistent with the provisions of this Agreement.&#160; While Executive remains employed by ActiveCare, Executive may participate in outside business activities as described in section 3.5. and in reasonable charitable activities and personal investment activities so long as such activities do not interfere with the performance of Executive's obligations under this Agreement.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="za63d1515533c42adae5e631445f9209e" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">3.4</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Location</u></font>. Executive's principal office shall initially be located in Orem, Utah, subject to necessary travel requirements of his position and duties hereunder.&#160; ActiveCare reserves the right to move Executive's principal office to a location within a 50 miles radius of said location.</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">1</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Compensation</u></font>.</font></div>

<div>
<table id="zeccb63ce018842e9ac8abd85dc06f59d" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">4.1</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Base Salary</u></font>. During the term of this Agreement, ActiveCare shall pay to Executive an annual Base Salary in the amount of $360,000 in consideration for Executive service to ActiveCare. Executive shall be entitled to annual compensation reviews in which all aspects of his compensation shall be compared with Chief Executive Officer of similarly situated companies with the objective of providing the Executive with appropriate rewards and incentives.&#160; In no event shall Executive's compensation be decreased.&#160; Executive's salary shall be paid in accordance with the Company's regularly established payroll practice.&#160; Executive's Base Salary will be reviewed from time to time in accordance with the established procedures of the Company for adjusting salaries.&#160; Effective as of the date of any change to Executive's Base Salary, the Base Salary as so changed shall be considered the new Base Salary for all purposes of this Agreement.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z44836a6f099641c3b1d13f8caf9ad051" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">4.2</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Bonus Compensation</u></font>.&#160; Subject to the attainment of such individual and ActiveCare objectives as the Board of Directors of ActiveCare shall establish, the Executive will be awarded a cash and or stock bonus from time to time as determined by the Board of Directors of ActiveCare.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z8d96444e7f2a49ea901d7be6dfc30077" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">4.3</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Long Term Incentive</u></font>. Executive shall receive 1,500 shares of Series H Preferred Stock of ActiveCare Stock.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zd75d3aa795404757a11b4ef6aa9b19db" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">4.4</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Participation in Benefit Plans</u></font>. During the Term, the Executive and, to the extent eligible, his dependents, shall be entitled to participate in and receive all benefits under any Executive benefit plans and programs provided by ActiveCare (including without limitation, 401(k), medical, dental, disability, group life (including accidental death and dismemberment) and business travel insurance plans and programs) to full-time senior management personnel of ActiveCare, subject, however, to the terms and conditions of the various plans and programs in effect from time to time.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z386d27bebb9c4ee1bc083c11e54b29d2" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">4.5</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Expenses</u></font>. ActiveCare agrees to pay or to reimburse the Executive during the Term for all reasonable, ordinary and necessary vouchered business or entertainment expenses incurred in the performance of his services hereunder in accordance with the policy of ActiveCare as from time to time in effect.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z837955f358c949059bbc98a7225717d5" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">4.6</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Personal Time Off</u></font>. Executive will be entitled to, and as described in the Executive Handbook, personal days off during each calendar year. The Executive shall accrue paid personal time off days in accordance with the personal time off days policy of ActiveCare applicable generally to Executives of ActiveCare in effect from time to time.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z2356edf1b7ec494d84f8f98ca411a440" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">4.7</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Benefit Program Changes</u></font>. Notwithstanding anything contained herein to the contrary, ActiveCare reserves the right to modify, amend or terminate any Executive benefit plan or policy as it deems appropriate in its discretion; provided that unless required by law, ActiveCare shall not amend, modify or terminate any such plan or policy in a manner that treats the Executive differently from other similarly situated Executives.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z8c6dfb5d5ca1460e9817a0b3d0f76fc3" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">4.8</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Withholdings</u></font>. All compensation, including without limitation the salary and bonus, paid to the Executive shall be subject to applicable tax withholding requirements as are required by federal, state and local laws, including, but not limited to, federal, state, and local income taxes, FICA and Medicare, and such other sums on which ActiveCare and Executive may agree from time-to-time in writing.<a name="_Ref20198990"><!--Anchor--></a></div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">2</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Confidential Information</u></font>.&#160; Except as permitted or directed by the Board, during the term of Executive's employment or at any time thereafter, Executive shall not divulge, furnish or make accessible to anyone or use in any way (other than in the ordinary course of the business of ActiveCare) any confidential or secret knowledge or information of ActiveCare that Executive has acquired or become acquainted with or will acquire or become acquainted with prior to the termination of the period of Executive's employment by ActiveCare (including employment by ActiveCare prior to the date of this Agreement), whether developed by Executive or by others, concerning any trade secrets, confidential or secret designs, processes, formulae, plans, devices or material (whether or not patented or patentable) directly or indirectly useful in any aspect of the business of ActiveCare, any customer or supplier lists of ActiveCare, any confidential or secret development or research work of ActiveCare, or any other confidential information or secret aspects of the business of ActiveCare.&#160; Executive acknowledges that the above-described knowledge or information constitutes a unique and valuable asset of ActiveCare and represents a substantial investment of time and expense by ActiveCare, and that any disclosure or other use of such knowledge or information other than for the exclusive benefit of ActiveCare would be wrongful and would cause irreparable harm to ActiveCare.&#160; Both during and after the term of Executive's employment, Executive will refrain from any acts or omissions that would reduce the value of such knowledge or information to ActiveCare.&#160; The foregoing obligations of confidentiality shall not apply to any knowledge or information that is (a) now made generally available to the public; (b)&#160;subsequently becomes generally publicly known in the form in which it was obtained from ActiveCare, other than as a direct or indirect result of the breach of this Agreement by Executive; or (c) was known to or held by Executive prior to disclosure thereof by ActiveCare to Executive, as evidenced by pre-existing written documentation.</font></div>

<div>
<table id="z9bf3853fad1f4447a76662edef299d40" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">5.1</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Good Faith Effort</u></font>. Notwithstanding the foregoing, in the event that Executive has knowledge of secret, confidential and/or proprietary information to which ActiveCare has a claim, then Executive shall not be liable to ActiveCare pursuant to the provisions of this Agreement for any disclosures of such information, if Executive makes a good faith attempt to maintain the information as secret, confidential and/or proprietary.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z75fa915ea174430ea73c6f80110e118f" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">5.2</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Right to Pursue "Outside Activities"</u></font>.&#160; Notwithstanding anything else contained in this Agreement and unless subsequently agreed by ActiveCare and Executive in writing, Executive shall not be prohibited from engaging in other Outside Activities during the term of this Agreement, or after termination of the Agreement, and ActiveCare shall not be entitled to damages, or other relief, by virtue of the fact that Executive is or continues to engage in University or other Outside Activities.</div>
</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 31.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 40.5pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a name="_Ref20198998"><!--Anchor--></a><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Noncompetition Covenant</u></font>.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6.1</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Agreement Not to Compete</u></font>.&#160; During the term of Executive's employment with ActiveCare Executive agrees to not compete in any manner in which ActiveCare engages in.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6.2</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Geographic Extent of Covenant</u></font>.&#160; The obligations of Executive under Section 6.1 shall apply to any geographic area in which ActiveCare (i) has engaged in business during the term of this Agreement through production, promotional, sales or marketing activity, or otherwise, or (ii) has otherwise established its goodwill, business reputation or any customer or supplier relations.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6.3</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Acknowledgment</u></font>.&#160; Executive agrees that the restrictions and agreements contained in this Section 6 are reasonable and necessary to protect the legitimate interests of ActiveCare and that any violation of this Section 6 will cause substantial and irreparable harm to ActiveCare that would not be quantifiable and for which no adequate remedy would exist at law and accordingly injunctive relief shall be available for any violation of this Section 6.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6.4</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Blue Pencil Doctrine</u></font>.&#160; If the duration or geographical extent of, or business activities covered by, this Section 6 are in excess of what is valid and enforceable under applicable law, then such provision shall be construed to cover only that duration, geographical extent or activities that are valid and enforceable.&#160; Executive acknowledges the uncertainty of the law in this respect and expressly stipulates that this Agreement be given the construction which renders its provisions valid and enforceable to the maximum extent (not exceeding its express terms) possible under applicable law.<a name="_Ref20199011"><!--Anchor--></a></font></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Termination of Employment</u></font><a name="_Ref20200333"><!--Anchor--></a>.</font></div>

<div>
<table id="z55574f2e67654d45a44a53b26749fbcb" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">7.1</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Termination for Cause</u></font>. This Agreement may be terminated by ActiveCare immediately and without notice only upon the occurrence of any of the following events (each of which shall constitute "Reasonable Cause" for termination):</div>
</td>
</tr>
</table>
</div>

<div>
<table id="za533eca55f424617be568fb4c8ef40c0" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">a.</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt">&#160;Executive commits any act of gross negligence, fraud, dishonesty, or willful violation of any law or material violation of any significant written policy of ActiveCare that causes any harm to ActiveCare;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zf41bef3dc0274736ba025873d13b70e5" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">b.</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt">Conviction of Executive of a felony or serious crime involving moral turpitude;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z4e246773986344ddbbfa1830f7b81df7" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">c.</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt">Repeated drunkenness or illegal narcotic drug use by Executive;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zece9600a85734fdab6a067a5c7aded75" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">d.</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt">Failure to substantially perform the duties reasonably assigned to Executive, or any intentional refusal without compelling reason by Executive to discharge Executive's job responsibilities and/or respond to ActiveCare's legitimate job-related requests, insofar as such responsibilities and/or requests do not contravene law;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zc0431ac696c54aa6af46212f4e619699" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">e.</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt">Any excessive and unexcused absenteeism by Executive;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z06e6b71136cc4b4294c918775efd56b5" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">f.</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt">Failure to cooperate in an investigation conducted and/or undertaken by ActiveCare or a governmental agency which has reasonable and legitimate objectives; and</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zb96a19cc1d6844c9b42d1095f7660afe" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 108pt; LINE-HEIGHT: 1.25">g.</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt">Except as otherwise authorized by the terms of this Agreement, any act of intentional conflict of interest by Executive to ActiveCare which has the potential to cause economic and/or other damage to ActiveCare.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zda12dc05b1b04e8c8177c8d72157eae0" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">7.2</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Voluntary Termination</u></font>. The Executive may, with three months' notice, terminate this Agreement at any time.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt">Upon the termination of the employment of the Executive with ActiveCare pursuant to this Section 7.2, the Executive shall be entitled to receive, subject to any offsets, amounts as defined by Section 7.5 (a), (b), (c), and (d). In addition, Executive's unit options shall be governed by Section 7.5 (e).</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7.3</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Death or Disability</u></font>. In the event the Executive shall be unable to perform his duties hereunder for a period of more than one hundred and twenty (120) days by virtue of illness or physical or mental incapacity or disability (from any cause or causes whatsoever) in substantially the manner and to the extent required hereunder prior to the commencement of such disability (all such causes being herein referred to as "disability"), ActiveCare shall have the right to terminate Executive's employment hereunder as at the end of any calendar month during the continuance of such disability upon at least 60 days' prior written notice to him. This provision shall comply with those rights to which Executive may be entitled under the Americans with Disabilities Act, Family Medical Leave Act, or other federal, state, or local laws.&#160; In the event of the Executive's death, the Date of Termination shall be the date of such death.</font></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">4</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt">In the event the Executive's employment terminates pursuant to this Section 7.3, the Executive, or in the case of his death, the Executive's estate, shall be entitled to receive, subject to any offsets, amounts as defined by Section 7.5 (a), (b), (c), (d) and (f). In addition, Executive's unit options, if any, shall be governed by Section 7.5 (e).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt">Except as provided in this Section 7.3, ActiveCare shall have no further liability to the Executive or the Executive's heirs, beneficiaries or estate for damages, compensation, benefits, severance, indemnities or other amount of whatever nature.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7.4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Constructive Termination</u></font>. In the event Executive terminates his employment as a result of a Constructive Termination (defined below), Executive shall be entitled to compensation, subject to any offsets, as set forth in Section 7.5 (a), (b), (c), (d), (f) and (i). Executive's unit options shall be governed by the provisions of Section 7.5 (g). In addition, Executive shall be entitled to the severance compensation as set forth in Section 7.5 (h).</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt">A "Constructive Termination" will exist in the event the Executive terminates his employment with ActiveCare after ActiveCare:&#160; (i) materially breaches this Agreement, which breach is not cured within 10 days following written notice from Executive; (ii) changes Executive's title, working conditions or duties such that Executive's powers are diminished, reduced or otherwise changed to include powers, duties, or working conditions which are not materially consistent with title, continuing after written notice and 10 days to cure; (iii) commits acts that would cause Executive to commit fraudulent acts or expose Executive to criminal liability; (iv) involuntarily relocates the Executive's primary place of employment beyond the location as defined in Section 1.2;&#160; (v) merges with or is acquired by another person or entity, or another person or entity, directly or indirectly, acquires sufficient power or control to direct the&#160; activities of ActiveCare, and ActiveCare fails to obtain the assumption in writing of its obligations to perform this Agreement by any within 15 days after the occurrence of the transaction resulting in such. For the purpose of this definition, "control" shall also mean the ability to cause any decision to be taken of or by ActiveCare through ownership of units, voting rights or control of the management; or (vi) ActiveCare decides to abandon or significantly change the direction of its scientific research and/or development, contrary to the direction advocated by Executive.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt">Except as provided in this Section 7.4, ActiveCare shall have no further liability to the Executive or the Executive's heirs, beneficiaries or estate for damages, compensation, benefits, severance, indemnities or other amount of whatever nature.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7.5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Termination Settlement</u></font>. The specific consideration due the Executive is controlled by the nature of the termination as defined in the above Sections. In each instance, calculations will be based on Date of Termination.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">a.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any earned but unpaid salary compensation;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">b.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any earned but unpaid cash bonus;</font></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">5</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">c.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any unused accrued vacation;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">d.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any unpaid reimbursable expenses;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">e.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Subject to such terms and conditions as expressly required by the applicable unit plans, (i) all vested unit options shall remain exercisable for a ninety (90) days (ii) all unvested unit options shall be forfeited, and (iii) all unvested units, shall be forfeited notwithstanding any contrary provisions in the unit grant;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">f.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">A pro rata annual incentive award for the year in which Executive's termination occurs, based on the maximum award opportunity for such year, payable in a single installment;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">g.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Full vesting of any outstanding long-term incentive awards, unit options and restricted units, granted to Executive under any long-term incentive plan or plans of ActiveCare in which Executive has participated;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">h.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">A lump sum severance payment in an amount equal to twice the Executive's Base Salary.&#160; This amount is to be paid within thirty (30) days of the termination of Executive's employment.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">i.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Continued medical insurance for eighteen (18) months, paid for entirely by ActiveCare.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">j.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All personal guarantees made by Executive on and in behalf the of ActiveCare shall be fully satisfied in all aspects, with no remaining personal guarantees by Executive to be remaining after 14 days of termination, by either voluntary or cause.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7.6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Base Salary for Severance Benefit Determinations</u></font>.&#160; Base salary shall be the highest received cash compensation by Executive over the last five years. </font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7.7</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>New Employment</u></font>. Executive shall inform ActiveCare of the identity of any new employer promptly (no more than twenty-four (24) hours) after accepting new employment and shall inform ActiveCare of all changes in employment for one (1) year following the termination, for any reason, of Executive's employment with ActiveCare.&#160; The acceptance of new employment by Executive does not mitigate ActiveCare's obligations under this agreement.&#160; ActiveCare may serve notice on any future employer of Executive that Executive has been exposed to secret, confidential or proprietary information, that Executive is subject to the terms of this Agreement, and that Executive has continuing obligations to ActiveCare under this Agreement.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; MARGIN-LEFT: 4.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 67.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7.8</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Resignation and Cooperation</u></font>.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font> Upon termination of Executive's employment, Executive shall be deemed to have resigned from all offices and directorships then held with the Company.&#160; Following any termination of employment, Executive shall cooperate with the Company in the winding up of pending work on behalf of the Company and the orderly transfer of work to other Executives.&#160; Executive shall also cooperate with the Company in the defense of any action brought by any third party against the Company that relates to Executive's employment by the Company.<a name="_Ref20205454"><!--Anchor--></a></font></div>

<div>
<table id="ze2c92d37e45e456390e4df9bd039349e" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">7.9</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 103.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Surrender of Records and Property</u></font>.&#160; Upon termination of Executive's employment with ActiveCare, Executive shall promptly deliver to ActiveCare all records, manuals, books, blank forms, documents, letters, memoranda, notes, notebooks, reports, data, tables, calculations or copies thereof that relate in any way to the business, products, practices or techniques of ActiveCare, and all other property, trade secrets and confidential information of ActiveCare, including, but not limited to, all documents that in whole or in part contain any trade secrets or confidential information of ActiveCare, which in any of these cases are in Executive's possession or under Executive's control.</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">6</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 31.5pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">8.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 40.5pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Settlement of Disputes</u></font>.</font></div>

<div>
<table id="z1739eb3cf0cf40c59cad7575281a68b3" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">8.1</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Resolution of Certain Claims&#8212;Injunctive Relief</u></font>.&#160; Executive acknowledges that it would be difficult to fully compensate ActiveCare for damages resulting from any breach by him of the provisions of this Agreement.&#160; Accordingly, Executive agrees that, in addition to, but not to the exclusion of any other available remedy, ActiveCare shall have the right to enforce the provisions of Sections 5, 6, 7, and 8) by applying for and obtaining temporary and permanent restraining orders or injunctions from a court of competent jurisdiction without the necessity of filing a bond therefore, and without the necessity of proving actual damages.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zbc991d793ea942a1a5e8fdff2f13051a" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">8.2</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Venue.</u></font>&#160; Any action at law, suit in equity or judicial proceeding arising directly, indirectly, or otherwise in connection with, out of, related to or from this Agreement, or any provision hereof, shall be litigated only in the courts of the State of Utah, Utah County.&#160; Executive waives any right Executive may have to transfer or change the venue of any litigation brought against the Executive by ActiveCare.</div>
</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">9.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Miscellaneous Provision</u></font>.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">9.1</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 40.5pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Waiver</u></font>.&#160; The parties hereby shall not be deemed to have waived any of their respective rights under this Agreement unless such waiver is in writing and signed by such waiving party.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">9.2</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Notices</u></font>.&#160; Any notice required or permitted to be given under this Agreement shall be sufficient if given in writing and sent by mail, postage prepaid, return receipt requested, or via hand delivery or overnight courier, to Executive at the last address given for Executive on file with ActiveCare, or to ActiveCare at its principal office.&#160; Such notice shall be deemed complete upon receipt or upon refusal of such delivery as evidenced by the receipt from the postal service or courier.</font></div>

<div>
<table id="z2afb699daecb42fcba38d32cab1c15a1" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.3</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Amendment</u></font>.&#160; No amendment or extension of this Agreement shall be deemed effective unless or until executed in writing by the parties hereto.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z888cf71bf1f2400b8c5f1c8a8c79bbda" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.4</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Governing Law</u></font>.&#160; This Agreement shall be governed by the laws of the State of Utah without giving effect to the conflict of law provisions thereof.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z1649925745d940afb8c57aff327627a7" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.5</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Binding Upon Heirs</u></font>.&#160; This Agreement shall inure to the benefit of and be binding upon the parties hereto, their successors, heirs, personal representative and permitted assigns.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="za43f5357b45149e5adeeb19c5b44692e" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.6</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Notice</u></font>. Any notice given to Executive pursuant to this Agreement shall be sufficiently given if sent to Executive by registered or certified mail addressed to the Executive at such address as Executive shall have designated in writing to ActiveCare. Any notice given to ActiveCare pursuant to this Agreement shall be sufficiently given if sent to ActiveCare by registered or certified mail to ActiveCare at such address as ActiveCare shall have designated in writing to Executive.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="ze686a40f90d547888c419c9f61e18a05" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.7</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Arbitration</u></font>. Any controversy or claim arising out of or relating to this Agreement, or breach thereof, shall be finally settled under the Commercial Arbitration Rules of AAA the arbitration shall be conducted before one (1) arbitrator selected by mutual agreement of ActiveCare and Executive; if no agreement is made within ten (10) business days from the date a demand for arbitration was filed with the AAA, ActiveCare and Executive shall request a list of at least seven (7) arbitrators from AAA, and the parties shall alternately strike a name from the list until one name is left. The arbitration shall otherwise be conducted as follows:</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">7</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">a.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The arbitration hearing shall take place no later than ninety (90) days following the AAA's notice of the selection of an arbitrator;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">b.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Discovery shall be permitted, including depositions, interrogatories, requests for admissions, or production of documents, as determined by the arbitrator;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">c.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The arbitrator shall give his/her decision in writing, after the conclusion of the proceeding. The arbitrator may request that the parties submit post-hearing briefs.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">d.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any arbitration proceeding under this Agreement shall (1) be conducted in such a manner that the proprietary or confidential information of ActiveCare remains protected, and (2) occur in Salt Lake City, Utah; and</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">e.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The decision of the arbitrator is final and binding, but is subject to review pursuant to the laws of the State of Utah.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div>
<table id="za81871b003e545f3aaaf3e7f7027bcf9" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.8</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Attorney Fees and Costs</u></font>.&#160; If there is a default hereunder, the defaulting party shall pay the attorney fees, legal expenses and costs of the non-defaulting party incurred in enforcing the terms of this Agreement or obtaining appropriate legal relief for such breach.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="zab9cb823fdba4224800017671f57cd26" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.9</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Nonassignability</u></font>.&#160; This Agreement and the rights and obligations of the parties hereto may not be assigned by any party without obtaining the prior written consent of the other, and the parties expressly agree that any attempt to assign the rights of any party hereunder without such consent shall be null and void.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z1f0ed9ef11a4400296422acc10f26632" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.10</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Integration; Severability</u></font>.&#160; This Agreement supersedes any and all other employment agreements, oral or written, between the parties.&#160; If any provision of this Agreement is held by a court and competent jurisdiction to be invalid, void or unenforceable, the remaining provisions shall nevertheless continue in full force and effect.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z9ed0a71b7ad14a8dad56469ce8081287" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.11</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Authority</u></font>. Each party represents and warrants that such party has the right, power and authority to enter into and execute this Agreement and to perform and discharge all of the obligations hereunder; and that this Agreement constitutes the valid and legally binding agreement and obligation of such party and is enforceable in accordance with its terms.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z6e2baaad935c457c8b0076bd40bfdd55" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.12</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Counterparts</u></font>.&#160; This Agreement may be executed in more than one counterpart, and each executed counterpart shall be considered as the original.</div>
</td>
</tr>
</table>
</div>

<div>
<table id="z0d34daebb5034d1e84a135ce1204e6df" class="DSPFListTable" style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.5pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 76.5pt; LINE-HEIGHT: 1.25">9.13</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 108pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Further Actions</u></font>.&#160; Each of the parties agree that it shall hereafter execute and deliver such further instruments and do such further acts and things as may be required or useful to carry out the intent and purpose of this Agreement and as are consistent with the terms hereof.</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">8</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 18pt">EXECUTIVE ACKNOWLEDGEMENT</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">EXECUTIVE ACKNOWLEDGES EXECUTIVE HAS HAD THE OPPORTUNITY TO CONSULT LEGAL COUNSEL CONCERNING THIS AGREEMENT, THAT EXECUTIVE HAS READ AND UNDERSTANDS THE AGREEMENT, THAT EXECUTIVE IS FULLY AWARE OF ITS LEGAL EFFECT, AND THAT EXECUTIVE HAS ENTERED INTO IT FREELY BASED ON EXECUTIVE'S OWN JUDGMENT AND NOT ON ANY REPRESENTATIONS OR PROMISES OTHER THAN THOSE CONTAINED IN THIS AGREEMENT.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 31.5pt">IN WITNESS WHEREOF<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">, </font>the parties have executed this Agreement as of the date set forth above to be effective on the Effective Date.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 180pt">ACTIVECARE:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 180pt">By:&#160; ______________________________________</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 180pt">Its:&#160; ______________________________________</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 180pt">EXECUTIVE:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 180pt">__________________________________________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 180pt">Jeffrey Peterson</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">9</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Addendum #1</div>

<div style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">To The Employment Agreement</div>

<div style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Between ActiveCare and Jeffrey Peterson</div>

<div style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Dated September 5, 2017</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Effective this 12<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup> day of October, 2017 that should Executive's title change and/or duties, specifically referencing section 7.4.ii in relation to constructive termination, are hereby waived by Executive.&#160; The Employment Agreement in its entirety shall remain in full force and effect with the one stated alteration above.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Further, by way of clarification, Executive's compensation was verbally agreed to in the board meeting on July 7, 2016 when he became CEO, which served as the basis of his compensation within the Employment Agreement under section 4.1.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">__________________________</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">Robert Welgos</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">Board Member</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">__________________________</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">Jeffrey Peterson</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">Executive</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div>&#160;</div>

<div>
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">10</font></div>
</div>

<div>
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>exh31_1.htm
<DESCRIPTION>CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER OF REGISTRANT PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 (RULE 13A-14(A) OR RULE 15D-14(A)). *
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.1
    Copyright 1995 - 2018 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">EXHIBIT 31.1</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PURSUANT TO 18 U.S.C. SECTION 1350,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AS ADOPTED PURSUANT TO SECTION 302 OF</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">THE SARBANES-OXLEY ACT OF 2002</div>

<div id="DSPFPageFooter"></div>

<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, Mark J. Rosenblum, certify that:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z62090466d3a34d91be8defb772009c8c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">I have reviewed this quarterly report on Form 10-Q of ActiveCare, Inc.;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdb2b92205b56486196157f7541972765" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb5e9ccd33d2e4f7da97f85438ad6f697" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5c040dcc229244e9831f3f0cc56f51fe" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za6e97cd350aa4dc080c6c455af953878" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd0e443f49aab4b489aaf8a0ba52cd93c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right"><!--Anchor--><!--Anchor--><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(b)</font></td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify"><!--Anchor--><!--Anchor-->Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z91e9d2f9c67848c1b1d64726bb6ef2d6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(c)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc613511766824620914f1700055cd164" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(d)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc508e77d422443219733aa1212592a94" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2ef656017174489dbc84c16d414d4973" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z8f7d2138675e48d8a001fdbe49bed125" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z9eead9f7f2764ba69eace9724f16eff7" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 44.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Date: January 31, 2018</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 55.7%; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: "><u>&#160;/s/ Mark J. Rosenblum</u></td>
</tr>

<tr>
<td style="WIDTH: 44.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 55.7%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div>Mark J. Rosenblum</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 55.7%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Executive Officer</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44.3%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 55.7%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Principal Executive Officer)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
 &#160;</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>exh31_2.htm
<DESCRIPTION>CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER OF REGISTRANT PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 (RULE 13A-14(A) OR RULE 15D-14(A)). *
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.1
    Copyright 1995 - 2018 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">EXHIBIT 31.2</font><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PURSUANT TO 18 U.S.C. SECTION 1350,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AS ADOPTED PURSUANT TO SECTION 302 OF</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">THE SARBANES-OXLEY ACT OF 2002</div>

<div id="DSPFPageFooter"></div>

<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, Jeffrey S. Peterson, certify that:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1314a2a174d04855a0fba55b1feffd38" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">I have reviewed this quarterly report on Form 10-Q of ActiveCare, Inc.;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z337970df9f78408a9d8c8febe50ecbee" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z526eaf022a874042a7ec417151b3e4a7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9b7d073cd7634861a3ebf4b6774a2963" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd4b3e95337a84dc49d6de3599498d74d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z918007bd3c6d4a668c96d27cbb293ccf" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za04f8441f27e4166bb564dcdd2e52364" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(c)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5e599a211aa04938ba88b4d1b2b425bc" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(d)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z385f6ce890904812941d14891d9735ed" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z30ed93d341ef45e791ad9f7dd74f8840" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z30c9f61109c6439f91c852ae6c6aabca" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zfa5cbb3eb5d043289483bdb083241c1f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 34.84%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Date: January 31, 2018</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 65.16%; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: "><u>&#160;/s/ Jeffrey S. Peterson</u></td>
</tr>

<tr style="HEIGHT: 12px">
<td style="WIDTH: 34.84%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 65.16%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div>Jeffrey S. Peterson</div>
</td>
</tr>

<tr>
<td style="WIDTH: 34.84%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 65.16%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Executive Vice President</div>
</div>
</td>
</tr>

<tr>
<td style="WIDTH: 34.84%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 65.16%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Principal Financial and Accounting Officer)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
<br style="LINE-HEIGHT: 1.25">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>exh32.htm
<DESCRIPTION>CERTIFICATION PURSUANT TO 18 U.S.C. 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. *
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.1
    Copyright 1995 - 2018 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="FONT-WEIGHT: bold; TEXT-ALIGN: right">EXHIBIT 32</div>

<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">CERTIFICATION PURSUANT TO</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">18 U.S.C. SECTION 1350,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AS ADOPTED PURSUANT TO</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In connection with this Quarterly Report of ActiveCare, Inc. (the "Company") on Form 10-Q for the quarter ended June 30, 2017 as filed with the U.S. Securities and Exchange Commission on the date hereof.&#160; I, Mark J. Rosenblum, Principal Executive Officer, and Jeffrey S. Peterson, Principal Financial and Accounting Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</div>

<div style="FONT-WEIGHT: normal; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal">(1)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; FONT-WEIGHT: normal; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Such Quarterly Report on Form 10-Q for the quarter ended June 30, 2017 </font>fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div>

<div style="FONT-WEIGHT: normal; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal">(2)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 36pt; FONT-WEIGHT: normal; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal">The information contained in <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">such Quarterly Report on Form 10-Q for the quarter ended June 30, 2017 </font>fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z581fdec6ff3e4a8e97cf963f37633439" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>/s/&#160; Mark J. Rosenblum</u></div>
</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark J. Rosenblum</div>
</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Executive Officer</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Principal Executive Officer)</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>/s/Jeffrey S. Peterson</u></div>
</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Jeffrey S. Peterson</div>
</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Executive Vice President</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 40.18%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">&#160;</td>
<td style="BORDER-TOP-COLOR: ; WIDTH: 59.82%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Principal Financial and Accounting Officer)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: January 31, 2018</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">This certification accompanies each Report pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of &#167;18 of the Securities Exchange Act of 1934, as amended.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 12pt; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>acar-20170630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by Southridge Services using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK611N9EKWVLDLN2EK]. www.edgarsuite.com -->
<xbrl xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-gaap/2017-01-31' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:fil='http://activecare.com/20170630' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:num='http://www.xbrl.org/dtr/type/numeric' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:xbrli='http://www.xbrl.org/2003/instance'>
	<link:schemaRef xlink:type='simple' xlink:href='acar-20170630.xsd' />
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='5' contextRef='E16Q3' unitRef='UsdPerShare'>0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized decimals='INF' contextRef='E16Q3' unitRef='Shares'>10000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesOutstanding decimals='INF' contextRef='E17Q2' unitRef='Shares'>158290</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockSharesOutstanding decimals='INF' contextRef='E16Q3' unitRef='Shares'>115070</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='5' contextRef='E17Q2' unitRef='UsdPerShare'>0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='5' contextRef='E16Q3' unitRef='UsdPerShare'>0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E16Q3' unitRef='Shares'>200000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E17Q2' unitRef='Shares'>239100</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E16Q3' unitRef='Shares'>232100</us-gaap:CommonStockSharesOutstanding>
	<fil:CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants decimals='INF' contextRef='Y17Q2' unitRef='USD'>1461457</fil:CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants>
	<fil:CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants decimals='INF' contextRef='Y16Q2' unitRef='USD'>1004211</fil:CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants>
	<fil:CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants decimals='INF' contextRef='D161001_170630' unitRef='USD'>2101037</fil:CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants>
	<fil:CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants decimals='INF' contextRef='D151001_160630' unitRef='USD'>3257614</fil:CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants>
	<us-gaap:AccountsReceivableNet decimals='INF' contextRef='E17Q2' unitRef='USD'>643857</us-gaap:AccountsReceivableNet>
	<us-gaap:AccountsReceivableNet decimals='INF' contextRef='E16Q3' unitRef='USD'>487001</us-gaap:AccountsReceivableNet>
	<us-gaap:NotesReceivableNet decimals='INF' contextRef='E17Q2' unitRef='USD'>500000</us-gaap:NotesReceivableNet>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>1816621</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>1504331</us-gaap:AssetsCurrent>
	<us-gaap:DepositsAssetsCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>12970</us-gaap:DepositsAssetsCurrent>
	<us-gaap:DepositsAssetsCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>17846</us-gaap:DepositsAssetsCurrent>
	<us-gaap:FiniteLivedIntangibleAssetsNet decimals='INF' contextRef='E17Q2' unitRef='USD'>8759</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet decimals='INF' contextRef='E16Q3' unitRef='USD'>9295</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:Assets decimals='INF' contextRef='E17Q2' unitRef='USD'>1894795</us-gaap:Assets>
	<us-gaap:Assets decimals='INF' contextRef='E16Q3' unitRef='USD'>1618206</us-gaap:Assets>
	<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>3453795</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>1700448</us-gaap:AccountsPayableCurrent>
	<us-gaap:DueToRelatedPartiesCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>242568</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>291753</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>750000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
	<us-gaap:DividendsPayableCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>733880</us-gaap:DividendsPayableCurrent>
	<us-gaap:DividendsPayableCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>606545</us-gaap:DividendsPayableCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>30548890</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>14375551</us-gaap:LiabilitiesCurrent>
	<us-gaap:Liabilities decimals='INF' contextRef='E17Q2' unitRef='USD'>36438060</us-gaap:Liabilities>
	<us-gaap:Liabilities decimals='INF' contextRef='E16Q3' unitRef='USD'>21729407</us-gaap:Liabilities>
	<us-gaap:PreferredStockValue decimals='INF' contextRef='E17Q2' unitRef='USD'>2</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue decimals='INF' contextRef='E16Q3' unitRef='USD'>1</us-gaap:PreferredStockValue>
	<us-gaap:CommonStockValue decimals='INF' contextRef='E17Q2' unitRef='USD'>2</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue decimals='INF' contextRef='E16Q3' unitRef='USD'>2</us-gaap:CommonStockValue>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E17Q2' unitRef='USD'>88786513</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E16Q3' unitRef='USD'>88067410</us-gaap:AdditionalPaidInCapital>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E17Q2' unitRef='USD'>-123329782</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E16Q3' unitRef='USD'>-108178614</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:StockholdersEquity decimals='INF' contextRef='E17Q2' unitRef='USD'>-34543265</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='INF' contextRef='E16Q3' unitRef='USD'>-20111201</us-gaap:StockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E17Q2' unitRef='USD'>1894795</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E16Q3' unitRef='USD'>1618206</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:SalesRevenueNet decimals='INF' contextRef='Y17Q2' unitRef='USD'>1037179</us-gaap:SalesRevenueNet>
	<us-gaap:SalesRevenueNet decimals='INF' contextRef='Y16Q2' unitRef='USD'>1858926</us-gaap:SalesRevenueNet>
	<us-gaap:SalesRevenueNet decimals='INF' contextRef='D161001_170630' unitRef='USD'>4311955</us-gaap:SalesRevenueNet>
	<us-gaap:SalesRevenueNet decimals='INF' contextRef='D151001_160630' unitRef='USD'>4972196</us-gaap:SalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet decimals='INF' contextRef='Y17Q2' unitRef='USD'>159025</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet decimals='INF' contextRef='Y16Q2' unitRef='USD'>317156</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet decimals='INF' contextRef='D161001_170630' unitRef='USD'>599339</us-gaap:OtherSalesRevenueNet>
	<us-gaap:OtherSalesRevenueNet decimals='INF' contextRef='D151001_160630' unitRef='USD'>888453</us-gaap:OtherSalesRevenueNet>
	<us-gaap:Revenues decimals='INF' contextRef='Y17Q2' unitRef='USD'>1196204</us-gaap:Revenues>
	<us-gaap:Revenues decimals='INF' contextRef='Y16Q2' unitRef='USD'>2176082</us-gaap:Revenues>
	<us-gaap:Revenues decimals='INF' contextRef='D161001_170630' unitRef='USD'>4911294</us-gaap:Revenues>
	<us-gaap:Revenues decimals='INF' contextRef='D151001_160630' unitRef='USD'>5860649</us-gaap:Revenues>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='Y17Q2' unitRef='USD'>733143</us-gaap:CostOfRevenue>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='Y16Q2' unitRef='USD'>1269828</us-gaap:CostOfRevenue>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='D161001_170630' unitRef='USD'>3054086</us-gaap:CostOfRevenue>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='D151001_160630' unitRef='USD'>3878972</us-gaap:CostOfRevenue>
	<us-gaap:CostOfServices decimals='INF' contextRef='Y17Q2' unitRef='USD'>114954</us-gaap:CostOfServices>
	<us-gaap:CostOfServices decimals='INF' contextRef='Y16Q2' unitRef='USD'>112486</us-gaap:CostOfServices>
	<us-gaap:CostOfServices decimals='INF' contextRef='D161001_170630' unitRef='USD'>319184</us-gaap:CostOfServices>
	<us-gaap:CostOfServices decimals='INF' contextRef='D151001_160630' unitRef='USD'>358436</us-gaap:CostOfServices>
	<us-gaap:CostOfGoodsAndServicesSold decimals='INF' contextRef='Y17Q2' unitRef='USD'>848097</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:CostOfGoodsAndServicesSold decimals='INF' contextRef='Y16Q2' unitRef='USD'>1382314</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:CostOfGoodsAndServicesSold decimals='INF' contextRef='D161001_170630' unitRef='USD'>3373270</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:CostOfGoodsAndServicesSold decimals='INF' contextRef='D151001_160630' unitRef='USD'>4237408</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:GrossProfit decimals='INF' contextRef='Y17Q2' unitRef='USD'>348107</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='INF' contextRef='Y16Q2' unitRef='USD'>793768</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='INF' contextRef='D161001_170630' unitRef='USD'>1538024</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='INF' contextRef='D151001_160630' unitRef='USD'>1623241</us-gaap:GrossProfit>
	<us-gaap:SellingGeneralAndAdministrativeExpense decimals='INF' contextRef='Y17Q2' unitRef='USD'>3225054</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense decimals='INF' contextRef='Y16Q2' unitRef='USD'>2169603</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense decimals='INF' contextRef='D161001_170630' unitRef='USD'>6382027</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense decimals='INF' contextRef='D151001_160630' unitRef='USD'>6944098</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='Y17Q2' unitRef='USD'>56191</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='Y16Q2' unitRef='USD'>57611</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='D161001_170630' unitRef='USD'>307137</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='D151001_160630' unitRef='USD'>139023</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='Y17Q2' unitRef='USD'>3281245</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='Y16Q2' unitRef='USD'>2227214</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='D161001_170630' unitRef='USD'>6689164</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='D151001_160630' unitRef='USD'>7083121</us-gaap:OperatingExpenses>
	<us-gaap:OperatingIncomeLoss decimals='INF' contextRef='Y17Q2' unitRef='USD'>-2933138</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss decimals='INF' contextRef='Y16Q2' unitRef='USD'>-1433446</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss decimals='INF' contextRef='D161001_170630' unitRef='USD'>-5151140</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss decimals='INF' contextRef='D151001_160630' unitRef='USD'>-5459880</us-gaap:OperatingIncomeLoss>
	<us-gaap:InterestExpense decimals='INF' contextRef='Y17Q2' unitRef='USD'>-2198631</us-gaap:InterestExpense>
	<us-gaap:InterestExpense decimals='INF' contextRef='Y16Q2' unitRef='USD'>-813517</us-gaap:InterestExpense>
	<us-gaap:InterestExpense decimals='INF' contextRef='D161001_170630' unitRef='USD'>-6856258</us-gaap:InterestExpense>
	<us-gaap:InterestExpense decimals='INF' contextRef='D151001_160630' unitRef='USD'>-1935486</us-gaap:InterestExpense>
	<fil:LossOnSettlement decimals='INF' contextRef='Y17Q2' unitRef='USD'>-750000</fil:LossOnSettlement>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt decimals='INF' contextRef='Y16Q2' unitRef='USD'>-15393</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<fil:GainOnLiabilitySettlements decimals='INF' contextRef='Y16Q2' unitRef='USD'>8859</fil:GainOnLiabilitySettlements>
	<us-gaap:OtherIncome decimals='INF' contextRef='Y17Q2' unitRef='USD'>2614</us-gaap:OtherIncome>
	<us-gaap:OtherIncome decimals='INF' contextRef='D161001_170630' unitRef='USD'>2614</us-gaap:OtherIncome>
	<us-gaap:OtherOperatingIncomeExpenseNet decimals='INF' contextRef='Y17Q2' unitRef='USD'>-2881872</us-gaap:OtherOperatingIncomeExpenseNet>
	<us-gaap:OtherOperatingIncomeExpenseNet decimals='INF' contextRef='Y16Q2' unitRef='USD'>4783360</us-gaap:OtherOperatingIncomeExpenseNet>
	<us-gaap:OtherOperatingIncomeExpenseNet decimals='INF' contextRef='D161001_170630' unitRef='USD'>-9872693</us-gaap:OtherOperatingIncomeExpenseNet>
	<us-gaap:OtherOperatingIncomeExpenseNet decimals='INF' contextRef='D151001_160630' unitRef='USD'>-2281541</us-gaap:OtherOperatingIncomeExpenseNet>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y17Q2' unitRef='USD'>-5815010</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y16Q2' unitRef='USD'>3349914</us-gaap:NetIncomeLoss>
	<us-gaap:DividendsPreferredStock decimals='INF' contextRef='Y17Q2' unitRef='USD'>58978</us-gaap:DividendsPreferredStock>
	<us-gaap:DividendsPreferredStock decimals='INF' contextRef='Y16Q2' unitRef='USD'>45781</us-gaap:DividendsPreferredStock>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic decimals='INF' contextRef='Y17Q2' unitRef='USD'>-5873988</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic decimals='INF' contextRef='Y16Q2' unitRef='USD'>3304133</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic decimals='INF' contextRef='D161001_170630' unitRef='USD'>-15151168</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic decimals='INF' contextRef='D151001_160630' unitRef='USD'>-14924907</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:EarningsPerShareBasic decimals='2' contextRef='Y17Q2' unitRef='UsdPerShare'>-24.77</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic decimals='2' contextRef='Y16Q2' unitRef='UsdPerShare'>15.18</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic decimals='2' contextRef='D161001_170630' unitRef='UsdPerShare'>-64.81</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic decimals='2' contextRef='D151001_160630' unitRef='UsdPerShare'>-81.57</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareDiluted decimals='2' contextRef='Y17Q2' unitRef='UsdPerShare'>-24.77</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted decimals='2' contextRef='Y16Q2' unitRef='UsdPerShare'>-3.78</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted decimals='2' contextRef='D161001_170630' unitRef='UsdPerShare'>-64.81</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted decimals='2' contextRef='D151001_160630' unitRef='UsdPerShare'>-82.78</us-gaap:EarningsPerShareDiluted>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D161001_170630' unitRef='USD'>-15023833</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D151001_160630' unitRef='USD'>-7741421</us-gaap:NetIncomeLoss>
	<us-gaap:AmortizationOfDebtDiscountPremium decimals='INF' contextRef='D161001_170630' unitRef='USD'>-4081912</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:AmortizationOfDebtDiscountPremium decimals='INF' contextRef='D151001_160630' unitRef='USD'>-904115</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt decimals='INF' contextRef='D161001_170630' unitRef='USD'>-2499212</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt decimals='INF' contextRef='D151001_160630' unitRef='USD'>-3058809</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:ShareBasedCompensation decimals='INF' contextRef='D161001_170630' unitRef='USD'>-1705975</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation decimals='INF' contextRef='D151001_160630' unitRef='USD'>-2801432</us-gaap:ShareBasedCompensation>
	<fil:LossOnSettlement decimals='INF' contextRef='D161001_170630' unitRef='USD'>-750000</fil:LossOnSettlement>
	<fil:StockAndWarrantsIssuedAndAccruedForServices decimals='INF' contextRef='D161001_170630' unitRef='USD'>-395062</fil:StockAndWarrantsIssuedAndAccruedForServices>
	<fil:StockAndWarrantsIssuedAndAccruedForServices decimals='INF' contextRef='D151001_160630' unitRef='USD'>-456182</fil:StockAndWarrantsIssuedAndAccruedForServices>
	<us-gaap:IncreaseDecreaseInNotesPayableCurrent decimals='INF' contextRef='D161001_170630' unitRef='USD'>482500</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
	<fil:StockAccruedForInterestExpense decimals='INF' contextRef='D161001_170630' unitRef='USD'>144000</fil:StockAccruedForInterestExpense>
	<us-gaap:DepreciationDepletionAndAmortization decimals='INF' contextRef='D161001_170630' unitRef='USD'>-33643</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DepreciationDepletionAndAmortization decimals='INF' contextRef='D151001_160630' unitRef='USD'>-39353</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:LossOnDerivativeInstrumentsPretax decimals='INF' contextRef='D161001_170630' unitRef='USD'>230163</us-gaap:LossOnDerivativeInstrumentsPretax>
	<us-gaap:LossOnDerivativeInstrumentsPretax decimals='INF' contextRef='D151001_160630' unitRef='USD'>2796542</us-gaap:LossOnDerivativeInstrumentsPretax>
	<fil:LossOnInducedConversionsOfDebt decimals='INF' contextRef='D151001_160630' unitRef='USD'>-379132</fil:LossOnInducedConversionsOfDebt>
	<fil:GainOnLiabilitySettlements decimals='INF' contextRef='D151001_160630' unitRef='USD'>295099</fil:GainOnLiabilitySettlements>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='INF' contextRef='D161001_170630' unitRef='USD'>-241844</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='INF' contextRef='D151001_160630' unitRef='USD'>-44459</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInInventories decimals='INF' contextRef='D161001_170630' unitRef='USD'>-297033</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories decimals='INF' contextRef='D151001_160630' unitRef='USD'>414110</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals='INF' contextRef='D161001_170630' unitRef='USD'>815799</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals='INF' contextRef='D151001_160630' unitRef='USD'>-178053</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade decimals='INF' contextRef='D161001_170630' unitRef='USD'>-2470310</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade decimals='INF' contextRef='D151001_160630' unitRef='USD'>732265</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D161001_170630' unitRef='USD'>-1796360</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D151001_160630' unitRef='USD'>-931492</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='D161001_170630' unitRef='USD'>-618100</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='D151001_160630' unitRef='USD'>-2803459</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment decimals='INF' contextRef='D151001_160630' unitRef='USD'>600</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquireMachineryAndEquipment decimals='INF' contextRef='D161001_170630' unitRef='USD'>2818</us-gaap:PaymentsToAcquireMachineryAndEquipment>
	<us-gaap:PaymentsToAcquireMachineryAndEquipment decimals='INF' contextRef='D151001_160630' unitRef='USD'>5004</us-gaap:PaymentsToAcquireMachineryAndEquipment>
	<us-gaap:IncreaseDecreaseInNotesReceivables decimals='INF' contextRef='D161001_170630' unitRef='USD'>500000</us-gaap:IncreaseDecreaseInNotesReceivables>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='D161001_170630' unitRef='USD'>-502818</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='D151001_160630' unitRef='USD'>-4404</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:ProceedsFromNotesPayable decimals='INF' contextRef='D161001_170630' unitRef='USD'>4421489</us-gaap:ProceedsFromNotesPayable>
	<us-gaap:ProceedsFromNotesPayable decimals='INF' contextRef='D151001_160630' unitRef='USD'>5709287</us-gaap:ProceedsFromNotesPayable>
	<us-gaap:ProceedsFromRelatedPartyDebt decimals='INF' contextRef='D151001_160630' unitRef='USD'>250000</us-gaap:ProceedsFromRelatedPartyDebt>
	<fil:ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable decimals='INF' contextRef='D151001_160630' unitRef='USD'>2967</fil:ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable>
	<us-gaap:RepaymentsOfRelatedPartyDebt decimals='INF' contextRef='D161001_170630' unitRef='USD'>28441</us-gaap:RepaymentsOfRelatedPartyDebt>
	<us-gaap:RepaymentsOfRelatedPartyDebt decimals='INF' contextRef='D151001_160630' unitRef='USD'>7795</us-gaap:RepaymentsOfRelatedPartyDebt>
	<us-gaap:RepaymentsOfNotesPayable decimals='INF' contextRef='D161001_170630' unitRef='USD'>3325427</us-gaap:RepaymentsOfNotesPayable>
	<us-gaap:RepaymentsOfNotesPayable decimals='INF' contextRef='D151001_160630' unitRef='USD'>3175603</us-gaap:RepaymentsOfNotesPayable>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='D161001_170630' unitRef='USD'>1067621</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='D151001_160630' unitRef='USD'>2778856</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:CashPeriodIncreaseDecrease decimals='INF' contextRef='D161001_170630' unitRef='USD'>-53297</us-gaap:CashPeriodIncreaseDecrease>
	<us-gaap:CashPeriodIncreaseDecrease decimals='INF' contextRef='D151001_160630' unitRef='USD'>-29007</us-gaap:CashPeriodIncreaseDecrease>
	<us-gaap:Cash decimals='INF' contextRef='E16Q3' unitRef='USD'>167737</us-gaap:Cash>
	<us-gaap:Cash decimals='INF' contextRef='E15Q3' unitRef='USD'>172436</us-gaap:Cash>
	<us-gaap:Cash decimals='INF' contextRef='E17Q2' unitRef='USD'>114440</us-gaap:Cash>
	<us-gaap:Cash decimals='INF' contextRef='E16Q2' unitRef='USD'>143429</us-gaap:Cash>
	<us-gaap:InterestPaidNet decimals='INF' contextRef='D161001_170630' unitRef='USD'>379589</us-gaap:InterestPaidNet>
	<us-gaap:InterestPaidNet decimals='INF' contextRef='D151001_160630' unitRef='USD'>191943</us-gaap:InterestPaidNet>
	<fil:IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees decimals='INF' contextRef='D161001_170630' unitRef='USD'>2103341</fil:IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees>
	<fil:IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees decimals='INF' contextRef='D151001_160630' unitRef='USD'>201058</fil:IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees>
	<fil:AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees decimals='INF' contextRef='D161001_170630' unitRef='USD'>148677</fil:AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees>
	<fil:AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees decimals='INF' contextRef='D161001_170630' unitRef='USD'>125000</fil:AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees>
	<us-gaap:DividendsPreferredStock decimals='INF' contextRef='D161001_170630' unitRef='USD'>127335</us-gaap:DividendsPreferredStock>
	<us-gaap:DividendsPreferredStock decimals='INF' contextRef='D151001_160630' unitRef='USD'>699250</us-gaap:DividendsPreferredStock>
	<fil:AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees decimals='INF' contextRef='D161001_170630' unitRef='USD'>60000</fil:AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees>
	<fil:DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants decimals='INF' contextRef='D151001_160630' unitRef='USD'>6484236</fil:DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants>
	<fil:ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable decimals='INF' contextRef='D151001_160630' unitRef='USD'>2555189</fil:ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable>
	<fil:AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty decimals='INF' contextRef='D151001_160630' unitRef='USD'>263082</fil:AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty>
	<fil:IssuanceOfSharesOfCommonStockForConsultingServices decimals='INF' contextRef='D151001_160630' unitRef='USD'>227500</fil:IssuanceOfSharesOfCommonStockForConsultingServices>
	<fil:AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees decimals='INF' contextRef='D151001_160630' unitRef='USD'>130246</fil:AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees>
	<fil:CancellationAndReissuanceOfSharesOfCommonStock decimals='INF' contextRef='D151001_160630' unitRef='USD'>121250</fil:CancellationAndReissuanceOfSharesOfCommonStock>
	<fil:ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable decimals='INF' contextRef='D151001_160630' unitRef='USD'>84404</fil:ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable>
	<fil:IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee decimals='INF' contextRef='D151001_160630' unitRef='USD'>70000</fil:IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee>
	<fil:IssuanceOfSharesOfCommonStockForLoanExtensionFees decimals='INF' contextRef='D151001_160630' unitRef='USD'>31250</fil:IssuanceOfSharesOfCommonStockForLoanExtensionFees>
	<fil:AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees decimals='INF' contextRef='D151001_160630' unitRef='USD'>28500</fil:AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees>
	<fil:IssuanceOfSharesOfCommonStockForDividends decimals='INF' contextRef='D151001_160630' unitRef='USD'>12434</fil:IssuanceOfSharesOfCommonStockForDividends>
	<fil:AccrualOfALiabilityToIssueSharesOfCommonStockForServices decimals='INF' contextRef='D151001_160630' unitRef='USD'>7600</fil:AccrualOfALiabilityToIssueSharesOfCommonStockForServices>
	<dei:DocumentType contextRef='D161001_170630'>10-Q</dei:DocumentType>
	<dei:DocumentPeriodEndDate contextRef='D161001_170630'>2017-06-30</dei:DocumentPeriodEndDate>
	<dei:AmendmentFlag contextRef='D161001_170630'>false</dei:AmendmentFlag>
	<dei:EntityRegistrantName contextRef='D161001_170630'>ACTIVECARE, INC.</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef='D161001_170630'>0001429896</dei:EntityCentralIndexKey>
	<dei:TradingSymbol contextRef='D161001_170630'>acar</dei:TradingSymbol>
	<dei:CurrentFiscalYearEndDate contextRef='D161001_170630'>--09-30</dei:CurrentFiscalYearEndDate>
	<dei:EntityCommonStockSharesOutstanding decimals='INF' contextRef='I180130' unitRef='Shares'>239100</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityFilerCategory contextRef='D161001_170630'>Smaller Reporting Company</dei:EntityFilerCategory>
	<dei:EntityCurrentReportingStatus contextRef='D161001_170630'>Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityVoluntaryFilers contextRef='D161001_170630'>No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef='D161001_170630'>No</dei:EntityWellKnownSeasonedIssuer>
	<dei:DocumentFiscalYearFocus contextRef='D161001_170630'>2017</dei:DocumentFiscalYearFocus>
	<dei:DocumentFiscalPeriodFocus contextRef='D161001_170630'>Q3</dei:DocumentFiscalPeriodFocus>
	<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:0in;margin-bottom:6.0pt;margin-left:.5in;text-align:left;text-indent:-.5in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Basis of Presentation &lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;The unaudited interim condensed consolidated financial statements of ActiveCare, Inc. (the &amp;#147;Company&amp;#148; or &amp;#147;ActiveCare&amp;#148;) have been prepared in accordance with Article 8 of Regulation S-X, promulgated by the Securities and Exchange Commission.&amp;nbsp;&amp;nbsp;Certain information and disclosures normally included in financial statements prepared in accordance with US generally accepted accounting principles (&amp;#147;US GAAP&amp;#148;) have been condensed or omitted pursuant to such rules and regulations.&amp;nbsp;&amp;nbsp;In the opinion of management, the accompanying interim condensed consolidated financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the Company&amp;#146;s financial position as of June 30, 2017 and September 30, 2016, and the results of its operations for the three and nine months ended June 30, 2017 and 2016 and its cash flows for the nine months ended June 30, 2017 and 2016.&amp;nbsp;&amp;nbsp;These financial statements should be read in conjunction with the annual consolidated financial statements and notes thereto that are included in the Company&amp;#146;s Annual Report on Form 10-K for the year ended September 30, 2016.&amp;nbsp;&amp;nbsp;The results of operations for the three and nine months ended June 30, 2017 may not be indicative of the results for the full fiscal year ending September 30, 2017.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;i&gt;Going Concern&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in&apos;&gt;The Company continues to incur negative cash flows from operating activities and net losses.&amp;#160; The Company had minimal cash, negative working capital and negative total equity as of June 30, 2017 and September 30, 2016.&amp;#160; In addition, the Company is in technical default on certain notes payable although the lenders in each case are working with the Company to resolve the defaults.&amp;#160; These factors, among others, raise substantial doubt about the Company&apos;s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;In order for the Company to eliminate substantial doubt about its ability to continue as a going concern, it must achieve profitability, generate positive cash flows from operating activities and obtain the necessary debt or equity funding to meet its projected capital investment requirements.&amp;#160; Management&apos;s plans with respect to this uncertainty consist of raising additional capital by issuing debt or equity securities and increasing the sales of the Company&apos;s services and products.&amp;#160; There can be no assurance that the Company will be able to raise sufficient additional capital or that revenues will increase rapidly enough to achieve operating profits.&amp;#160; If the Company is unable to increase revenues or obtain additional financing, it will be unable to continue the development of its products and services and may have to cease operations.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;Use of Estimates in the Preparation of Financial Statements&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the reporting periods. Actual results could differ from these estimates.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Company measures the fair values of its assets and liabilities using the US GAAP hierarchy.&amp;#160; The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts receivable, accounts payable, and accrued liabilities approximate fair values due to the short-term nature of these financial instruments. Derivative financial instruments are recorded at fair value based on current market pricing models. The carrying amounts reported for notes payable approximate fair values because the underlying instruments are at interest rates which approximate current market rates.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Certain prior year amounts have been reclassified to conform to the current period&amp;#146;s presentation. The reclassifications had no effect on the previously reported net loss.&lt;/p&gt; </us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;font style=&apos;line-height:115%&apos;&gt; &lt;/font&gt;&amp;#160; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Net Loss per Common Share&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Basic net loss per common share (&amp;quot;Basic EPS&amp;quot;) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period.&lt;/p&gt; &lt;p style=&apos;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Diluted net loss per common share (&amp;quot;Diluted EPS&amp;quot;) is computed by dividing net loss available to common stockholders by the sum of the weighted average number of common shares outstanding and the weighted-average dilutive potential common shares outstanding.&amp;#160; The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Potential common shares consist of shares issuable upon the exercise of common stock warrants and options, shares issuable from restricted stock grants, and shares issuable pursuant to convertible notes and convertible Series D and Series E preferred stock.&amp;#160; The following table reflects the calculation of basic and diluted net loss per common share for the periods indicated: &lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;649&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;193&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:144.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;169&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&apos;width:126.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Net loss attributable to common stockholders&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(5,873,988)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;3,304,133&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(15,151,168)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(14,924,907)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;Effect of dilutive securities on net loss:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt&apos;&gt;Common stock warrants&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(2,427,640)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt&apos;&gt;Convertible debt&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(1,860,373)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(1,790,407)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total net loss for purpose of &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;&amp;#160; calculating diluted net loss&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;&amp;#160; per common share&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(5,873,988)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(983,880)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(15,151,168)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(16,715,314)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;Number of shares used in per common share &lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;&amp;#160; calculations:&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total shares for purposes of calculating basic&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;&amp;#160; net loss per common share&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;237,100&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;217,595&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;233,767&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;182,979&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;Weighted-average effect of dilutive securities:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt&apos;&gt;Common stock warrants&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;3,337&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt&apos;&gt;Convertible debt&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;39,334&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;18,949&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total shares for purpose of calculating diluted &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;&amp;#160; net loss per common share&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;237,100&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;260,266&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;233,767&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;201,928&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;Net loss per common share:&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Basic&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(24.77)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(64.81)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(81.57)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Diluted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(24.77)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(3.78)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(64.81)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(82.78)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;The effect of dilutive securities on the numerator for purposes of calculating diluted loss per common share is related to the convertible debt and related warrants due to the reduction of the gain on derivatives liability for warrants that were in the money.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;As of June 30, 2017 and 2016, there were certain outstanding potential common shares that were not included in the computation of Diluted EPS as their effect would be anti-dilutive for the three and nine months then ended.&amp;#160; The potential common shares outstanding consist of the following:&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;649&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;193&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:144.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;169&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&apos;width:126.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Common stock warrants&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;109,174&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;18,346&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;109,174&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;42,378&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Series D convertible preferred stock&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;450&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;450&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;450&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;450&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Series E convertible preferred stock&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;961&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;961&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;961&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;961&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Convertible debt&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;158,798&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;95,799&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;158,798&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;95,799&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Restricted shares of common stock&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Liability to issue common stock and warrants&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;358,097&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,246&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;358,097&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,246&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:16.1pt&apos;&gt;Total common stock equivalents&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;627,495&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;117,817&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;627,495&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;141,849&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; </us-gaap:EarningsPerShareTextBlock>
	<us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:.5in;line-height:115%;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in;text-autospace:none&apos;&gt;&lt;b&gt;&lt;font style=&apos;line-height:115%&apos;&gt;3.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/b&gt;&lt;b&gt;&lt;font style=&apos;line-height:115%&apos;&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In May 2014, August 2015 and May 2016, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;, ASU 2015-14 &lt;i&gt;Revenue from Contracts with Customers, Deferral of the Effective Date&lt;/i&gt;, ASU 2016-12 &lt;i&gt;Revenue from Contracts with Customers, Narrow-Scope Improvements and Practical Expedients&lt;/i&gt;, ASU 2017-13 &lt;i&gt;Revenue Recognition, Revenue from Contracts with Customers, Leases, and Leases: Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments&lt;/i&gt;, and ASU 2017-14 &lt;i&gt;Income Statement&amp;#151;Reporting Comprehensive Income, Revenue Recognition, and Revenue from Contracts with Customers&lt;/i&gt;, respectively, which implement ASC Topic 606. ASC Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance under US GAAP, including industry-specific guidance. It also requires entities to disclose both quantitative and qualitative information that enable financial statements users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amendments in these ASUs are effective for annual periods beginning after December 15, 2017, and interim periods therein, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted for annual periods beginning after December 15, 2016. These ASUs may be applied retrospectively to all prior periods presented, or retrospectively with a cumulative adjustment to retained earnings in the year of adoption. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In August 2014, the FASB issued ASU 2014-15, &lt;i&gt;Disclosure of Uncertainties about an Entity&apos;s Ability to Continue as a Going Concern&lt;/i&gt;. This standard sets forth management&apos;s responsibility to evaluate, each reporting period, whether there is substantial doubt about the Company&apos;s ability to continue as a going concern, and if so, to provide related disclosures. ASU 2014-15 is effective for annual reporting periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its evaluation of going concern.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In July 2015, the FASB issued ASU 2015-11, &lt;i&gt;Inventory: Simplifying the Measurement of Inventory&lt;/i&gt;. The purpose of ASU 2015-11 is to more closely align the measurement of inventory in US GAAP with the measurement of inventory in International Financial Reporting Standards. ASU 2015-11 requires entities to measure most inventory at the &amp;quot;lower of cost or net realizable value.&amp;quot; Additionally, some of the amendments are designed to more clearly articulate the requirements for the measurement and disclosure of inventory. ASU 2015-11 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In February 2016, the FASB issued ASU 2016-02, &lt;i&gt;Leases&lt;/i&gt;.&amp;#160; The purpose of ASU 2016-02 is to establish the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. This guidance results in a more faithful representation of the rights and obligations arising from operating and capital leases by requiring lessees to recognize the lease assets and lease liabilities that arise from leases in the statement of financial position and to disclose qualitative and quantitative information about lease transactions, such as information about variable lease payments and options to renew and terminate leases. ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In March 2016, the FASB issued ASU 2016-09, &lt;i&gt;Stock Compensation: Improvements to Employee Share-Based Payment Accounting&lt;/i&gt;.&amp;#160; The purpose of ASU 2016-09 is to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equities or liabilities, and classification of amounts in the statement of cash flows.&amp;#160; ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017.&amp;#160; The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In August 2016, the FASB issued ASU 2016-15, &lt;i&gt;Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments&lt;/i&gt;. The amendments in this update provided guidance on eight specific cash flow issues. This update is to provide specific guidance on each of the eight issues, thereby reducing the diversity in practice in how certain transactions are classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In May 2017, the FASB issued ASU 2017-09, &lt;i&gt;Stock Compensation: Scope of Modification Accounting&lt;/i&gt;. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. ASU 2017-09 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In July 2017, the FASB issued ASU 2017-11, &lt;i&gt;Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivative and Hedging (Topic 815)&lt;/i&gt;. The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down-round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down-round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&amp;#146;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down-round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (&amp;#147;EPS&amp;#148;) in accordance with Topic 260 to recognize the effect of the down-round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down-round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt-Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Accounting Standards Codification, to a scope exception. Those amendments do not have an accounting effect. ASU 2017-11 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; </us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
	<us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:.5in;line-height:115%;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;&lt;font style=&apos;line-height:115%&apos;&gt;4.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/b&gt;&lt;b&gt;&lt;font style=&apos;line-height:115%&apos;&gt;Accounts Receivable&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts.&amp;#160; Specific reserves are estimated by management based on certain assumptions and variables, including the customer&amp;#146;s financial condition, age of the customer&amp;#146;s receivables and changes in payment histories.&amp;#160; Accounts receivable are written off when management determines the likelihood of collection is remote.&amp;#160; A receivable is considered to be past due if any portion of the receivable balance has not been received by the contractual payment date.&amp;#160; Interest is not charged on accounts receivable that are past due.&amp;#160; The Company recorded an allowance for doubtful accounts of $25,468 and $75,161 as of June 30, 2017 and September 30, 2016, respectively.&amp;#160; During the three months ended June 30, 2017, the Company wrote off approximately $103,000 of accounts receivable that were previously allowed against.&lt;/p&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
	<us-gaap:InventoryDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:.5in;line-height:115%;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in;line-height:normal&apos;&gt;&lt;b&gt;5.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Inventory &lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Inventory is recorded at the lower of cost or market value, cost being determined using the first-in, first-out (&amp;quot;FIFO&amp;quot;) method. Inventory consists of diabetic supplies.&amp;#160; Inventory held by distributors is reported as inventory until the supplies are shipped to the end user by the distributor.&amp;#160; The Company estimates an inventory reserve for obsolescence and excessive quantities.&amp;#160; Due to competitive pressures and technological innovation, it is possible that estimates of net realizable values could change in the near term.&amp;#160; Inventory consists of the following as of:&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; June 30, 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;b&gt;September 30, 2016 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Finished goods &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;503,477&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;206,444&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Inventory reserve&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(1,708)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(1,708)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:13.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:7.95pt&apos;&gt;Net inventory&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;501,769&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;204,736&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:2.25pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; </us-gaap:InventoryDisclosureTextBlock>
	<us-gaap:OtherCurrentAssetsTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-indent:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;6.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Prepaid Expenses and Other Current Assets&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Prepaid expenses and other current assets consisted of the following as of:&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:white;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; June 30, 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;b&gt;September 30, 2016 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Prepaid information technology services &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;38,081&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;57,073&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Other &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;12,249&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;112,117&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Prepaid insurance &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;6,225&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;14,602&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Prepaid legal and professional fees &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;333,741&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Research and development &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;96,346&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Line of credit acquisition fees &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;30,978&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:26.25pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:7.95pt&apos;&gt;Total prepaid expenses and &amp;#160;&amp;#160; other current assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;56,555&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;644,857&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; </us-gaap:OtherCurrentAssetsTextBlock>
	<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-indent:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;7.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Property and Equipment&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Property and equipment are stated at cost, less accumulated depreciation and amortization.&amp;#160; Depreciation and amortization are determined using the straight-line method over the estimated useful lives of the assets, which range between 3 and 7 years.&amp;#160; Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the terms of the lease.&amp;#160; Expenditures for maintenance and repairs are expensed as incurred.&amp;#160; Upon the sale or disposal of property and equipment, any gains or losses are included in operations.&amp;#160; Property and equipment consisted of the following as of:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; June 30, 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;b&gt;September 30, 2016 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Software&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;47,974&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;47,974&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Leasehold improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;98,023&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;98,023&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Furniture&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;68,758&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;68,758&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Equipment&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;47,191&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;49,772&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total property and equipment&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;261,946&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;264,527&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Accumulated depreciation and amortization&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(205,501)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(177,793)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:13.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;56,445&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;86,734&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:6.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Assets to be disposed of are reported at the lower of the carrying amounts or fair values, less the estimated costs to sell or dispose.&amp;#160; During the nine months ended June 30, 2016, the Company recorded a gain on the disposal of property and equipment of $245.&amp;#160; Depreciation expense for the nine months ended June 30, 2017 and 2016, was $33,107 and $38,817, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
	<us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;8.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Accrued Expenses&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Accrued expenses consisted of the following as of: &lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:white;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; June 30, 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;b&gt;September 30, 2016 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;#160;Interest &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,694,545&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;1,206,387&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;#160;Liability to issue warrants for the purchase &amp;#160;&amp;#160; shares of common stock &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,081,254&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Liability to issue common stock &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,000,933&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;240,000&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Finance fees &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;333,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;#160;Payroll expense &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;329,615&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;207,052&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Other &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;141,394&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;89,828&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Deferred revenue &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;85,399&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;111,803&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Warranty liability &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;58,300&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;134,330&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;#160;Commissions and fees &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;40,997&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;52,311&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Severance &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;60,000&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:13.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total accrued expenses&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;7,765,437&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,101,711&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:6.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; </us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
	<us-gaap:DebtDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;9.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Notes Payable &lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Company had the following notes payable outstanding as of:&amp;#160; &amp;#160;&amp;#160;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;bottom&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;bottom&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured notes payable with interest at 10% per annum, due November 2018.&amp;#160; The notes may go into default in the event other notes payable go into default subsequent to the effective date of the note.&amp;#160; Some of the notes are currently in technical default. However, as of the time of this report, the lenders have informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; &amp;#160;&amp;#160;In February 2016, the Company redeemed all 5,361 shares of its Series F Convertible Preferred Stock (&amp;quot;Series F preferred&amp;quot;) plus accrued dividends of $673,948 for 20,005 shares of common stock with a fair value of $1,600,000 containing certain temporary restrictions, and $5,900,000 of notes payable. Payments on the notes are partially or fully convertible at the Company&apos;s option at the lesser of (i) 80% of the per share price of the common stock to be offered in the proposed offering that is described in the Form S-1 filed on July 19, 2016 (the &amp;quot;Offering&amp;quot;), (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering to a maximum of 39,334 shares of common stock.&amp;#160; The conversion rate is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&amp;#160; A note may only be converted if the holder owns less than 4.99% of the Company&apos;s common stock after conversion.&amp;#160; The Company recorded a derivative liability of $2,461,899 related to the conversion feature of the notes.&amp;#160; In connection with the redemption of the Series F preferred stock, the Company issued new warrants in exchange for warrants held by the Series F preferred stockholders for the purchase of 11,070 shares of common stock at an exercise price of the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering, adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&amp;#160; The Company is also required to issue additional warrants for the purchase of up to 16,000 shares of common stock exercisable at $0.50 per share, also adjustable, that vest upon certain events of default.&amp;#160; On December 11, 2017, the Company entered into Securities Purchase Agreements that adjusted the conversion rate to exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in a contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the &amp;#147;Private Placement&amp;#148;) (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment (see Note 18).&amp;#160; The fair value of $1,344,608 related to the new warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value of the stock, conversion feature, warrants and $25,000 of fees, in excess of the carrying value of the Series F preferred stock were recorded as a deemed dividend of $6,484,236.&amp;#160; During the three months ended March 31, 2017, the Company entered into letter agreements related to the note to convert the outstanding principal and interest into shares of common stock contingent upon the Offering, which also removes the maximum share limitation conversion, which have expired (see Note 17).&amp;#160; Subsequent to June 30, 2017, the Company received letters related to the notes wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 (see Note 18).&amp;#160; In December 2017, the Company entered into those certain forbearance and lock up letter agreements with four of the eight debtors, with principal balances in the aggregate amount of $1,134,658, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of Common Stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more.&amp;#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&amp;#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&amp;#160; In addition, two of the five debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity (see Note 18). On January 12, 2018, the Company received letters from four of the debtors where the debtors forbear against any historical and future events of default and remedies through February 15, 2018. Further, the maturity date was extended through February 15, 2018.&amp;#160; As part of the letters, the Company agreed not to initiate any new financing arrangements without the consent of the debtors. (see Note 18).&amp;#160; On December 11, 2017, the Company borrowed an aggregate additional $300,000 from two of the lenders under new note payable agreements (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;5,900,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;5,900,000 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured borrowings from a third party that purchased $3,257,600 of customer receivables for $2,100,000, with due dates ranging from January 2018 to October 2018, and payable in daily payments ranging from $5,000 to $13,000.&amp;#160; The $1,157,600 difference between the customer receivables and cash received is being amortized to interest expense over the term of the respective notes.&amp;#160; The secured borrowings are guaranteed by a former chief executive officer of the Company and are subordinated to other notes payable. On April 17, 2017, the Company entered into a factoring agreement which provides for an advance of $1,794,000, comprised of $1,000,000 in cash and the consolidation of $794,000 from four prior factoring agreements into the amounts owed under the factoring agreement (collectively, the &amp;quot;Funds&amp;quot;). In consideration for the Funds, the Company sold to the lender all future receipts until the total amount of $2,511,601 has been paid. The factoring agreement requires payment of the minimum daily amount of $12,999.99 for 193 days. The $2,511,601 can be reduced if repayment occurs more quickly. Repayment of the amounts owing is with recourse and secured by all accounts, chattel paper, documents, equipment, general intangibles, instruments, and inventory of the Company and subordinated to other notes payable.&amp;#160; In June 2017, the lender verbally agreed to reduce the minimum daily amount to $5,000 and, in November 2017, verbally agreed to further reduce the minimum daily amount to $2,600 through January 7, 2018, after which the daily amount would return to $13,000.&amp;#160; Subsequent to June 30, 2017, the Company entered into similar secured borrowings and related verbal or written reductions in the daily amounts.&amp;#160; On January 5, 2018, the Company further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018 &amp;#160;(see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 1,974,602 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 689,318 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;bottom&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Unsecured note payable with a vendor with interest at 0.65% per annum payable at the end of each calendar year, due January 2018, issued in March 2016 upon the conversion of $2,523,937 in accounts payable to the vendor.&amp;#160; The note requires payments of $50,000 per month in April 2016 through December 2016, $100,000 per month in January 2017 through December 2017 and the remaining balance due in January 2018.&amp;#160; In September 2017, the Company entered into agreements with the vendor which supersedes the unsecured note payable agreement and provides new terms (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 1,773,937 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 2,223,937 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with a third party with no interest, was due the earlier of November 2016 or the third business day after the closing of a proposed Offering. The note is currently in technical default. However, as of the time of this report, the lender has provided bridge capital since going in default and has informally agreed to work with the Company until such time as the note can be repaid. &amp;#160;Pursuant to the note, the Company may borrow up to $1,500,000 upon meeting certain milestones and may be converted into shares of common stock upon default.&amp;#160; The note required a payment of common stock on the 5th trading day after the pricing of the proposed Offering, but no later than December 15, 2016.&amp;#160; The number of common shares will equal $200,000 divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the common shares or during the ten days prior to the date of the Purchase Agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price of the Offering, or (iv) the exercise price of any warrants issued in the Offering.&amp;#160; The estimated fair value of $240,000 of the stock is included in accrued liabilities and is being amortized to interest expense over the life of the note.&amp;#160; In connection with the issuance of the note, the Company also issued 20,000 warrants to purchase shares of common stock at an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock in the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering, or (iv) the exercise price of any warrants issued in the Offering and the number of shares will reset upon the closing of the Offering.&amp;#160; The warrants may only be exercised to the extent the holder would own a maximum of 9.99% of the Company&apos;s common stock after exercise.&amp;#160; The fair value of $493,590 related to the replacement warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; Of this fair value amount, $220,000 was recorded as a debt discount and is being amortized over the life of the note and the remaining $273,590 was recorded as a loss on derivative liability.&amp;#160; In the event of borrowing in excess of an initial $500,000, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to the initial warrants issued.&amp;#160; In November 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $286,171 related to the November 2016 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&amp;#160; In November 2016, the Company amended the note to extend the maturity date to the earlier of January 31, 2017 or the third business day after the closing of the Offering.&amp;#160; In addition, the amendment adjusted the origination shares to equal 20% of the note divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the shares or during the ten days prior to the date of the agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Offering.&amp;#160; In December 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $349,819 related to the December 2016 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&amp;#160; On January 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $567,753 related to the January 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note. On January 30, 2017, the Company amended the note to extend the maturity date to the earlier of March 15, 2017 or the third business day after the closing of the Offering. Also on January 30, 2017. the Company borrowed the remaining $300,000 on the note and issued an additional warrant for the purchase of 12,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $899,598 related to the January 30, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&amp;#160; On March 3, 2017, the Company amended the note to increase the maximum sum from $1,500,000 to $2,000,000. Also on March 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $407,947 related to the March 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The Company recorded a loss on extinguishment of debt of $501,969 related to the March 3, 2017 amendment and additional borrowing. Effective March 27, 2017, the Company amended the note to extend the maturity date to the earlier of April 15, 2017 or the third business day after the closing of the Offering. Additionally, the lender agreed to enter into a lock up prohibiting the sale or other transfer of all securities of the Company owned by them for a period of 6 months. In consideration for entering into the lock-up agreement the Company has agreed to pay a $340,000 fee, payable in shares of common stock at a rate of the lowest of (i) 80% of the common stock Offering price of the Offering, (ii) 80% of the unit price Offering price of the Offering (if applicable), or (iii) 80% of the exercise price of any warrants issued in the Offering.&amp;#160; The lock-up agreement was signed during April 2017, which has expired. Effective April 19, 2017, the Company amended the note to extend the maturity date to the earlier of May 20, 2017 or the third business day after the closing of the Offering. On December 11, 2017, the Company borrowed an additional $250,000 from the lender under a new note payable agreement (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;1,700,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 500,000 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured note payable to a third party with interest at 12.75% per annum, due February 2019, in default.&amp;#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&amp;#160; The Company entered into the note payable agreement in conjunction with a line of credit.&amp;#160; The Company initially borrowed $1,500,000 and may borrow additional amounts under the note payable agreement up to a total balance of $3,000,000 as the Company meets certain milestones.&amp;#160; The interest rate may also reduce to 11.25% per annum as the Company meets certain milestones.&amp;#160; In conjunction with the note and related line of credit, the Company issued warrants to the lender to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&amp;#160; The Company has recorded discounts of $1,500,000, which are being amortized to interest expense over the term of the note.&amp;#160; In April 2016, the Company borrowed an additional $500,000 on the note and incurred additional fees of $25,000, which are being amortized to interest expense over the remaining term of the note.&amp;#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issue the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the &amp;quot;November Forbearance Agreement&amp;quot;). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the &amp;quot;November Forbearance&amp;quot;) with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&amp;#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company&apos;s Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company&apos;s Series G Preferred Stock to certain affiliates of the Company.&amp;#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&amp;#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&amp;#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&amp;#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the &amp;quot;December Forbearance&amp;quot;). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&amp;#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&amp;#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&amp;#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&amp;#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&amp;#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&amp;#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $15,470 on the note payable. &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;1,152,778 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;1,652,778 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured line of credit with a third party with interest at 12.25% per annum, due February 2018, in default.&amp;#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&amp;#160; The Company entered into the line of credit agreement in conjunction with a note payable.&amp;#160; The Company may draw up to the lesser of 80% of certain accounts receivable or $1,500,000 and increase the maximum it may borrow under the agreement up to a total balance of $3,000,000 at $500,000 per increase as the Company meets certain milestones.&amp;#160; The interest rate may also reduce to 10.75% per annum as the Company meets certain milestones.&amp;#160; In conjunction with the line of credit and related note, the Company issued warrants to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&amp;#160; The Company has recorded prepaid expenses of $44,665, which are being amortized to interest expense over the term of the line of credit.&amp;#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issuance of the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the &amp;quot;November Forbearance Agreement&amp;quot;). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the &amp;quot;November Forbearance&amp;quot;) with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&amp;#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company&apos;s Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company&apos;s Series G Preferred Stock to certain affiliates of the Company.&amp;#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&amp;#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&amp;#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&amp;#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the &amp;quot;December Forbearance&amp;quot;). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&amp;#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&amp;#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&amp;#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&amp;#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&amp;#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&amp;#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $16,997 on the note payable.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;1,259,007 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;929,518 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 18% per annum, with no maturity date.&amp;#160; The note payable is from a verbal agreement with the lender which converted $617,500 of advances into $1,100,000 of principal on the note payable.&amp;#160; The additional $482,500 of principal plus agreed upon fees of $95,226 have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&amp;#146;s common stock at the most favorable rate available as of the date of the agreement.&amp;#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,100,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 2.8% of total revenue per annum, with no maturity date.&amp;#160; The note payable is from a verbal agreement with the lender which converted a $350,000 advance into the note payable.&amp;#160; Agreed upon fees of $143,987 and a future payoff fee of 20%, or $70,000, have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to where the Company is required to pay any outstanding interest at the end of the first month following a quarter end, the lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and to become convertible into shares of the Company&amp;#146;s common stock at the most favorable rate available as of the date of the agreement.&amp;#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;350,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Note payable previously secured by CareServices customer contracts.&amp;#160; In January 2015, the note was amended to reduce the outstanding principal to $375,000, interest at 9% per annum, and payable in 15 monthly installments beginning in February 2015.&amp;#160; The amendment released the collateralized customer contracts and the note payable is guaranteed by both a former Executive Chairman of the Board of Directors and a member of the Board of Directors.&amp;#160; A gain on the extinguishment of the old note of $769,449 was recorded in other income.&amp;#160; In December 2015, the note was amended to extend maturity to January 2018 payable in monthly installments beginning in July 2016, convert $31,252 from accrued interest into principal, interest at 10% per annum, and provide that the note is convertible into common stock at its fair value per share.&amp;#160; The Company recorded a derivative in connection with the convertible feature of the note (see Note 12) and is amortizing the initial $302,690 fair value of the derivative liability over the life of the note.&amp;#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016.&amp;#160; In July 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or November 2016 and included additional default penalties and payment terms.&amp;#160; In October 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or December 31, 2016 and included additional default penalties and payment terms.&amp;#160; In December 2016, February 2017 and March 2017, the note was further amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or February 15, 2017, March 31, 2017, and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;334,464 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;334,464 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 12% per annum, due February 2016, convertible into common stock at $150 per share.&amp;#160; In connection with the issuance of the note, the Company repriced previously issued warrants to purchase shares of common stock.&amp;#160; The $22,397 increase in relative fair value of the warrants was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&amp;#160; The note also required a payment of 6,000 shares of common stock.&amp;#160; The fair value of $780,000 was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&amp;#160; The maturity date was subsequently extended on two occasions for a total of 500 shares of common stock and the note was due May 2016.&amp;#160; The $31,250 fair value of these shares was being amortized over the extension period.&amp;#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company&apos;s common stock on the date of the amendment.&amp;#160; The note may only be converted if the holder owns less than 9.99% of the Company&apos;s common stock after conversion.&amp;#160; The Company recorded the value of the beneficial conversion feature of $381,299 to loss on termination of debt as a result of the modification.&amp;#160; In May 2016, the note was amended to extend the maturity date to the earlier of an equity raise of $10,000,000 or October 2016 which required a payment of 600 shares of common stock.&amp;#160; The $28,500 fair value of these shares has been included in accrued liabilities and was amortized over the extension period.&amp;#160; In October 2016, the Company extended the maturity date of the note month-by-month through no later than April 30, 2017 for a fee of $5,000 per month extended.&amp;#160; During September 2017, the Board of Directors granted 200 shares of Series H Preferred Stock for extension fees. In October 2017, the Company entered into a settlement agreement related to the note where the Company borrowed an additional $200,000 and modified the terms of the note payable to become secured by inventory owned by the Company, requires issuance of 3,000 shares of Series H Preferred Stock, which were authorized for grant by the Board of Directors on September 5, 2017 and are required to be able to convert the lender&amp;#146;s shares into 300,000 shares of the Company&amp;#146;s common stock, and requires payments of $8,600 for 72 consecutive weeks.&amp;#160; If any payment is late, the Company is required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&amp;#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&amp;#160; The fair value of the shares will be amortized over the life of the amended note.&amp;#160; The note terms are adjustable for any terms subsequently provided to other investors (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;300,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;300,000 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured note payable with interest at 12.25% per annum, due May 2017, in default. The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note. The Company entered into the agreement in conjunction with a modification to another note payable and line of credit. The note requires payment of a $3,000 modification fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&amp;#160; The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $4,050 on the note payable.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;300,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;-&amp;#160;&amp;#160; &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 12.75% per annum, due June 2017, in default, subordinated to other notes payable. The note requires payment of a $3,000 closing fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&amp;#160; The $3,000 closing fee is being amortized to interest expense over the remaining term of the note and the $50,000 fees are being accrued as incurred.&amp;#160; On January 12, 2018, the lender forbore against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;300,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;-&amp;#160;&amp;#160; &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 12% per annum, due September 2016, in default, subordinated to other notes payable.&amp;#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&amp;#160; The $100,000 fair value of the stock was amortized to interest expense over the term of the note.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). On January 12, 2018, the lender forbore against9/ any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;250,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;250,000 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured cash advance with fees at $1,000 per day for the first 15 days and $1,500 per day thereafter, with no maturity date.&amp;#160; The terms of the advance are verbal. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&amp;#146;s common stock at the most favorable rate available as of the date of the agreement.&amp;#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;100,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured notes with interest at 18% per annum, due April 2013, in default.&amp;#160; The Company issued 20,000 shares of Series D preferred stock as loan origination fees.&amp;#160; The $195,000 fair value of the preferred stock was amortized over the original term of the note.&amp;#160;&amp;#160; Principal of $50,000 and accrued interest of $13,333 were converted to common stock in December 2013.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 64,261 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 64,261 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured note payable to a third party with interest at 18% per annum, due June 2017.&amp;#160; The note was secured by shares of the Company&apos;s common stock held by, and other assets of an entity controlled by, a former Executive Chairman of the Board of Directors. &amp;#160;The note was guaranteed by a former Executive Chairman of the Board of Directors and his related entity and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&amp;#160; Payments on the note were convertible at the holder&apos;s option into common stock at 75% of its fair value if not paid by its respective due date, which is subject to a 20 trading day true-up and is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of other certain raises.&amp;#160; The Company recognized a derivative liability related to the conversion feature with a fair value of $181,670, which was recognized as a loss on termination of debt.&amp;#160; In June 2016, $13,713 of principal and $11,287 of accrued interest converted into 953 shares of common stock, pursuant to the terms of the note.&amp;#160; In August 2016, $64,654 of principal and $10,346 of accrued interest converted into 9,203 shares of common stock, pursuant to the terms of the note.&amp;#160; This note was terminated by paying the remaining principal and accrued interest in cash with no additional consideration.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;-&amp;#160;&amp;#160; &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;162,539 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160; Total notes payable before discount&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 16,859,049 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;13,006,815 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Less discount&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; (1,468,335)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; (1,930,060) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160; Total notes payable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;15,390,714 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;11,076,755 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Less current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; (9,501,544)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; (3,722,899) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160; Notes payable, net of current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 5,889,170 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;7,353,856 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:DebtDisclosureTextBlock>
	<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;10.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Related-Party Notes Payable &lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Company had the following related-party notes payable outstanding as of: &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;bottom&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;bottom&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt; Secured borrowings from entities controlled by an officer who purchased a $2,813,175 customer receivable for $1,710,500.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; The Company repurchased the receivable for $1,950,000 less cash received by the entities through March 2015.&amp;#160; The $239,500 difference between the buyback and cash received plus $253,500 of loan origination fees was amortized to interest expense through March 2015.&amp;#160; In September 2015, the note was modified to extend the maturity date to January 2017, with interest at 18% per annum.&amp;#160; The Company added $81,600 of extension fees and issued 6,000 shares of common stock to a lender as part of the modification.&amp;#160; The note is convertible into common stock at $150 per share.&amp;#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&amp;#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company&apos;s stock on the date of the amendment.&amp;#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lenders.&amp;#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lenders, if not paid by maturity.&amp;#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&amp;#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&amp;#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,721,100&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,721,100&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt; Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due January 2017, convertible into common stock at $150 per share.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; The Company issued 6,000 shares of common stock to a lender as loan origination fees.&amp;#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&amp;#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and reduced the conversion price to $30 per share, which was below the fair value of the Company&apos;s stock on the date of the amendment.&amp;#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lender.&amp;#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lender, if not paid by maturity.&amp;#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&amp;#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&amp;#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,303,135&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,303,135&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to an entity controlled by a former Executive Chairman of the Board of Directors with interest at 18% per annum, due January 2017.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; In February 2016, notes payable to the same entity, with outstanding balances of $511,005 plus accrued interest of $30,999 combined into this note.&amp;#160;&amp;#160; The note is subordinated to notes payable to unrelated parties and is convertible into shares of common stock at $30 per share, which was below the fair value of the Company&apos;s stock on the date of the agreement.&amp;#160; The conversion of the note is limited to a maximum of 18,500 common shares.&amp;#160; The Company recorded the value of the beneficial conversion feature of $632,339 to loss on termination of debt.&amp;#160; The note has a default penalty of 1,469 shares of common stock if not paid by maturity. The note may only be converted if the holder owns less than 4.99% of the Company&apos;s common stock after conversion.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;542,004&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;542,004&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to an entity controlled by an officer with interest at 12% per annum, due September 2016, subordinated to other third party notes payable.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&amp;#160; The $70,000 fair value of the stock is being amortized to interest expense over the term of the note.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&amp;#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&amp;#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;250,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;250,000&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to a former officer with interest at 12% per annum, due September 2013.&amp;#160; This note is in default and is convertible into common stock at $375 per share.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;26,721&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;26,721&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due on demand.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; In February 2016, the note was amended to subordinate the note to other notes payable also issued during February 2016.&amp;#160; The note is convertible into shares of common stock at $30 per share, which was below the fair value of the Company&apos;s stock on the date of the amendment.&amp;#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the entity.&amp;#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the entity, if not paid by maturity.&amp;#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&amp;#160; In January 2017 and February 2017, the note was amended to extend the maturity date to February 15, 2017 and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&amp;#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&amp;#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;25,463&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;25,463&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to a former officer with interest at 15% per annum, due June 2012, in default.&amp;#160; The note included a $3,000 loan origination fee added to the principal and is convertible into common stock at $250 per share.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,260&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;17,227&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to a former officer with interest at 12% per annum, due on demand.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;12,474&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;#160;&amp;#160; Total notes payable, related-party&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;3,869,683&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;3,898,124&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Less current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(3,869,683)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(3,898,124)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;#160;&amp;#160; Notes payable, related-party, net of current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
	<us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;11.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Company measures the fair values of its assets and liabilities using the US GAAP hierarchy levels as follows: &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;width:100.0%;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:15.0pt&apos;&gt; &lt;td width=&quot;14%&quot; valign=&quot;top&quot; style=&apos;width:14.94%;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:15.0pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Level 1&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;85%&quot; valign=&quot;top&quot; style=&apos;width:85.06%;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:15.0pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;The Company does not have any Level 1 inputs available to measure its assets.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:15.0pt&apos;&gt; &lt;td width=&quot;14%&quot; valign=&quot;top&quot; style=&apos;width:14.94%;padding:0in 5.4pt 0in 5.4pt;height:15.0pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Level 2 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;85%&quot; valign=&quot;top&quot; style=&apos;width:85.06%;padding:0in 5.4pt 0in 5.4pt;height:15.0pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Certain of the Company&amp;#146;s embedded derivative liabilities are measured on a recurring basis using Level 2 inputs.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:15.0pt&apos;&gt; &lt;td width=&quot;14%&quot; valign=&quot;top&quot; style=&apos;width:14.94%;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:15.0pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Level 3 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;85%&quot; valign=&quot;top&quot; style=&apos;width:85.06%;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:15.0pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Certain of the Company&amp;#146;s embedded derivative liabilities are measured on a recurring basis using Level 3 inputs.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&apos;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Items measured at fair value on a recurring basis include embedded derivatives related to the Company&amp;#146;s warrants and notes payable. During the nine months ended June 30, 2017, the Company has not changed the manner in which it values liabilities that are measured at fair value using Level 3 inputs. The following fair value hierarchy table presents information about the Company&apos;s financial liabilities measured at fair value on a recurring basis:&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;top&quot; style=&apos;width:1.1%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;Quoted Prices in Active Markets for Identical Items (Level 1) &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;Significant Other Observable Inputs (Level 2) &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;Significant Unobservable Inputs (Level 3) &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;Total &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;June 30, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;top&quot; style=&apos;width:1.1%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:20.0pt&apos;&gt;Derivatives liability&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.1%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;269,427&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;3,962,556&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;4,231,983 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;top&quot; style=&apos;width:1.1%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;September 30, 2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;top&quot; style=&apos;width:1.1%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:20.0pt&apos;&gt;Derivatives liability&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.1%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;281,613&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;1,772,458&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;2,054,071&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in&apos;&gt;The following is a reconciliation of the opening and closing balances for the derivatives liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended June 30, 2017:&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;98%&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Derivatives Liability&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Balance, September 30, 2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,772,458 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;Issuance of warrants recorded as derivatives&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;2,511,288&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;Gain on termination of debt resulting from&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;&amp;#160; payments on notes payable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(103,213) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;Loss on derivatives liability resulting&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;&amp;#160; from changes in fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(217,997)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Balance, June 30, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;3,962,556&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Company&amp;#146;s embedded derivative liabilities are re-measured to fair value as of each reporting date.&amp;#160; See Note 12 for more information about the valuation methods of derivatives and the inputs used for calculating fair value.&lt;/p&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
	<us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;12.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Derivatives Liability&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The derivatives liability as of June 30, 2017 and September 30, 2016, was&lt;font style=&apos;display:none&apos;&gt; &lt;/font&gt;$4,231,983 and $2,054,071, respectively. The derivatives liability as of June 30, 2017 and September 30, 2016 is related to a variable conversion price adjustment on outstanding notes payable and warrants.&amp;#160; All of the derivatives outstanding as of September 30, 2015, were eliminated during February 2016, due to the conversion of notes payable into shares of common stock.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During the nine months ended June 30, 2017, the Company estimated the fair value of some of the embedded derivatives upon issuance at the end of each reporting period using a binomial option-pricing model with the following assumptions, according to the instrument: exercise price of $8 to $15 per share; risk free interest rate of 0.85% to 1.14%; expected life of 0.53 to 1.03 years; expected dividends of 0%; volatility factor of 260.57% to 282.07%; and stock price of $8 to $15.&amp;#160; During the nine months ended June 30, 2017, the Company estimated the fair value of the remaining embedded derivatives upon issuance and at the end of each reporting period using a Monte Carlo valuation model with the following assumptions: exercise prices ranging from $2.50 to $25.00 per share; risk free interest rates ranging from 0.44% to 1.99%; expected lives ranging from 0.09 to 4.93 years; expected dividends of 0%; volatility factors of 128% - 194%; and stock prices ranging from $2.50 to $25.00.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During fiscal year 2016, the Company estimated the fair value of some of the embedded derivatives upon issuance, at the end of each reporting period and prior to their conversion and elimination using a binomial option-pricing model with the following assumptions, according to the instrument: exercise prices ranging from $14.50 to $46.75 per share; risk free interest rates ranging from 0.16% to 1.06%; expected lives ranging from 0.05 to 2.09 years; expected dividends of 0%; volatility factors ranging from 125.33% to 510.03%; and stock prices ranging from $15 to $70. During fiscal 2016, the Company estimated the fair value of the remaining embedded derivatives upon issuance and at the end of each reporting period using a Monte Carlo valuation model with the following assumptions: exercise prices ranging from $20 to $125 per share; risk free interest rates ranging from 0.18% to 1.44%; expected lives ranging from 0.04 to 6.40 years; expected dividends of 0%; volatility factors of 129% to 140%; and stock prices ranging from $20 to $475 per share.&amp;#160; The expected lives of the instruments were equal to the average term of the conversion option or expected exercise period of the warrants.&amp;#160; The expected volatility is based on the historical price volatility of the Company&apos;s common stock.&amp;#160; The risk-free interest rate represents the US Treasury constant maturities rate for the expected life of the related conversion option. The dividend yield represents anticipated cash dividends to be paid over the expected life of the conversion option.&amp;#160; The Company recognized a gain on derivatives liability for the three months ended June 30, 2017 of $64,145 and a gain on derivatives liability for the three months ended June 30, 2016 of $5,603,411.&amp;#160; The Company recognized a gain on derivatives liability for the nine months ended June 30, 2017 of $230,163 and a gain on derivatives liability for the nine months ended June 30, 2016 of $2,796,542.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
	<us-gaap:PreferredStockTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;13.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Preferred Stock&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Company is authorized to issue 10,000,000 shares of preferred stock, with a par value of $0.00001 per share.&amp;#160; Pursuant to the Company&apos;s Certificate of Incorporation, the Board of Directors has the authority to amend the Company&apos;s Certificate of Incorporation, without further stockholder approval, to designate and determine the preferences, limitations and relative rights of the preferred stock before any issuance of the preferred stock and to create one or more series of preferred stock, fix the number of shares of each such series, and determine the preferences, limitations and relative rights of each series of preferred stock, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, and liquidation preferences.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;&lt;u&gt;Series D Convertible Preferred Stock &lt;/u&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Board of Directors has designated 1,000,000 shares of preferred stock as Series D Convertible Preferred Stock (&amp;quot;Series D Preferred &amp;quot;).&amp;#160; The Series D Preferred votes on an as-converted basis.&amp;#160; The Series D Preferred has a dividend rate of 8%, payable quarterly.&amp;#160; The Company may redeem the Series D Preferred at a redemption price equal to 120% of the original purchase price with 15 days&apos; notice. During the nine months ended June 30, 2017 and 2016, the Company accrued $24,800 and $18,617 of dividends on Series D preferred stock, respectively, and settled $0 and $12,434 of accrued dividends, respectively, by issuing 0 and 455 shares of common stock, respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;&lt;u&gt;Series E Convertible Preferred Stock &lt;/u&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During fiscal year 2013, the Board of Directors designated shares of preferred stock as Series E Convertible Preferred Stock (&amp;quot;Series E Preferred&amp;quot;), convertible into common stock at $500 per share, adjustable if there are distributions of common stock or stock splits by the Company.&amp;#160; The Series E Preferred is non-voting and receives a monthly dividend of 3.322% for 25 to 32 months.&amp;#160; In addition, the convertibility and the redemption price of the Series E Preferred is gradually reduced by dividend payments over 25 to 32 months.&amp;#160; After the dividend payment term, the redemption price of Series E Preferred is $0, the Series E Preferred has no convertibility to common stock and the holders are entitled to receive a pro-rata share of cumulative royalties totaling 4% of the Company&apos;s gross profits payable quarterly for a two-year period.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During the three months ended June 30, 2017 and 2016, the Company accrued dividends of $34,178 and $39,598, respectively, payable to Series E Preferred.&amp;#160; During the nine months ended June 30, 2017 and 2016, the Company accrued dividends of $102,535 and $185,485, respectively, payable to Series E Preferred. &amp;#160;As of June 30, 2017 and September 30, 2016, the aggregate redemption price for the Series E Preferred was $477,829.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;&lt;u&gt;Series F Convertible Preferred Stock &lt;/u&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During fiscal year 2014, the Board of Directors designated 7,803 shares of preferred stock as Series F Convertible Preferred Stock (&amp;quot;Series F Preferred&amp;quot;).&amp;#160; In April 2014, the Company increased the authorized shares of Series F Preferred &amp;#160;to 10,000.&amp;#160; Series F Preferred is non-voting, has a stated value of $1,000 per share and is convertible into common stock at $166.85 per share (see Note 12).&amp;#160; Series F Preferred has a dividend rate, payable quarterly, of 8% until April 30, 2015, 16% from May 1, 2015 to July 31, 2015, 20% from August 1, 2015 to October 31, 2015, and 25% thereafter.&amp;#160; In February 2016, the Company redeemed all 5,361 outstanding shares and $673,848 of accrued dividends for 20,005 shares of common stock, $5,900,000 of notes payable and exchanged warrants for the purchase of 11,070 shares of common stock held by Series F Preferred stockholders for new warrants with new terms for the purchase of the same number of shares (see Note 15).&amp;#160; The Company recorded a deemed dividend of $6,484,236 as a result of the transactions.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During the three and nine months ended June 30, 2016, the Company accrued dividends of $0 and $495,148, respectively, payable to Series F Preferred stockholders.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;&lt;u&gt;Series G Convertible Preferred Stock &lt;/u&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During January 2017, the Board of Directors designated 43,220 shares of preferred stock as Series G Convertible Preferred Stock (&amp;quot;Series F Preferred&amp;quot;).&amp;#160; Series G Preferred votes on an as-converted basis, has a stated value of $500 per share. The Series G Preferred will automatically convert the stated value of such shares into fully paid and non-assessable shares of common stock (Series G Conversion Shares&amp;#148;) of the Company upon (i) the Company&amp;#146;s receipt of $50,000,000 or more in gross revenue in a single fiscal year, (ii) the sale of the Company via asset purchase, stock sale, merger or other business combination in which the Company and/or its stockholders receive aggregate gross proceeds of $25,000,000 or more, or (iii) the closing of an underwritten offering by the Company pursuant to which the Company receives aggregate gross proceeds of at least $10,000,000 in consideration of the purchase of shares of common stock and/or which results in the listing of the Company&amp;#146;s common stock on the Nasdaq National Market, the Nasdaq Capital Market, the New York Stock Exchange, or the NYSE MKT. The number of Series G Conversion Shares issuable upon conversion shall equal the stated value divided by the conversion price then in effect. The conversion price of the Series G Preferred is $22.50. Upon the trigger of an automatic conversion, all of the shares of Series G Preferred owned by such holders will convert into common stock at the conversion price then in effect.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;On January 31, 2017, the Company issued 32,415 shares of Series G Preferred to an entity affiliated with one of the Company&amp;#146;s former Chief Executive Officers and 10,805 shares of Series G Preferred to a different former Chief Executive Officer and consultant to the Company. The consideration for such issuance relates to services rendered to the Company. Each of the two recipients of the Series G Preferred stock have entered into lock-up agreements, as amended, prohibiting the sale or other transfer of the Common Shares issued pursuant to the conversion of the Series G Preferred securities of the Company owned by each of them for the longer of (i) 18 months or (ii) the date the Company first has annual gross revenues in an amount of at least $20,000,000. The lock-up agreements initially expired if the Offering was not completed by February 15, 2017, whose expirations were extended to March 31, 2017 with new agreements signed during February 2017.&amp;#160; As of June 30, 2017, the agreements have expired.&amp;#160; On September 5, 2017, the Board of Directors of the Company agreed to modify the terms of the Series G Convertible Preferred stock to remove the 18-month lock-up period, however, no such amendment to the Series G Preferred has not been filed with the State of Delaware as of the date of this filing.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;&lt;u&gt;Liquidation Preference&lt;/u&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Upon any liquidation, dissolution or winding up of the Company, before any distribution or payment may be made to the holders of the common stock, the holders of the Series D Preferred, Series E Preferred, and Series F Preferred are entitled to be paid out of the assets an amount equal to $1.00 per share plus all accrued but unpaid dividends.&amp;#160; If the assets of the Company are insufficient to make payment in full to all holders of preferred stock, then the assets shall be distributed among the holders of preferred stock ratably in proportion to the full amounts to which they would otherwise be entitled.&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:.5in;line-height:115%;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in;line-height:normal&apos;&gt;&lt;b&gt;14.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Common Stock&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;In April 2014, the Company amended its Certificate of Incorporation increasing the total number of authorized shares of common stock from 50,000,000 shares to 200,000,000 shares.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;On January 27, 2017, the Company effected a 1-for-500 reverse stock split of its outstanding common stock, which caused the then outstanding common stock to decrease from 115,112,802 to 232,100 while keeping the authorized capitalization unchanged.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During the nine months ended June 30, 2017, the Company issued 7,000 shares of common stock (post reverse stock split) for services provided by an independent consultant; the value on the date of grant was $70,000.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<fil:Stockoptionsandwarrants0TextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;15.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Common Stock Options and Warrants&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The fair value of each stock option or warrant is estimated on the date of grant using a binomial option-pricing model or the Monte Carlo valuation model.&amp;#160; The expected life of stock options or warrants represents the period of time that the stock options or warrants are expected to be outstanding, based on the simplified method.&amp;#160; Expected volatilities are based on historical volatility of the Company&apos;s common stock, among other factors.&amp;#160; The Company uses the simplified method within the binomial option-pricing valuation model due to the Company&apos;s short trading history.&amp;#160; The risk-free rate related to the expected term of the stock options or warrants is based on the US Treasury yield curve in effect at the time of grant.&amp;#160; The dividend yield is zero.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During fiscal 2016, the Company granted warrants to purchase 24,032 common shares with an exercise price of $32.50 per share in connection with the acquisition of a note payable and line of credit; warrants for the purchase of 14,786 shares vested immediately, 3,696 vested upon the disbursement of the second tranche of the related note payable, and 5,550 vest evenly in the event of three available increases on the related line of credit (see Note 9). The warrants expire in February 2023, may be exercised via cashless exercise and are puttable upon expiration or liquidation for the greater of $500,000 or up to 6.5% of the equity value of the Company, depending on the number of warrants vested. The fair value of the warrants upon grant of $3,731,969 was recorded as a derivative and the Company received cash of $2,967 upon issuance of the warrants. The Company recognized $1,419,541 as debt discount for the portion allocated to the note payable and the debt discount is being amortized over the life of the note payable to interest expense. During September 2016, the Company entered into a conditionally effective warrant cancellation agreement with the warrant holders, which has expired (see Note 17).&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During February 2016, the Company exchanged warrants held by the holders of its Series F Preferred for the purchase of 11,070 shares of common stock in connection with the redemption of Series F Preferred for new warrants for the purchase of the same number of shares on different terms. The new warrants were initially exercisable for $150 per share, adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises. During September 2016, the Company issued warrants for the purchase of common stock that adjusted the warrants to have an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering. On December 11, 2017, the Company entered into Securities Purchase Agreements that adjusted the conversion rate to exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in a contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the &amp;#147;Private Placement&amp;#148;) (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment (see Note 18). The new warrants expire in February 2021, and may be exercised via cashless exercise. Additional warrants for the purchase of 16,000 shares of common stock may be issued in the event of default on the related notes payable, exercisable at $0.50 per share, with 25% issuable upon the first event of default, 37.5% upon the second event, and 37.5% upon the third event. The warrants issuable upon default expire in February 2026 (if issued), may be exercised via cashless exercise, and are puttable upon expiration or liquidation with the primary warrants. The new warrants may only be exercised to the extent the respective holder would own a maximum of 4.99% of the Company&amp;#146;s common stock after exercise, but the holders may elect to increase the maximum to 9.99%. The Company recognized a deemed dividend of $6,484,236 as a result of the exchange and related redemption of Series F Preferred.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;During September 2016, the Company granted warrants to purchase 20,000 shares in connection with the acquisition of a note payable at an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering. Upon the closing of the Offering, the number of shares issuable under the warrant will reset to an amount of shares equal to the aggregate exercise amount of the warrants (as defined therein) divided by the exercise price then in effect. The warrants expire in September 2021, and may be exercised via cashless exercise. The warrants may only be exercised to the extent the holder would own a maximum of 9.99% of the Company&amp;#146;s common stock after exercise. The Company recognized $220,000 of the $493,590 fair value of the warrants as a debt discount, which is being amortized over the life of the borrowing, and recognized the remaining $273,590 as a loss on derivatives liability. In the event the Company borrows additional amounts above the initial $500,000 under the note payable, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to warrants issued as part of the initial borrowing. During the nine months ended June 30, 2017, the Company borrowed an additional $1,000,000 on the note and issued warrants for the purchase of 40,000 shares of common stock with the same terms as the initial warrants. The Company recognized the $2,103,341 fair value of the warrants as debt discounts, which are being amortized over the remaining life of the borrowing. &amp;#160;Effective March 3, 2017, the note was amended to increase the maximum principal sum from $1,500,000 to $2,000,000 under which the Company borrowed an additional $200,000 in consideration and issued the lender a warrant to purchase up to 8,000 shares of common stock with the same terms as the warrants previously issued under the previous terms of the note.&amp;#160; The Company recognized the $407,947 fair value of the warrants as part of the total on extinguishment of debt of $501,969.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;During the nine months ended June 30, 2017, the Company measured the fair value of warrants classified as liabilities on the date of issuance and on each re-measurement date using the Monte Carlo valuation model. For this liability, the Company and specialist developed their own assumptions that do not have observable inputs or available market data to support the fair value. This method of valuation involves using inputs such as the fair value of the Company&amp;#146;s common stock, stock price volatility, the contractual term of the warrants, risk&amp;#150;free interest rates and dividend yields. Due to the nature of these inputs, the valuation of the warrants uses Level 3 measurements. The following assumptions were used:&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;626&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Exercise price&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;$2.50 - $25.00&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Expected term (years)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;0.21 - 4.93&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Volatility&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;128% - 194%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Risk-free rate&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;0.49% - 1.99%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Dividend rate&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;0%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Common stock price&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;$2.50 - $25.00&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;The following table summarizes information about stock options and warrants outstanding as of June 30, 2017:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;93%&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;border:none;border-bottom:solid windowtext 1.0pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Options and Warrants&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Number of Options and Warrants&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Outstanding as of October 1, 2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;65,045&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;35.06&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Granted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;48,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;25.00&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Forfeited&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(3,871)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;357.84&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Outstanding as of June 30, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;109,174&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;37.12&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Exercisable as of June 30, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;102,225&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;34.46&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;As of June 30, 2017, the outstanding warrants have an aggregate intrinsic value of $0 and the weighted average remaining term of the warrants was 4.52 years. The total compensation cost related to unvested awards not yet recognized (warrants and shares) was $38,468.&lt;/p&gt;</fil:Stockoptionsandwarrants0TextBlock>
	<fil:RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;16.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Related-Party Transactions Not Otherwise Disclosed&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;In February 2016, the Company amended a consulting agreement dated September 2015, with an entity controlled by a former Executive Chairman of the Board of Directors, effective January 2016.&amp;#160; The amendment extended the agreement through December 2016, which automatically renews on a monthly basis until otherwise cancelled in accordance with the terms therein, changing the monthly compensation of $6,000 to an hourly rate of $250 per hour, and eliminated the previously included bonus structure.&amp;#160; During May 2017, the Company granted 1,719 shares of common stock, with a value of $17,207 on the date of grant, to the consultant as a bonus for services performed.&amp;#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&amp;#160; On September 5, 2017, the Company granted 1,500 shares of the Company&amp;#146;s Series H Preferred stock to an entity controlled by a former Executive Chairman of the Board of Directors for past services rendered in addition to amounts earned under an existing consulting agreement.&amp;#160; The shares of Series H Preferred stock have not yet been issued.&amp;#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&amp;#160; On November 13, 2017, the former Executive Chairman of the Board of Directors terminated the consulting agreement.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;In July 2016, the Company entered into a Consulting Agreement with a former Executive Chairman and Chief Executive Officer of the Company.&amp;#160; This Consulting Agreement is for an initial period of one year, and shall automatically renew for consecutive one month periods unless terminated by the Company or the former Executive Chairman and Chief Executive Officer. As consideration for the services to be performed thereunder, the Company shall pay the former Executive Chairman and Chief Executive Officer at the rate of $250 per hour, but such compensation may not exceed $20,000 during any calendar month. &amp;#160;During May 2017, the Company granted 10,324 shares of common stock, with a value of $103,343 on the date of grant, to the consultant as a bonus for services performed.&amp;#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&amp;#160; On September 5, 2017, the agreement was replaced with a new agreement for an initial period of one year, and shall automatically renew for consecutive one month periods unless terminated by the Company or the former Executive Chairman and Chief Executive Officer.&amp;#160; As consideration for the services, the Company shall pay the former Executive Chairman and Chief Executive Officer at the rate of $250 per hour, but such compensation may not exceed $20,000 during any calendar month, plus 1,500 shares of the Company&amp;#146;s Series H Preferred stock.&amp;#160; The shares of Series H Preferred stock have not yet been issued.&amp;#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;In August 2016, the Company received a cash advance for $135,000 from a former Executive Chairman and Chief Executive Officer of the Company.&amp;#160; During the nine months ended June 30, 2017, the Company repaid the advance.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During May 2017, the Company granted 96,275 shares of common stock, with a value of $963,713 on the date of grant, to a former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, as a bonus for services performed.&amp;#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&amp;#160; On September 5, 2017, the Board of Directors of the Company granted 963 shares of Series H Preferred stock to the former Executive Chairman and Chief Executive Officer of the Company in lieu of the 96,275 shares of previously granted common stock.&amp;#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&amp;#160; The Series H Preferred shares have not yet been issued.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;In September 2017, the Company entered into an employment agreement with the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, for a period of two years for services as the Executive Chairman and Chief Executive Officer of the Company.&amp;#160; The initial term of the agreement is for two years and shall automatically renew on a year to year basis, unless terminated sooner.&amp;#160; The base compensation is $360,000 per year plus 1,500 shares of the Company&amp;#146;s Series H Preferred stock.&amp;#160; The shares of Series H Preferred stock have not yet been issued.&amp;#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&amp;#160; An additional cash or stock bonus may be awarded, subject to the attainment of such individual of certain objectives as the Board of Directors of the Company shall establish from time to time.&amp;#160; Upon certain termination conditions contained in the agreement, the Company may be required to pay severance of twice the base compensation at its highest point during the five-year period prior to termination.&amp;#160; Effective October 12, 2017, the former Executive Chairman and Chief Executive Officer has waived any constructive termination in relation to changes in title, working conditions or duties such that his powers are diminished, reduced or otherwise changed to include powers, duties, or working conditions which are note materially consistent with title, continuing after written notice and 10 days to cure.&lt;/p&gt;</fil:RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;17.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Commitments and Contingencies&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During the nine months ended June 30, 2017, the Company leased office space under a non-cancelable operating lease.&amp;#160; In February 2015, the Company entered into a sublease agreement for part of the office space under the non-cancelable operating lease through the end of the original lease period.&amp;#160; Payments under the sublease were made by the sublessee directly to the Company&apos;s landlord.&amp;#160; The non-cancelable operating lease was terminated during June 2015.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During June 2015, the Company entered into a new non-cancelable operating lease for its existing office space, excluding the previously subleased space, with payments beginning in July 2015.&amp;#160; Future minimum rental payments under the non-cancelable operating lease as of June 30, 2017, were as follows:&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&lt;u&gt;Years Ending September 30,&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;32,908&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;2018&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;111,340&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;border:none;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;144,248&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Company&apos;s rent expense under the new non-cancelable operating lease for nine months ended June 30, 2017 and 2016, was approximately $97,000 and $94,000, respectively.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During February 2016, the Company entered into an agreement with one if its vendors to purchase a minimum of $200,000 of inventory per quarter through January 2018.&amp;#160; The agreement was cancelled subsequent to June 30, 2017.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During February 2016, the Company redeemed all of its Series F preferred stock in exchange for 20,005 shares of common stock and $5,900,000 of notes payable (see Note 9).&amp;#160; As part of the redemption, the Company exchanged warrants held by the Series F Preferred stockholders for the purchase of 11,070 shares of common stock for new warrants to purchase the same number of shares with different terms.&amp;#160; As part of the redemption, the Company may be required to issue additional warrants for the purchase of up to 16,000 shares of common stock upon three events of default on the notes payable (see Note 15).&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During February 2016, the Company converted notes payable and accrued interest payable to an entity controlled by a former Executive Chairman of the Board of Directors into a convertible note payable (see Note 10).&amp;#160; The Company may be required to issue 1,469 shares of common stock if the note is not paid by maturity.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During February 2016, the Company amended notes payable to an entity controlled by an officer of the Company to subordinate to notes payable also issued during February 2016, reduced the conversion price per share to $30 per share and limited the shares into which it is convertible (see Note 10).&amp;#160; The Company may be required to issue 8,407 shares of common stock if the note is not paid by maturity.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During September 2016, the Company issued a note payable to a third party for up to $1,500,000.&amp;#160; The Company initially borrowed $500,000 under the note and may borrow up to $1,500,000 upon meeting certain milestones.&amp;#160; The Company subsequently drew an additional $1,000,000 under the note and issued additional warrants for the purchase of 40,000 shares of common stock at similar terms to warrants issued as part of the initial borrowing.&amp;#160; During March 2017, the note was amended to increase the maximum principal sum from $1,500,000 to $2,000,000 under which the Company borrowed an additional $200,000 in consideration and issued the lender a warrant to purchase up to 8,000 shares of common stock with the same terms as the warrants previously issued under the previous terms of the note.&amp;#160; In the event the Company borrows any part of the remaining $300,000 available, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to warrants issued as part of the initial borrowing.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;During September 2016, the Company entered into a conditionally effective warrant cancellation agreement (the &amp;quot;Warrant Cancellation Agreement&amp;quot;) with certain warrant holders who were issued the warrants in connection with a secured note payable and line of credit. Pursuant to the terms of the Warrant Cancellation Agreement, upon the Company&apos;s consummation of an equity financing of at least $15,000,000, the warrant holders agree to terminate and cancel the warrants they currently hold. As an inducement to enter into the Warrant Cancellation Agreement, the warrant holders will receive upon termination and cancelation of the warrants an aggregate of 10,800 shares of the Company&apos;s common stock, which will be subject to a 6-month lock-up agreement. Additionally, if the warrant holders terminate and cancel the warrants, the Company will issue the related note holder a new unsecured promissory note with an initial principal amount of $180,000, no cash interest, and a three-year term. In lieu of cash interest, the principal of the note will increase in the amount $3,333 each month not to exceed a maximum of $300,000.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Effective November 1, 2016, the Board approved the 2016 Incentive Stock Option plan providing for the issuance of options to purchase up to 377,250 shares.&amp;#160; No shares have been approved under the Plan as of June 30, 2017.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;On April 17, 2017 the Company entered into a Joint Venture Agreement, effective March 31, 2017 (the &amp;quot;JV Agreement&amp;quot;) with Colorado Choice Health Plans (&amp;quot;CCHP&amp;quot;), a customer. Under the JV Agreement: (i) CCHP is providing various services to the Company to improve the Company&apos;s diabetes programs, (ii) the Company loaned CCHP $500,000 under a debenture note (recorded as a note receivable in the accompanying consolidated condensed balance sheets), and (iii) the JV Agreement will terminate upon the later of (a) repayment of the debenture note or (b) the one year anniversary of the JV Agreement. The debenture note: (i) bears interest at the rate of five percent per annum, (ii) is subordinated to the rights of CCHP policyholders, claimants and beneficiary claims and all other classes of CCHP creditors other than subordinated debenture holders, (iii) does not become a liability of CCHP until and unless the Commissioner of the Colorado Department of Regulatory Agencies, Division of Insurance (&amp;quot;Division of Insurance&amp;quot;) authorizes repayment of the debenture agreement, and shall be treated by CCHP as surplus until the time of such approval, (iv) is only repayable from available funds in excess of CCHP&apos;s minimum net surplus required to be maintained by the Division of Insurance, and (v) is otherwise repayable on March 31, 2018, assuming approval by the Division of Insurance.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;On May 28, 2015, an investor of the Company filed a lawsuit claiming damages of $1,000,000 exclusive of interest and costs against the Company, a former Executive Chairman, an entity controlled by another former Executive Chairman, and 4G Biometrics, a wholly owned subsidiary of the Company, for breach of contract. The Company has engaged legal counsel regarding the matter.&amp;#160; The Company has assessed a high probability of settling the matter for $750,000 in cash, equity, or a combination thereof.&amp;#160; The Company has accrued a contingent liability of $750,000 and loss on settlement as of June 30, 2017.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;On November 4, 2015, the Company received a demand for payment of $275,000 from a former employee of the Company and former principal of 4G Biometrics whose employment was terminated for cause.&amp;#160; On December 4, 2015, the Company filed a complaint against the former owners of 4G Biometrics, including this former employee, seeking damages in excess of $300,000 related to alleged misrepresentations made to induce the Company to acquire 4G Biometrics.&amp;#160; Between February 4, 2016 and February 8, 2016, the Company settled the complaint with each of the former owners of 4G Biometrics and all parties released each other from all outstanding claims, including any current monetary obligations to each party, excluding one former owner of 4G Biometrics who continues to be employed by the Company.&amp;#160; A Stipulation for Order of Dismissal with Prejudice of all Claims and Counterclaims has been filed and is in the process of being approved.&amp;#160; The settlement resulted in the termination of $39,863 of related-party accounts payable.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:SubsequentEventsTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in&apos;&gt;&lt;b&gt;18.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/b&gt;&lt;b&gt;Subsequent Events&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;Subsequent to June 30, 2017, the Company entered into the following agreements and transactions:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(1)&amp;nbsp;&amp;nbsp;&amp;nbsp; On August 2, 2017, the Company received a cash advance from a third party in the amount of $100,000, which incurs fees of $1,500 per day until repaid.&amp;#160; During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&amp;#146;s common stock at the most favorable rate available as of the date of the agreement.&amp;#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(2)&amp;nbsp;&amp;nbsp;&amp;nbsp; On August 7, 2017, the Company received a cash advance from a third party in the amount of $50,000, which incurs fees of $750 per day until repaid. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&amp;#146;s common stock at the most favorable rate available as of the date of the agreement.&amp;#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(3)&amp;nbsp;&amp;nbsp;&amp;nbsp; During August 2017, the Company received letters related to unsecured notes payable with third parties with principal balances totaling $5,900,000 as of June 30, 2017 where the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(4)&amp;nbsp;&amp;nbsp;&amp;nbsp; During August 2017, the Company received a letter related to an unsecured note payable with a third party with a principal balance of $334,464 as of June 30, 2017 wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&amp;#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(5)&amp;nbsp;&amp;nbsp;&amp;nbsp; During August 2017, the Company received a letter related to secured and unsecured notes payable with entities controlled by the Company&amp;#146;s former chief executive officer and Executive Chairman of the Board of Directors, who was in office at the time, with principal balances of $1,721,100, $1,303,135, $250,000 and $25,463 as of June 30, 2017, wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&amp;#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through January 12, 2018 and extended maturity date was extended through January 12, 2018.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(6)&amp;nbsp;&amp;nbsp;&amp;nbsp; During August 2017, the Company received a letter related to an unsecured note payable with a former Executive Chairman of the Board of Directors with a principal balance of $542,004 as of June 30, 2017 wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017. &amp;#160;On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through January 12, 2018 and extended maturity date was extended through January 12, 2018.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(7)&amp;nbsp;&amp;nbsp;&amp;nbsp; During July 2017, the Company granted 1,562 shares of common stock, with a value of $12,496 on the date of grant, to the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, as a bonus for services performed during the three months ended June 30, 2017.&amp;#160; The value of the shares has been included in accrued expenses as of June 30, 2017. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(8)&amp;nbsp;&amp;nbsp;&amp;nbsp; On August 16, 2017, the Company sold $248,500 of future customer receipts to a third party for $175,000 in cash.&amp;#160; The $73,500 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company&amp;#146;s former Executive Chairman and Chief Executive Officer, who was in office at the time.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(9)&amp;nbsp;&amp;nbsp;&amp;nbsp; During July 2017, the Company granted 50,000 shares of common stock, with a value of $400,000 on the date of grant, to a third party as part of a one-year consulting agreement.&amp;#160; The value of the shares will be amortized to selling, general and administrative expenses evenly over the service period.&amp;#160; On September 5, 2017, the Board of Directors granted the issuance of 500 shares of Series H Preferred stock in lieu of the 50,000 shares of common stock, to which the third party has verbally agreed.&amp;#160; The Series H Preferred shares have not yet been issued.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(10) During July 2017, the Company granted 3,937 shares of common stock to employees for bonuses.&amp;#160; The $31,500 fair value of the shares has been included in accrued expenses as of June 30, 2017.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(11) On August 28, 2017, the Company sold $224,850 of future customer receipts to a third party for $150,000 in cash.&amp;#160; The $74,850 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company&amp;#146;s former Executive Chairman and Chief Executive Officer, who was in office at the time.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(12) On August 31, 2017, the Company sold $119,920 of future customer receipts to a third party for $80,000 in cash.&amp;#160; The $39,920 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company&amp;#146;s former Executive Chairman and Chief Executive Officer, who was in office at the time.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(13) On September 5, 2017, the Board of Directors of the Company modified the terms of the Series G Convertible Preferred stock to remove the 18-month lock-up period.&amp;#160; The amendment has not been filed with the State of Delaware as of the date of this filing.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(14) On September 5, 2017, the Board of Directors of the Company ratified a change to the Series H Preferred stock, previously contemplated and approved by the Board of Directors, to where each share of the Series H Preferred stock is convertible into 100 shares of the Company&amp;#146;s common stock, is limited to a total ownership of 4.99% of the outstanding common stock at the time of conversion, is to be non-voting stock, does not bear interest or dividends, and is transferable with the same terms.&amp;#160; The Certificate of Designation for the Series H Preferred stock has not been filed with the State of Delaware as of the time of this filing and no shares had been issued prior to September 5, 2017.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(15) On September 5, 2017, the Company entered into a consulting agreement with a former Executive Chairman and Chief Executive Officer of the Company, which replaced and existing consulting agreement, for certain consulting services to the Company including, but not limited to (i) developing business plans, (ii) making introductions to potential customers and/or suppliers, (iii) identifying qualified employees and other service providers, (iv) sales, marketing, manufacturing and other operating activities, and (v) meeting with the Company&apos;s and its affiliates&apos; respective managers, officers, employees, agents, and other service providers regarding the business, prospects and affairs of the Company and its affiliates. The former officer may not engage in and shall not be entitled to any fees or consideration for (i) negotiating the purchase and/or sale of Company securities, (ii) making recommendations regarding transactions involving Company securities, (iii) or any other matters involving transactions of Company securities.&amp;#160; The agreement is for one year and includes compensation of $250.00 per hour, but such compensation may not exceed $20,000 during any calendar month, plus 1,500 shares of the Company&amp;#146;s Series H Preferred stock.&amp;#160; The shares of Series H Preferred stock have not been issued at the time of this filing.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(16) On September 5, 2017, the Company renewed an existing license and royalty agreement with an entity controlled by a former Executive Chairman and Chief Executive Officer of the Company (the &amp;#147;licensee&amp;#148;).&amp;#160; Under the agreement, the licensee receives the right to make, sell and use products related to the Company&amp;#146;s intellectual property regarding diabetics, cellular, GPS and CareCenter arena and generally characterized as the CareCenter Technology in a certain region.&amp;#160; The Company shall receive a royalty of 15% of the licensee&amp;#146;s gross sales price for the product.&amp;#160; The initial term is for three years whereby the licensee must achieve a minimum royalty of $10,000 per month to maintain the agreement, whereby the agreement will be extended for one addition year unless terminated.&amp;#160; If the minimum monthly royalty is not maintained, the licensee may pay a sum to bring the total payment up to $360,000 within 60 days of the end of the three-year term to extend the agreement for one additional year.&amp;#160; The Company may terminate the agreement if the licensee does not commence to manufacture, distribute and sell product within a 6-month period after the execution of the agreement.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(17) On September 5, 2017, the Company granted 1,500 shares of the Company&amp;#146;s Series H Preferred stock to an entity controlled by a former Executive Chairman of the Board of Directors for past services rendered in addition to amounts earned under an existing consulting agreement.&amp;#160; The shares of Series H Preferred stock have not been issued at the time of this filing.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(18) On September 5, 2017, the Company entered into an employment agreement with the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, for a period of two years for services as the Executive Chairman and Chief Executive Officer of the Company.&amp;#160; The initial term of the agreement is for two years and shall automatically renew on a year to year basis, unless terminated sooner.&amp;#160; The base compensation is $360,000 per year plus 1,500 shares of the Company&amp;#146;s Series H Preferred stock.&amp;#160; The shares of Series H Preferred stock have not yet been issued.&amp;#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&amp;#160; An additional cash or stock bonus may be awarded, subject to the attainment of such individual and ActiveCare objectives as the Board of Directors of the Company shall establish from time to time as determined by the Board of Directors of the Company.&amp;#160; Upon certain termination conditions upon termination of the agreement, the Company may be required to pay severance of twice the base compensation of the former Executive Chairman and Chief Executive Officer at its highest point during the five-year period prior to termination. In addition, the Board of Directors approved compensation at a level of $360,000 per year retroactive from July 2017, when the former Executive Chairman and Chief Executive Officer was appointed, until the employment agreement was signed. Effective October 12, 2017, the agreement was amended to waive any constructive termination in relation to changes in title, working conditions or duties such that his powers are diminished, reduced or otherwise changed to include powers, duties, or working conditions which are note materially consistent with title, continuing after written notice and 10 days to cure.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(19) On September 5, 2017, the Board of Directors granted 963 shares of Series H Preferred stock to the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, in lieu of 96,275 shares of previously granted common stock as a bonus for services performed.&amp;#160; The Series H Preferred shares have not yet been issued.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(20) On September 5, 2017, the Board of Directors granted 200 shares of Series H Preferred stock to the holder of an unsecured note payable with a balance of $300,000 as of June 30, 2017 for the extension of the note payable.&amp;#160; The Series H Preferred shares have not yet been issued.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(21) From September 21, 2017 through December 1, 2017, the Company received cash advances totaling $230,000 from an entity controlled by the Company&amp;#146;s former Executive Chairman and Chief Executive Officer, who was in office at the time, and repaid $10,000 plus the reimbursement of bank fees of $200.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(22) On September 25, 2017, the Company entered into agreements with its primary product vendor that supersedes all prior agreements with the vendor.&amp;#160; Under the agreements, the vendor will provide all products and services to the Company&amp;#146;s service members as they are assigned to the vendor.&amp;#160; In return, the vendor will pay the Company a fee for services rendered to the vendor and to the members for monitoring and reporting.&amp;#160; The Company also earns commissions on all members assigned under the agreement to be paid upon completion of certain milestones met with each individual member.&amp;#160; The agreements also modify the terms of an existing note payable to the vendor.&amp;#160; The note accrues interest at 0.65% per annum, is reduced by the amount of commissions earned by the Company under the agreements and matures on September 25, 2019.&amp;#160; The agreements also add interest fees on existing accounts payable at 0.65% per annum and the accounts payable are reduced by the amount of commissions earned by the Company under the agreements for a minimum of 24 months.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(23) On September 27, 2017, the Company received a cash advance from a third party in the amount of $40,000, which incurs fees of $600 per day until repaid.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(24) In October 2017, the Company entered into a settlement agreement related to an unsecured note payable with a principal balance of $300,000 as of June 30, 2017.&amp;#160; As part of the agreement, the lender lent the Company an additional $200,000 which has been added to the principal balance of the note payable.&amp;#160; The agreement modified the terms of the note payable to become secured by inventory owned by the Company, requires issuance of 3,000 shares of Series H Preferred Stock, which were granted by the Board of Directors on September 5, 2017 and are required to be able to convert the lender&amp;#146;s shares into 300,000 shares of the Company&amp;#146;s common stock, and requires payments of $8,600 for 72 consecutive weeks.&amp;#160; If any payment is late, the Company is required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&amp;#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&amp;#160; The fair value of the shares will be amortized over the life of the amended note.&amp;#160; The note terms are adjustable for any terms subsequently provided to other investors.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(25) On November 7, 2017, the Company entered into individual agreements related to secured borrowings from four different parties that each previously purchased customer receivables that require daily payments.&amp;#160; The agreements modified each agreement to reduce the amount of the respective daily payment to approximately half of the amount previously drawn through January 7, 2018, whereafter the amount of the payment returns to the payment required under the respective agreement plus an additional amount equal to the amount shorted during the period of lower payments divided by the number of remaining payments remaining on the original term of the respective note payable.&amp;#160; Three of the four agreements are verbal.&amp;#160; On January 5, 2018, the Company further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018.&amp;#160; Three of the four agreements are verbal.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(26) On November 13, 2017, an entity controlled by a former Executive Chairman of the Board of Directors, with whom we contracted for consulting, terminated the existing consulting arrangement.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(27) On November 13, 2017, the Company entered into a sales broker agreement with an entity controlled by a former Executive Chairman of the Board (the &amp;#147;Sales Broker&amp;#148;).&amp;#160; Under the Sales Broker agreement, the Company will provide services to certain customers referred to the Company and the Sales Broker will receive administration fees in the amount of 15% of gross revenues, as defined by the Sales Broker agreement, as long as the Company services the respective customer even in the event the Sales Broker agreement is terminated.&amp;#160; The Sales Broker will promote the Company, its services and products, and introduce potential customers to the Company as a sales representative.&amp;#160; The initial term of the Sales Broker agreement is one year, which automatically renews for additional one-year periods until cancelled by either party.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(28) On November 30, 2017, the Company signed a letter of understanding with a former consultant where the Company agreed to convert $100,000 of past consulting fees owed into an equivalent value of equity in the Company upon a qualifying capital raise.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(29) On November 10, 2017, the Company signed a formal agreement replacing a former verbal agreement with an unsecured note holder, with principal due of $350,000 as of June 30, 2017.&amp;#160; The new agreement memorialized previously agreed upon terms whereby the lender converted a $350,000 advance into an unsecured note payable, with interest at 2.8% of revenues, for $143,987 in fees and a future payoff fee of 20% of the principal, or $70,000, which are included in accrued liabilities and interest expense as of June 30, 2017.&amp;#160; The written agreement adjusted the verbal agreement to where the Company is required to pay any outstanding interest at the end of the first month following a quarter end. The lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and the written agreement includes a most favored nations clause in relation to conversion features.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(30) On November 27, 2017, the Company signed a formal agreement memorializing previous agreements with the holder of an unsecured note and cash advance, with aggregate principal due of $1,200,000 as of June 30, 2017, as well as additional advances with aggregate principal of $190,000 that were received subsequent to June 30, 2017.&amp;#160; The new agreement memorialized the terms of the note payable whereby the lender converted $617,500 in advances into a $1,100,000 unsecured note payable, with interest at 18% per annum for $95,226 in fees, which have been included in accrued liabilities and interest expense as of June 30, 2017.&amp;#160; In addition, the new agreement allows for advances to incur fees at 1.5% of the advance principal per calendar day until paid in full.&amp;#160; The written agreement adjusted the verbal agreements to where the note payable and advance balances and fees may be called by the lender at any time and are due by May 30, 2018, and the new agreement includes a most favored nations clause in relation to conversion features on the note payable and advances.&amp;#160; The new agreement also assigned $2,000,000 of note payable principal held by an entity controlled by an officer of the Company to the lender.&amp;#160; All interest accrued on the assigned balance is payable to the officer. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(31) On December 6, 2017 the Company entered into those certain forbearance and lock up letter agreements with three (3) debtors which held convertible debentures in the aggregate principal amount of $1,109,345 at the time of the agreements, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more.&amp;#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&amp;#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&amp;#160; In addition, two (2) of the debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(32) Effective December 11, 2017, the Company entered into a Securities Purchase Agreement (the &amp;#147;Purchase Agreement&amp;#148;) with four accredited investors, including the Company&amp;#146;s new Chief Executive Officer in connection with the closing of a bridge financing (the &amp;#147;Bridge Financing&amp;#148;) in the gross amount of $600,000. The three remaining accredited investors hold notes payable with an aggregate principal balance of $3,865,865 as of June 30, 2017. Pursuant to the Purchase Agreements, the Investors purchased from the Company (i) Promissory Notes in the aggregate principal amount of $631,578.06 (the &amp;#147;Notes&amp;#148;) due and payable six months from the Effective Date and (ii) Common Stock Purchase Warrants (the &amp;#147;Warrant&amp;#148;), exercisable for five years from the date of issuance, to purchase up that certain amount of shares with an aggregate exercise amount equal to $600,000 at an exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in the companies contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the &amp;#147;Private Placement&amp;#148;) (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment hereunder (the &amp;#147;Exercise Price&amp;#148;). The Notes were issued in favor of the Investors with an original issue discount equal to five percent (5%). Additionally, pursuant to the Purchase Agreement, the Company will issue the investors common stock (the &amp;#147;Origination Shares&amp;#148;) worth 30% of the purchase price paid by each investor (the &amp;#147;Origination Dollar Amount&amp;#148;) on the 5th trading day after the pricing of the Private Placement, but in no event later than six months from the Effective Date. The Origination Dollar amount will divided by the lowest of (i) $3.00 (subject to adjustment for stock splits), (ii) 80% of the common stock offering price in the Private Placement, (iii) 80% of the offering price of the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement.&amp;#160; At the closing of the Private Placement the Note shall automatically convert into a subscription into the Private Placement in an amount equal to 125% of the Note balance, subject to certain conditions as outlined therein. If the Company fails to repay the balance due under the Note on its Maturity the Investors have the right, at any time, at their election, to convert all or part of the outstanding and unpaid principal sum and accrued interest (and any other fees) into shares of fully paid and non-assessable shares of common stock of the Company pursuant to the following conversion formula: number of shares receivable upon conversion equals the dollar amount being converted divided by the Conversion Price. The Conversion Price is the lesser of $3.00 (subject to adjustment for stock splits) or 60% of the lowest trade price in the 25 trading days. Further, in the event of any default, the outstanding principal amount of the Notes, plus accrued but unpaid interest, liquidated damages, fees and other amounts owing in respect thereof through the date of acceleration (the &amp;#147;Note Balance&amp;#148;), shall become, at the Investor&amp;#146;s election, immediately due and payable in cash at the Mandatory Default Amount. The Mandatory Default Amount means the investor&amp;#146;s choice of (this choice may be made at any time without presentment, demand, or notice of any kind): (i) the Note Balance divided by the Conversion Price on the date of the default multiplied by the closing price on the date of the default; or (ii) the Note Balance divided by the Conversion Price on the date the Mandatory Default Amount is either (a) demanded or (b) paid in full, whichever has a lower Conversion Price, multiplied by the closing price on the date the Mandatory Default Amount is either (a) demanded or (b) paid in full, whichever has a higher closing price; or (iii) 150% of the Note Balance. If, at any time the Note is outstanding, the Company issues a Variable Security (as defined therein), then in such event the Investors shall have the right to convert all or any portion of the outstanding balance of the Notes into shares of Common Stock on the same terms as granted in any applicable Variable Security issued by the Company.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(33) On November 17, 2017, the Company received cash advances from third parties totaling $60,000.&amp;#160; On January 5, 2018, the advances converted into agreements with the same terms as the Bridge Financing entered into on December 11, 2017.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(34) On December 11, 2017, Eric Robinson voluntarily resigned as Chief Financial Officer, Secretary and In-House Counsel, and all other positions with the Company to which he has been assigned regardless of whether he served in such capacity, effective immediately. On the same date, Jeffrey S. Peterson voluntarily resigned as Chairman of the Board of Directors, while acknowledging that he will continue to serve the Company as a Director and Executive Vice President.&amp;#160; On the same date, Robert J. Welgos and Bradley Robinson voluntarily resigned as members of the Board of Directors and all other positions with the Company to which they may have been assigned, regardless of whether they served in such capacity, effective immediately.&amp;#160; These resignations were not as a result of any disagreements with the Company.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(35) On December 11, 2017, Isaac Onn was appointed as a member of the Company&amp;#146;s board of Directors and Mark J. Rosenblum was appointed as the Company&amp;#146;s Chairman of the Board of Directors and Chief Executive Officer in connection with the Bridge Financing.&amp;#160; In connection with Mr. Rosenblum&amp;#146;s appointment as the Company&amp;#146;s Chief Executive Officer, on December 11, 2017, the Company and Mr. Rosenblum finalized the terms of his employment and entered into an employment agreement (the &amp;#147;Rosenblum Employment Agreement&amp;#148;). Mr. Rosenblum shall have such duties, responsibilities and authority which shall include, but not be limited to the responsibility for the overall management, direction and strategy of the Company. The Company shall pay Mr. Rosenblum a salary at a rate of Three Hundred Thousand and 00/100 Dollars ($300,000) per year (the &amp;#147;Initial Base Salary&amp;#148;). The Initial Base Salary shall increase to an annual rate of Three Hundred and Sixty Thousand Dollars ($360,000) (the &amp;#147;Base Salary&amp;#148;) upon the Company closing a financing of at least Five Million Dollars ($5,000,000). Mr. Rosenblum shall be eligible for an annual performance-based cash bonus of up to 100% of the Base Salary (as further defined in the Rosenblum Employment Agreement&amp;#148;). The Rosenblum Employment Agreement is for a term of three (3) years and will be automatically renewed for one year periods, unless otherwise terminated by the Company or Mr. Rosenblum. Upon execution of the Rosenblum Employment Agreement the Company agreed to issue restricted shares equal to $300,000 valued at the offering price of the next equity offering of the Company (&amp;#147;RSU&amp;#148;) and an option to purchase an aggregate $600,000 valued at the offering price of the next equity offering of the Company at an exercise price equal to the market price for the next equity offering of the Company (the &amp;#147;Options&amp;#148;). One-third of these Options shall vest immediately, another third on the first anniversary of the Rosenblum Employment Agreement, and the final third on the second anniversary of the Rosenblum Employment Agreement. The RSUs shall vest 50% immediately upon issuance and 25% on each of the first and second anniversaries of the Rosenblum Employment Agreement. If the Company terminates Mr. Rosenblum&amp;#146;s employment without just cause or if Mr. Rosenblum&amp;#146;s employment is terminated due to Disability (as defined therein), Mr. Rosenblum shall be entitled to receive, in addition to any accrued and unpaid Base Salary, plus any accrued but unused vacation time and unpaid expenses that have been earned as of the date of such termination, the following severance payments (the &amp;#147;Severance Payments&amp;#148;): (i) equal monthly installments at the applicable Base Salary rate then in effect, as determined on the first day of the calendar month immediately preceding the day of termination, to be paid beginning on the first day of the month following such termination and continuing until the later of (A) the expiration of the Term or (B) the expiration of (i) six (6) months following the effective termination date; provided, however, that if the Company terminates the Agreement without Just Cause (as defined in the Rosenblum Employment Agreement) within six (6) months of the effective date, then Mr. Rosenblum will only be entitled to three (3) months of severance instead of six (6) months; and (ii) during the Severance Period (as defined in the Rosenblum Employment Agreement), health and life insurance benefits substantially similar to those which Mr. Rosenblum was receiving or entitled to receive immediately prior to termination; provided, however, such insurance benefits shall be reduced to the extent comparable benefits during such period following Mr. Rosenblum&amp;#146;s termination, and any benefits actually received shall be reported by Mr. Rosenblum to the Company.&amp;#160; The Company will reimburse Mr. Rosenblum for any reasonably travel and relocation expenses.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(36) During December 2017, the Company entered into those certain forbearance and lock up letter agreements with a debtor which holds convertible debentures in the principal amount of $25,312 as of December 5, 2017, whereby the debtor agreed that, without prior written consent of the Company, the debtor will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more. Additionally, the debtor agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the convertible debentures. The forbearance and lock up letter agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(37) On January 12, 2018, the Company received letters from four (4) debtors which hold convertible debentures with principal balances totaling $3,162,955 as of June 30, 2017 where the debtors forbear against any historical and future events of default and remedies through February 15, 2018. Further, the maturity date was extended through February 15, 2018. &amp;#160;As part of the letters, the Company agreed not to initiate any new financing arrangements without the consent of the debtors.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(38) On January 12, 2018, the Company received a letter from a lender who holds two unsecured notes payable with principal balances totaling $550,000 as of June 30, 2017 where the lender forbears against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in&apos;&gt;(39) &amp;#160;On December 22, 2017, the Company entered into a Services Agreement (the &amp;#147;Cleveland Clinic Agreement&amp;#148;) with the Cleveland Clinic Foundation d.b.a. Cleveland Clinic, an Ohio nonprofit corporation (&amp;#147;Cleveland Clinic&amp;#148;). Pursuant to the Cleveland Clinic Agreement, the Company will be providing services to Cleveland Clinic as agreed to by the parties in any mutually agreed form pursuant to a &amp;#147;Statement of Work&amp;#148;. Pursuant to the Statement of Work included in the Cleveland Clinic Agreement, the Company will provide monitoring services to Cleveland Clinic&amp;#146;s expected beneficiary diabetic population within the Cleveland Clinic Medicare ACO. The initial term of the Cleveland Clinic Agreement is for three years and shall automatically renew after the term for a successive twelve (12) month period from year to year unless sooner terminated by either party in accordance with the terms of the Cleveland Clinic Agreement. As consideration for the Company&amp;#146;s Services, the Company is to receive a fixed monthly fee per Covered Diabetic Patient (as defined in the Cleveland Clinic Agreement). In addition, at such time the Cleveland Clinic Accountable Care Organization (&amp;#147;CCACO&amp;#148;) shall receive a shared savings payment from the Centers for Medicare and Medicaid Services, CCACO shall share such savings with the Company based on a formula defined in the Cleveland Clinic Agreement. Cleveland Clinic may, by written notice to the Company, terminate the Agreement, any purchase order or any portion of a purchase order if the Company (i) is in material breach of any of the terms and conditions of the Cleveland Clinic Agreement or any Purchase Order, which breach in not cured within thirty (30) days after notification of such breach, (ii) terminates or suspends its business, becomes insolvent, or becomes subject to any bankruptcy or insolvency proceeding under Federal or State law. Cleveland Clinic further may terminate the Cleveland Clinic Agreement, any Purchase Order or any portion of any Purchase Order for convenience upon ninety (90) days&amp;#146; prior written notice to Company (&amp;#147;Termination for Convenience&amp;#148;). In connection with any Termination for Convenience, Cleveland Clinic will reimburse Company for the actual cost reasonably incurred for work in process up to the time of cancellation, as well as any non-cancellable contract of Company, or non-cancellable purchase order to a third party, entered into for the benefit of Cleveland Clinic. The Cleveland Clinic Agreement is nonexclusive, and Cleveland Clinic may contract with others to perform similar services. Accordingly, the Company may also perform similar services for others.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
	<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;i&gt;Going Concern&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in&apos;&gt;The Company continues to incur negative cash flows from operating activities and net losses.&amp;#160; The Company had minimal cash, negative working capital and negative total equity as of June 30, 2017 and September 30, 2016.&amp;#160; In addition, the Company is in technical default on certain notes payable although the lenders in each case are working with the Company to resolve the defaults.&amp;#160; These factors, among others, raise substantial doubt about the Company&apos;s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other&apos;&gt;In order for the Company to eliminate substantial doubt about its ability to continue as a going concern, it must achieve profitability, generate positive cash flows from operating activities and obtain the necessary debt or equity funding to meet its projected capital investment requirements.&amp;#160; Management&apos;s plans with respect to this uncertainty consist of raising additional capital by issuing debt or equity securities and increasing the sales of the Company&apos;s services and products.&amp;#160; There can be no assurance that the Company will be able to raise sufficient additional capital or that revenues will increase rapidly enough to achieve operating profits.&amp;#160; If the Company is unable to increase revenues or obtain additional financing, it will be unable to continue the development of its products and services and may have to cease operations.&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
	<us-gaap:UseOfEstimates contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;Use of Estimates in the Preparation of Financial Statements&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the reporting periods. Actual results could differ from these estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
	<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;The Company measures the fair values of its assets and liabilities using the US GAAP hierarchy.&amp;#160; The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts receivable, accounts payable, and accrued liabilities approximate fair values due to the short-term nature of these financial instruments. Derivative financial instruments are recorded at fair value based on current market pricing models. The carrying amounts reported for notes payable approximate fair values because the underlying instruments are at interest rates which approximate current market rates.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
	<us-gaap:Reclassifications contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Certain prior year amounts have been reclassified to conform to the current period&amp;#146;s presentation. The reclassifications had no effect on the previously reported net loss.&lt;/p&gt;</us-gaap:Reclassifications>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In May 2014, August 2015 and May 2016, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;, ASU 2015-14 &lt;i&gt;Revenue from Contracts with Customers, Deferral of the Effective Date&lt;/i&gt;, ASU 2016-12 &lt;i&gt;Revenue from Contracts with Customers, Narrow-Scope Improvements and Practical Expedients&lt;/i&gt;, ASU 2017-13 &lt;i&gt;Revenue Recognition, Revenue from Contracts with Customers, Leases, and Leases: Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments&lt;/i&gt;, and ASU 2017-14 &lt;i&gt;Income Statement&amp;#151;Reporting Comprehensive Income, Revenue Recognition, and Revenue from Contracts with Customers&lt;/i&gt;, respectively, which implement ASC Topic 606. ASC Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance under US GAAP, including industry-specific guidance. It also requires entities to disclose both quantitative and qualitative information that enable financial statements users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amendments in these ASUs are effective for annual periods beginning after December 15, 2017, and interim periods therein, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted for annual periods beginning after December 15, 2016. These ASUs may be applied retrospectively to all prior periods presented, or retrospectively with a cumulative adjustment to retained earnings in the year of adoption. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In August 2014, the FASB issued ASU 2014-15, &lt;i&gt;Disclosure of Uncertainties about an Entity&apos;s Ability to Continue as a Going Concern&lt;/i&gt;. This standard sets forth management&apos;s responsibility to evaluate, each reporting period, whether there is substantial doubt about the Company&apos;s ability to continue as a going concern, and if so, to provide related disclosures. ASU 2014-15 is effective for annual reporting periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its evaluation of going concern.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In July 2015, the FASB issued ASU 2015-11, &lt;i&gt;Inventory: Simplifying the Measurement of Inventory&lt;/i&gt;. The purpose of ASU 2015-11 is to more closely align the measurement of inventory in US GAAP with the measurement of inventory in International Financial Reporting Standards. ASU 2015-11 requires entities to measure most inventory at the &amp;quot;lower of cost or net realizable value.&amp;quot; Additionally, some of the amendments are designed to more clearly articulate the requirements for the measurement and disclosure of inventory. ASU 2015-11 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In February 2016, the FASB issued ASU 2016-02, &lt;i&gt;Leases&lt;/i&gt;.&amp;#160; The purpose of ASU 2016-02 is to establish the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. This guidance results in a more faithful representation of the rights and obligations arising from operating and capital leases by requiring lessees to recognize the lease assets and lease liabilities that arise from leases in the statement of financial position and to disclose qualitative and quantitative information about lease transactions, such as information about variable lease payments and options to renew and terminate leases. ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In March 2016, the FASB issued ASU 2016-09, &lt;i&gt;Stock Compensation: Improvements to Employee Share-Based Payment Accounting&lt;/i&gt;.&amp;#160; The purpose of ASU 2016-09 is to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equities or liabilities, and classification of amounts in the statement of cash flows.&amp;#160; ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017.&amp;#160; The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In August 2016, the FASB issued ASU 2016-15, &lt;i&gt;Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments&lt;/i&gt;. The amendments in this update provided guidance on eight specific cash flow issues. This update is to provide specific guidance on each of the eight issues, thereby reducing the diversity in practice in how certain transactions are classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In May 2017, the FASB issued ASU 2017-09, &lt;i&gt;Stock Compensation: Scope of Modification Accounting&lt;/i&gt;. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. ASU 2017-09 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;In July 2017, the FASB issued ASU 2017-11, &lt;i&gt;Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivative and Hedging (Topic 815)&lt;/i&gt;. The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down-round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down-round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&amp;#146;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down-round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (&amp;#147;EPS&amp;#148;) in accordance with Topic 260 to recognize the effect of the down-round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down-round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt-Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Accounting Standards Codification, to a scope exception. Those amendments do not have an accounting effect. ASU 2017-11 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;649&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;193&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:144.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;169&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&apos;width:126.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Net loss attributable to common stockholders&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(5,873,988)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;3,304,133&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(15,151,168)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(14,924,907)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;Effect of dilutive securities on net loss:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt&apos;&gt;Common stock warrants&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(2,427,640)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt&apos;&gt;Convertible debt&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(1,860,373)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(1,790,407)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total net loss for purpose of &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;&amp;#160; calculating diluted net loss&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;&amp;#160; per common share&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(5,873,988)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(983,880)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(15,151,168)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(16,715,314)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;Number of shares used in per common share &lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;&amp;#160; calculations:&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total shares for purposes of calculating basic&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;&amp;#160; net loss per common share&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;237,100&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;217,595&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;233,767&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;182,979&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;Weighted-average effect of dilutive securities:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt&apos;&gt;Common stock warrants&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;3,337&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt&apos;&gt;Convertible debt&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;39,334&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;18,949&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total shares for purpose of calculating diluted &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt&apos;&gt;&amp;#160; net loss per common share&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;237,100&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;260,266&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;233,767&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;201,928&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&lt;b&gt;Net loss per common share:&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Basic&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(24.77)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(64.81)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(81.57)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Diluted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(24.77)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(3.78)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(64.81)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(82.78)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<fil:ScheduleOfCommonStockEquivalents0TextBlock contextRef='D161001_170630'>&lt;!--egx--&gt; &lt;p style=&apos;margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;649&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;193&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:144.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;169&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&apos;width:126.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;bottom&quot; style=&apos;width:2.8in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Common stock warrants&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;109,174&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;18,346&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;109,174&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;42,378&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Series D convertible preferred stock&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;450&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;450&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;450&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;450&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Series E convertible preferred stock&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;961&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;961&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;961&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;961&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Convertible debt&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;158,798&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;95,799&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;158,798&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;95,799&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Restricted shares of common stock&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Liability to issue common stock and warrants&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;358,097&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,246&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;358,097&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,246&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;269&quot; valign=&quot;top&quot; style=&apos;width:2.8in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:16.1pt&apos;&gt;Total common stock equivalents&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;8&quot; valign=&quot;bottom&quot; style=&apos;width:6.35pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;89&quot; valign=&quot;bottom&quot; style=&apos;width:66.55pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;627,495&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;117,817&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;72&quot; valign=&quot;bottom&quot; style=&apos;width:.75in;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;627,495&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:14.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;78&quot; valign=&quot;bottom&quot; style=&apos;width:58.5pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;141,849&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</fil:ScheduleOfCommonStockEquivalents0TextBlock>
	<us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; June 30, 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;b&gt;September 30, 2016 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Finished goods &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;503,477&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;206,444&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Inventory reserve&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(1,708)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(1,708)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:13.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:7.95pt&apos;&gt;Net inventory&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;501,769&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;204,736&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:2.25pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
	<us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:white;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; June 30, 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;b&gt;September 30, 2016 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Prepaid information technology services &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;38,081&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;57,073&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Other &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;12,249&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;112,117&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Prepaid insurance &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;6,225&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;14,602&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Prepaid legal and professional fees &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;333,741&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Research and development &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;96,346&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;Line of credit acquisition fees &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;30,978&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:26.25pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:7.95pt&apos;&gt;Total prepaid expenses and &amp;#160;&amp;#160; other current assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;56,555&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;644,857&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
	<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; June 30, 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;b&gt;September 30, 2016 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Software&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;47,974&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;47,974&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Leasehold improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;98,023&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;98,023&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Furniture&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;68,758&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;68,758&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Equipment&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;47,191&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;49,772&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total property and equipment&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;261,946&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;264,527&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;Accumulated depreciation and amortization&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(205,501)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;(177,793)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:13.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;56,445&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;86,734&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:6.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
	<us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:white;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt; June 30, 2017 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;b&gt;September 30, 2016 &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;#160;Interest &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,694,545&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;1,206,387&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:25.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;#160;Liability to issue warrants for the purchase &amp;#160;&amp;#160; shares of common stock &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,081,254&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Liability to issue common stock &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,000,933&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;240,000&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Finance fees &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;333,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;#160;Payroll expense &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;329,615&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;207,052&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Other &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;141,394&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;89,828&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Deferred revenue &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;85,399&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;111,803&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Warranty liability &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;58,300&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;134,330&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;#160;Commissions and fees &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;40,997&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;52,311&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt; Severance &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;60,000&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:12.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:13.5pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt&apos;&gt;Total accrued expenses&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;7,765,437&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right&apos;&gt;2,101,711&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:6.75pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;16&quot; valign=&quot;bottom&quot; style=&apos;width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
	<us-gaap:ScheduleOfDebtTableTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;bottom&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;bottom&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured notes payable with interest at 10% per annum, due November 2018.&amp;#160; The notes may go into default in the event other notes payable go into default subsequent to the effective date of the note.&amp;#160; Some of the notes are currently in technical default. However, as of the time of this report, the lenders have informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; &amp;#160;&amp;#160;In February 2016, the Company redeemed all 5,361 shares of its Series F Convertible Preferred Stock (&amp;quot;Series F preferred&amp;quot;) plus accrued dividends of $673,948 for 20,005 shares of common stock with a fair value of $1,600,000 containing certain temporary restrictions, and $5,900,000 of notes payable. Payments on the notes are partially or fully convertible at the Company&apos;s option at the lesser of (i) 80% of the per share price of the common stock to be offered in the proposed offering that is described in the Form S-1 filed on July 19, 2016 (the &amp;quot;Offering&amp;quot;), (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering to a maximum of 39,334 shares of common stock.&amp;#160; The conversion rate is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&amp;#160; A note may only be converted if the holder owns less than 4.99% of the Company&apos;s common stock after conversion.&amp;#160; The Company recorded a derivative liability of $2,461,899 related to the conversion feature of the notes.&amp;#160; In connection with the redemption of the Series F preferred stock, the Company issued new warrants in exchange for warrants held by the Series F preferred stockholders for the purchase of 11,070 shares of common stock at an exercise price of the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering, adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&amp;#160; The Company is also required to issue additional warrants for the purchase of up to 16,000 shares of common stock exercisable at $0.50 per share, also adjustable, that vest upon certain events of default.&amp;#160; On December 11, 2017, the Company entered into Securities Purchase Agreements that adjusted the conversion rate to exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in a contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the &amp;#147;Private Placement&amp;#148;) (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment (see Note 18).&amp;#160; The fair value of $1,344,608 related to the new warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value of the stock, conversion feature, warrants and $25,000 of fees, in excess of the carrying value of the Series F preferred stock were recorded as a deemed dividend of $6,484,236.&amp;#160; During the three months ended March 31, 2017, the Company entered into letter agreements related to the note to convert the outstanding principal and interest into shares of common stock contingent upon the Offering, which also removes the maximum share limitation conversion, which have expired (see Note 17).&amp;#160; Subsequent to June 30, 2017, the Company received letters related to the notes wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 (see Note 18).&amp;#160; In December 2017, the Company entered into those certain forbearance and lock up letter agreements with four of the eight debtors, with principal balances in the aggregate amount of $1,134,658, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of Common Stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more.&amp;#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&amp;#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&amp;#160; In addition, two of the five debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity (see Note 18). On January 12, 2018, the Company received letters from four of the debtors where the debtors forbear against any historical and future events of default and remedies through February 15, 2018. Further, the maturity date was extended through February 15, 2018.&amp;#160; As part of the letters, the Company agreed not to initiate any new financing arrangements without the consent of the debtors. (see Note 18).&amp;#160; On December 11, 2017, the Company borrowed an aggregate additional $300,000 from two of the lenders under new note payable agreements (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;5,900,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;5,900,000 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured borrowings from a third party that purchased $3,257,600 of customer receivables for $2,100,000, with due dates ranging from January 2018 to October 2018, and payable in daily payments ranging from $5,000 to $13,000.&amp;#160; The $1,157,600 difference between the customer receivables and cash received is being amortized to interest expense over the term of the respective notes.&amp;#160; The secured borrowings are guaranteed by a former chief executive officer of the Company and are subordinated to other notes payable. On April 17, 2017, the Company entered into a factoring agreement which provides for an advance of $1,794,000, comprised of $1,000,000 in cash and the consolidation of $794,000 from four prior factoring agreements into the amounts owed under the factoring agreement (collectively, the &amp;quot;Funds&amp;quot;). In consideration for the Funds, the Company sold to the lender all future receipts until the total amount of $2,511,601 has been paid. The factoring agreement requires payment of the minimum daily amount of $12,999.99 for 193 days. The $2,511,601 can be reduced if repayment occurs more quickly. Repayment of the amounts owing is with recourse and secured by all accounts, chattel paper, documents, equipment, general intangibles, instruments, and inventory of the Company and subordinated to other notes payable.&amp;#160; In June 2017, the lender verbally agreed to reduce the minimum daily amount to $5,000 and, in November 2017, verbally agreed to further reduce the minimum daily amount to $2,600 through January 7, 2018, after which the daily amount would return to $13,000.&amp;#160; Subsequent to June 30, 2017, the Company entered into similar secured borrowings and related verbal or written reductions in the daily amounts.&amp;#160; On January 5, 2018, the Company further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018 &amp;#160;(see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 1,974,602 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 689,318 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;bottom&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Unsecured note payable with a vendor with interest at 0.65% per annum payable at the end of each calendar year, due January 2018, issued in March 2016 upon the conversion of $2,523,937 in accounts payable to the vendor.&amp;#160; The note requires payments of $50,000 per month in April 2016 through December 2016, $100,000 per month in January 2017 through December 2017 and the remaining balance due in January 2018.&amp;#160; In September 2017, the Company entered into agreements with the vendor which supersedes the unsecured note payable agreement and provides new terms (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 1,773,937 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 2,223,937 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with a third party with no interest, was due the earlier of November 2016 or the third business day after the closing of a proposed Offering. The note is currently in technical default. However, as of the time of this report, the lender has provided bridge capital since going in default and has informally agreed to work with the Company until such time as the note can be repaid. &amp;#160;Pursuant to the note, the Company may borrow up to $1,500,000 upon meeting certain milestones and may be converted into shares of common stock upon default.&amp;#160; The note required a payment of common stock on the 5th trading day after the pricing of the proposed Offering, but no later than December 15, 2016.&amp;#160; The number of common shares will equal $200,000 divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the common shares or during the ten days prior to the date of the Purchase Agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price of the Offering, or (iv) the exercise price of any warrants issued in the Offering.&amp;#160; The estimated fair value of $240,000 of the stock is included in accrued liabilities and is being amortized to interest expense over the life of the note.&amp;#160; In connection with the issuance of the note, the Company also issued 20,000 warrants to purchase shares of common stock at an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock in the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering, or (iv) the exercise price of any warrants issued in the Offering and the number of shares will reset upon the closing of the Offering.&amp;#160; The warrants may only be exercised to the extent the holder would own a maximum of 9.99% of the Company&apos;s common stock after exercise.&amp;#160; The fair value of $493,590 related to the replacement warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; Of this fair value amount, $220,000 was recorded as a debt discount and is being amortized over the life of the note and the remaining $273,590 was recorded as a loss on derivative liability.&amp;#160; In the event of borrowing in excess of an initial $500,000, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to the initial warrants issued.&amp;#160; In November 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $286,171 related to the November 2016 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&amp;#160; In November 2016, the Company amended the note to extend the maturity date to the earlier of January 31, 2017 or the third business day after the closing of the Offering.&amp;#160; In addition, the amendment adjusted the origination shares to equal 20% of the note divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the shares or during the ten days prior to the date of the agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Offering.&amp;#160; In December 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $349,819 related to the December 2016 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&amp;#160; On January 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $567,753 related to the January 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note. On January 30, 2017, the Company amended the note to extend the maturity date to the earlier of March 15, 2017 or the third business day after the closing of the Offering. Also on January 30, 2017. the Company borrowed the remaining $300,000 on the note and issued an additional warrant for the purchase of 12,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $899,598 related to the January 30, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&amp;#160; On March 3, 2017, the Company amended the note to increase the maximum sum from $1,500,000 to $2,000,000. Also on March 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&amp;#160; The fair value of $407,947 related to the March 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&amp;#160; The Company recorded a loss on extinguishment of debt of $501,969 related to the March 3, 2017 amendment and additional borrowing. Effective March 27, 2017, the Company amended the note to extend the maturity date to the earlier of April 15, 2017 or the third business day after the closing of the Offering. Additionally, the lender agreed to enter into a lock up prohibiting the sale or other transfer of all securities of the Company owned by them for a period of 6 months. In consideration for entering into the lock-up agreement the Company has agreed to pay a $340,000 fee, payable in shares of common stock at a rate of the lowest of (i) 80% of the common stock Offering price of the Offering, (ii) 80% of the unit price Offering price of the Offering (if applicable), or (iii) 80% of the exercise price of any warrants issued in the Offering.&amp;#160; The lock-up agreement was signed during April 2017, which has expired. Effective April 19, 2017, the Company amended the note to extend the maturity date to the earlier of May 20, 2017 or the third business day after the closing of the Offering. On December 11, 2017, the Company borrowed an additional $250,000 from the lender under a new note payable agreement (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;1,700,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 500,000 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured note payable to a third party with interest at 12.75% per annum, due February 2019, in default.&amp;#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&amp;#160; The Company entered into the note payable agreement in conjunction with a line of credit.&amp;#160; The Company initially borrowed $1,500,000 and may borrow additional amounts under the note payable agreement up to a total balance of $3,000,000 as the Company meets certain milestones.&amp;#160; The interest rate may also reduce to 11.25% per annum as the Company meets certain milestones.&amp;#160; In conjunction with the note and related line of credit, the Company issued warrants to the lender to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&amp;#160; The Company has recorded discounts of $1,500,000, which are being amortized to interest expense over the term of the note.&amp;#160; In April 2016, the Company borrowed an additional $500,000 on the note and incurred additional fees of $25,000, which are being amortized to interest expense over the remaining term of the note.&amp;#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issue the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the &amp;quot;November Forbearance Agreement&amp;quot;). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the &amp;quot;November Forbearance&amp;quot;) with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&amp;#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company&apos;s Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company&apos;s Series G Preferred Stock to certain affiliates of the Company.&amp;#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&amp;#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&amp;#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&amp;#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the &amp;quot;December Forbearance&amp;quot;). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&amp;#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&amp;#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&amp;#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&amp;#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&amp;#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&amp;#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $15,470 on the note payable. &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;1,152,778 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;1,652,778 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured line of credit with a third party with interest at 12.25% per annum, due February 2018, in default.&amp;#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&amp;#160; The Company entered into the line of credit agreement in conjunction with a note payable.&amp;#160; The Company may draw up to the lesser of 80% of certain accounts receivable or $1,500,000 and increase the maximum it may borrow under the agreement up to a total balance of $3,000,000 at $500,000 per increase as the Company meets certain milestones.&amp;#160; The interest rate may also reduce to 10.75% per annum as the Company meets certain milestones.&amp;#160; In conjunction with the line of credit and related note, the Company issued warrants to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&amp;#160; The Company has recorded prepaid expenses of $44,665, which are being amortized to interest expense over the term of the line of credit.&amp;#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issuance of the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the &amp;quot;November Forbearance Agreement&amp;quot;). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the &amp;quot;November Forbearance&amp;quot;) with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&amp;#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company&apos;s Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company&apos;s Series G Preferred Stock to certain affiliates of the Company.&amp;#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&amp;#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&amp;#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&amp;#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the &amp;quot;December Forbearance&amp;quot;). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&amp;#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&amp;#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&amp;#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&amp;#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&amp;#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&amp;#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $16,997 on the note payable.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;1,259,007 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;929,518 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 18% per annum, with no maturity date.&amp;#160; The note payable is from a verbal agreement with the lender which converted $617,500 of advances into $1,100,000 of principal on the note payable.&amp;#160; The additional $482,500 of principal plus agreed upon fees of $95,226 have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&amp;#146;s common stock at the most favorable rate available as of the date of the agreement.&amp;#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,100,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 2.8% of total revenue per annum, with no maturity date.&amp;#160; The note payable is from a verbal agreement with the lender which converted a $350,000 advance into the note payable.&amp;#160; Agreed upon fees of $143,987 and a future payoff fee of 20%, or $70,000, have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to where the Company is required to pay any outstanding interest at the end of the first month following a quarter end, the lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and to become convertible into shares of the Company&amp;#146;s common stock at the most favorable rate available as of the date of the agreement.&amp;#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;350,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Note payable previously secured by CareServices customer contracts.&amp;#160; In January 2015, the note was amended to reduce the outstanding principal to $375,000, interest at 9% per annum, and payable in 15 monthly installments beginning in February 2015.&amp;#160; The amendment released the collateralized customer contracts and the note payable is guaranteed by both a former Executive Chairman of the Board of Directors and a member of the Board of Directors.&amp;#160; A gain on the extinguishment of the old note of $769,449 was recorded in other income.&amp;#160; In December 2015, the note was amended to extend maturity to January 2018 payable in monthly installments beginning in July 2016, convert $31,252 from accrued interest into principal, interest at 10% per annum, and provide that the note is convertible into common stock at its fair value per share.&amp;#160; The Company recorded a derivative in connection with the convertible feature of the note (see Note 12) and is amortizing the initial $302,690 fair value of the derivative liability over the life of the note.&amp;#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016.&amp;#160; In July 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or November 2016 and included additional default penalties and payment terms.&amp;#160; In October 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or December 31, 2016 and included additional default penalties and payment terms.&amp;#160; In December 2016, February 2017 and March 2017, the note was further amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or February 15, 2017, March 31, 2017, and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;334,464 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;334,464 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 12% per annum, due February 2016, convertible into common stock at $150 per share.&amp;#160; In connection with the issuance of the note, the Company repriced previously issued warrants to purchase shares of common stock.&amp;#160; The $22,397 increase in relative fair value of the warrants was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&amp;#160; The note also required a payment of 6,000 shares of common stock.&amp;#160; The fair value of $780,000 was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&amp;#160; The maturity date was subsequently extended on two occasions for a total of 500 shares of common stock and the note was due May 2016.&amp;#160; The $31,250 fair value of these shares was being amortized over the extension period.&amp;#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company&apos;s common stock on the date of the amendment.&amp;#160; The note may only be converted if the holder owns less than 9.99% of the Company&apos;s common stock after conversion.&amp;#160; The Company recorded the value of the beneficial conversion feature of $381,299 to loss on termination of debt as a result of the modification.&amp;#160; In May 2016, the note was amended to extend the maturity date to the earlier of an equity raise of $10,000,000 or October 2016 which required a payment of 600 shares of common stock.&amp;#160; The $28,500 fair value of these shares has been included in accrued liabilities and was amortized over the extension period.&amp;#160; In October 2016, the Company extended the maturity date of the note month-by-month through no later than April 30, 2017 for a fee of $5,000 per month extended.&amp;#160; During September 2017, the Board of Directors granted 200 shares of Series H Preferred Stock for extension fees. In October 2017, the Company entered into a settlement agreement related to the note where the Company borrowed an additional $200,000 and modified the terms of the note payable to become secured by inventory owned by the Company, requires issuance of 3,000 shares of Series H Preferred Stock, which were authorized for grant by the Board of Directors on September 5, 2017 and are required to be able to convert the lender&amp;#146;s shares into 300,000 shares of the Company&amp;#146;s common stock, and requires payments of $8,600 for 72 consecutive weeks.&amp;#160; If any payment is late, the Company is required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&amp;#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&amp;#160; The fair value of the shares will be amortized over the life of the amended note.&amp;#160; The note terms are adjustable for any terms subsequently provided to other investors (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;300,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;300,000 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured note payable with interest at 12.25% per annum, due May 2017, in default. The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note. The Company entered into the agreement in conjunction with a modification to another note payable and line of credit. The note requires payment of a $3,000 modification fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&amp;#160; The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $4,050 on the note payable.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;300,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;-&amp;#160;&amp;#160; &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 12.75% per annum, due June 2017, in default, subordinated to other notes payable. The note requires payment of a $3,000 closing fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&amp;#160; The $3,000 closing fee is being amortized to interest expense over the remaining term of the note and the $50,000 fees are being accrued as incurred.&amp;#160; On January 12, 2018, the lender forbore against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;300,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;-&amp;#160;&amp;#160; &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable with interest at 12% per annum, due September 2016, in default, subordinated to other notes payable.&amp;#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&amp;#160; The $100,000 fair value of the stock was amortized to interest expense over the term of the note.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). On January 12, 2018, the lender forbore against9/ any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;250,000 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;250,000 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured cash advance with fees at $1,000 per day for the first 15 days and $1,500 per day thereafter, with no maturity date.&amp;#160; The terms of the advance are verbal. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&amp;#146;s common stock at the most favorable rate available as of the date of the agreement.&amp;#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;100,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured notes with interest at 18% per annum, due April 2013, in default.&amp;#160; The Company issued 20,000 shares of Series D preferred stock as loan origination fees.&amp;#160; The $195,000 fair value of the preferred stock was amortized over the original term of the note.&amp;#160;&amp;#160; Principal of $50,000 and accrued interest of $13,333 were converted to common stock in December 2013.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 64,261 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 64,261 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Secured note payable to a third party with interest at 18% per annum, due June 2017.&amp;#160; The note was secured by shares of the Company&apos;s common stock held by, and other assets of an entity controlled by, a former Executive Chairman of the Board of Directors. &amp;#160;The note was guaranteed by a former Executive Chairman of the Board of Directors and his related entity and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&amp;#160; Payments on the note were convertible at the holder&apos;s option into common stock at 75% of its fair value if not paid by its respective due date, which is subject to a 20 trading day true-up and is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of other certain raises.&amp;#160; The Company recognized a derivative liability related to the conversion feature with a fair value of $181,670, which was recognized as a loss on termination of debt.&amp;#160; In June 2016, $13,713 of principal and $11,287 of accrued interest converted into 953 shares of common stock, pursuant to the terms of the note.&amp;#160; In August 2016, $64,654 of principal and $10,346 of accrued interest converted into 9,203 shares of common stock, pursuant to the terms of the note.&amp;#160; This note was terminated by paying the remaining principal and accrued interest in cash with no additional consideration.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;-&amp;#160;&amp;#160; &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;162,539 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160; Total notes payable before discount&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 16,859,049 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;13,006,815 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Less discount&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; (1,468,335)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; (1,930,060) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160; Total notes payable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;15,390,714 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;11,076,755 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Less current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; (9,501,544)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; (3,722,899) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;451&quot; valign=&quot;top&quot; style=&apos;width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;#160; Notes payable, net of current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:.95in;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt; 5,889,170 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.25pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;#160;7,353,856 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
	<us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;bottom&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;bottom&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt; Secured borrowings from entities controlled by an officer who purchased a $2,813,175 customer receivable for $1,710,500.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; The Company repurchased the receivable for $1,950,000 less cash received by the entities through March 2015.&amp;#160; The $239,500 difference between the buyback and cash received plus $253,500 of loan origination fees was amortized to interest expense through March 2015.&amp;#160; In September 2015, the note was modified to extend the maturity date to January 2017, with interest at 18% per annum.&amp;#160; The Company added $81,600 of extension fees and issued 6,000 shares of common stock to a lender as part of the modification.&amp;#160; The note is convertible into common stock at $150 per share.&amp;#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&amp;#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company&apos;s stock on the date of the amendment.&amp;#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lenders.&amp;#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lenders, if not paid by maturity.&amp;#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&amp;#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&amp;#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,721,100&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,721,100&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt; Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due January 2017, convertible into common stock at $150 per share.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; The Company issued 6,000 shares of common stock to a lender as loan origination fees.&amp;#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&amp;#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and reduced the conversion price to $30 per share, which was below the fair value of the Company&apos;s stock on the date of the amendment.&amp;#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lender.&amp;#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lender, if not paid by maturity.&amp;#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&amp;#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&amp;#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,303,135&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,303,135&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to an entity controlled by a former Executive Chairman of the Board of Directors with interest at 18% per annum, due January 2017.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; In February 2016, notes payable to the same entity, with outstanding balances of $511,005 plus accrued interest of $30,999 combined into this note.&amp;#160;&amp;#160; The note is subordinated to notes payable to unrelated parties and is convertible into shares of common stock at $30 per share, which was below the fair value of the Company&apos;s stock on the date of the agreement.&amp;#160; The conversion of the note is limited to a maximum of 18,500 common shares.&amp;#160; The Company recorded the value of the beneficial conversion feature of $632,339 to loss on termination of debt.&amp;#160; The note has a default penalty of 1,469 shares of common stock if not paid by maturity. The note may only be converted if the holder owns less than 4.99% of the Company&apos;s common stock after conversion.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;542,004&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;542,004&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to an entity controlled by an officer with interest at 12% per annum, due September 2016, subordinated to other third party notes payable.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&amp;#160; The $70,000 fair value of the stock is being amortized to interest expense over the term of the note.&amp;#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&amp;#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&amp;#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;250,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;250,000&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to a former officer with interest at 12% per annum, due September 2013.&amp;#160; This note is in default and is convertible into common stock at $375 per share.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;26,721&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;26,721&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due on demand.&amp;#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&amp;#160; In February 2016, the note was amended to subordinate the note to other notes payable also issued during February 2016.&amp;#160; The note is convertible into shares of common stock at $30 per share, which was below the fair value of the Company&apos;s stock on the date of the amendment.&amp;#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the entity.&amp;#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the entity, if not paid by maturity.&amp;#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&amp;#160; In January 2017 and February 2017, the note was amended to extend the maturity date to February 15, 2017 and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&amp;#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&amp;#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;25,463&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;25,463&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to a former officer with interest at 15% per annum, due June 2012, in default.&amp;#160; The note included a $3,000 loan origination fee added to the principal and is convertible into common stock at $250 per share.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,260&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;17,227&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;Unsecured note payable to a former officer with interest at 12% per annum, due on demand.&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;12,474&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;#160;&amp;#160; Total notes payable, related-party&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;3,869,683&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;3,898,124&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Less current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(3,869,683)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(3,898,124)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;450&quot; valign=&quot;top&quot; style=&apos;width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph&apos;&gt;&amp;#160;&amp;#160; Notes payable, related-party, net of current portion&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;7&quot; valign=&quot;bottom&quot; style=&apos;width:5.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;91&quot; valign=&quot;bottom&quot; style=&apos;width:68.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;100%&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;top&quot; style=&apos;width:1.1%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;Quoted Prices in Active Markets for Identical Items (Level 1) &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;Significant Other Observable Inputs (Level 2) &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;Significant Unobservable Inputs (Level 3) &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&amp;#160;Total &lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;June 30, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;top&quot; style=&apos;width:1.1%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:20.0pt&apos;&gt;Derivatives liability&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.1%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;269,427&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;3,962,556&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;4,231,983 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;top&quot; style=&apos;width:1.1%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;September 30, 2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;top&quot; style=&apos;width:1.1%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;23%&quot; valign=&quot;bottom&quot; style=&apos;width:23.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:20.0pt&apos;&gt;Derivatives liability&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.1%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19%&quot; valign=&quot;bottom&quot; style=&apos;width:19.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18%&quot; valign=&quot;bottom&quot; style=&apos;width:18.74%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;281,613&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.66%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;1,772,458&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.58%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.12%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11%&quot; valign=&quot;bottom&quot; style=&apos;width:11.88%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;2,054,071&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
	<us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;98%&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Derivatives Liability&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Balance, September 30, 2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;1,772,458 &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;Issuance of warrants recorded as derivatives&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;2,511,288&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;Gain on termination of debt resulting from&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;&amp;#160; payments on notes payable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(103,213) &lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;Loss on derivatives liability resulting&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt&apos;&gt;&amp;#160; from changes in fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(217,997)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;70%&quot; valign=&quot;bottom&quot; style=&apos;width:70.16%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Balance, June 30, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.54%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1%&quot; valign=&quot;bottom&quot; style=&apos;width:1.8%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;25%&quot; valign=&quot;bottom&quot; style=&apos;width:25.5%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;3,962,556&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
	<fil:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;626&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Exercise price&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;$2.50 - $25.00&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Expected term (years)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;0.21 - 4.93&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Volatility&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;128% - 194%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Risk-free rate&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;0.49% - 1.99%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Dividend rate&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;0%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Common stock price&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;top&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:1.1in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;$2.50 - $25.00&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</fil:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock>
	<us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;93%&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;border:none;border-bottom:solid windowtext 1.0pt;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Options and Warrants&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Number of Options and Warrants&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Outstanding as of October 1, 2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;65,045&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;35.06&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Granted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;48,000&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;25.00&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Forfeited&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;(3,871)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;357.84&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Outstanding as of June 30, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;109,174&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;37.12&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;61%&quot; valign=&quot;bottom&quot; style=&apos;width:61.38%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;Exercisable as of June 30, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;top&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;102,225&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;2%&quot; valign=&quot;bottom&quot; style=&apos;width:2.44%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;16%&quot; valign=&quot;bottom&quot; style=&apos;width:16.86%;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;34.46&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
	<us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef='D161001_170630'>&lt;!--egx--&gt;&lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:white;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&lt;b&gt;&lt;u&gt;Years Ending September 30,&lt;/u&gt;&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;32,908&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center&apos;&gt;2018&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;111,340&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;border:none;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style=&apos;height:9.35pt&apos;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;15&quot; valign=&quot;bottom&quot; style=&apos;width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;106&quot; valign=&quot;bottom&quot; style=&apos;width:79.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right&apos;&gt;144,248&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='Y17Q2' unitRef='USD'>-5873988</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='Y16Q2' unitRef='USD'>3304133</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='D161001_170630' unitRef='USD'>-15151168</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='D151001_160630' unitRef='USD'>-14924907</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther decimals='INF' contextRef='Y16Q2_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-CommonStockOptionsAndWarrants' unitRef='USD'>-2427640</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
	<us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther decimals='INF' contextRef='Y16Q2_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-ConvertibleDebt1' unitRef='USD'>-1860373</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
	<us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther decimals='INF' contextRef='D151001_160630_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-ConvertibleDebt1' unitRef='USD'>-1790407</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
	<us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther decimals='INF' contextRef='Y17Q2' unitRef='USD'>-5873988</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
	<us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther decimals='INF' contextRef='Y16Q2' unitRef='USD'>-983880</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
	<us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther decimals='INF' contextRef='D161001_170630' unitRef='USD'>-15151168</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
	<us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther decimals='INF' contextRef='D151001_160630' unitRef='USD'>-16715314</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals='INF' contextRef='Y17Q2' unitRef='Shares'>237100</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals='INF' contextRef='Y16Q2' unitRef='Shares'>217595</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals='INF' contextRef='D161001_170630' unitRef='Shares'>233767</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals='INF' contextRef='D151001_160630' unitRef='Shares'>182979</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount decimals='INF' contextRef='Y16Q2_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-CommonStockOptionsAndWarrants' unitRef='UsdPerShare'>3337</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount decimals='INF' contextRef='Y16Q2_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-ConvertibleDebt1' unitRef='UsdPerShare'>39334</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount decimals='INF' contextRef='D151001_160630_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-ConvertibleDebt1' unitRef='UsdPerShare'>18949</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals='INF' contextRef='Y17Q2' unitRef='Shares'>237100</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals='INF' contextRef='Y16Q2' unitRef='Shares'>260266</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals='INF' contextRef='D161001_170630' unitRef='Shares'>233767</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals='INF' contextRef='D151001_160630' unitRef='Shares'>201928</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:IncomeLossFromContinuingOperationsPerBasicShare decimals='2' contextRef='Y17Q2' unitRef='UsdPerShare'>-24.77</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerBasicShare decimals='2' contextRef='Y16Q2' unitRef='UsdPerShare'>15.18</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerBasicShare decimals='2' contextRef='D161001_170630' unitRef='UsdPerShare'>-64.81</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerBasicShare decimals='2' contextRef='D151001_160630' unitRef='UsdPerShare'>-81.57</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare decimals='2' contextRef='Y17Q2' unitRef='UsdPerShare'>-24.77</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare decimals='2' contextRef='Y16Q2' unitRef='UsdPerShare'>-3.78</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare decimals='2' contextRef='D161001_170630' unitRef='UsdPerShare'>-64.81</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare decimals='2' contextRef='D151001_160630' unitRef='UsdPerShare'>-82.78</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
	<fil:ExerciseOfOutstandingCommonStockOptionsAndWarrants decimals='INF' contextRef='Y17Q2' unitRef='Shares'>109174</fil:ExerciseOfOutstandingCommonStockOptionsAndWarrants>
	<fil:ExerciseOfOutstandingCommonStockOptionsAndWarrants decimals='INF' contextRef='Y16Q2' unitRef='Shares'>18346</fil:ExerciseOfOutstandingCommonStockOptionsAndWarrants>
	<fil:ExerciseOfOutstandingCommonStockOptionsAndWarrants decimals='INF' contextRef='D161001_170630' unitRef='Shares'>109174</fil:ExerciseOfOutstandingCommonStockOptionsAndWarrants>
	<fil:ExerciseOfOutstandingCommonStockOptionsAndWarrants decimals='INF' contextRef='D151001_160630' unitRef='Shares'>42378</fil:ExerciseOfOutstandingCommonStockOptionsAndWarrants>
	<fil:ConversionOfSeriesDPreferredStock decimals='INF' contextRef='Y17Q2' unitRef='Shares'>450</fil:ConversionOfSeriesDPreferredStock>
	<fil:ConversionOfSeriesDPreferredStock decimals='INF' contextRef='Y16Q2' unitRef='Shares'>450</fil:ConversionOfSeriesDPreferredStock>
	<fil:ConversionOfSeriesDPreferredStock decimals='INF' contextRef='D161001_170630' unitRef='Shares'>450</fil:ConversionOfSeriesDPreferredStock>
	<fil:ConversionOfSeriesDPreferredStock decimals='INF' contextRef='D151001_160630' unitRef='Shares'>450</fil:ConversionOfSeriesDPreferredStock>
	<fil:ConversionOfSeriesEPreferredStock decimals='INF' contextRef='Y17Q2' unitRef='Shares'>961</fil:ConversionOfSeriesEPreferredStock>
	<fil:ConversionOfSeriesEPreferredStock decimals='INF' contextRef='Y16Q2' unitRef='Shares'>961</fil:ConversionOfSeriesEPreferredStock>
	<fil:ConversionOfSeriesEPreferredStock decimals='INF' contextRef='D161001_170630' unitRef='Shares'>961</fil:ConversionOfSeriesEPreferredStock>
	<fil:ConversionOfSeriesEPreferredStock decimals='INF' contextRef='D151001_160630' unitRef='Shares'>961</fil:ConversionOfSeriesEPreferredStock>
	<fil:ConversionOfDebt decimals='INF' contextRef='Y17Q2' unitRef='Shares'>158798</fil:ConversionOfDebt>
	<fil:ConversionOfDebt decimals='INF' contextRef='Y16Q2' unitRef='Shares'>95799</fil:ConversionOfDebt>
	<fil:ConversionOfDebt decimals='INF' contextRef='D161001_170630' unitRef='Shares'>158798</fil:ConversionOfDebt>
	<fil:ConversionOfDebt decimals='INF' contextRef='D151001_160630' unitRef='Shares'>95799</fil:ConversionOfDebt>
	<fil:IssuanceOfEmployeeRestrictedShares decimals='INF' contextRef='Y17Q2' unitRef='Shares'>15</fil:IssuanceOfEmployeeRestrictedShares>
	<fil:IssuanceOfEmployeeRestrictedShares decimals='INF' contextRef='Y16Q2' unitRef='Shares'>15</fil:IssuanceOfEmployeeRestrictedShares>
	<fil:IssuanceOfEmployeeRestrictedShares decimals='INF' contextRef='D161001_170630' unitRef='Shares'>15</fil:IssuanceOfEmployeeRestrictedShares>
	<fil:IssuanceOfEmployeeRestrictedShares decimals='INF' contextRef='D151001_160630' unitRef='Shares'>15</fil:IssuanceOfEmployeeRestrictedShares>
	<fil:LiabilityToIssueCommonStock decimals='INF' contextRef='Y17Q2' unitRef='Shares'>358097</fil:LiabilityToIssueCommonStock>
	<fil:LiabilityToIssueCommonStock decimals='INF' contextRef='Y16Q2' unitRef='Shares'>2246</fil:LiabilityToIssueCommonStock>
	<fil:LiabilityToIssueCommonStock decimals='INF' contextRef='D161001_170630' unitRef='Shares'>358097</fil:LiabilityToIssueCommonStock>
	<fil:LiabilityToIssueCommonStock decimals='INF' contextRef='D151001_160630' unitRef='Shares'>2246</fil:LiabilityToIssueCommonStock>
	<fil:CommonStockEquivalents decimals='INF' contextRef='Y17Q2' unitRef='Shares'>627495</fil:CommonStockEquivalents>
	<fil:CommonStockEquivalents decimals='INF' contextRef='Y16Q2' unitRef='Shares'>117817</fil:CommonStockEquivalents>
	<fil:CommonStockEquivalents decimals='INF' contextRef='D161001_170630' unitRef='Shares'>627495</fil:CommonStockEquivalents>
	<fil:CommonStockEquivalents decimals='INF' contextRef='D151001_160630' unitRef='Shares'>141849</fil:CommonStockEquivalents>
	<us-gaap:AllowanceForDoubtfulAccountsReceivable decimals='INF' contextRef='E17Q2' unitRef='USD'>25468</us-gaap:AllowanceForDoubtfulAccountsReceivable>
	<us-gaap:AllowanceForDoubtfulAccountsReceivable decimals='INF' contextRef='E16Q3' unitRef='USD'>75161</us-gaap:AllowanceForDoubtfulAccountsReceivable>
	<us-gaap:InventoryFinishedGoods decimals='INF' contextRef='E17Q2' unitRef='USD'>503477</us-gaap:InventoryFinishedGoods>
	<us-gaap:InventoryFinishedGoods decimals='INF' contextRef='E16Q3' unitRef='USD'>206444</us-gaap:InventoryFinishedGoods>
	<us-gaap:InventoryValuationReserves decimals='INF' contextRef='E17Q2' unitRef='USD'>-1708</us-gaap:InventoryValuationReserves>
	<us-gaap:InventoryValuationReserves decimals='INF' contextRef='E16Q3' unitRef='USD'>-1708</us-gaap:InventoryValuationReserves>
	<us-gaap:InventoryNet decimals='INF' contextRef='E17Q2' unitRef='USD'>501769</us-gaap:InventoryNet>
	<us-gaap:InventoryNet decimals='INF' contextRef='E16Q3' unitRef='USD'>204736</us-gaap:InventoryNet>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E17Q2_BalanceSheetLocation-PrepaidInfTechnologyServices' unitRef='USD'>38081</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E16Q3_BalanceSheetLocation-PrepaidInfTechnologyServices' unitRef='USD'>57073</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E17Q2_BalanceSheetLocation-Other' unitRef='USD'>12249</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E16Q3_BalanceSheetLocation-Other' unitRef='USD'>112117</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E17Q2_BalanceSheetLocation-PrepaidInsurance1' unitRef='USD'>6225</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E16Q3_BalanceSheetLocation-PrepaidInsurance1' unitRef='USD'>14602</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E16Q3_BalanceSheetLocation-PrepaidProfessionalFees' unitRef='USD'>333741</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E16Q3_BalanceSheetLocation-ResearchAndDvlp' unitRef='USD'>96346</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E16Q3_BalanceSheetLocation-LineOfCreditAcquisitionFees' unitRef='USD'>30978</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E17Q2' unitRef='USD'>56555</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PrepaidExpenseAndOtherAssets decimals='INF' contextRef='E16Q3' unitRef='USD'>644857</us-gaap:PrepaidExpenseAndOtherAssets>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E17Q2_PpeByType-ComputerSoftwareIntangibleAsset' unitRef='USD'>47974</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16Q3_PpeByType-ComputerSoftwareIntangibleAsset' unitRef='USD'>47974</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E17Q2_PpeByType-LeaseholdsAndLeaseholdImprovements' unitRef='USD'>98023</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16Q3_PpeByType-LeaseholdsAndLeaseholdImprovements' unitRef='USD'>98023</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E17Q2_PpeByType-FurnitureAndFixtures' unitRef='USD'>68758</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16Q3_PpeByType-FurnitureAndFixtures' unitRef='USD'>68758</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E17Q2_PpeByType-Equipment' unitRef='USD'>47191</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16Q3_PpeByType-Equipment' unitRef='USD'>49772</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='INF' contextRef='E17Q2' unitRef='USD'>261946</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='INF' contextRef='E16Q3' unitRef='USD'>264527</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='INF' contextRef='E17Q2' unitRef='USD'>205501</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='INF' contextRef='E16Q3' unitRef='USD'>177793</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E17Q2' unitRef='USD'>56445</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16Q3' unitRef='USD'>86734</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:GainLossOnSaleOfProperty decimals='INF' contextRef='D151001_160630' unitRef='USD'>245</us-gaap:GainLossOnSaleOfProperty>
	<us-gaap:DepreciationAmortizationAndAccretionNet decimals='INF' contextRef='D161001_170630' unitRef='USD'>33107</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet decimals='INF' contextRef='D151001_160630' unitRef='USD'>38817</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-InterestExpense' unitRef='USD'>2694545</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3_IncomeStLocation-InterestExpense' unitRef='USD'>1206387</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-LiabToIssueWarrants' unitRef='USD'>2081254</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-LiabToIssueCommonStock' unitRef='USD'>2000933</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3_IncomeStLocation-LiabToIssueCommonStock' unitRef='USD'>240000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-FinanceFees' unitRef='USD'>333000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-PayrollExpense' unitRef='USD'>329615</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3_IncomeStLocation-PayrollExpense' unitRef='USD'>207052</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-Other' unitRef='USD'>141394</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3_IncomeStLocation-Other' unitRef='USD'>89828</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-DeferredRev' unitRef='USD'>85399</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3_IncomeStLocation-DeferredRev' unitRef='USD'>111803</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-WarrantyLiab' unitRef='USD'>58300</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3_IncomeStLocation-WarrantyLiab' unitRef='USD'>134330</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2_IncomeStLocation-CommissionsAndFees' unitRef='USD'>40997</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3_IncomeStLocation-CommissionsAndFees' unitRef='USD'>52311</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3_IncomeStLocation-Severance' unitRef='USD'>60000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>7765437</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>2101711</us-gaap:AccruedLiabilitiesCurrent>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note1' unitRef='USD'>5900000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note1' unitRef='USD'>5900000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note2' unitRef='USD'>1974602</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note2' unitRef='USD'>689318</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note3' unitRef='USD'>1773937</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note3' unitRef='USD'>2223937</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note4' unitRef='USD'>1700000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note4' unitRef='USD'>500000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note5' unitRef='USD'>1152778</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note5' unitRef='USD'>1652778</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note6' unitRef='USD'>1259007</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note6' unitRef='USD'>929518</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note7' unitRef='USD'>1100000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note8' unitRef='USD'>350000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note9' unitRef='USD'>334464</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note9' unitRef='USD'>334464</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note10' unitRef='USD'>300000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note10' unitRef='USD'>300000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note11' unitRef='USD'>300000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note12' unitRef='USD'>300000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note13' unitRef='USD'>250000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note13' unitRef='USD'>250000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note14' unitRef='USD'>100000</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2_LongtermDebtType-Note15' unitRef='USD'>64261</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note15' unitRef='USD'>64261</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3_LongtermDebtType-Note16' unitRef='USD'>162539</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E17Q2' unitRef='USD'>16859049</fil:GrossNotesPayableBeforeDiscount>
	<fil:GrossNotesPayableBeforeDiscount decimals='INF' contextRef='E16Q3' unitRef='USD'>13006815</fil:GrossNotesPayableBeforeDiscount>
	<fil:DiscountOnNotesPayable decimals='INF' contextRef='E17Q2' unitRef='USD'>-1468335</fil:DiscountOnNotesPayable>
	<fil:DiscountOnNotesPayable decimals='INF' contextRef='E16Q3' unitRef='USD'>-1930060</fil:DiscountOnNotesPayable>
	<fil:NotesPayableCurrentAndNoncurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>15390714</fil:NotesPayableCurrentAndNoncurrent>
	<fil:NotesPayableCurrentAndNoncurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>11076755</fil:NotesPayableCurrentAndNoncurrent>
	<us-gaap:NotesPayableCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>9501544</us-gaap:NotesPayableCurrent>
	<us-gaap:NotesPayableCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>3722899</us-gaap:NotesPayableCurrent>
	<us-gaap:LongTermNotesPayable decimals='INF' contextRef='E17Q2' unitRef='USD'>5889170</us-gaap:LongTermNotesPayable>
	<us-gaap:LongTermNotesPayable decimals='INF' contextRef='E16Q3' unitRef='USD'>7353856</us-gaap:LongTermNotesPayable>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E17Q2_LongtermDebtType-RelPtyNote1' unitRef='USD'>1721100</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3_LongtermDebtType-RelPtyNote1' unitRef='USD'>1721100</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E17Q2_LongtermDebtType-RelPtyNote2' unitRef='USD'>1303135</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3_LongtermDebtType-RelPtyNote2' unitRef='USD'>1303135</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E17Q2_LongtermDebtType-RelPtyNote3' unitRef='USD'>542004</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3_LongtermDebtType-RelPtyNote3' unitRef='USD'>542004</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E17Q2_LongtermDebtType-RelPtyNote4' unitRef='USD'>250000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3_LongtermDebtType-RelPtyNote4' unitRef='USD'>250000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E17Q2_LongtermDebtType-RelPtyNote5' unitRef='USD'>26721</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3_LongtermDebtType-RelPtyNote5' unitRef='USD'>26721</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E17Q2_LongtermDebtType-RelPtyNote6' unitRef='USD'>25463</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3_LongtermDebtType-RelPtyNote6' unitRef='USD'>25463</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E17Q2_LongtermDebtType-RelPtyNote7' unitRef='USD'>1260</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3_LongtermDebtType-RelPtyNote7' unitRef='USD'>17227</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3_LongtermDebtType-RelPtyNote8' unitRef='USD'>12474</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>3869683</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>3898124</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
	<us-gaap:NotesPayableRelatedPartiesClassifiedCurrent decimals='INF' contextRef='E17Q2' unitRef='USD'>3869683</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
	<us-gaap:NotesPayableRelatedPartiesClassifiedCurrent decimals='INF' contextRef='E16Q3' unitRef='USD'>3898124</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
	<us-gaap:DerivativeLiabilities decimals='INF' contextRef='E17Q2_FvByFvHierarchyLevel-FvInputsLevel2' unitRef='USD'>269427</us-gaap:DerivativeLiabilities>
	<us-gaap:DerivativeLiabilities decimals='INF' contextRef='E16Q3_FvByFvHierarchyLevel-FvInputsLevel2' unitRef='USD'>281613</us-gaap:DerivativeLiabilities>
	<us-gaap:DerivativeLiabilities decimals='INF' contextRef='E16Q3_FvByFvHierarchyLevel-FvInputsLevel3' unitRef='USD'>1772458</us-gaap:DerivativeLiabilities>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3' unitRef='USD'>2511288</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3' unitRef='USD'>-103213</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3' unitRef='USD'>-217997</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:DerivativeLiabilities decimals='INF' contextRef='E17Q2_FvByFvHierarchyLevel-FvInputsLevel3' unitRef='USD'>3962556</us-gaap:DerivativeLiabilities>
	<us-gaap:DerivativeLiabilities decimals='INF' contextRef='E17Q2' unitRef='USD'>4231983</us-gaap:DerivativeLiabilities>
	<us-gaap:DerivativeLiabilities decimals='INF' contextRef='E16Q3' unitRef='USD'>2054071</us-gaap:DerivativeLiabilities>
	<us-gaap:DerivativeGainLossOnDerivativeNet decimals='INF' contextRef='Y17Q2' unitRef='USD'>64145</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DerivativeGainLossOnDerivativeNet decimals='INF' contextRef='Y16Q2' unitRef='USD'>5603411</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DerivativeGainLossOnDerivativeNet decimals='INF' contextRef='D161001_170630' unitRef='USD'>230163</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DerivativeGainLossOnDerivativeNet decimals='INF' contextRef='D151001_160630' unitRef='USD'>2796542</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:PreferredStockSharesAuthorized decimals='INF' contextRef='E17Q2' unitRef='Shares'>10000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='5' contextRef='E17Q2' unitRef='UsdPerShare'>0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<fil:ConvertiblePreferredStockSharesDesignated decimals='INF' contextRef='Y17Q2_StEqComps-SeriesDPrefStock' unitRef='Shares'>1000000</fil:ConvertiblePreferredStockSharesDesignated>
	<fil:IncreaseDecreaseInDividendsPayable decimals='INF' contextRef='D161001_170630_StEqComps-SeriesDPrefStock' unitRef='USD'>24800</fil:IncreaseDecreaseInDividendsPayable>
	<fil:IncreaseDecreaseInDividendsPayable decimals='INF' contextRef='D151001_160630_StEqComps-SeriesDPrefStock' unitRef='USD'>18617</fil:IncreaseDecreaseInDividendsPayable>
	<fil:IncreaseDecreaseInDividendsPayable decimals='INF' contextRef='Y17Q2_StEqComps-SeriesEPrefStock' unitRef='USD'>34178</fil:IncreaseDecreaseInDividendsPayable>
	<fil:IncreaseDecreaseInDividendsPayable decimals='INF' contextRef='Y16Q2_StEqComps-SeriesEPrefStock' unitRef='USD'>39598</fil:IncreaseDecreaseInDividendsPayable>
	<fil:IncreaseDecreaseInDividendsPayable decimals='INF' contextRef='D161001_170630_StEqComps-SeriesEPrefStock' unitRef='USD'>102535</fil:IncreaseDecreaseInDividendsPayable>
	<fil:IncreaseDecreaseInDividendsPayable decimals='INF' contextRef='D151001_160630_StEqComps-SeriesEPrefStock' unitRef='USD'>185485</fil:IncreaseDecreaseInDividendsPayable>
	<fil:RedemptionPriceOfSeriesEPreferredStock decimals='INF' contextRef='E17Q2_StEqComps-SeriesEPrefStock' unitRef='USD'>477829</fil:RedemptionPriceOfSeriesEPreferredStock>
	<fil:RedemptionPriceOfSeriesEPreferredStock decimals='INF' contextRef='E16Q3_StEqComps-SeriesEPrefStock' unitRef='USD'>477829</fil:RedemptionPriceOfSeriesEPreferredStock>
	<fil:ConvertiblePreferredStockSharesDesignated decimals='INF' contextRef='D131001_140930_StEqComps-SeriesFPrefStock' unitRef='Shares'>7803</fil:ConvertiblePreferredStockSharesDesignated>
	<fil:IncreaseDecreaseInDividendsPayable decimals='INF' contextRef='Y16Q2_StEqComps-SeriesFPrefStock' unitRef='USD'>0</fil:IncreaseDecreaseInDividendsPayable>
	<fil:IncreaseDecreaseInDividendsPayable decimals='INF' contextRef='D151001_160630_StEqComps-SeriesFPrefStock' unitRef='USD'>495148</fil:IncreaseDecreaseInDividendsPayable>
	<fil:ConvertiblePreferredStockSharesDesignated decimals='INF' contextRef='D161001_170630_StEqComps-SeriesGPrefStock' unitRef='Shares'>43220</fil:ConvertiblePreferredStockSharesDesignated>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E17Q2' unitRef='Shares'>200000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:StockholdersEquityReverseStockSplit contextRef='D161001_170630'>On January 27, 2017, the Company effected a 1-for-500 reverse stock split of its outstanding common stock, which caused the then outstanding common stock to decrease from 115,112,802 to 232,100 while keeping the authorized capitalization unchanged.</us-gaap:StockholdersEquityReverseStockSplit>
	<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices decimals='INF' contextRef='D161001_170630' unitRef='Shares'>7000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
	<us-gaap:StockIssuedDuringPeriodValueIssuedForServices decimals='INF' contextRef='D161001_170630' unitRef='USD'>70000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
	<fil:DeemedDividendsOnRedemptionOfPreferredStock decimals='INF' contextRef='D151001_160630' unitRef='USD'>6484236</fil:DeemedDividendsOnRedemptionOfPreferredStock>
	<us-gaap:FairValueAssumptionsExercisePrice decimals='INF' contextRef='E17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Minimum' unitRef='UsdPerShare'>2.50</us-gaap:FairValueAssumptionsExercisePrice>
	<us-gaap:FairValueAssumptionsExercisePrice decimals='INF' contextRef='E17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Maximum' unitRef='UsdPerShare'>25.00</us-gaap:FairValueAssumptionsExercisePrice>
	<us-gaap:FairValueAssumptionsExpectedTerm contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Minimum'>P2M16D</us-gaap:FairValueAssumptionsExpectedTerm>
	<us-gaap:FairValueAssumptionsExpectedTerm contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Maximum'>P4Y11M5D</us-gaap:FairValueAssumptionsExpectedTerm>
	<us-gaap:FairValueAssumptionsExpectedVolatilityRate decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Minimum' unitRef='Pure'>1.2800</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
	<us-gaap:FairValueAssumptionsExpectedVolatilityRate decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Maximum' unitRef='Pure'>1.9400</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
	<us-gaap:FairValueAssumptionsRiskFreeInterestRate decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Minimum' unitRef='Pure'>0.0049</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:FairValueAssumptionsRiskFreeInterestRate decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Maximum' unitRef='Pure'>0.0199</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
	<fil:FairValueAssumptionsCommonStockPrice decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Minimum' unitRef='UsdPerShare'>2.50</fil:FairValueAssumptionsCommonStockPrice>
	<fil:FairValueAssumptionsCommonStockPrice decimals='INF' contextRef='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Maximum' unitRef='UsdPerShare'>25.00</fil:FairValueAssumptionsCommonStockPrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber decimals='INF' contextRef='E16Q3' unitRef='Shares'>65045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice decimals='INF' contextRef='E16Q3' unitRef='UsdPerShare'>35.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod decimals='INF' contextRef='Y17Q2' unitRef='Shares'>48000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice decimals='INF' contextRef='Y17Q2' unitRef='UsdPerShare'>25.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod decimals='INF' contextRef='Y17Q2' unitRef='Shares'>-3871</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice decimals='INF' contextRef='Y17Q2' unitRef='UsdPerShare'>357.84</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber decimals='INF' contextRef='E17Q2' unitRef='Shares'>109174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice decimals='INF' contextRef='E17Q2' unitRef='UsdPerShare'>37.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber decimals='INF' contextRef='E17Q2' unitRef='Shares'>102225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice decimals='INF' contextRef='E17Q2' unitRef='UsdPerShare'>34.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue decimals='INF' contextRef='E17Q2' unitRef='USD'>0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
	<fil:WeightedAverageRemainingTermOfTheWarrants decimals='INF' contextRef='E17Q2' unitRef='Pure'>4.52</fil:WeightedAverageRemainingTermOfTheWarrants>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 decimals='INF' contextRef='D161001_170630' unitRef='USD'>38468</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
	<fil:RelatedPartyCompensationHourlyRate decimals='INF' contextRef='Y17Q2_RelPtyTrnsByRelPty-FormerExecutiveChairmanOfTheBoardOfDirectors' unitRef='USD'>250</fil:RelatedPartyCompensationHourlyRate>
	<fil:RelatedPartyCompensationHourlyRate decimals='INF' contextRef='Y17Q2_RelPtyTrnsByRelPty-FormerExecutiveChairmanAndChiefExecutiveOfficer' unitRef='USD'>250</fil:RelatedPartyCompensationHourlyRate>
	<us-gaap:RepaymentsOfNotesPayable decimals='INF' contextRef='D161001_170630_RelPtyTrnsByRelPty-FormerExecutiveChairmanAndChiefExecutiveOfficer' unitRef='USD'>135000</us-gaap:RepaymentsOfNotesPayable>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths decimals='INF' contextRef='E17Q2' unitRef='USD'>32908</us-gaap:OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears decimals='INF' contextRef='E17Q2' unitRef='USD'>111340</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDue decimals='INF' contextRef='E17Q2' unitRef='USD'>144248</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
	<us-gaap:OperatingLeasesRentExpenseNet decimals='INF' contextRef='D161001_170630' unitRef='USD'>97000</us-gaap:OperatingLeasesRentExpenseNet>
	<us-gaap:OperatingLeasesRentExpenseNet decimals='INF' contextRef='D151001_160630' unitRef='USD'>94000</us-gaap:OperatingLeasesRentExpenseNet>
	<context id='D161001_170630'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<startDate>2016-10-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='E17Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='Y17Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<startDate>2017-04-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='Y16Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<startDate>2016-04-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='D151001_160630'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<startDate>2015-10-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='E15Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<instant>2015-09-30</instant>
		</period>
	</context>
	<context id='E16Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<instant>2016-06-30</instant>
		</period>
	</context>
	<context id='Y16Q2_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-CommonStockOptionsAndWarrants'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis'>fil:CommonStockOptionsAndWarrantsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-04-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='Y16Q2_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-ConvertibleDebt1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis'>fil:ConvertibleDebt1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-04-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='D151001_160630_AntidilutiveSecExcludedFromComputationOfEarningsPerShareByAntidilutiveSec-ConvertibleDebt1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis'>fil:ConvertibleDebt1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-10-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='E17Q2_BalanceSheetLocation-PrepaidInfTechnologyServices'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:PrepaidInformationTechnologyServicesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_BalanceSheetLocation-PrepaidInfTechnologyServices'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:PrepaidInformationTechnologyServicesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_BalanceSheetLocation-Other'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:OtherMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_BalanceSheetLocation-Other'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:OtherMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_BalanceSheetLocation-PrepaidInsurance1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:PrepaidInsurance1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_BalanceSheetLocation-PrepaidInsurance1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:PrepaidInsurance1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E16Q3_BalanceSheetLocation-PrepaidProfessionalFees'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:PrepaidProfessionalFeesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E16Q3_BalanceSheetLocation-ResearchAndDvlp'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:ResearchAndDevelopmentMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E16Q3_BalanceSheetLocation-LineOfCreditAcquisitionFees'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:BalanceSheetLocationAxis'>fil:LineOfCreditAcquisitionFeesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_PpeByType-ComputerSoftwareIntangibleAsset'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_PpeByType-ComputerSoftwareIntangibleAsset'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_PpeByType-LeaseholdsAndLeaseholdImprovements'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_PpeByType-LeaseholdsAndLeaseholdImprovements'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_PpeByType-FurnitureAndFixtures'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_PpeByType-FurnitureAndFixtures'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_PpeByType-Equipment'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:EquipmentMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_PpeByType-Equipment'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:EquipmentMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-InterestExpense'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>us-gaap:InterestExpenseMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_IncomeStLocation-InterestExpense'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>us-gaap:InterestExpenseMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-LiabToIssueWarrants'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:LiabilityToIssueWarrantsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-LiabToIssueCommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:LiabilityToIssueCommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_IncomeStLocation-LiabToIssueCommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:LiabilityToIssueCommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-FinanceFees'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:FinanceFeesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-PayrollExpense'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:PayrollExpenseMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_IncomeStLocation-PayrollExpense'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:PayrollExpenseMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-Other'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:OtherMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_IncomeStLocation-Other'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:OtherMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-DeferredRev'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:DeferredRevenueMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_IncomeStLocation-DeferredRev'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:DeferredRevenueMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-WarrantyLiab'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:WarrantyLiabilityMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_IncomeStLocation-WarrantyLiab'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:WarrantyLiabilityMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_IncomeStLocation-CommissionsAndFees'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:CommissionsAndFeesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_IncomeStLocation-CommissionsAndFees'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:CommissionsAndFeesMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E16Q3_IncomeStLocation-Severance'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:IncomeStatementLocationAxis'>fil:SeveranceMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note3Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note3Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note4'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note4Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note4'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note4Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note5'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note5Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note5'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note5Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note6'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note6Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note6'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note6Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note7'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note7Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note8'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note8Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note9'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note9Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note10'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note10Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note11'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note11Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note12'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note12Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note13'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note13Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-RelPtyNote1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-RelPtyNote1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-RelPtyNote2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-RelPtyNote2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-RelPtyNote3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote3Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-RelPtyNote3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote3Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-RelPtyNote4'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote4Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-RelPtyNote4'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote4Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-RelPtyNote5'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote5Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-RelPtyNote5'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote5Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-RelPtyNote6'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote6Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-RelPtyNote6'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote6Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-RelPtyNote7'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote7Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-RelPtyNote7'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote7Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-RelPtyNote8'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:RelatedPartyNote8Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_FvByFvHierarchyLevel-FvInputsLevel2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_FvByFvHierarchyLevel-FvInputsLevel3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_FvByFvHierarchyLevel-FvInputsLevel2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E16Q3_FvByFvHierarchyLevel-FvInputsLevel3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-04-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='Y17Q2_StEqComps-SeriesDPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-04-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='D161001_170630_StEqComps-SeriesDPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-10-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='D151001_160630_StEqComps-SeriesDPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-10-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='Y17Q2_StEqComps-SeriesEPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-04-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='Y16Q2_StEqComps-SeriesEPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-04-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='D161001_170630_StEqComps-SeriesEPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-10-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='D151001_160630_StEqComps-SeriesEPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-10-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='E17Q2_StEqComps-SeriesEPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_StEqComps-SeriesEPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='D131001_140930_StEqComps-SeriesFPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2013-10-01</startDate>
			<endDate>2014-09-30</endDate>
		</period>
	</context>
	<context id='Y16Q2_StEqComps-SeriesFPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-04-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='D151001_160630_StEqComps-SeriesFPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-10-01</startDate>
			<endDate>2016-06-30</endDate>
		</period>
	</context>
	<context id='D161001_170630_StEqComps-SeriesGPrefStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-10-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='E17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Minimum'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension='us-gaap:RangeAxis'>us-gaap:MinimumMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Maximum'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension='us-gaap:RangeAxis'>us-gaap:MaximumMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Minimum'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension='us-gaap:RangeAxis'>us-gaap:MinimumMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-04-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='Y17Q2_FvByFvHierarchyLevel-FvInputsLevel3_Range-Maximum'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension='us-gaap:RangeAxis'>us-gaap:MaximumMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-04-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='Y17Q2_RelPtyTrnsByRelPty-FormerExecutiveChairmanOfTheBoardOfDirectors'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:RelatedPartyTransactionsByRelatedPartyAxis'>fil:FormerExecutiveChairmanOfTheBoardOfDirectorsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-04-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='Y17Q2_RelPtyTrnsByRelPty-FormerExecutiveChairmanAndChiefExecutiveOfficer'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:RelatedPartyTransactionsByRelatedPartyAxis'>fil:FormerExecutiveChairmanAndChiefExecutiveOfficerMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-04-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='D161001_170630_RelPtyTrnsByRelPty-FormerExecutiveChairmanAndChiefExecutiveOfficer'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:RelatedPartyTransactionsByRelatedPartyAxis'>fil:FormerExecutiveChairmanAndChiefExecutiveOfficerMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-10-01</startDate>
			<endDate>2017-06-30</endDate>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note9'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note9Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note10'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note10Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note13'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note13Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note14'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note14Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17Q2_LongtermDebtType-Note15'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note15Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note15'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note15Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='E16Q3_LongtermDebtType-Note16'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:Note16Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='I180130'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0001429896</identifier>
		</entity>
		<period>
			<instant>2018-01-30</instant>
		</period>
	</context>
	<unit id='USD'>
		<measure>iso4217:USD</measure>
	</unit>
	<unit id='Shares'>
		<measure>xbrli:shares</measure>
	</unit>
	<unit id='UsdPerShare'>
		<divide>
			<unitNumerator>
				<measure>iso4217:USD</measure>
			</unitNumerator>
			<unitDenominator>
				<measure>xbrli:shares</measure>
			</unitDenominator>
		</divide>
	</unit>
	<unit id='Pure'>
		<measure>pure</measure>
	</unit>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>acar-20170630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by Southridge Services using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK611N9EKWVLDLN2EK]. www.edgarsuite.com -->
<schema xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-gaap/2017-01-31' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:fil='http://activecare.com/20170630' targetNamespace='http://activecare.com/20170630' xmlns:num='http://www.xbrl.org/dtr/type/numeric' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xbrli='http://www.xbrl.org/2003/instance' attributeFormDefault='unqualified' elementFormDefault='qualified'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="acar-20170630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="acar-20170630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="acar-20170630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="acar-20170630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrants" id="idr_Disclosure15CommonStockOptionsAndWarrants">
				<link:definition>000210 - Disclosure - 15. Common Stock Options and Warrants</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurements" id="idr_Disclosure11FairValueMeasurements">
				<link:definition>000170 - Disclosure - 11. Fair Value Measurements</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperations" id="idr_CondensedConsolidatedStatementsOfOperations">
				<link:definition>000040 - Statement - Condensed Consolidated Statements of Operations</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentDetails" id="idr_Disclosure7PropertyAndEquipmentDetails">
				<link:definition>000490 - Disclosure - 7. Property and Equipment (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables" id="idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables">
				<link:definition>000300 - Disclosure - 2. Net Loss per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables" id="idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables">
				<link:definition>000410 - Disclosure - 15. Common Stock Options and Warrants: Schedule of Share-based Compensation, Activity (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails" id="idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails">
				<link:definition>000440 - Disclosure - 2. Net Loss per Common Share: Schedule of Common Stock Equivalents (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables" id="idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables">
				<link:definition>000370 - Disclosure - 10. Related Party Notes Payable: Schedule of Related Party Transactions (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables" id="idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables">
				<link:definition>000340 - Disclosure - 7. Property and Equipment: Property, Plant and Equipment (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfCashFlows" id="idr_CondensedConsolidatedStatementsOfCashFlows">
				<link:definition>000060 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails" id="idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails">
				<link:definition>000530 - Disclosure - 11. Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivableDetails" id="idr_Disclosure4AccountsReceivableDetails">
				<link:definition>000450 - Disclosure - 4. Accounts Receivable (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiability" id="idr_Disclosure12DerivativesLiability">
				<link:definition>000180 - Disclosure - 12. Derivatives Liability</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperationsParenthetical" id="idr_CondensedConsolidatedStatementsOfOperationsParenthetical">
				<link:definition>000050 - Statement - Condensed Consolidated Statements of Operations Parenthetical</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details" id="idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details">
				<link:definition>000590 - Disclosure - 15. Common Stock Options and Warrants: Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3 (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipment" id="idr_Disclosure7PropertyAndEquipment">
				<link:definition>000130 - Disclosure - 7. Property and Equipment</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesDetails" id="idr_Disclosure17CommitmentsAndContingenciesDetails">
				<link:definition>000630 - Disclosure - 17. Commitments and Contingencies (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables" id="idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables">
				<link:definition>000390 - Disclosure - 11. Fair Value Measurements: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables" id="idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables">
				<link:definition>000310 - Disclosure - 2. Net Loss per Common Share: Schedule of Common Stock Equivalents (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShare" id="idr_Disclosure2NetLossPerCommonShare">
				<link:definition>000080 - Disclosure - 2. Net Loss per Common Share</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsDetails" id="idr_Disclosure15CommonStockOptionsAndWarrantsDetails">
				<link:definition>000580 - Disclosure - 15. Common Stock Options and Warrants (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables" id="idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables">
				<link:definition>000420 - Disclosure - 17. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails" id="idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails">
				<link:definition>000470 - Disclosure - 6. Prepaid Expenses and Other Current Assets: Schedule of Other Current Assets (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables" id="idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables">
				<link:definition>000400 - Disclosure - 15. Common Stock Options and Warrants: Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3 (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails" id="idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails">
				<link:definition>000480 - Disclosure - 7. Property and Equipment: Property, Plant and Equipment (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure14CommonStockDetails" id="idr_Disclosure14CommonStockDetails">
				<link:definition>000570 - Disclosure - 14. Common Stock (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayable" id="idr_Disclosure10RelatedPartyNotesPayable">
				<link:definition>000160 - Disclosure - 10. Related Party Notes Payable</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails" id="idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails">
				<link:definition>000510 - Disclosure - 9. Notes Payable: Schedule of Debt - Other (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure13PreferredStockDetails" id="idr_Disclosure13PreferredStockDetails">
				<link:definition>000560 - Disclosure - 13. Preferred Stock (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure14CommonStock" id="idr_Disclosure14CommonStock">
				<link:definition>000200 - Disclosure - 14. Common Stock</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" id="idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails">
				<link:definition>000540 - Disclosure - 11. Fair Value Measurements: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheetsParenthetical" id="idr_CondensedConsolidatedBalanceSheetsParenthetical">
				<link:definition>000030 - Statement - Condensed Consolidated Balance Sheets Parenthetical</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure5Inventory" id="idr_Disclosure5Inventory">
				<link:definition>000110 - Disclosure - 5. Inventory</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingencies" id="idr_Disclosure17CommitmentsAndContingencies">
				<link:definition>000230 - Disclosure - 17. Commitments and Contingencies</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure13PreferredStock" id="idr_Disclosure13PreferredStock">
				<link:definition>000190 - Disclosure - 13. Preferred Stock</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure18SubsequentEvents" id="idr_Disclosure18SubsequentEvents">
				<link:definition>000240 - Disclosure - 18. Subsequent Events</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies" id="idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies">
				<link:definition>000280 - Disclosure - 1. Organization and Nature of Operations: Reclassifications (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails" id="idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails">
				<link:definition>000610 - Disclosure - 16. Related-party Transactions Not Otherwise Disclosed (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies" id="idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies">
				<link:definition>000260 - Disclosure - 1. Organization and Nature of Operations: Use of Estimates in The Preparation of Financial Statements (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" id="idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails">
				<link:definition>000620 - Disclosure - 17. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies" id="idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies">
				<link:definition>000270 - Disclosure - 1. Organization and Nature of Operations: Fair Value of Financial Instruments (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables" id="idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables">
				<link:definition>000380 - Disclosure - 11. Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies" id="idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies">
				<link:definition>000290 - Disclosure - 3. Recent Accounting Pronouncements: New Accounting Pronouncements (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed" id="idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed">
				<link:definition>000220 - Disclosure - 16. Related-party Transactions Not Otherwise Disclosed</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements" id="idr_Disclosure3RecentAccountingPronouncements">
				<link:definition>000090 - Disclosure - 3. Recent Accounting Pronouncements</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails" id="idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails">
				<link:definition>000500 - Disclosure - 8. Accrued Expenses: Schedule of Accrued Liabilities (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperations" id="idr_Disclosure1OrganizationAndNatureOfOperations">
				<link:definition>000070 - Disclosure - 1. Organization and Nature of Operations</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables" id="idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables">
				<link:definition>000350 - Disclosure - 8. Accrued Expenses: Schedule of Accrued Liabilities (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails" id="idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails">
				<link:definition>000600 - Disclosure - 15. Common Stock Options and Warrants: Schedule of Share-based Compensation, Activity (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryTables" id="idr_Disclosure5InventoryScheduleOfInventoryTables">
				<link:definition>000320 - Disclosure - 5. Inventory: Schedule of Inventory (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiabilityDetails" id="idr_Disclosure12DerivativesLiabilityDetails">
				<link:definition>000550 - Disclosure - 12. Derivatives Liability (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies" id="idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies">
				<link:definition>000250 - Disclosure - 1. Organization and Nature of Operations: Going Concern (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryDetails" id="idr_Disclosure5InventoryScheduleOfInventoryDetails">
				<link:definition>000460 - Disclosure - 5. Inventory: Schedule of Inventory (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails" id="idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails">
				<link:definition>000520 - Disclosure - 10. Related Party Notes Payable: Schedule of Related Party Transactions (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables" id="idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables">
				<link:definition>000330 - Disclosure - 6. Prepaid Expenses and Other Current Assets: Schedule of Other Current Assets (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivable" id="idr_Disclosure4AccountsReceivable">
				<link:definition>000100 - Disclosure - 4. Accounts Receivable</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayable" id="idr_Disclosure9NotesPayable">
				<link:definition>000150 - Disclosure - 9. Notes Payable</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherTables" id="idr_Disclosure9NotesPayableScheduleOfDebtOtherTables">
				<link:definition>000360 - Disclosure - 9. Notes Payable: Schedule of Debt - Other (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails" id="idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails">
				<link:definition>000430 - Disclosure - 2. Net Loss per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets" id="idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets">
				<link:definition>000120 - Disclosure - 6. Prepaid Expenses and Other Current Assets</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheets" id="idr_CondensedConsolidatedBalanceSheets">
				<link:definition>000020 - Statement - Condensed Consolidated Balance Sheets</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpenses" id="idr_Disclosure8AccruedExpenses">
				<link:definition>000140 - Disclosure - 8. Accrued Expenses</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import namespace='http://fasb.org/us-gaap/2017-01-31' schemaLocation='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd' />
	<import namespace='http://xbrl.sec.gov/dei/2014-01-31' schemaLocation='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DocumentAndEntityInformationAbstract' name='DocumentAndEntityInformationAbstract' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note1Member' name='Note1Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note2Member' name='Note2Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note3Member' name='Note3Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note4Member' name='Note4Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note5Member' name='Note5Member' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants' name='CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note6Member' name='Note6Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note7Member' name='Note7Member' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable' name='ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_WarrantyLiabilityMember' name='WarrantyLiabilityMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_LiabilityToIssueCommonStockMember' name='LiabilityToIssueCommonStockMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PayrollExpenseMember' name='PayrollExpenseMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DeferredRevenueMember' name='DeferredRevenueMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommissionsAndFeesMember' name='CommissionsAndFeesMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note8Member' name='Note8Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note9Member' name='Note9Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note10Member' name='Note10Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note11Member' name='Note11Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_LineOfCreditAcquisitionFeesMember' name='LineOfCreditAcquisitionFeesMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PrepaidInformationTechnologyServicesMember' name='PrepaidInformationTechnologyServicesMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PrepaidProfessionalFeesMember' name='PrepaidProfessionalFeesMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PrepaidInsurance1Member' name='PrepaidInsurance1Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_OtherMember' name='OtherMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_SeveranceMember' name='SeveranceMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ResearchAndDevelopmentMember' name='ResearchAndDevelopmentMember' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees' name='AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees' name='AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_DeemedDividendsOnRedemptionOfPreferredStock' name='DeemedDividendsOnRedemptionOfPreferredStock' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyNote1Member' name='RelatedPartyNote1Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyNote2Member' name='RelatedPartyNote2Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyNote3Member' name='RelatedPartyNote3Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyNote4Member' name='RelatedPartyNote4Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyNote5Member' name='RelatedPartyNote5Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyNote6Member' name='RelatedPartyNote6Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyNote7Member' name='RelatedPartyNote7Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyNote8Member' name='RelatedPartyNote8Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember' name='FormerExecutiveChairmanOfTheBoardOfDirectorsMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember' name='FormerExecutiveChairmanAndChiefExecutiveOfficerMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_LiabilityToIssueWarrantsMember' name='LiabilityToIssueWarrantsMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_FinanceFeesMember' name='FinanceFeesMember' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_LossOnInducedConversionsOfDebt' name='LossOnInducedConversionsOfDebt' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_GainOnLiabilitySettlements' name='GainOnLiabilitySettlements' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' name='ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants' name='DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable' name='ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty' name='AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees' name='AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_CancellationAndReissuanceOfSharesOfCommonStock' name='CancellationAndReissuanceOfSharesOfCommonStock' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices' name='AccrualOfALiabilityToIssueSharesOfCommonStockForServices' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfSharesOfCommonStockForDividends' name='IssuanceOfSharesOfCommonStockForDividends' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note12Member' name='Note12Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note13Member' name='Note13Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommonStockOptionsAndWarrantsMember' name='CommonStockOptionsAndWarrantsMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ConvertibleDebt1Member' name='ConvertibleDebt1Member' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract' name='CondensedConsolidatedStatementsOfOperationsParentheticalAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_StockAndWarrantsIssuedAndAccruedForServices' name='StockAndWarrantsIssuedAndAccruedForServices' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_StockAccruedForInterestExpense' name='StockAccruedForInterestExpense' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' name='IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfSharesOfCommonStockForConsultingServices' name='IssuanceOfSharesOfCommonStockForConsultingServices' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee' name='IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees' name='IssuanceOfSharesOfCommonStockForLoanExtensionFees' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees' name='AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants' name='ExerciseOfOutstandingCommonStockOptionsAndWarrants' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ConversionOfSeriesDPreferredStock' name='ConversionOfSeriesDPreferredStock' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ConversionOfSeriesEPreferredStock' name='ConversionOfSeriesEPreferredStock' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ConversionOfDebt' name='ConversionOfDebt' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_IssuanceOfEmployeeRestrictedShares' name='IssuanceOfEmployeeRestrictedShares' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_LiabilityToIssueCommonStock' name='LiabilityToIssueCommonStock' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommonStockEquivalents' name='CommonStockEquivalents' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_GrossNotesPayableBeforeDiscount' name='GrossNotesPayableBeforeDiscount' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_DiscountOnNotesPayable' name='DiscountOnNotesPayable' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_NotesPayableCurrentAndNoncurrent' name='NotesPayableCurrentAndNoncurrent' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ConvertiblePreferredStockSharesDesignated' name='ConvertiblePreferredStockSharesDesignated' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_IncreaseDecreaseInDividendsPayable' name='IncreaseDecreaseInDividendsPayable' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_RedemptionPriceOfSeriesEPreferredStock' name='RedemptionPriceOfSeriesEPreferredStock' />
	<element nillable='true' type='num:perShareItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_FairValueAssumptionsCommonStockPrice' name='FairValueAssumptionsCommonStockPrice' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageRemainingTermOfTheWarrants' name='WeightedAverageRemainingTermOfTheWarrants' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_RelatedPartyCompensationHourlyRate' name='RelatedPartyCompensationHourlyRate' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_LossOnSettlement' name='LossOnSettlement' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees' name='AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note14Member' name='Note14Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note15Member' name='Note15Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note16Member' name='Note16Member' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Stockoptionsandwarrants0TextBlock' name='Stockoptionsandwarrants0TextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock' name='RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ScheduleOfCommonStockEquivalents0TextBlock' name='ScheduleOfCommonStockEquivalents0TextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock' name='ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>acar-20170630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by Southridge Services using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK611N9EKWVLDLN2EK]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://activecare.com/20170630"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedBalanceSheets"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheets">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNet' xlink:label='us-gaap_AccountsReceivableNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_AccountsReceivableNet' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_Cash' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepositsAssetsCurrent' xlink:label='us-gaap_DepositsAssetsCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_DepositsAssetsCurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet' xlink:label='us-gaap_FiniteLivedIntangibleAssetsNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_FiniteLivedIntangibleAssetsNet' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_InventoryNet' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesReceivableNet' xlink:label='us-gaap_NotesReceivableNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_NotesReceivableNet' use='optional' order='6.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets' xlink:label='us-gaap_PrepaidExpenseAndOtherAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_PrepaidExpenseAndOtherAssets' use='optional' order='7.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='8.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_AccountsReceivableNet' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_Cash' use='optional' order='2.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_InventoryNet' use='optional' order='3.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_NotesReceivableNet' use='optional' order='4.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_PrepaidExpenseAndOtherAssets' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccountsPayableCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_DueToRelatedPartiesCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent' xlink:label='us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_NotesPayableCurrent' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities' xlink:label='us-gaap_DerivativeLiabilities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_DerivativeLiabilities' use='optional' order='6.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPayableCurrent' xlink:label='us-gaap_DividendsPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_DividendsPayableCurrent' use='optional' order='7.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' use='optional' order='8.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable' xlink:label='us-gaap_LongTermNotesPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_LongTermNotesPayable' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_AccountsPayableCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_DueToRelatedPartiesCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_CommonStockValue' use='optional' order='6.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent' use='optional' order='7.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_NotesPayableCurrent' use='optional' order='8.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_DerivativeLiabilities' use='optional' order='9.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_DividendsPayableCurrent' use='optional' order='10.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_LongTermNotesPayable' use='optional' order='11.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' use='optional' order='12.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_PreferredStockValue' use='optional' order='13.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='2.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_CommonStockValue' use='optional' order='3.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_PreferredStockValue' use='optional' order='4.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedStatementsOfOperations"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperations">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_GrossProfit' xlink:to='us-gaap_Revenues' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold' xlink:label='us-gaap_CostOfGoodsAndServicesSold'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_GrossProfit' xlink:to='us-gaap_CostOfGoodsAndServicesSold' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='us-gaap_GrossProfit' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='us-gaap_OperatingExpenses' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:label='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeemedDividendsOnRedemptionOfPreferredStock' xlink:label='fil_DeemedDividendsOnRedemptionOfPreferredStock'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:to='fil_DeemedDividendsOnRedemptionOfPreferredStock' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStock' xlink:label='us-gaap_DividendsPreferredStock'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:to='us-gaap_DividendsPreferredStock' use='optional' order='3.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet' xlink:label='us-gaap_OtherSalesRevenueNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Revenues' xlink:to='us-gaap_OtherSalesRevenueNet' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Revenues' xlink:to='us-gaap_SalesRevenueNet' use='optional' order='2.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedStatementsOfCashFlows"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfCashFlows">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable' xlink:label='us-gaap_ProceedsFromNotesPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_ProceedsFromNotesPayable' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt' xlink:label='us-gaap_ProceedsFromRelatedPartyDebt'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_ProceedsFromRelatedPartyDebt' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' xlink:label='fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable' xlink:label='us-gaap_RepaymentsOfNotesPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_RepaymentsOfNotesPayable' use='optional' order='4.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt' xlink:label='us-gaap_RepaymentsOfRelatedPartyDebt'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_RepaymentsOfRelatedPartyDebt' use='optional' order='5.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment' xlink:label='us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesReceivables' xlink:label='us-gaap_IncreaseDecreaseInNotesReceivables'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_IncreaseDecreaseInNotesReceivables' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment' xlink:label='us-gaap_PaymentsToAcquireMachineryAndEquipment'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_PaymentsToAcquireMachineryAndEquipment' use='optional' order='3.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInAccountsReceivable' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInInventories' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:label='us-gaap_IncreaseDecreaseInNotesPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInNotesPayableCurrent' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_StockAccruedForInterestExpense' xlink:label='fil_StockAccruedForInterestExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='fil_StockAccruedForInterestExpense' use='optional' order='6.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium' xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_AmortizationOfDebtDiscountPremium' use='optional' order='7.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayableTrade' use='optional' order='8.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='9.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization' xlink:label='us-gaap_DepreciationDepletionAndAmortization'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_DepreciationDepletionAndAmortization' use='optional' order='10.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossOnDerivativeInstrumentsPretax' xlink:label='us-gaap_LossOnDerivativeInstrumentsPretax'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_LossOnDerivativeInstrumentsPretax' use='optional' order='11.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfProperty' xlink:label='us-gaap_GainLossOnSaleOfProperty'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_GainLossOnSaleOfProperty' use='optional' order='12.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_GainOnLiabilitySettlements' xlink:label='fil_GainOnLiabilitySettlements'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='fil_GainOnLiabilitySettlements' use='optional' order='13.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt' xlink:label='us-gaap_GainsLossesOnExtinguishmentOfDebt'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_GainsLossesOnExtinguishmentOfDebt' use='optional' order='14.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LossOnInducedConversionsOfDebt' xlink:label='fil_LossOnInducedConversionsOfDebt'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='fil_LossOnInducedConversionsOfDebt' use='optional' order='15.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LossOnSettlement' xlink:label='fil_LossOnSettlement'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='fil_LossOnSettlement' use='optional' order='16.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_StockAndWarrantsIssuedAndAccruedForServices' xlink:label='fil_StockAndWarrantsIssuedAndAccruedForServices'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='fil_StockAndWarrantsIssuedAndAccruedForServices' use='optional' order='17.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_ShareBasedCompensation' use='optional' order='18.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease' xlink:label='us-gaap_CashPeriodIncreaseDecrease'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='2.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='3.0' weight='1.0'/>
	</link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>acar-20170630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by Southridge Services using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK611N9EKWVLDLN2EK]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://activecare.com/20170630"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_DocumentDocumentAndEntityInformation"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedBalanceSheets"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheets"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedBalanceSheetsParenthetical"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheetsParenthetical"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedStatementsOfOperations"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperations"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedStatementsOfOperationsParenthetical"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperationsParenthetical"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedStatementsOfCashFlows"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfCashFlows"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperations" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperations"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperations"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShare" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShare"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShare"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure3RecentAccountingPronouncements"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivable" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure4AccountsReceivable"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivable"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure5Inventory" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure5Inventory"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure5Inventory"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipment" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure7PropertyAndEquipment"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipment"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpenses" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure8AccruedExpenses"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpenses"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayable" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure9NotesPayable"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure9NotesPayable"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayable" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure10RelatedPartyNotesPayable"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayable"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurements" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurements"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurements"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiability" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure12DerivativesLiability"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiability"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure13PreferredStock" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure13PreferredStock"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure13PreferredStock"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure14CommonStock" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure14CommonStock"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure14CommonStock"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrants" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrants"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrants"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingencies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure17CommitmentsAndContingencies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingencies"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure18SubsequentEvents" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure18SubsequentEvents"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure18SubsequentEvents"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure5InventoryScheduleOfInventoryTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure9NotesPayableScheduleOfDebtOtherTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:label='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain' xlink:label='us-gaap_AntidilutiveSecuritiesNameDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:to='us-gaap_AntidilutiveSecuritiesNameDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain' xlink:label='us-gaap_AntidilutiveSecuritiesNameDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:to='us-gaap_AntidilutiveSecuritiesNameDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CommonStockOptionsAndWarrantsMember' xlink:label='fil_CommonStockOptionsAndWarrantsMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AntidilutiveSecuritiesNameDomain' xlink:to='fil_CommonStockOptionsAndWarrantsMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConvertibleDebt1Member' xlink:label='fil_ConvertibleDebt1Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_AntidilutiveSecuritiesNameDomain' xlink:to='fil_ConvertibleDebt1Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther' xlink:label='us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount' xlink:label='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare' xlink:label='us-gaap_IncomeLossFromContinuingOperationsPerBasicShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeLossFromContinuingOperationsPerBasicShare' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare' xlink:label='us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare' use='optional' order='7.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivableDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure4AccountsReceivableDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivableDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure5InventoryScheduleOfInventoryDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis' xlink:label='us-gaap_BalanceSheetLocationAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_BalanceSheetLocationAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain' xlink:label='us-gaap_BalanceSheetLocationDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='us-gaap_BalanceSheetLocationDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain' xlink:label='us-gaap_BalanceSheetLocationDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='us-gaap_BalanceSheetLocationDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LineOfCreditAcquisitionFeesMember' xlink:label='fil_LineOfCreditAcquisitionFeesMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_BalanceSheetLocationDomain' xlink:to='fil_LineOfCreditAcquisitionFeesMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidInformationTechnologyServicesMember' xlink:label='fil_PrepaidInformationTechnologyServicesMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_BalanceSheetLocationDomain' xlink:to='fil_PrepaidInformationTechnologyServicesMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidProfessionalFeesMember' xlink:label='fil_PrepaidProfessionalFeesMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_BalanceSheetLocationDomain' xlink:to='fil_PrepaidProfessionalFeesMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidInsurance1Member' xlink:label='fil_PrepaidInsurance1Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_BalanceSheetLocationDomain' xlink:to='fil_PrepaidInsurance1Member' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_OtherMember' xlink:label='fil_OtherMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_BalanceSheetLocationDomain' xlink:to='fil_OtherMember' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ResearchAndDevelopmentMember' xlink:label='fil_ResearchAndDevelopmentMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_BalanceSheetLocationDomain' xlink:to='fil_ResearchAndDevelopmentMember' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets' xlink:label='us-gaap_PrepaidExpenseAndOtherAssets'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PrepaidExpenseAndOtherAssets' use='optional' order='1.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-gaap_PropertyPlantAndEquipmentByTypeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_PropertyPlantAndEquipmentByTypeAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-gaap_PropertyPlantAndEquipmentTypeDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_PropertyPlantAndEquipmentTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-gaap_PropertyPlantAndEquipmentTypeDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_PropertyPlantAndEquipmentTypeDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquipmentMember' xlink:label='us-gaap_EquipmentMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-gaap_EquipmentMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FurnitureAndFixturesMember' xlink:label='us-gaap_FurnitureAndFixturesMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-gaap_FurnitureAndFixturesMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember' xlink:label='us-gaap_ComputerSoftwareIntangibleAssetMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-gaap_ComputerSoftwareIntangibleAssetMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:label='us-gaap_LeaseholdsAndLeaseholdImprovementsMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-gaap_LeaseholdsAndLeaseholdImprovementsMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure7PropertyAndEquipmentDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis' xlink:label='us-gaap_IncomeStatementLocationAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_IncomeStatementLocationAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain' xlink:label='us-gaap_IncomeStatementLocationDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='us-gaap_IncomeStatementLocationDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain' xlink:label='us-gaap_IncomeStatementLocationDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='us-gaap_IncomeStatementLocationDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseMember' xlink:label='us-gaap_InterestExpenseMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='us-gaap_InterestExpenseMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_WarrantyLiabilityMember' xlink:label='fil_WarrantyLiabilityMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_WarrantyLiabilityMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LiabilityToIssueCommonStockMember' xlink:label='fil_LiabilityToIssueCommonStockMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_LiabilityToIssueCommonStockMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PayrollExpenseMember' xlink:label='fil_PayrollExpenseMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_PayrollExpenseMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeferredRevenueMember' xlink:label='fil_DeferredRevenueMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_DeferredRevenueMember' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CommissionsAndFeesMember' xlink:label='fil_CommissionsAndFeesMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_CommissionsAndFeesMember' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_SeveranceMember' xlink:label='fil_SeveranceMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_SeveranceMember' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LiabilityToIssueWarrantsMember' xlink:label='fil_LiabilityToIssueWarrantsMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_LiabilityToIssueWarrantsMember' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_OtherMember' xlink:label='fil_OtherMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_OtherMember' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FinanceFeesMember' xlink:label='fil_FinanceFeesMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='fil_FinanceFeesMember' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='1.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis' xlink:label='us-gaap_LongtermDebtTypeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_LongtermDebtTypeAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note1Member' xlink:label='fil_Note1Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note1Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note2Member' xlink:label='fil_Note2Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note2Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note3Member' xlink:label='fil_Note3Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note3Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note4Member' xlink:label='fil_Note4Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note4Member' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note5Member' xlink:label='fil_Note5Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note5Member' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note6Member' xlink:label='fil_Note6Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note6Member' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note7Member' xlink:label='fil_Note7Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note7Member' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note8Member' xlink:label='fil_Note8Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note8Member' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note9Member' xlink:label='fil_Note9Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note9Member' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note10Member' xlink:label='fil_Note10Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note10Member' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note11Member' xlink:label='fil_Note11Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note11Member' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note12Member' xlink:label='fil_Note12Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note12Member' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note13Member' xlink:label='fil_Note13Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note13Member' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note14Member' xlink:label='fil_Note14Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note14Member' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note15Member' xlink:label='fil_Note15Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note15Member' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note16Member' xlink:label='fil_Note16Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_Note16Member' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_GrossNotesPayableBeforeDiscount' xlink:label='fil_GrossNotesPayableBeforeDiscount'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_GrossNotesPayableBeforeDiscount' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DiscountOnNotesPayable' xlink:label='fil_DiscountOnNotesPayable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DiscountOnNotesPayable' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_NotesPayableCurrentAndNoncurrent' xlink:label='fil_NotesPayableCurrentAndNoncurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NotesPayableCurrentAndNoncurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesPayableCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable' xlink:label='us-gaap_LongTermNotesPayable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_LongTermNotesPayable' use='optional' order='5.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis' xlink:label='us-gaap_LongtermDebtTypeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_LongtermDebtTypeAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote1Member' xlink:label='fil_RelatedPartyNote1Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_RelatedPartyNote1Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote2Member' xlink:label='fil_RelatedPartyNote2Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_RelatedPartyNote2Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote3Member' xlink:label='fil_RelatedPartyNote3Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_RelatedPartyNote3Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote4Member' xlink:label='fil_RelatedPartyNote4Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_RelatedPartyNote4Member' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote5Member' xlink:label='fil_RelatedPartyNote5Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_RelatedPartyNote5Member' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote6Member' xlink:label='fil_RelatedPartyNote6Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_RelatedPartyNote6Member' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote7Member' xlink:label='fil_RelatedPartyNote7Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_RelatedPartyNote7Member' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote8Member' xlink:label='fil_RelatedPartyNote8Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_RelatedPartyNote8Member' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesNoncurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesPayableRelatedPartiesNoncurrent' use='optional' order='3.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByFairValueHierarchyLevelAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member' xlink:label='us-gaap_FairValueInputsLevel2Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:to='us-gaap_FairValueInputsLevel2Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member' xlink:label='us-gaap_FairValueInputsLevel3Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:to='us-gaap_FairValueInputsLevel3Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities' xlink:label='us-gaap_DerivativeLiabilities'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DerivativeLiabilities' use='optional' order='1.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByFairValueHierarchyLevelAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member' xlink:label='us-gaap_FairValueInputsLevel3Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:to='us-gaap_FairValueInputsLevel3Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities' xlink:label='us-gaap_DerivativeLiabilities'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DerivativeLiabilities' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings' use='optional' order='4.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiabilityDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure12DerivativesLiabilityDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiabilityDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure13PreferredStockDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure13PreferredStockDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure13PreferredStockDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesDPreferredStockMember' xlink:label='us-gaap_SeriesDPreferredStockMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_SeriesDPreferredStockMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesEPreferredStockMember' xlink:label='us-gaap_SeriesEPreferredStockMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_SeriesEPreferredStockMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesFPreferredStockMember' xlink:label='us-gaap_SeriesFPreferredStockMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_SeriesFPreferredStockMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesGPreferredStockMember' xlink:label='us-gaap_SeriesGPreferredStockMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_SeriesGPreferredStockMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConvertiblePreferredStockSharesDesignated' xlink:label='fil_ConvertiblePreferredStockSharesDesignated'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_ConvertiblePreferredStockSharesDesignated' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IncreaseDecreaseInDividendsPayable' xlink:label='fil_IncreaseDecreaseInDividendsPayable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IncreaseDecreaseInDividendsPayable' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RedemptionPriceOfSeriesEPreferredStock' xlink:label='fil_RedemptionPriceOfSeriesEPreferredStock'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_RedemptionPriceOfSeriesEPreferredStock' use='optional' order='5.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure14CommonStockDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure14CommonStockDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure14CommonStockDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_RangeAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RangeMember' xlink:to='us-gaap_MinimumMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RangeMember' xlink:to='us-gaap_MaximumMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByFairValueHierarchyLevelAxis' use='optional' order='2.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member' xlink:label='us-gaap_FairValueInputsLevel3Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:to='us-gaap_FairValueInputsLevel3Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice' xlink:label='us-gaap_FairValueAssumptionsExercisePrice'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueAssumptionsExercisePrice' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm' xlink:label='us-gaap_FairValueAssumptionsExpectedTerm'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueAssumptionsExpectedTerm' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate' xlink:label='us-gaap_FairValueAssumptionsExpectedVolatilityRate'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueAssumptionsExpectedVolatilityRate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate' xlink:label='us-gaap_FairValueAssumptionsRiskFreeInterestRate'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueAssumptionsRiskFreeInterestRate' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FairValueAssumptionsCommonStockPrice' xlink:label='fil_FairValueAssumptionsCommonStockPrice'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_FairValueAssumptionsCommonStockPrice' use='optional' order='5.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:label='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain' xlink:label='us-gaap_RelatedPartyDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-gaap_RelatedPartyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain' xlink:label='us-gaap_RelatedPartyDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-gaap_RelatedPartyDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember' xlink:label='fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RelatedPartyDomain' xlink:to='fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember' xlink:label='fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RelatedPartyDomain' xlink:to='fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyCompensationHourlyRate' xlink:label='fil_RelatedPartyCompensationHourlyRate'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_RelatedPartyCompensationHourlyRate' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable' xlink:label='us-gaap_RepaymentsOfNotesPayable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_RepaymentsOfNotesPayable' use='optional' order='2.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"/>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure17CommitmentsAndContingenciesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesDetails"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>acar-20170630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by Southridge Services using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK611N9EKWVLDLN2EK]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://activecare.com/20170630"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote3Member' xlink:label='fil_RelatedPartyNote3Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyNote3Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RelatedPartyNote3Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyNote3Member' xlink:to='lab_fil_RelatedPartyNote3Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note7Member' xlink:label='fil_Note7Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note7Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 7</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note7Member' xlink:to='lab_fil_Note7Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PayrollExpenseMember' xlink:label='fil_PayrollExpenseMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PayrollExpenseMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Payroll Expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PayrollExpenseMember' xlink:to='lab_fil_PayrollExpenseMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis' xlink:label='us-gaap_BalanceSheetLocationAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BalanceSheetLocationAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance Sheet Location [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='lab_us-gaap_BalanceSheetLocationAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryValuationReserves' xlink:label='us-gaap_InventoryValuationReserves'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryValuationReserves' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory Valuation Reserves</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryValuationReserves' xlink:to='lab_us-gaap_InventoryValuationReserves'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfDebt' xlink:label='fil_ConversionOfDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Conversion of debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfDebt' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Conversion of debt (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConversionOfDebt' xlink:to='lab_fil_ConversionOfDebt'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount' xlink:label='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount' xlink:to='lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PolicyTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='lab_us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:label='us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>10. Related Party Notes Payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:to='lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInInventories' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Change in inventory</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInInventories' xlink:to='lab_us-gaap_IncreaseDecreaseInInventories'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted' xlink:label='us-gaap_EarningsPerShareDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net loss per common share - diluted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareDiluted' xlink:to='lab_us-gaap_EarningsPerShareDiluted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfServices' xlink:label='us-gaap_CostOfServices'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Chronic illness monitoring fee cost of revenues</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfServices' xlink:to='lab_us-gaap_CostOfServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable' xlink:label='us-gaap_LongTermNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongTermNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes payable, net of current portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongTermNotesPayable' xlink:to='lab_us-gaap_LongTermNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyCompensationHourlyRate' xlink:label='fil_RelatedPartyCompensationHourlyRate'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyCompensationHourlyRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Related Party Compensation, Hourly Rate</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyCompensationHourlyRate' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Related Party Compensation, Hourly Rate, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyCompensationHourlyRate' xlink:to='lab_fil_RelatedPartyCompensationHourlyRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice' xlink:label='us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote6Member' xlink:label='fil_RelatedPartyNote6Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyNote6Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RelatedPartyNote6Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyNote6Member' xlink:to='lab_fil_RelatedPartyNote6Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note13Member' xlink:label='fil_Note13Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note13Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note13Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note13Member' xlink:to='lab_fil_Note13Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongtermDebtTypeDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-term Debt, Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='lab_us-gaap_LongtermDebtTypeDomain'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LiabilityToIssueCommonStockMember' xlink:label='fil_LiabilityToIssueCommonStockMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LiabilityToIssueCommonStockMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Liability To Issue Common Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LiabilityToIssueCommonStockMember' xlink:to='lab_fil_LiabilityToIssueCommonStockMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis' xlink:label='us-gaap_IncomeStatementLocationAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeStatementLocationAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income Statement Location [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='lab_us-gaap_IncomeStatementLocationAxis'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LineOfCreditAcquisitionFeesMember' xlink:label='fil_LineOfCreditAcquisitionFeesMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LineOfCreditAcquisitionFeesMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Line of credit acquisition fees</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LineOfCreditAcquisitionFeesMember' xlink:to='lab_fil_LineOfCreditAcquisitionFeesMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock' xlink:label='us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Share-based Compensation, Activity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureTextBlock' xlink:label='us-gaap_InventoryDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>5. Inventory</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryDisclosureTextBlock' xlink:to='lab_us-gaap_InventoryDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock' xlink:label='us-gaap_EarningsPerShareTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>2. Net Loss per Common Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareTextBlock' xlink:to='lab_us-gaap_EarningsPerShareTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:label='us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>1. Organization and Nature of Operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:to='lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee' xlink:label='fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of shares of common stock for related-party loan origination fee</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Issuance of shares of common stock for related-party loan origination fee, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee' xlink:to='lab_fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:label='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Non-Cash Investing and Financing Activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable' xlink:label='us-gaap_ProceedsFromNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from issuance of notes payable, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromNotesPayable' xlink:to='lab_us-gaap_ProceedsFromNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization' xlink:label='us-gaap_DepreciationDepletionAndAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepreciationDepletionAndAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation and amortization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepreciationDepletionAndAmortization' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Depreciation and amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DepreciationDepletionAndAmortization' xlink:to='lab_us-gaap_DepreciationDepletionAndAmortization'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic' xlink:label='us-gaap_EarningsPerShareBasic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net loss per common share - basic</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasic' xlink:to='lab_us-gaap_EarningsPerShareBasic'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:label='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net loss attributable to common stockholders</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net loss attributable to common stockholders</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:to='lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold' xlink:label='us-gaap_CostOfGoodsAndServicesSold'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfGoodsAndServicesSold' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Chronic illness monitoring cost of revenues</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfGoodsAndServicesSold' xlink:to='lab_us-gaap_CostOfGoodsAndServicesSold'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalYearFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Year Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalYearFocus' xlink:to='lab_dei_DocumentFiscalYearFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesGPreferredStockMember' xlink:label='us-gaap_SeriesGPreferredStockMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SeriesGPreferredStockMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series G Preferred Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SeriesGPreferredStockMember' xlink:to='lab_us-gaap_SeriesGPreferredStockMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote5Member' xlink:label='fil_RelatedPartyNote5Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyNote5Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RelatedPartyNote5Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyNote5Member' xlink:to='lab_fil_RelatedPartyNote5Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note15Member' xlink:label='fil_Note15Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note15Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note15Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note15Member' xlink:to='lab_fil_Note15Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare' xlink:label='us-gaap_IncomeLossFromContinuingOperationsPerBasicShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income (Loss) from Continuing Operations, Per Basic Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsPerBasicShare' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConvertibleDebt1Member' xlink:label='fil_ConvertibleDebt1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertibleDebt1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertibleDebt1Member' xlink:to='lab_fil_ConvertibleDebt1Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Reclassifications' xlink:label='us-gaap_Reclassifications'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Reclassifications' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Reclassifications</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Reclassifications' xlink:to='lab_us-gaap_Reclassifications'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock' xlink:label='us-gaap_DebtDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>9. Notes Payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtDisclosureTextBlock' xlink:to='lab_us-gaap_DebtDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CancellationAndReissuanceOfSharesOfCommonStock' xlink:label='fil_CancellationAndReissuanceOfSharesOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CancellationAndReissuanceOfSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cancellation and reissuance of shares of common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CancellationAndReissuanceOfSharesOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Cancellation and reissuance of shares of common stock, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CancellationAndReissuanceOfSharesOfCommonStock' xlink:to='lab_fil_CancellationAndReissuanceOfSharesOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees' xlink:label='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrual of a liability to issue shares of common stock for loan forbearance fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Accrual of a liability to issue shares of common stock for loan forbearance fees, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees' xlink:to='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable' xlink:label='us-gaap_RepaymentsOfNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RepaymentsOfNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Principal payments on notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RepaymentsOfNotesPayable' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Principal payments on notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RepaymentsOfNotesPayable' xlink:to='lab_us-gaap_RepaymentsOfNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Change in accrued liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Change in accrued liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:to='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Changes in operating assets and liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash flows from operating activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStock' xlink:label='us-gaap_DividendsPreferredStock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DividendsPreferredStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Dividends on preferred stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DividendsPreferredStock' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Dividends on preferred stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DividendsPreferredStock' xlink:to='lab_us-gaap_DividendsPreferredStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract' xlink:label='us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherIncomeAndExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other income (expense):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='lab_us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpenses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total operating expenses</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpenses' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total operating expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpenses' xlink:to='lab_us-gaap_OperatingExpenses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SalesRevenueNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Chronic illness monitoring supplies revenues</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SalesRevenueNet' xlink:to='lab_us-gaap_SalesRevenueNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total stockholders&apos; deficit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total stockholders&apos; deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquity' xlink:to='lab_us-gaap_StockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConvertiblePreferredStockSharesDesignated' xlink:label='fil_ConvertiblePreferredStockSharesDesignated'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertiblePreferredStockSharesDesignated' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Convertible Preferred Stock Shares Designated</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConvertiblePreferredStockSharesDesignated' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Convertible Preferred Stock Shares Designated (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConvertiblePreferredStockSharesDesignated' xlink:to='lab_fil_ConvertiblePreferredStockSharesDesignated'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesEPreferredStockMember' xlink:label='us-gaap_SeriesEPreferredStockMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SeriesEPreferredStockMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series E Preferred Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SeriesEPreferredStockMember' xlink:to='lab_us-gaap_SeriesEPreferredStockMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss (gain) on derivative liability resulting from changes in fair value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings' xlink:to='lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Hierarchy</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:to='lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note11Member' xlink:label='fil_Note11Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note11Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 11</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note11Member' xlink:to='lab_fil_Note11Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:to='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CommonStockOptionsAndWarrantsMember' xlink:label='fil_CommonStockOptionsAndWarrantsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockOptionsAndWarrantsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CommonStockOptionsAndWarrantsMember</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockOptionsAndWarrantsMember' xlink:to='lab_fil_CommonStockOptionsAndWarrantsMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain' xlink:label='us-gaap_AntidilutiveSecuritiesNameDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AntidilutiveSecuritiesNameDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Antidilutive Securities, Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AntidilutiveSecuritiesNameDomain' xlink:to='lab_us-gaap_AntidilutiveSecuritiesNameDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementTable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Table]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementTable' xlink:to='lab_us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>New Accounting Pronouncements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:to='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>14. Common Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:to='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable' xlink:label='fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Conversion of related-party accounts payable and accrued liabilities to related-party notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Conversion of related-party accounts payable and accrued liabilities to related-party notes payable, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable' xlink:to='lab_fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' xlink:label='fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from issuance of warrants in connection with notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Proceeds from issuance of warrants in connection with notes payable, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' xlink:to='lab_fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ResearchAndDevelopmentExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Research and development</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ResearchAndDevelopmentExpense' xlink:to='lab_us-gaap_ResearchAndDevelopmentExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense' xlink:label='us-gaap_SellingGeneralAndAdministrativeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SellingGeneralAndAdministrativeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Selling, general and administrative (including $1,461,457, $1,004,211, $2,101,037 and $3,257,614, respectively, of stock-based compensation)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SellingGeneralAndAdministrativeExpense' xlink:to='lab_us-gaap_SellingGeneralAndAdministrativeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Revenues' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Chronic illness monitoring revenues</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Revenues' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total Chronic illness monitoring revenues</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Revenues' xlink:to='lab_us-gaap_Revenues'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities' xlink:label='us-gaap_DerivativeLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DerivativeLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Derivatives liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DerivativeLiabilities' xlink:to='lab_us-gaap_DerivativeLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes payable, related party</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Notes payable, related party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' xlink:to='lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DueToRelatedPartiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts payable, related party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DueToRelatedPartiesCurrent' xlink:to='lab_us-gaap_DueToRelatedPartiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets' xlink:label='us-gaap_PrepaidExpenseAndOtherAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PrepaidExpenseAndOtherAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid expenses and other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PrepaidExpenseAndOtherAssets' xlink:to='lab_us-gaap_PrepaidExpenseAndOtherAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryNet' xlink:to='lab_us-gaap_InventoryNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments Due</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDue' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based compensation arrangement by share-based payment award, Options, Grants in period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RangeAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Range [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RangeAxis' xlink:to='lab_us-gaap_RangeAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesDPreferredStockMember' xlink:label='us-gaap_SeriesDPreferredStockMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SeriesDPreferredStockMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series D Preferred Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SeriesDPreferredStockMember' xlink:to='lab_us-gaap_SeriesDPreferredStockMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote1Member' xlink:label='fil_RelatedPartyNote1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyNote1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RelatedPartyNote1Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyNote1Member' xlink:to='lab_fil_RelatedPartyNote1Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note14Member' xlink:label='fil_Note14Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note14Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note14Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note14Member' xlink:to='lab_fil_Note14Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note4Member' xlink:label='fil_Note4Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note4Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 4</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note4Member' xlink:to='lab_fil_Note4Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FinanceFeesMember' xlink:label='fil_FinanceFeesMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FinanceFeesMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finance Fees</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FinanceFeesMember' xlink:to='lab_fil_FinanceFeesMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:label='us-gaap_LeaseholdsAndLeaseholdImprovementsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Leaseholds and Leasehold Improvements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:to='lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfSeriesDPreferredStock' xlink:label='fil_ConversionOfSeriesDPreferredStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfSeriesDPreferredStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Conversion of Series D preferred stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfSeriesDPreferredStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Conversion of Series D preferred stock (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConversionOfSeriesDPreferredStock' xlink:to='lab_fil_ConversionOfSeriesDPreferredStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' xlink:label='us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Related Party Transactions</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:label='us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Inventory</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaidNet' xlink:label='us-gaap_InterestPaidNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestPaidNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid for interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestPaidNet' xlink:to='lab_us-gaap_InterestPaidNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt' xlink:label='us-gaap_ProceedsFromRelatedPartyDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromRelatedPartyDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from issuance of related-party notes payable, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromRelatedPartyDebt' xlink:to='lab_us-gaap_ProceedsFromRelatedPartyDebt'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_StockAccruedForInterestExpense' xlink:label='fil_StockAccruedForInterestExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockAccruedForInterestExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock accrued for interest expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockAccruedForInterestExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Stock accrued for interest expense, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockAccruedForInterestExpense' xlink:to='lab_fil_StockAccruedForInterestExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock, $.00001 par value: 10,000,000 shares authorized; 45,000 shares of Series D; 70,070 shares of Series E; and 43,220 and 0 shares of Series G issued and outstanding, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockValue' xlink:to='lab_us-gaap_PreferredStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders&apos; deficit:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='lab_us-gaap_StockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableCurrent' xlink:to='lab_us-gaap_AccountsPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Fiscal Year End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued During Period, Shares, Issued for Services</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:to='lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EquityComponentDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity Component</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EquityComponentDomain' xlink:to='lab_us-gaap_EquityComponentDomain'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DiscountOnNotesPayable' xlink:label='fil_DiscountOnNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountOnNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Discount on notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DiscountOnNotesPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Discount on notes payable, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DiscountOnNotesPayable' xlink:to='lab_fil_DiscountOnNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CommissionsAndFeesMember' xlink:label='fil_CommissionsAndFeesMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommissionsAndFeesMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CommissionsAndFeesMember</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommissionsAndFeesMember' xlink:to='lab_fil_CommissionsAndFeesMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidInsurance1Member' xlink:label='fil_PrepaidInsurance1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidInsurance1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid insurance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidInsurance1Member' xlink:to='lab_fil_PrepaidInsurance1Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants' xlink:label='fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Exercise of outstanding common stock warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Exercise of outstanding common stock warrants (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants' xlink:to='lab_fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockTextBlock' xlink:label='us-gaap_PreferredStockTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>13. Preferred Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockTextBlock' xlink:to='lab_us-gaap_PreferredStockTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' xlink:label='fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants to purchase shares of common stock for loan origination fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' xlink:role='http://www.xbrl.org/2003/role/verboseLabel' xml:lang='en-US'>Issuance of warrants to purchase shares of common stock for loan origination fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Issuance of warrants for the purchase shares of common stock for loan origination fees, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' xlink:to='lab_fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease' xlink:label='us-gaap_CashPeriodIncreaseDecrease'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net decrease in cash</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net decrease in cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashPeriodIncreaseDecrease' xlink:to='lab_us-gaap_CashPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Change in accounts payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Change in accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock shares authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesAuthorized' xlink:to='lab_us-gaap_PreferredStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsAccumulatedDeficit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsAccumulatedDeficit' xlink:to='lab_us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Liabilities' xlink:to='lab_us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Liabilities and Stockholders&apos; Deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IncreaseDecreaseInDividendsPayable' xlink:label='fil_IncreaseDecreaseInDividendsPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncreaseDecreaseInDividendsPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>IncreaseDecreaseInDividendsPayable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IncreaseDecreaseInDividendsPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of IncreaseDecreaseInDividendsPayable, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IncreaseDecreaseInDividendsPayable' xlink:to='lab_fil_IncreaseDecreaseInDividendsPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementEquityComponentsAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity Components [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='lab_us-gaap_StatementEquityComponentsAxis'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote7Member' xlink:label='fil_RelatedPartyNote7Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyNote7Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RelatedPartyNote7Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyNote7Member' xlink:to='lab_fil_RelatedPartyNote7Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note3Member' xlink:label='fil_Note3Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note3Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 3</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note3Member' xlink:to='lab_fil_Note3Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeferredRevenueMember' xlink:label='fil_DeferredRevenueMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredRevenueMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>DeferredRevenueMember</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DeferredRevenueMember' xlink:to='lab_fil_DeferredRevenueMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquipmentMember' xlink:label='us-gaap_EquipmentMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EquipmentMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EquipmentMember' xlink:to='lab_us-gaap_EquipmentMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>17. Commitments and Contingencies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:to='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees' xlink:label='fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of shares of common stock for loan extension fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Issuance of shares of common stock for loan extension fees, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees' xlink:to='lab_fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SupplementalCashFlowInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Supplemental Cash Flow Information:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='lab_us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncome' xlink:label='us-gaap_OtherIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherIncome' xlink:to='lab_us-gaap_OtherIncome'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss from operations</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Loss from operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='lab_us-gaap_OperatingIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating expenses:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='lab_us-gaap_OperatingExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gross profit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Gross profit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GrossProfit' xlink:to='lab_us-gaap_GrossProfit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet' xlink:label='us-gaap_OtherSalesRevenueNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherSalesRevenueNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Chronic illness monitoring fee revenues</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherSalesRevenueNet' xlink:to='lab_us-gaap_OtherSalesRevenueNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract' xlink:label='us-gaap_IncomeStatementAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeStatementAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Condensed Consolidated Statements of Operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='lab_us-gaap_IncomeStatementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Current Reporting Status</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued During Period, Value, Issued for Services</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:to='lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit' xlink:label='us-gaap_StockholdersEquityReverseStockSplit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityReverseStockSplit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders&apos; Equity, Reverse Stock Split</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityReverseStockSplit' xlink:to='lab_us-gaap_StockholdersEquityReverseStockSplit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of embedded derivatives related to notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome' xlink:to='lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Hierarchy [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='lab_us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote2Member' xlink:label='fil_RelatedPartyNote2Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyNote2Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RelatedPartyNote2Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyNote2Member' xlink:to='lab_fil_RelatedPartyNote2Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet' xlink:label='us-gaap_DepreciationAmortizationAndAccretionNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepreciationAmortizationAndAccretionNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation, Amortization and Accretion, Net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DepreciationAmortizationAndAccretionNet' xlink:to='lab_us-gaap_DepreciationAmortizationAndAccretionNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock' xlink:label='us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Other Current Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>18. Subsequent Events</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventsTextBlock' xlink:to='lab_us-gaap_SubsequentEventsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>7. Property and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DisclosureTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='lab_us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices' xlink:label='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrual of a liability to issue shares of common stock for services</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Accrual of a liability to issue shares of common stock for services, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices' xlink:to='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees' xlink:label='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrual of a liability to issue shares of common stock for loan origination fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Accrual of a liability to issue shares of common stock for loan origination fees, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees' xlink:to='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash used in operating activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash used in operating activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock-based compensation expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensation' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Stock-based compensation expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensation' xlink:to='lab_us-gaap_ShareBasedCompensation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium' xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AmortizationOfDebtDiscountPremium' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization of debt discounts</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AmortizationOfDebtDiscountPremium' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Amortization of debt discounts</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AmortizationOfDebtDiscountPremium' xlink:to='lab_us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants' xlink:label='fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Compensation expense paid in stock or amortization of stock options and warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Compensation expense paid in stock or amortization of stock options and warrants, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants' xlink:to='lab_fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock par value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='lab_us-gaap_AccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments, Next Rolling Twelve Months</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MinimumMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Minimum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MinimumMember' xlink:to='lab_us-gaap_MinimumMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RedemptionPriceOfSeriesEPreferredStock' xlink:label='fil_RedemptionPriceOfSeriesEPreferredStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RedemptionPriceOfSeriesEPreferredStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Redemption Price of Series E preferred stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RedemptionPriceOfSeriesEPreferredStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Redemption Price of Series E preferred stock, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RedemptionPriceOfSeriesEPreferredStock' xlink:to='lab_fil_RedemptionPriceOfSeriesEPreferredStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember' xlink:label='us-gaap_ComputerSoftwareIntangibleAssetMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ComputerSoftwareIntangibleAssetMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Computer Software, Intangible Asset</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ComputerSoftwareIntangibleAssetMember' xlink:to='lab_us-gaap_ComputerSoftwareIntangibleAssetMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidProfessionalFeesMember' xlink:label='fil_PrepaidProfessionalFeesMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidProfessionalFeesMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid professional fees</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidProfessionalFeesMember' xlink:to='lab_fil_PrepaidProfessionalFeesMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidInformationTechnologyServicesMember' xlink:label='fil_PrepaidInformationTechnologyServicesMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PrepaidInformationTechnologyServicesMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid information technology services</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PrepaidInformationTechnologyServicesMember' xlink:to='lab_fil_PrepaidInformationTechnologyServicesMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoods' xlink:label='us-gaap_InventoryFinishedGoods'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryFinishedGoods' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory, Finished Goods, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryFinishedGoods' xlink:to='lab_us-gaap_InventoryFinishedGoods'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare' xlink:label='us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther' xlink:label='us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther' xlink:to='lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TextBlockAbstract' xlink:to='lab_us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ScheduleOfCommonStockEquivalents0TextBlock' xlink:label='fil_ScheduleOfCommonStockEquivalents0TextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfCommonStockEquivalents0TextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Common Stock Equivalents</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfCommonStockEquivalents0TextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the textual narrative disclosure of Schedule of Common Stock Equivalents, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfCommonStockEquivalents0TextBlock' xlink:to='lab_fil_ScheduleOfCommonStockEquivalents0TextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock' xlink:label='us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>12. Derivatives Liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock' xlink:to='lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock' xlink:label='us-gaap_OtherCurrentAssetsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherCurrentAssetsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>6. Prepaid Expenses and Other Current Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherCurrentAssetsTextBlock' xlink:to='lab_us-gaap_OtherCurrentAssetsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock' xlink:label='us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>4. Accounts Receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock' xlink:to='lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesReceivables' xlink:label='us-gaap_IncreaseDecreaseInNotesReceivables'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInNotesReceivables' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in contingent note receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInNotesReceivables' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Investment in contingent note receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInNotesReceivables' xlink:to='lab_us-gaap_IncreaseDecreaseInNotesReceivables'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet' xlink:label='us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherOperatingIncomeExpenseNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total other income (expense)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherOperatingIncomeExpenseNet' xlink:to='lab_us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestExpense' xlink:to='lab_us-gaap_InterestExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenuesAbstract' xlink:label='us-gaap_RevenuesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RevenuesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revenues:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RevenuesAbstract' xlink:to='lab_us-gaap_RevenuesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesOutstanding' xlink:to='lab_us-gaap_PreferredStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet' xlink:label='us-gaap_FiniteLivedIntangibleAssetsNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Domain name, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsNet' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsNet'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DocumentAndEntityInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document and Entity Information:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='lab_fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice' xlink:label='us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FairValueAssumptionsCommonStockPrice' xlink:label='fil_FairValueAssumptionsCommonStockPrice'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueAssumptionsCommonStockPrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Assumptions Common Stock Price</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FairValueAssumptionsCommonStockPrice' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the per-share monetary value of Fair Value Assumptions Common Stock Price, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FairValueAssumptionsCommonStockPrice' xlink:to='lab_fil_FairValueAssumptionsCommonStockPrice'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm' xlink:label='us-gaap_FairValueAssumptionsExpectedTerm'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueAssumptionsExpectedTerm' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Assumptions, Expected Term</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueAssumptionsExpectedTerm' xlink:to='lab_us-gaap_FairValueAssumptionsExpectedTerm'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1' xlink:label='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1' xlink:to='lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member' xlink:label='us-gaap_FairValueInputsLevel2Member'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueInputsLevel2Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Inputs, Level 2</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueInputsLevel2Member' xlink:to='lab_us-gaap_FairValueInputsLevel2Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote4Member' xlink:label='fil_RelatedPartyNote4Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyNote4Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RelatedPartyNote4Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyNote4Member' xlink:to='lab_fil_RelatedPartyNote4Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AllowanceForDoubtfulAccountsReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Allowance for Doubtful Accounts Receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AllowanceForDoubtfulAccountsReceivable' xlink:to='lab_us-gaap_AllowanceForDoubtfulAccountsReceivable'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CommonStockEquivalents' xlink:label='fil_CommonStockEquivalents'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockEquivalents' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock equivalents</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockEquivalents' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Common stock equivalents (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockEquivalents' xlink:to='lab_fil_CommonStockEquivalents'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock' xlink:label='us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Liabilities Measured on Recurring Basis</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock' xlink:to='lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' xlink:label='us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Accrued Liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_UseOfEstimates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Use of Estimates in The Preparation of Financial Statements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_UseOfEstimates' xlink:to='lab_us-gaap_UseOfEstimates'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:label='us-gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Going Concern</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:to='lab_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfSharesOfCommonStockForDividends' xlink:label='fil_IssuanceOfSharesOfCommonStockForDividends'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStockForDividends' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of shares of common stock for dividends</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStockForDividends' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Issuance of shares of common stock for dividends, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfSharesOfCommonStockForDividends' xlink:to='lab_fil_IssuanceOfSharesOfCommonStockForDividends'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants' xlink:label='fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deemed dividend on the redemption of preferred stock and accrued dividends for notes payable, common stock and exchange of warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Deemed dividend on the redemption of preferred stock and accrued dividends for notes payable, common stock and exchange of warrants, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants' xlink:to='lab_fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Change in accounts receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:label='us-gaap_IncreaseDecreaseInNotesPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase in note payable principal recorded as interest expense to convert accounts payable into notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:to='lab_us-gaap_IncreaseDecreaseInNotesPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesOutstanding' xlink:to='lab_us-gaap_CommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPayableCurrent' xlink:label='us-gaap_DividendsPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DividendsPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Dividends payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DividendsPayableCurrent' xlink:to='lab_us-gaap_DividendsPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesFPreferredStockMember' xlink:label='us-gaap_SeriesFPreferredStockMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SeriesFPreferredStockMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Series F Preferred Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SeriesFPreferredStockMember' xlink:to='lab_us-gaap_SeriesFPreferredStockMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesPayableRelatedPartiesNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes Payable, Related Parties, Noncurrent</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesPayableRelatedPartiesNoncurrent' xlink:to='lab_us-gaap_NotesPayableRelatedPartiesNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_NotesPayableCurrentAndNoncurrent' xlink:label='fil_NotesPayableCurrentAndNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesPayableCurrentAndNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes payable current and noncurrent</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesPayableCurrentAndNoncurrent' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Notes payable current and noncurrent, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotesPayableCurrentAndNoncurrent' xlink:to='lab_fil_NotesPayableCurrentAndNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_GrossNotesPayableBeforeDiscount' xlink:label='fil_GrossNotesPayableBeforeDiscount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GrossNotesPayableBeforeDiscount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gross notes payable before discount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GrossNotesPayableBeforeDiscount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Gross notes payable before discount, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GrossNotesPayableBeforeDiscount' xlink:to='lab_fil_GrossNotesPayableBeforeDiscount'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note12Member' xlink:label='fil_Note12Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note12Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note12Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note12Member' xlink:to='lab_fil_Note12Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note9Member' xlink:label='fil_Note9Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note9Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 9</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note9Member' xlink:to='lab_fil_Note9Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis' xlink:label='us-gaap_LongtermDebtTypeAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongtermDebtTypeAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-term Debt, Type [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='lab_us-gaap_LongtermDebtTypeAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-gaap_PropertyPlantAndEquipmentTypeDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment, Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentTypeDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock' xlink:label='us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock' xlink:to='lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TableTextBlockSupplementAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tables/Schedules</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='lab_us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy' xlink:label='us-gaap_FairValueOfFinancialInstrumentsPolicy'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueOfFinancialInstrumentsPolicy' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value of Financial Instruments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueOfFinancialInstrumentsPolicy' xlink:to='lab_us-gaap_FairValueOfFinancialInstrumentsPolicy'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract' xlink:label='fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Condensed Consolidated Statements of Operations Parenthetical</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract' xlink:to='lab_fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted average common shares outstanding - basic</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:to='lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeemedDividendsOnRedemptionOfPreferredStock' xlink:label='fil_DeemedDividendsOnRedemptionOfPreferredStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeemedDividendsOnRedemptionOfPreferredStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deemed dividends on redemption of preferred stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeemedDividendsOnRedemptionOfPreferredStock' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Deemed dividends on redemption of preferred stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeemedDividendsOnRedemptionOfPreferredStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Deemed dividends on redemption of preferred stock, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DeemedDividendsOnRedemptionOfPreferredStock' xlink:to='lab_fil_DeemedDividendsOnRedemptionOfPreferredStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfProperty' xlink:label='us-gaap_GainLossOnSaleOfProperty'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainLossOnSaleOfProperty' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gain on disposal of property and equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainLossOnSaleOfProperty' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Gain on disposal of property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GainLossOnSaleOfProperty' xlink:to='lab_us-gaap_GainLossOnSaleOfProperty'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock, $.00001 par value: 200,000,000 shares authorized; 239,100 and 232,100 shares outstanding, respectively</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockValue' xlink:to='lab_us-gaap_CommonStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current assets:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='lab_us-gaap_AssetsCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note8Member' xlink:label='fil_Note8Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note8Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 8</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note8Member' xlink:to='lab_fil_Note8Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FurnitureAndFixturesMember' xlink:label='us-gaap_FurnitureAndFixturesMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FurnitureAndFixturesMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Furniture and Fixtures</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FurnitureAndFixturesMember' xlink:to='lab_us-gaap_FurnitureAndFixturesMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income (loss), excluding discontinued operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementLineItems' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Line Items]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementLineItems' xlink:to='lab_us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Stockoptionsandwarrants0TextBlock' xlink:label='fil_Stockoptionsandwarrants0TextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Stockoptionsandwarrants0TextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>15. Common Stock Options and Warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Stockoptionsandwarrants0TextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the textual narrative disclosure of 15. Common Stock Options and Warrants, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Stockoptionsandwarrants0TextBlock' xlink:to='lab_fil_Stockoptionsandwarrants0TextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable' xlink:label='fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Conversion of accounts payable and accrued liabilities to notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Conversion of accounts payable and accrued liabilities to notes payable, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable' xlink:to='lab_fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Change in prepaid expenses and other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:to='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock par value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total liabilities and stockholders&apos; deficit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total liabilities and stockholders&apos; deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrent' xlink:to='lab_us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Central Index Key</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Period End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:label='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Related Party [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate' xlink:label='us-gaap_FairValueAssumptionsRiskFreeInterestRate'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueAssumptionsRiskFreeInterestRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Assumptions, Risk Free Interest Rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueAssumptionsRiskFreeInterestRate' xlink:to='lab_us-gaap_FairValueAssumptionsRiskFreeInterestRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Aggregate Intrinsic Value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member' xlink:label='us-gaap_FairValueInputsLevel3Member'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueInputsLevel3Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Inputs, Level 3</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueInputsLevel3Member' xlink:to='lab_us-gaap_FairValueInputsLevel3Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote8Member' xlink:label='fil_RelatedPartyNote8Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyNote8Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>RelatedPartyNote8Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyNote8Member' xlink:to='lab_fil_RelatedPartyNote8Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note6Member' xlink:label='fil_Note6Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note6Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 6</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note6Member' xlink:to='lab_fil_Note6Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LiabilityToIssueWarrantsMember' xlink:label='fil_LiabilityToIssueWarrantsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LiabilityToIssueWarrantsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LiabilityToIssueWarrantsMember</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LiabilityToIssueWarrantsMember' xlink:to='lab_fil_LiabilityToIssueWarrantsMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain' xlink:label='us-gaap_IncomeStatementLocationDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeStatementLocationDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income Statement Location</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeStatementLocationDomain' xlink:to='lab_us-gaap_IncomeStatementLocationDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain' xlink:label='us-gaap_BalanceSheetLocationDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BalanceSheetLocationDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance Sheet Location</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BalanceSheetLocationDomain' xlink:to='lab_us-gaap_BalanceSheetLocationDomain'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfEmployeeRestrictedShares' xlink:label='fil_IssuanceOfEmployeeRestrictedShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfEmployeeRestrictedShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of employee restricted shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfEmployeeRestrictedShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Issuance of employee restricted shares (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfEmployeeRestrictedShares' xlink:to='lab_fil_IssuanceOfEmployeeRestrictedShares'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:label='us-gaap_FairValueMeasurementInputsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>11. Fair Value Measurements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:to='lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees' xlink:label='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrual of a liability to issue shares of common stock for loan amendment fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Accrual of a liability to issue shares of common stock for loan amendment fees, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees' xlink:to='lab_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash provided by financing activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash provided by financing activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash used in investing activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash used in investing activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment' xlink:label='us-gaap_PaymentsToAcquireMachineryAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireMachineryAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchases of property and equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireMachineryAndEquipment' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Purchases of property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquireMachineryAndEquipment' xlink:to='lab_us-gaap_PaymentsToAcquireMachineryAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_StockAndWarrantsIssuedAndAccruedForServices' xlink:label='fil_StockAndWarrantsIssuedAndAccruedForServices'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockAndWarrantsIssuedAndAccruedForServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock and warrants issued and accrued for services</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockAndWarrantsIssuedAndAccruedForServices' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Stock and warrants issued and accrued for services</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_StockAndWarrantsIssuedAndAccruedForServices' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Stock and warrants issued and accrued for services, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_StockAndWarrantsIssuedAndAccruedForServices' xlink:to='lab_fil_StockAndWarrantsIssuedAndAccruedForServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt' xlink:label='us-gaap_GainsLossesOnExtinguishmentOfDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainsLossesOnExtinguishmentOfDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on extinguishment of debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainsLossesOnExtinguishmentOfDebt' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Loss on extinguishment of debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GainsLossesOnExtinguishmentOfDebt' xlink:to='lab_us-gaap_GainsLossesOnExtinguishmentOfDebt'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet' xlink:label='us-gaap_DerivativeGainLossOnDerivativeNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DerivativeGainLossOnDerivativeNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gain on derivatives liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DerivativeGainLossOnDerivativeNet' xlink:to='lab_us-gaap_DerivativeGainLossOnDerivativeNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue' xlink:label='us-gaap_CostOfRevenue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfRevenue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Chronic illness monitoring supplies cost of revenues</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfRevenue' xlink:to='lab_us-gaap_CostOfRevenue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current portion of notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesPayableCurrent' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Current portion of notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesPayableCurrent' xlink:to='lab_us-gaap_NotesPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesReceivableNet' xlink:label='us-gaap_NotesReceivableNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesReceivableNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesReceivableNet' xlink:to='lab_us-gaap_NotesReceivableNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNet' xlink:label='us-gaap_AccountsReceivableNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsReceivableNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts receivable, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsReceivableNet' xlink:to='lab_us-gaap_AccountsReceivableNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalPeriodFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Period Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalPeriodFocus' xlink:to='lab_dei_DocumentFiscalPeriodFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain' xlink:label='us-gaap_RelatedPartyDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RelatedPartyDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Related Party</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RelatedPartyDomain' xlink:to='lab_us-gaap_RelatedPartyDomain'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_WeightedAverageRemainingTermOfTheWarrants' xlink:label='fil_WeightedAverageRemainingTermOfTheWarrants'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageRemainingTermOfTheWarrants' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted average remaining term of the warrants</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageRemainingTermOfTheWarrants' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Weighted average remaining term of the warrants, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageRemainingTermOfTheWarrants' xlink:to='lab_fil_WeightedAverageRemainingTermOfTheWarrants'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note1Member' xlink:label='fil_Note1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 1</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note1Member' xlink:to='lab_fil_Note1Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_WarrantyLiabilityMember' xlink:label='fil_WarrantyLiabilityMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WarrantyLiabilityMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Warranty Liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WarrantyLiabilityMember' xlink:to='lab_fil_WarrantyLiabilityMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_OtherMember' xlink:label='fil_OtherMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OtherMember' xlink:to='lab_fil_OtherMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock' xlink:label='fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the textual narrative disclosure of Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock' xlink:to='lab_fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees' xlink:label='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrual of a liability to issue warrants to purchase shares of common stock for loan forbearance fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Accrual of a liability to issue warrants to purchase shares of common stock for loan forbearance fees, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees' xlink:to='lab_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net loss</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetIncomeLoss' xlink:to='lab_us-gaap_NetIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenueAbstract' xlink:label='us-gaap_CostOfRevenueAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfRevenueAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cost of revenues:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfRevenueAbstract' xlink:to='lab_us-gaap_CostOfRevenueAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock shares authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesAuthorized' xlink:to='lab_us-gaap_CommonStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Assets {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsAbstract' xlink:to='lab_us-gaap_AssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet' xlink:label='us-gaap_OperatingLeasesRentExpenseNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesRentExpenseNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Rent Expense, Net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesRentExpenseNet' xlink:to='lab_us-gaap_OperatingLeasesRentExpenseNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember' xlink:label='fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>FormerExecutiveChairmanAndChiefExecutiveOfficerMember</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember' xlink:to='lab_fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-gaap_PropertyPlantAndEquipmentByTypeAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment, Type [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ResearchAndDevelopmentMember' xlink:label='fil_ResearchAndDevelopmentMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ResearchAndDevelopmentMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Research and Development</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ResearchAndDevelopmentMember' xlink:to='lab_fil_ResearchAndDevelopmentMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LiabilityToIssueCommonStock' xlink:label='fil_LiabilityToIssueCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LiabilityToIssueCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Liability to issue common stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LiabilityToIssueCommonStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Liability to issue common stock (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LiabilityToIssueCommonStock' xlink:to='lab_fil_LiabilityToIssueCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:label='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Antidilutive Securities [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:to='lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock' xlink:label='us-gaap_ScheduleOfDebtTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfDebtTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Debt - Other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfDebtTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfDebtTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty' xlink:label='fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Assignment of related-party notes payable to an unrelated third party</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Assignment of related-party notes payable to an unrelated third party, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty' xlink:to='lab_fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt' xlink:label='us-gaap_RepaymentsOfRelatedPartyDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RepaymentsOfRelatedPartyDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Principal payments on related-party notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RepaymentsOfRelatedPartyDebt' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Principal payments on related-party notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RepaymentsOfRelatedPartyDebt' xlink:to='lab_us-gaap_RepaymentsOfRelatedPartyDebt'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment' xlink:label='us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from sale of property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment' xlink:to='lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash flows from investing activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossOnDerivativeInstrumentsPretax' xlink:label='us-gaap_LossOnDerivativeInstrumentsPretax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LossOnDerivativeInstrumentsPretax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gain on derivatives liability {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LossOnDerivativeInstrumentsPretax' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Gain on derivatives liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LossOnDerivativeInstrumentsPretax' xlink:to='lab_us-gaap_LossOnDerivativeInstrumentsPretax'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_GainOnLiabilitySettlements' xlink:label='fil_GainOnLiabilitySettlements'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainOnLiabilitySettlements' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gain on liability settlements</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainOnLiabilitySettlements' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Gain on liability settlements</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GainOnLiabilitySettlements' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Gain on liability settlements, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GainOnLiabilitySettlements' xlink:to='lab_fil_GainOnLiabilitySettlements'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:label='us-gaap_StockTransactionsParentheticalDisclosuresAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Condensed Consolidated Balance Sheets Parenthetical</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Assets' xlink:to='lab_us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepositsAssetsCurrent' xlink:label='us-gaap_DepositsAssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepositsAssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deposits and other assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DepositsAssetsCurrent' xlink:to='lab_us-gaap_DepositsAssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Voluntary Filers</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember' xlink:label='fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>FormerExecutiveChairmanOfTheBoardOfDirectorsMember</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember' xlink:to='lab_fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MaximumMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Maximum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MaximumMember' xlink:to='lab_us-gaap_MaximumMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RangeMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Range</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RangeMember' xlink:to='lab_us-gaap_RangeMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note16Member' xlink:label='fil_Note16Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note16Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note16Member</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note16Member' xlink:to='lab_fil_Note16Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note10Member' xlink:label='fil_Note10Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note10Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 10</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note10Member' xlink:to='lab_fil_Note10Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note5Member' xlink:label='fil_Note5Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note5Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 5</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note5Member' xlink:to='lab_fil_Note5Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseMember' xlink:label='us-gaap_InterestExpenseMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpenseMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest Expense {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpenseMember' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Interest Expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestExpenseMember' xlink:to='lab_us-gaap_InterestExpenseMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfSeriesEPreferredStock' xlink:label='fil_ConversionOfSeriesEPreferredStock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfSeriesEPreferredStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Conversion of Series E preferred stock</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ConversionOfSeriesEPreferredStock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Conversion of Series E preferred stock (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ConversionOfSeriesEPreferredStock' xlink:to='lab_fil_ConversionOfSeriesEPreferredStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:label='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Future Minimum Rental Payments for Operating Leases</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:label='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Earnings Per Share, Basic and Diluted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfSharesOfCommonStockForConsultingServices' xlink:label='fil_IssuanceOfSharesOfCommonStockForConsultingServices'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStockForConsultingServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of shares of common stock for consulting services</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_IssuanceOfSharesOfCommonStockForConsultingServices' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Issuance of shares of common stock for consulting services, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IssuanceOfSharesOfCommonStockForConsultingServices' xlink:to='lab_fil_IssuanceOfSharesOfCommonStockForConsultingServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash flows from financing activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract' xlink:label='us-gaap_StatementOfCashFlowsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementOfCashFlowsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Condensed Consolidated Statements of Cash Flows</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='lab_us-gaap_StatementOfCashFlowsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Cash' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Cash' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Cash, beginning of the period</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Cash' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Cash, end of the period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Cash' xlink:to='lab_us-gaap_Cash'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate' xlink:label='us-gaap_FairValueAssumptionsExpectedVolatilityRate'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueAssumptionsExpectedVolatilityRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Assumptions, Expected Volatility Rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueAssumptionsExpectedVolatilityRate' xlink:to='lab_us-gaap_FairValueAssumptionsExpectedVolatilityRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice' xlink:label='us-gaap_FairValueAssumptionsExercisePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueAssumptionsExercisePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Assumptions, Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueAssumptionsExercisePrice' xlink:to='lab_us-gaap_FairValueAssumptionsExercisePrice'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of warrants recorded as derivative</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues' xlink:to='lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes Payable, Related Parties</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent' xlink:to='lab_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note2Member' xlink:label='fil_Note2Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note2Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 2</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note2Member' xlink:to='lab_fil_Note2Member'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_SeveranceMember' xlink:label='fil_SeveranceMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_SeveranceMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Severance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_SeveranceMember' xlink:to='lab_fil_SeveranceMember'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock' xlink:label='fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>16. Related-party Transactions Not Otherwise Disclosed</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the textual narrative disclosure of 16. Related-party Transactions Not Otherwise Disclosed, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock' xlink:to='lab_fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock' xlink:label='us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>8. Accrued Expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock' xlink:to='lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>3. Recent Accounting Pronouncements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' xlink:to='lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees' xlink:label='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrual of a liability to issue warrants to purchase shares of common stock for loan origination fees</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Accrual of a liability to issue warrants to purchase shares of common stock for loan origination fees, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees' xlink:to='lab_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted average common shares outstanding - diluted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:to='lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LossOnInducedConversionsOfDebt' xlink:label='fil_LossOnInducedConversionsOfDebt'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnInducedConversionsOfDebt' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on induced conversions of debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnInducedConversionsOfDebt' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Loss on induced conversions of debt</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnInducedConversionsOfDebt' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Loss on induced conversions of debt, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LossOnInducedConversionsOfDebt' xlink:to='lab_fil_LossOnInducedConversionsOfDebt'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LossOnSettlement' xlink:label='fil_LossOnSettlement'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnSettlement' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on settlement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnSettlement' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Loss on settlement</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LossOnSettlement' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Loss on settlement, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LossOnSettlement' xlink:to='lab_fil_LossOnSettlement'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional paid-in capital, common and preferred</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapital' xlink:to='lab_us-gaap_AdditionalPaidInCapital'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total current liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='lab_us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent' xlink:label='us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Contingent liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent' xlink:to='lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract' xlink:label='us-gaap_StatementOfFinancialPositionAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementOfFinancialPositionAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Condensed Consolidated Balance Sheets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='lab_us-gaap_StatementOfFinancialPositionAbstract'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>acar-20170630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by Southridge Services using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK611N9EKWVLDLN2EK]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://activecare.com/20170630"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentType' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_TradingSymbol' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalYearFocus' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalPeriodFocus' use='optional' order='14.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedBalanceSheets"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheets">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract' xlink:label='us-gaap_StatementOfFinancialPositionAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AssetsAbstract' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AssetsCurrentAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_Cash' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNet' xlink:label='us-gaap_AccountsReceivableNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AccountsReceivableNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_InventoryNet' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesReceivableNet' xlink:label='us-gaap_NotesReceivableNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_NotesReceivableNet' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets' xlink:label='us-gaap_PrepaidExpenseAndOtherAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_PrepaidExpenseAndOtherAssets' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AssetsCurrent' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepositsAssetsCurrent' xlink:label='us-gaap_DepositsAssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_DepositsAssetsCurrent' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet' xlink:label='us-gaap_FiniteLivedIntangibleAssetsNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsNet' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_Assets' use='optional' order='10.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquityAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_LiabilitiesCurrentAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccountsPayableCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent' xlink:label='us-gaap_DueToRelatedPartiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_DueToRelatedPartiesCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent' xlink:label='us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_NotesPayableCurrent' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPayableCurrent' xlink:label='us-gaap_DividendsPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_DividendsPayableCurrent' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities' xlink:label='us-gaap_DerivativeLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_DerivativeLiabilities' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='9.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable' xlink:label='us-gaap_LongTermNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_LongTermNotesPayable' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_Liabilities' use='optional' order='11.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_StockholdersEquityAbstract' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_PreferredStockValue' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_CommonStockValue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquity' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquity' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedBalanceSheetsParenthetical"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheetsParenthetical">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:label='us-gaap_StockTransactionsParentheticalDisclosuresAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_PreferredStockSharesOutstanding' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_CommonStockParOrStatedValuePerShare' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockTransactionsParentheticalDisclosuresAbstract' xlink:to='us-gaap_CommonStockSharesOutstanding' use='optional' order='6.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedStatementsOfOperations"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperations">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract' xlink:label='us-gaap_IncomeStatementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenuesAbstract' xlink:label='us-gaap_RevenuesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_RevenuesAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_SalesRevenueNet' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSalesRevenueNet' xlink:label='us-gaap_OtherSalesRevenueNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_OtherSalesRevenueNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues' xlink:label='us-gaap_Revenues'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RevenuesAbstract' xlink:to='us-gaap_Revenues' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenueAbstract' xlink:label='us-gaap_CostOfRevenueAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_CostOfRevenueAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue' xlink:label='us-gaap_CostOfRevenue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CostOfRevenueAbstract' xlink:to='us-gaap_CostOfRevenue' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfServices' xlink:label='us-gaap_CostOfServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CostOfRevenueAbstract' xlink:to='us-gaap_CostOfServices' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold' xlink:label='us-gaap_CostOfGoodsAndServicesSold'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CostOfRevenueAbstract' xlink:to='us-gaap_CostOfGoodsAndServicesSold' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CostOfRevenueAbstract' xlink:to='us-gaap_GrossProfit' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OperatingExpensesAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense' xlink:label='us-gaap_SellingGeneralAndAdministrativeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_SellingGeneralAndAdministrativeExpense' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_ResearchAndDevelopmentExpense' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_OperatingExpenses' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_OperatingIncomeLoss' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract' xlink:label='us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OtherIncomeAndExpensesAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_InterestExpense' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LossOnSettlement' xlink:label='fil_LossOnSettlement'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='fil_LossOnSettlement' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet' xlink:label='us-gaap_DerivativeGainLossOnDerivativeNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_DerivativeGainLossOnDerivativeNet' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt' xlink:label='us-gaap_GainsLossesOnExtinguishmentOfDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_GainsLossesOnExtinguishmentOfDebt' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfProperty' xlink:label='us-gaap_GainLossOnSaleOfProperty'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_GainLossOnSaleOfProperty' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_GainOnLiabilitySettlements' xlink:label='fil_GainOnLiabilitySettlements'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='fil_GainOnLiabilitySettlements' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LossOnInducedConversionsOfDebt' xlink:label='fil_LossOnInducedConversionsOfDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='fil_LossOnInducedConversionsOfDebt' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncome' xlink:label='us-gaap_OtherIncome'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_OtherIncome' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet' xlink:label='us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='us-gaap_OtherOperatingIncomeExpenseNet' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeemedDividendsOnRedemptionOfPreferredStock' xlink:label='fil_DeemedDividendsOnRedemptionOfPreferredStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='fil_DeemedDividendsOnRedemptionOfPreferredStock' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStock' xlink:label='us-gaap_DividendsPreferredStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_DividendsPreferredStock' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' xlink:label='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic' xlink:label='us-gaap_EarningsPerShareBasic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_EarningsPerShareBasic' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted' xlink:label='us-gaap_EarningsPerShareDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_EarningsPerShareDiluted' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' use='optional' order='12.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedStatementsOfOperationsParenthetical"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperationsParenthetical">
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract' xlink:label='fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants' xlink:label='fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract' xlink:to='fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_CondensedConsolidatedStatementsOfCashFlows"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfCashFlows">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract' xlink:label='us-gaap_StatementOfCashFlowsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium' xlink:label='us-gaap_AmortizationOfDebtDiscountPremium'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_AmortizationOfDebtDiscountPremium' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt' xlink:label='us-gaap_GainsLossesOnExtinguishmentOfDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_GainsLossesOnExtinguishmentOfDebt' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_ShareBasedCompensation' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LossOnSettlement' xlink:label='fil_LossOnSettlement'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_LossOnSettlement' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_StockAndWarrantsIssuedAndAccruedForServices' xlink:label='fil_StockAndWarrantsIssuedAndAccruedForServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_StockAndWarrantsIssuedAndAccruedForServices' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:label='us-gaap_IncreaseDecreaseInNotesPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_IncreaseDecreaseInNotesPayableCurrent' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_StockAccruedForInterestExpense' xlink:label='fil_StockAccruedForInterestExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_StockAccruedForInterestExpense' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization' xlink:label='us-gaap_DepreciationDepletionAndAmortization'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_DepreciationDepletionAndAmortization' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossOnDerivativeInstrumentsPretax' xlink:label='us-gaap_LossOnDerivativeInstrumentsPretax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_LossOnDerivativeInstrumentsPretax' use='optional' order='9.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfProperty' xlink:label='us-gaap_GainLossOnSaleOfProperty'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_GainLossOnSaleOfProperty' use='optional' order='10.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LossOnInducedConversionsOfDebt' xlink:label='fil_LossOnInducedConversionsOfDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_LossOnInducedConversionsOfDebt' use='optional' order='11.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_GainOnLiabilitySettlements' xlink:label='fil_GainOnLiabilitySettlements'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='fil_GainOnLiabilitySettlements' use='optional' order='12.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsReceivable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInInventories' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayableTrade' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment' xlink:label='us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment' xlink:label='us-gaap_PaymentsToAcquireMachineryAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_PaymentsToAcquireMachineryAndEquipment' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesReceivables' xlink:label='us-gaap_IncreaseDecreaseInNotesReceivables'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_IncreaseDecreaseInNotesReceivables' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable' xlink:label='us-gaap_ProceedsFromNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromNotesPayable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt' xlink:label='us-gaap_ProceedsFromRelatedPartyDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromRelatedPartyDebt' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' xlink:label='fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt' xlink:label='us-gaap_RepaymentsOfRelatedPartyDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_RepaymentsOfRelatedPartyDebt' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable' xlink:label='us-gaap_RepaymentsOfNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_RepaymentsOfNotesPayable' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease' xlink:label='us-gaap_CashPeriodIncreaseDecrease'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_CashPeriodIncreaseDecrease' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_Cash' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash' xlink:label='us-gaap_Cash_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_Cash_1' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_SupplementalCashFlowInformationAbstract' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaidNet' xlink:label='us-gaap_InterestPaidNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='us-gaap_InterestPaidNet' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:label='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' xlink:label='fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/verboseLabel'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees' xlink:label='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees' xlink:label='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStock' xlink:label='us-gaap_DividendsPreferredStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='us-gaap_DividendsPreferredStock' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees' xlink:label='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants' xlink:label='fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable' xlink:label='fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty' xlink:label='fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfSharesOfCommonStockForConsultingServices' xlink:label='fil_IssuanceOfSharesOfCommonStockForConsultingServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_IssuanceOfSharesOfCommonStockForConsultingServices' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees' xlink:label='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CancellationAndReissuanceOfSharesOfCommonStock' xlink:label='fil_CancellationAndReissuanceOfSharesOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_CancellationAndReissuanceOfSharesOfCommonStock' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable' xlink:label='fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee' xlink:label='fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees' xlink:label='fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees' xlink:label='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfSharesOfCommonStockForDividends' xlink:label='fil_IssuanceOfSharesOfCommonStockForDividends'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_IssuanceOfSharesOfCommonStockForDividends' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices' xlink:label='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices' use='optional' order='17.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperations" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperations"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperations">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' xlink:label='us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShare" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShare"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShare">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock' xlink:label='us-gaap_EarningsPerShareTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_EarningsPerShareTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure3RecentAccountingPronouncements"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivable" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure4AccountsReceivable"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivable">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock' xlink:label='us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure5Inventory" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure5Inventory"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure5Inventory">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryDisclosureTextBlock' xlink:label='us-gaap_InventoryDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_InventoryDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock' xlink:label='us-gaap_OtherCurrentAssetsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_OtherCurrentAssetsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipment" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure7PropertyAndEquipment"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipment">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpenses" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure8AccruedExpenses"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpenses">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock' xlink:label='us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayable" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure9NotesPayable"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure9NotesPayable">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock' xlink:label='us-gaap_DebtDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_DebtDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayable" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure10RelatedPartyNotesPayable"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayable">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock' xlink:label='us-gaap_RelatedPartyTransactionsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_RelatedPartyTransactionsDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurements" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurements"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurements">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock' xlink:label='us-gaap_FairValueMeasurementInputsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_FairValueMeasurementInputsDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiability" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure12DerivativesLiability"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiability">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock' xlink:label='us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure13PreferredStock" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure13PreferredStock"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure13PreferredStock">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockTextBlock' xlink:label='us-gaap_PreferredStockTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_PreferredStockTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure14CommonStock" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure14CommonStock"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure14CommonStock">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_StockholdersEquityNoteDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrants" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrants"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrants">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Stockoptionsandwarrants0TextBlock' xlink:label='fil_Stockoptionsandwarrants0TextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='fil_Stockoptionsandwarrants0TextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock' xlink:label='fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingencies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure17CommitmentsAndContingencies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingencies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure18SubsequentEvents" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure18SubsequentEvents"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure18SubsequentEvents">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SubsequentEventsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' xlink:label='us-gaap_SubstantialDoubtAboutGoingConcernTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_SubstantialDoubtAboutGoingConcernTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_UseOfEstimates' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy' xlink:label='us-gaap_FairValueOfFinancialInstrumentsPolicy'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_FairValueOfFinancialInstrumentsPolicy' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Reclassifications' xlink:label='us-gaap_Reclassifications'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_Reclassifications' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:label='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ScheduleOfCommonStockEquivalents0TextBlock' xlink:label='fil_ScheduleOfCommonStockEquivalents0TextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='fil_ScheduleOfCommonStockEquivalents0TextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure5InventoryScheduleOfInventoryTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:label='us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfInventoryCurrentTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock' xlink:label='us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' xlink:label='us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure9NotesPayableScheduleOfDebtOtherTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock' xlink:label='us-gaap_ScheduleOfDebtTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfDebtTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' xlink:label='us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock' xlink:label='us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock' xlink:label='us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock' xlink:label='fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock' xlink:label='us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:label='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:label='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain' xlink:label='us-gaap_AntidilutiveSecuritiesNameDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:to='us-gaap_AntidilutiveSecuritiesNameDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CommonStockOptionsAndWarrantsMember' xlink:label='fil_CommonStockOptionsAndWarrantsMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:to='fil_CommonStockOptionsAndWarrantsMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConvertibleDebt1Member' xlink:label='fil_ConvertibleDebt1Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis' xlink:to='fil_ConvertibleDebt1Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther' xlink:label='us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount' xlink:label='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare' xlink:label='us-gaap_IncomeLossFromContinuingOperationsPerBasicShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeLossFromContinuingOperationsPerBasicShare' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare' xlink:label='us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare' use='optional' order='7.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants' xlink:label='fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfSeriesDPreferredStock' xlink:label='fil_ConversionOfSeriesDPreferredStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_ConversionOfSeriesDPreferredStock' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfSeriesEPreferredStock' xlink:label='fil_ConversionOfSeriesEPreferredStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_ConversionOfSeriesEPreferredStock' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConversionOfDebt' xlink:label='fil_ConversionOfDebt'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_ConversionOfDebt' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IssuanceOfEmployeeRestrictedShares' xlink:label='fil_IssuanceOfEmployeeRestrictedShares'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_IssuanceOfEmployeeRestrictedShares' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LiabilityToIssueCommonStock' xlink:label='fil_LiabilityToIssueCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_LiabilityToIssueCommonStock' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CommonStockEquivalents' xlink:label='fil_CommonStockEquivalents'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CommonStockEquivalents' use='optional' order='7.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivableDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure4AccountsReceivableDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivableDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AllowanceForDoubtfulAccountsReceivable' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure5InventoryScheduleOfInventoryDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoods' xlink:label='us-gaap_InventoryFinishedGoods'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_InventoryFinishedGoods' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryValuationReserves' xlink:label='us-gaap_InventoryValuationReserves'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_InventoryValuationReserves' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_InventoryNet' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis' xlink:label='us-gaap_BalanceSheetLocationAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_BalanceSheetLocationAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain' xlink:label='us-gaap_BalanceSheetLocationDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='us-gaap_BalanceSheetLocationDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidInformationTechnologyServicesMember' xlink:label='fil_PrepaidInformationTechnologyServicesMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='fil_PrepaidInformationTechnologyServicesMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_OtherMember' xlink:label='fil_OtherMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='fil_OtherMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidInsurance1Member' xlink:label='fil_PrepaidInsurance1Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='fil_PrepaidInsurance1Member' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PrepaidProfessionalFeesMember' xlink:label='fil_PrepaidProfessionalFeesMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='fil_PrepaidProfessionalFeesMember' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ResearchAndDevelopmentMember' xlink:label='fil_ResearchAndDevelopmentMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='fil_ResearchAndDevelopmentMember' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LineOfCreditAcquisitionFeesMember' xlink:label='fil_LineOfCreditAcquisitionFeesMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_BalanceSheetLocationAxis' xlink:to='fil_LineOfCreditAcquisitionFeesMember' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets' xlink:label='us-gaap_PrepaidExpenseAndOtherAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PrepaidExpenseAndOtherAssets' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-gaap_PropertyPlantAndEquipmentByTypeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_PropertyPlantAndEquipmentByTypeAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-gaap_PropertyPlantAndEquipmentTypeDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_PropertyPlantAndEquipmentTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember' xlink:label='us-gaap_ComputerSoftwareIntangibleAssetMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_ComputerSoftwareIntangibleAssetMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember' xlink:label='us-gaap_LeaseholdsAndLeaseholdImprovementsMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_LeaseholdsAndLeaseholdImprovementsMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FurnitureAndFixturesMember' xlink:label='us-gaap_FurnitureAndFixturesMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_FurnitureAndFixturesMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquipmentMember' xlink:label='us-gaap_EquipmentMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_EquipmentMember' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure7PropertyAndEquipmentDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfProperty' xlink:label='us-gaap_GainLossOnSaleOfProperty'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_GainLossOnSaleOfProperty' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet' xlink:label='us-gaap_DepreciationAmortizationAndAccretionNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DepreciationAmortizationAndAccretionNet' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis' xlink:label='us-gaap_IncomeStatementLocationAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_IncomeStatementLocationAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain' xlink:label='us-gaap_IncomeStatementLocationDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='us-gaap_IncomeStatementLocationDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseMember' xlink:label='us-gaap_InterestExpenseMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='us-gaap_InterestExpenseMember' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LiabilityToIssueWarrantsMember' xlink:label='fil_LiabilityToIssueWarrantsMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_LiabilityToIssueWarrantsMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_LiabilityToIssueCommonStockMember' xlink:label='fil_LiabilityToIssueCommonStockMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_LiabilityToIssueCommonStockMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FinanceFeesMember' xlink:label='fil_FinanceFeesMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_FinanceFeesMember' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_PayrollExpenseMember' xlink:label='fil_PayrollExpenseMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_PayrollExpenseMember' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_OtherMember' xlink:label='fil_OtherMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_OtherMember' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeferredRevenueMember' xlink:label='fil_DeferredRevenueMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_DeferredRevenueMember' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_WarrantyLiabilityMember' xlink:label='fil_WarrantyLiabilityMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_WarrantyLiabilityMember' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_CommissionsAndFeesMember' xlink:label='fil_CommissionsAndFeesMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_CommissionsAndFeesMember' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_SeveranceMember' xlink:label='fil_SeveranceMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementLocationAxis' xlink:to='fil_SeveranceMember' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis' xlink:label='us-gaap_LongtermDebtTypeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_LongtermDebtTypeAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note1Member' xlink:label='fil_Note1Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note1Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note2Member' xlink:label='fil_Note2Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note2Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note3Member' xlink:label='fil_Note3Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note3Member' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note4Member' xlink:label='fil_Note4Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note4Member' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note5Member' xlink:label='fil_Note5Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note5Member' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note6Member' xlink:label='fil_Note6Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note6Member' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note7Member' xlink:label='fil_Note7Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note7Member' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note8Member' xlink:label='fil_Note8Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note8Member' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note9Member' xlink:label='fil_Note9Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note9Member' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note10Member' xlink:label='fil_Note10Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note10Member' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note11Member' xlink:label='fil_Note11Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note11Member' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note12Member' xlink:label='fil_Note12Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note12Member' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note13Member' xlink:label='fil_Note13Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note13Member' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note14Member' xlink:label='fil_Note14Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note14Member' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note15Member' xlink:label='fil_Note15Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note15Member' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_Note16Member' xlink:label='fil_Note16Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_Note16Member' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_GrossNotesPayableBeforeDiscount' xlink:label='fil_GrossNotesPayableBeforeDiscount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_GrossNotesPayableBeforeDiscount' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DiscountOnNotesPayable' xlink:label='fil_DiscountOnNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_DiscountOnNotesPayable' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_NotesPayableCurrentAndNoncurrent' xlink:label='fil_NotesPayableCurrentAndNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_NotesPayableCurrentAndNoncurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableCurrent' xlink:label='us-gaap_NotesPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesPayableCurrent' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermNotesPayable' xlink:label='us-gaap_LongTermNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_LongTermNotesPayable' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis' xlink:label='us-gaap_LongtermDebtTypeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_LongtermDebtTypeAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote1Member' xlink:label='fil_RelatedPartyNote1Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_RelatedPartyNote1Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote2Member' xlink:label='fil_RelatedPartyNote2Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_RelatedPartyNote2Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote3Member' xlink:label='fil_RelatedPartyNote3Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_RelatedPartyNote3Member' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote4Member' xlink:label='fil_RelatedPartyNote4Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_RelatedPartyNote4Member' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote5Member' xlink:label='fil_RelatedPartyNote5Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_RelatedPartyNote5Member' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote6Member' xlink:label='fil_RelatedPartyNote6Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_RelatedPartyNote6Member' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote7Member' xlink:label='fil_RelatedPartyNote7Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_RelatedPartyNote7Member' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyNote8Member' xlink:label='fil_RelatedPartyNote8Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_RelatedPartyNote8Member' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesPayableRelatedPartiesClassifiedCurrent' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent' xlink:label='us-gaap_NotesPayableRelatedPartiesNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesPayableRelatedPartiesNoncurrent' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByFairValueHierarchyLevelAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member' xlink:label='us-gaap_FairValueInputsLevel2Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueInputsLevel2Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member' xlink:label='us-gaap_FairValueInputsLevel3Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueInputsLevel3Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities' xlink:label='us-gaap_DerivativeLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DerivativeLiabilities' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByFairValueHierarchyLevelAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member' xlink:label='us-gaap_FairValueInputsLevel3Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueInputsLevel3Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities' xlink:label='us-gaap_DerivativeLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DerivativeLiabilities' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings' xlink:label='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings' use='optional' order='4.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiabilityDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure12DerivativesLiabilityDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiabilityDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities' xlink:label='us-gaap_DerivativeLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DerivativeLiabilities' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet' xlink:label='us-gaap_DerivativeGainLossOnDerivativeNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DerivativeGainLossOnDerivativeNet' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure13PreferredStockDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure13PreferredStockDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure13PreferredStockDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesDPreferredStockMember' xlink:label='us-gaap_SeriesDPreferredStockMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_SeriesDPreferredStockMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesEPreferredStockMember' xlink:label='us-gaap_SeriesEPreferredStockMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_SeriesEPreferredStockMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesFPreferredStockMember' xlink:label='us-gaap_SeriesFPreferredStockMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_SeriesFPreferredStockMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesGPreferredStockMember' xlink:label='us-gaap_SeriesGPreferredStockMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_SeriesGPreferredStockMember' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_ConvertiblePreferredStockSharesDesignated' xlink:label='fil_ConvertiblePreferredStockSharesDesignated'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_ConvertiblePreferredStockSharesDesignated' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_IncreaseDecreaseInDividendsPayable' xlink:label='fil_IncreaseDecreaseInDividendsPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_IncreaseDecreaseInDividendsPayable' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RedemptionPriceOfSeriesEPreferredStock' xlink:label='fil_RedemptionPriceOfSeriesEPreferredStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_RedemptionPriceOfSeriesEPreferredStock' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure14CommonStockDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure14CommonStockDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure14CommonStockDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit' xlink:label='us-gaap_StockholdersEquityReverseStockSplit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StockholdersEquityReverseStockSplit' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StockIssuedDuringPeriodSharesIssuedForServices' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StockIssuedDuringPeriodValueIssuedForServices' use='optional' order='4.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_DeemedDividendsOnRedemptionOfPreferredStock' xlink:label='fil_DeemedDividendsOnRedemptionOfPreferredStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_DeemedDividendsOnRedemptionOfPreferredStock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_WeightedAverageRemainingTermOfTheWarrants' xlink:label='fil_WeightedAverageRemainingTermOfTheWarrants'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_WeightedAverageRemainingTermOfTheWarrants' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1' xlink:label='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1' use='optional' order='4.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_RangeAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_MinimumMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_MaximumMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByFairValueHierarchyLevelAxis' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member' xlink:label='us-gaap_FairValueInputsLevel3Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueInputsLevel3Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice' xlink:label='us-gaap_FairValueAssumptionsExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueAssumptionsExercisePrice' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm' xlink:label='us-gaap_FairValueAssumptionsExpectedTerm'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueAssumptionsExpectedTerm' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate' xlink:label='us-gaap_FairValueAssumptionsExpectedVolatilityRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueAssumptionsExpectedVolatilityRate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate' xlink:label='us-gaap_FairValueAssumptionsRiskFreeInterestRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_FairValueAssumptionsRiskFreeInterestRate' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FairValueAssumptionsCommonStockPrice' xlink:label='fil_FairValueAssumptionsCommonStockPrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_FairValueAssumptionsCommonStockPrice' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice' xlink:label='us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice' xlink:label='us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:label='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain' xlink:label='us-gaap_RelatedPartyDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='us-gaap_RelatedPartyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember' xlink:label='fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember' xlink:label='fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RelatedPartyTransactionsByRelatedPartyAxis' xlink:to='fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='acar-20170630.xsd#fil_RelatedPartyCompensationHourlyRate' xlink:label='fil_RelatedPartyCompensationHourlyRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_RelatedPartyCompensationHourlyRate' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable' xlink:label='us-gaap_RepaymentsOfNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_RepaymentsOfNotesPayable' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDue' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="acar-20170630.xsd#idr_Disclosure17CommitmentsAndContingenciesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet' xlink:label='us-gaap_OperatingLeasesRentExpenseNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesRentExpenseNet' use='optional' order='1.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753457312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jan. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ACTIVECARE, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">acar<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001429896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753889440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 114,440<span></span>
</td>
<td class="nump">$ 167,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">643,857<span></span>
</td>
<td class="nump">487,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">501,769<span></span>
</td>
<td class="nump">204,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Note receivable</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">56,555<span></span>
</td>
<td class="nump">644,857<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,816,621<span></span>
</td>
<td class="nump">1,504,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">56,445<span></span>
</td>
<td class="nump">86,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Deposits and other assets</a></td>
<td class="nump">12,970<span></span>
</td>
<td class="nump">17,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Domain name, net</a></td>
<td class="nump">8,759<span></span>
</td>
<td class="nump">9,295<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,894,795<span></span>
</td>
<td class="nump">1,618,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,453,795<span></span>
</td>
<td class="nump">1,700,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Accounts payable, related party</a></td>
<td class="nump">242,568<span></span>
</td>
<td class="nump">291,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">7,765,437<span></span>
</td>
<td class="nump">2,101,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent liabilities</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">9,501,544<span></span>
</td>
<td class="nump">3,722,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Notes payable, related party</a></td>
<td class="nump">3,869,683<span></span>
</td>
<td class="nump">3,898,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">733,880<span></span>
</td>
<td class="nump">606,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives liability</a></td>
<td class="nump">4,231,983<span></span>
</td>
<td class="nump">2,054,071<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">30,548,890<span></span>
</td>
<td class="nump">14,375,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">5,889,170<span></span>
</td>
<td class="nump">7,353,856<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">36,438,060<span></span>
</td>
<td class="nump">21,729,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.00001 par value: 10,000,000 shares authorized; 45,000 shares of Series D; 70,070 shares of Series E; and 43,220 and 0 shares of Series G issued and outstanding, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.00001 par value: 200,000,000 shares authorized; 239,100 and 232,100 shares outstanding, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital, common and preferred</a></td>
<td class="nump">88,786,513<span></span>
</td>
<td class="nump">88,067,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(123,329,782)<span></span>
</td>
<td class="num">(108,178,614)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(34,543,265)<span></span>
</td>
<td class="num">(20,111,201)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' deficit</a></td>
<td class="nump">$ 1,894,795<span></span>
</td>
<td class="nump">$ 1,618,206<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=82849420&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13495-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net amount of the investment in a contractual right to receive money on demand or on fixed or determinable dates that is recognized as an asset in the creditor's statement of financial position. Examples include, but are not limited to, credit card receivables, notes receivable and receivables relating to lessor's rights to payments from leases other than operating leases that have been recorded as assets. Excludes trade accounts receivable with contractual maturity of one year or less and arose from the sale of goods or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6908081104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets Parenthetical - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract', window );"><strong>Condensed Consolidated Balance Sheets Parenthetical</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="nump">158,290<span></span>
</td>
<td class="nump">115,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="nump">239,100<span></span>
</td>
<td class="nump">232,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockTransactionsParentheticalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754495728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Chronic illness monitoring supplies revenues</a></td>
<td class="nump">$ 1,037,179<span></span>
</td>
<td class="nump">$ 1,858,926<span></span>
</td>
<td class="nump">$ 4,311,955<span></span>
</td>
<td class="nump">$ 4,972,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSalesRevenueNet', window );">Chronic illness monitoring fee revenues</a></td>
<td class="nump">159,025<span></span>
</td>
<td class="nump">317,156<span></span>
</td>
<td class="nump">599,339<span></span>
</td>
<td class="nump">888,453<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Chronic illness monitoring revenues</a></td>
<td class="nump">1,196,204<span></span>
</td>
<td class="nump">2,176,082<span></span>
</td>
<td class="nump">4,911,294<span></span>
</td>
<td class="nump">5,860,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Chronic illness monitoring supplies cost of revenues</a></td>
<td class="nump">733,143<span></span>
</td>
<td class="nump">1,269,828<span></span>
</td>
<td class="nump">3,054,086<span></span>
</td>
<td class="nump">3,878,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfServices', window );">Chronic illness monitoring fee cost of revenues</a></td>
<td class="nump">114,954<span></span>
</td>
<td class="nump">112,486<span></span>
</td>
<td class="nump">319,184<span></span>
</td>
<td class="nump">358,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total Chronic illness monitoring cost of revenues</a></td>
<td class="nump">848,097<span></span>
</td>
<td class="nump">1,382,314<span></span>
</td>
<td class="nump">3,373,270<span></span>
</td>
<td class="nump">4,237,408<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">348,107<span></span>
</td>
<td class="nump">793,768<span></span>
</td>
<td class="nump">1,538,024<span></span>
</td>
<td class="nump">1,623,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative (including $1,461,457, $1,004,211, $2,101,037 and $3,257,614, respectively, of stock-based compensation)</a></td>
<td class="nump">3,225,054<span></span>
</td>
<td class="nump">2,169,603<span></span>
</td>
<td class="nump">6,382,027<span></span>
</td>
<td class="nump">6,944,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">56,191<span></span>
</td>
<td class="nump">57,611<span></span>
</td>
<td class="nump">307,137<span></span>
</td>
<td class="nump">139,023<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">3,281,245<span></span>
</td>
<td class="nump">2,227,214<span></span>
</td>
<td class="nump">6,689,164<span></span>
</td>
<td class="nump">7,083,121<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(2,933,138)<span></span>
</td>
<td class="num">(1,433,446)<span></span>
</td>
<td class="num">(5,151,140)<span></span>
</td>
<td class="num">(5,459,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="num">(2,198,631)<span></span>
</td>
<td class="num">(813,517)<span></span>
</td>
<td class="num">(6,856,258)<span></span>
</td>
<td class="num">(1,935,486)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LossOnSettlement', window );">Loss on settlement</a></td>
<td class="num">(750,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(750,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivatives liability</a></td>
<td class="nump">64,145<span></span>
</td>
<td class="nump">5,603,411<span></span>
</td>
<td class="nump">230,163<span></span>
</td>
<td class="nump">2,796,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,393)<span></span>
</td>
<td class="num">(2,499,212)<span></span>
</td>
<td class="num">(3,058,809)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfProperty', window );">Gain on disposal of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GainOnLiabilitySettlements', window );">Gain on liability settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LossOnInducedConversionsOfDebt', window );">Loss on induced conversions of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(379,132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="nump">2,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Total other income (expense)</a></td>
<td class="num">(2,881,872)<span></span>
</td>
<td class="nump">4,783,360<span></span>
</td>
<td class="num">(9,872,693)<span></span>
</td>
<td class="num">(2,281,541)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(5,815,010)<span></span>
</td>
<td class="nump">3,349,914<span></span>
</td>
<td class="num">(15,023,833)<span></span>
</td>
<td class="num">(7,741,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DeemedDividendsOnRedemptionOfPreferredStock', window );">Deemed dividends on redemption of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,484,236)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends on preferred stock</a></td>
<td class="num">(58,978)<span></span>
</td>
<td class="num">(45,781)<span></span>
</td>
<td class="num">(127,335)<span></span>
</td>
<td class="num">(699,250)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (5,873,988)<span></span>
</td>
<td class="nump">$ 3,304,133<span></span>
</td>
<td class="num">$ (15,151,168)<span></span>
</td>
<td class="num">$ (14,924,907)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic</a></td>
<td class="num">$ (24.77)<span></span>
</td>
<td class="nump">$ 15.18<span></span>
</td>
<td class="num">$ (64.81)<span></span>
</td>
<td class="num">$ (81.57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted</a></td>
<td class="num">$ (24.77)<span></span>
</td>
<td class="num">$ (3.78)<span></span>
</td>
<td class="num">$ (64.81)<span></span>
</td>
<td class="num">$ (82.78)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="nump">237,100<span></span>
</td>
<td class="nump">217,595<span></span>
</td>
<td class="nump">233,767<span></span>
</td>
<td class="nump">182,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="nump">237,100<span></span>
</td>
<td class="nump">260,266<span></span>
</td>
<td class="nump">233,767<span></span>
</td>
<td class="nump">201,928<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DeemedDividendsOnRedemptionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Deemed dividends on redemption of preferred stock, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DeemedDividendsOnRedemptionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GainOnLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Gain on liability settlements, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_GainOnLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LossOnInducedConversionsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Loss on induced conversions of debt, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LossOnInducedConversionsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LossOnSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Loss on settlement, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LossOnSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to services rendered by an entity during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5618551-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a),(c),(d),(e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=96948231&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of oil and gas property or timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after sales adjustments, returns, allowances, and discounts, of revenue classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754613920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations Parenthetical - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract', window );"><strong>Condensed Consolidated Statements of Operations Parenthetical</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants', window );">Compensation expense paid in stock or amortization of stock options and warrants</a></td>
<td class="nump">$ 1,461,457<span></span>
</td>
<td class="nump">$ 1,004,211<span></span>
</td>
<td class="nump">$ 2,101,037<span></span>
</td>
<td class="nump">$ 3,257,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Compensation expense paid in stock or amortization of stock options and warrants, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompensationExpensePaidInStockOrAmortizationOfStockOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CondensedConsolidatedStatementsOfOperationsParentheticalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753420928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (15,023,833)<span></span>
</td>
<td class="num">$ (7,741,421)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discounts</a></td>
<td class="nump">4,081,912<span></span>
</td>
<td class="nump">904,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">2,499,212<span></span>
</td>
<td class="nump">3,058,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">1,705,975<span></span>
</td>
<td class="nump">2,801,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LossOnSettlement', window );">Loss on settlement</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockAndWarrantsIssuedAndAccruedForServices', window );">Stock and warrants issued and accrued for services</a></td>
<td class="nump">395,062<span></span>
</td>
<td class="nump">456,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent', window );">Increase in note payable principal recorded as interest expense to convert accounts payable into notes payable</a></td>
<td class="nump">482,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockAccruedForInterestExpense', window );">Stock accrued for interest expense</a></td>
<td class="nump">144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">33,643<span></span>
</td>
<td class="nump">39,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnDerivativeInstrumentsPretax', window );">Gain on derivatives liability</a></td>
<td class="num">(230,163)<span></span>
</td>
<td class="num">(2,796,542)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfProperty', window );">Gain on disposal of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LossOnInducedConversionsOfDebt', window );">Loss on induced conversions of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GainOnLiabilitySettlements', window );">Gain on liability settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(295,099)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Change in accounts receivable</a></td>
<td class="num">(241,844)<span></span>
</td>
<td class="num">(44,459)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Change in inventory</a></td>
<td class="num">(297,033)<span></span>
</td>
<td class="nump">414,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Change in prepaid expenses and other</a></td>
<td class="nump">815,799<span></span>
</td>
<td class="num">(178,053)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Change in accounts payable</a></td>
<td class="nump">2,470,310<span></span>
</td>
<td class="num">(732,265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Change in accrued liabilities</a></td>
<td class="nump">1,796,360<span></span>
</td>
<td class="nump">931,492<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(618,100)<span></span>
</td>
<td class="num">(2,803,459)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMachineryAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,818)<span></span>
</td>
<td class="num">(5,004)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesReceivables', window );">Investment in contingent note receivable</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(502,818)<span></span>
</td>
<td class="num">(4,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of notes payable, net</a></td>
<td class="nump">4,421,489<span></span>
</td>
<td class="nump">5,709,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from issuance of related-party notes payable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable', window );">Proceeds from issuance of warrants in connection with notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Principal payments on related-party notes payable</a></td>
<td class="num">(28,441)<span></span>
</td>
<td class="num">(7,795)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on notes payable</a></td>
<td class="num">(3,325,427)<span></span>
</td>
<td class="num">(3,175,603)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,067,621<span></span>
</td>
<td class="nump">2,778,856<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashPeriodIncreaseDecrease', window );">Net decrease in cash</a></td>
<td class="num">(53,297)<span></span>
</td>
<td class="num">(29,007)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash, beginning of the period</a></td>
<td class="nump">167,737<span></span>
</td>
<td class="nump">172,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash, end of the period</a></td>
<td class="nump">114,440<span></span>
</td>
<td class="nump">143,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">379,589<span></span>
</td>
<td class="nump">191,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-Cash Investing and Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees', window );">Issuance of warrants to purchase shares of common stock for loan origination fees</a></td>
<td class="nump">2,103,341<span></span>
</td>
<td class="nump">201,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees', window );">Accrual of a liability to issue warrants to purchase shares of common stock for loan forbearance fees</a></td>
<td class="nump">148,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees', window );">Accrual of a liability to issue shares of common stock for loan origination fees</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends on preferred stock</a></td>
<td class="nump">127,335<span></span>
</td>
<td class="nump">699,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees', window );">Accrual of a liability to issue shares of common stock for loan forbearance fees</a></td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants', window );">Deemed dividend on the redemption of preferred stock and accrued dividends for notes payable, common stock and exchange of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,484,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable', window );">Conversion of accounts payable and accrued liabilities to notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,555,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty', window );">Assignment of related-party notes payable to an unrelated third party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfSharesOfCommonStockForConsultingServices', window );">Issuance of shares of common stock for consulting services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees', window );">Accrual of a liability to issue warrants to purchase shares of common stock for loan origination fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CancellationAndReissuanceOfSharesOfCommonStock', window );">Cancellation and reissuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable', window );">Conversion of related-party accounts payable and accrued liabilities to related-party notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee', window );">Issuance of shares of common stock for related-party loan origination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees', window );">Issuance of shares of common stock for loan extension fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees', window );">Accrual of a liability to issue shares of common stock for loan amendment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfSharesOfCommonStockForDividends', window );">Issuance of shares of common stock for dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices', window );">Accrual of a liability to issue shares of common stock for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Accrual of a liability to issue shares of common stock for loan amendment fees, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanAmendmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Accrual of a liability to issue shares of common stock for loan forbearance fees, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanForbearanceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Accrual of a liability to issue shares of common stock for loan origination fees, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccrualOfALiabilityToIssueSharesOfCommonStockForLoanOriginationFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Accrual of a liability to issue shares of common stock for services, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccrualOfALiabilityToIssueSharesOfCommonStockForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Accrual of a liability to issue warrants to purchase shares of common stock for loan forbearance fees, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanForbearanceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Accrual of a liability to issue warrants to purchase shares of common stock for loan origination fees, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AccrualOfALiabilityToIssueWarrantsToPurchaseSharesOfCommonStockForLoanOriginationFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Assignment of related-party notes payable to an unrelated third party, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_AssignmentOfRelatedPartyNotesPayableToAnUnrelatedThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CancellationAndReissuanceOfSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Cancellation and reissuance of shares of common stock, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CancellationAndReissuanceOfSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Conversion of accounts payable and accrued liabilities to notes payable, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConversionOfAccountsPayableAndAccruedLiabilitiesToNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Conversion of related-party accounts payable and accrued liabilities to related-party notes payable, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConversionOfRelatedPartyAccountsPayableAndAccruedLiabilitiesToRelatedPartyNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Deemed dividend on the redemption of preferred stock and accrued dividends for notes payable, common stock and exchange of warrants, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DeemedDividendOnTheRedemptionOfPreferredStockAndAccruedDividendsForNotesPayableCommonStockAndExchangeOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GainOnLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Gain on liability settlements, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_GainOnLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfSharesOfCommonStockForConsultingServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Issuance of shares of common stock for consulting services, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfSharesOfCommonStockForConsultingServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfSharesOfCommonStockForDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Issuance of shares of common stock for dividends, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfSharesOfCommonStockForDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Issuance of shares of common stock for loan extension fees, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfSharesOfCommonStockForLoanExtensionFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Issuance of shares of common stock for related-party loan origination fee, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfSharesOfCommonStockForRelatedPartyLoanOriginationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Issuance of warrants for the purchase shares of common stock for loan origination fees, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfWarrantsForThePurchaseSharesOfCommonStockForLoanOriginationFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LossOnInducedConversionsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Loss on induced conversions of debt, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LossOnInducedConversionsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LossOnSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Loss on settlement, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LossOnSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Proceeds from issuance of warrants in connection with notes payable, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ProceedsFromIssuanceOfWarrantsInConnectionWithNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockAccruedForInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Stock accrued for interest expense, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockAccruedForInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockAndWarrantsIssuedAndAccruedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Stock and warrants issued and accrued for services, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_StockAndWarrantsIssuedAndAccruedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of oil and gas property or timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the amounts due from borrowers for outstanding secured or unsecured loans evidenced by a note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid, after deduction of cash paid for capitalized interest, for interest. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnDerivativeInstrumentsPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate loss on all derivative instruments charged against earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnDerivativeInstrumentsPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619104144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Nature of Operations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">1. Organization and Nature of Operations</a></td>
<td class="text"><!--egx--><p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:0in;margin-bottom:6.0pt;margin-left:.5in;text-align:left;text-indent:-.5in;text-autospace:ideograph-numeric ideograph-other'><b>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Basis of Presentation </b></p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other'>The unaudited interim condensed consolidated financial statements of ActiveCare, Inc. (the &#147;Company&#148; or &#147;ActiveCare&#148;) have been prepared in accordance with Article 8 of Regulation S-X, promulgated by the Securities and Exchange Commission.&nbsp;&nbsp;Certain information and disclosures normally included in financial statements prepared in accordance with US generally accepted accounting principles (&#147;US GAAP&#148;) have been condensed or omitted pursuant to such rules and regulations.&nbsp;&nbsp;In the opinion of management, the accompanying interim condensed consolidated financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the Company&#146;s financial position as of June 30, 2017 and September 30, 2016, and the results of its operations for the three and nine months ended June 30, 2017 and 2016 and its cash flows for the nine months ended June 30, 2017 and 2016.&nbsp;&nbsp;These financial statements should be read in conjunction with the annual consolidated financial statements and notes thereto that are included in the Company&#146;s Annual Report on Form 10-K for the year ended September 30, 2016.&nbsp;&nbsp;The results of operations for the three and nine months ended June 30, 2017 may not be indicative of the results for the full fiscal year ending September 30, 2017.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other'><i>Going Concern</i></p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in'>The Company continues to incur negative cash flows from operating activities and net losses.&#160; The Company had minimal cash, negative working capital and negative total equity as of June 30, 2017 and September 30, 2016.&#160; In addition, the Company is in technical default on certain notes payable although the lenders in each case are working with the Company to resolve the defaults.&#160; These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other'>In order for the Company to eliminate substantial doubt about its ability to continue as a going concern, it must achieve profitability, generate positive cash flows from operating activities and obtain the necessary debt or equity funding to meet its projected capital investment requirements.&#160; Management's plans with respect to this uncertainty consist of raising additional capital by issuing debt or equity securities and increasing the sales of the Company's services and products.&#160; There can be no assurance that the Company will be able to raise sufficient additional capital or that revenues will increase rapidly enough to achieve operating profits.&#160; If the Company is unable to increase revenues or obtain additional financing, it will be unable to continue the development of its products and services and may have to cease operations.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i>Use of Estimates in the Preparation of Financial Statements</i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the reporting periods. Actual results could differ from these estimates.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i>Fair Value of Financial Instruments</i></p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>The Company measures the fair values of its assets and liabilities using the US GAAP hierarchy.&#160; The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts receivable, accounts payable, and accrued liabilities approximate fair values due to the short-term nature of these financial instruments. Derivative financial instruments are recorded at fair value based on current market pricing models. The carrying amounts reported for notes payable approximate fair values because the underlying instruments are at interest rates which approximate current market rates.</p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i>Reclassifications</i></p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>Certain prior year amounts have been reclassified to conform to the current period&#146;s presentation. The reclassifications had no effect on the previously reported net loss.</p> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637072096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Net Loss per Common Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">2. Net Loss per Common Share</a></td>
<td class="text"><!--egx--><font style='line-height:115%'> </font>&#160; <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Net Loss per Common Share</b></p> <p style='margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Basic net loss per common share (&quot;Basic EPS&quot;) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period.</p> <p style='margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Diluted net loss per common share (&quot;Diluted EPS&quot;) is computed by dividing net loss available to common stockholders by the sum of the weighted average number of common shares outstanding and the weighted-average dilutive potential common shares outstanding.&#160; The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect.</p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>Potential common shares consist of shares issuable upon the exercise of common stock warrants and options, shares issuable from restricted stock grants, and shares issuable pursuant to convertible notes and convertible Series D and Series E preferred stock.&#160; The following table reflects the calculation of basic and diluted net loss per common share for the periods indicated: </p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="649" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="193" colspan="4" valign="bottom" style='width:144.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>Three Months Ended</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>June 30,</b></p> </td> <td width="18" valign="top" style='width:13.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="169" colspan="3" valign="bottom" style='width:126.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>Nine Months Ended</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>June 30,</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> 2017 </b></p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2016</b></p> </td> <td width="18" valign="top" style='width:13.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2017</b></p> </td> <td width="19" valign="bottom" style='width:14.45pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2016</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'><b>Numerator:</b></p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Net loss attributable to common stockholders</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(5,873,988)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>3,304,133</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(15,151,168)</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(14,924,907)</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>Effect of dilutive securities on net loss:</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt'>Common stock warrants</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(2,427,640)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt'>Convertible debt</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(1,860,373)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(1,790,407)</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total net loss for purpose of </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>&#160; calculating diluted net loss</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>&#160; per common share</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(5,873,988)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(983,880)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(15,151,168)</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(16,715,314)</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'><b>Number of shares used in per common share </b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'><b>&#160; calculations:</b></p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total shares for purposes of calculating basic</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>&#160; net loss per common share</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>237,100</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>217,595</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>233,767</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>182,979</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>Weighted-average effect of dilutive securities:</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt'>Common stock warrants</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>3,337</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt'>Convertible debt</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>39,334</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>18,949</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total shares for purpose of calculating diluted </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>&#160; net loss per common share</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>237,100</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>260,266</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>233,767</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>201,928</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'><b>Net loss per common share:</b></p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Basic</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(24.77)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15.18</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(64.81)</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(81.57)</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Diluted</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(24.77)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(3.78)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(64.81)</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(82.78)</p> </td> </tr> </table> </div> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>The effect of dilutive securities on the numerator for purposes of calculating diluted loss per common share is related to the convertible debt and related warrants due to the reduction of the gain on derivatives liability for warrants that were in the money.</p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>As of June 30, 2017 and 2016, there were certain outstanding potential common shares that were not included in the computation of Diluted EPS as their effect would be anti-dilutive for the three and nine months then ended.&#160; The potential common shares outstanding consist of the following:</p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="649" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="193" colspan="4" valign="bottom" style='width:144.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>Three Months Ended</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>June 30,</b></p> </td> <td width="18" valign="top" style='width:13.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="169" colspan="3" valign="bottom" style='width:126.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>Nine Months Ended</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>June 30,</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> 2017 </b></p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2016</b></p> </td> <td width="18" valign="top" style='width:13.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2017</b></p> </td> <td width="19" valign="bottom" style='width:14.45pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2016</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Common stock warrants</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>109,174</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>18,346</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>109,174</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>42,378</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Series D convertible preferred stock</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>450</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>450</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>450</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>450</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Series E convertible preferred stock</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>961</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>961</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>961</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>961</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Convertible debt</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>158,798</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>95,799</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>158,798</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>95,799</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Restricted shares of common stock</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Liability to issue common stock and warrants</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>358,097</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,246</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>358,097</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,246</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:16.1pt'>Total common stock equivalents</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>627,495</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>117,817</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>627,495</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>141,849</p> </td> </tr> </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909570448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">3. Recent Accounting Pronouncements</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:.5in;line-height:115%;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in;text-autospace:none'><b><font style='line-height:115%'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><b><font style='line-height:115%'>Recent Accounting Pronouncements</font></b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In May 2014, August 2015 and May 2016, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, <i>Revenue from Contracts with Customers</i>, ASU 2015-14 <i>Revenue from Contracts with Customers, Deferral of the Effective Date</i>, ASU 2016-12 <i>Revenue from Contracts with Customers, Narrow-Scope Improvements and Practical Expedients</i>, ASU 2017-13 <i>Revenue Recognition, Revenue from Contracts with Customers, Leases, and Leases: Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments</i>, and ASU 2017-14 <i>Income Statement&#151;Reporting Comprehensive Income, Revenue Recognition, and Revenue from Contracts with Customers</i>, respectively, which implement ASC Topic 606. ASC Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance under US GAAP, including industry-specific guidance. It also requires entities to disclose both quantitative and qualitative information that enable financial statements users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amendments in these ASUs are effective for annual periods beginning after December 15, 2017, and interim periods therein, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted for annual periods beginning after December 15, 2016. These ASUs may be applied retrospectively to all prior periods presented, or retrospectively with a cumulative adjustment to retained earnings in the year of adoption. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In August 2014, the FASB issued ASU 2014-15, <i>Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern</i>. This standard sets forth management's responsibility to evaluate, each reporting period, whether there is substantial doubt about the Company's ability to continue as a going concern, and if so, to provide related disclosures. ASU 2014-15 is effective for annual reporting periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its evaluation of going concern.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In July 2015, the FASB issued ASU 2015-11, <i>Inventory: Simplifying the Measurement of Inventory</i>. The purpose of ASU 2015-11 is to more closely align the measurement of inventory in US GAAP with the measurement of inventory in International Financial Reporting Standards. ASU 2015-11 requires entities to measure most inventory at the &quot;lower of cost or net realizable value.&quot; Additionally, some of the amendments are designed to more clearly articulate the requirements for the measurement and disclosure of inventory. ASU 2015-11 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In February 2016, the FASB issued ASU 2016-02, <i>Leases</i>.&#160; The purpose of ASU 2016-02 is to establish the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. This guidance results in a more faithful representation of the rights and obligations arising from operating and capital leases by requiring lessees to recognize the lease assets and lease liabilities that arise from leases in the statement of financial position and to disclose qualitative and quantitative information about lease transactions, such as information about variable lease payments and options to renew and terminate leases. ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In March 2016, the FASB issued ASU 2016-09, <i>Stock Compensation: Improvements to Employee Share-Based Payment Accounting</i>.&#160; The purpose of ASU 2016-09 is to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equities or liabilities, and classification of amounts in the statement of cash flows.&#160; ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017.&#160; The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In August 2016, the FASB issued ASU 2016-15, <i>Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments</i>. The amendments in this update provided guidance on eight specific cash flow issues. This update is to provide specific guidance on each of the eight issues, thereby reducing the diversity in practice in how certain transactions are classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In May 2017, the FASB issued ASU 2017-09, <i>Stock Compensation: Scope of Modification Accounting</i>. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. ASU 2017-09 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In July 2017, the FASB issued ASU 2017-11, <i>Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivative and Hedging (Topic 815)</i>. The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down-round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down-round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&#146;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down-round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (&#147;EPS&#148;) in accordance with Topic 260 to recognize the effect of the down-round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down-round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt-Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Accounting Standards Codification, to a scope exception. Those amendments do not have an accounting effect. ASU 2017-11 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909659232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">4. Accounts Receivable</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:.5in;line-height:115%;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b><font style='line-height:115%'>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><b><font style='line-height:115%'>Accounts Receivable</font></b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts.&#160; Specific reserves are estimated by management based on certain assumptions and variables, including the customer&#146;s financial condition, age of the customer&#146;s receivables and changes in payment histories.&#160; Accounts receivable are written off when management determines the likelihood of collection is remote.&#160; A receivable is considered to be past due if any portion of the receivable balance has not been received by the contractual payment date.&#160; Interest is not charged on accounts receivable that are past due.&#160; The Company recorded an allowance for doubtful accounts of $25,468 and $75,161 as of June 30, 2017 and September 30, 2016, respectively.&#160; During the three months ended June 30, 2017, the Company wrote off approximately $103,000 of accounts receivable that were previously allowed against.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5066-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5162-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909642016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Inventory<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">5. Inventory</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:.5in;line-height:115%;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in;line-height:normal'><b>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Inventory </b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Inventory is recorded at the lower of cost or market value, cost being determined using the first-in, first-out (&quot;FIFO&quot;) method. Inventory consists of diabetic supplies.&#160; Inventory held by distributors is reported as inventory until the supplies are shipped to the end user by the distributor.&#160; The Company estimates an inventory reserve for obsolescence and excessive quantities.&#160; Due to competitive pressures and technological innovation, it is possible that estimates of net realizable values could change in the near term.&#160; Inventory consists of the following as of:</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> June 30, 2017 </b></p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>&#160;</b><b>September 30, 2016 </b></p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Finished goods </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>503,477</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>206,444</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Inventory reserve</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(1,708)</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(1,708)</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:13.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:7.95pt'>Net inventory</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>501,769</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>204,736</p> </td> </tr> <tr style='height:2.25pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> </tr> </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909640528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Prepaid Expenses and Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">6. Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-indent:0in;text-autospace:ideograph-numeric ideograph-other'><b>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Prepaid Expenses and Other Current Assets</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other'>Prepaid expenses and other current assets consisted of the following as of:</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;background:white;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> June 30, 2017 </b></p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>&#160;</b><b>September 30, 2016 </b></p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Prepaid information technology services </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>38,081</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>57,073</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Other </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>12,249</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>112,117</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Prepaid insurance </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>6,225</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>14,602</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Prepaid legal and professional fees </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>333,741</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Research and development </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>96,346</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Line of credit acquisition fees </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>30,978</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:26.25pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:7.95pt'>Total prepaid expenses and &#160;&#160; other current assets</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>56,555</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>644,857</p> </td> </tr> </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909551392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">7. Property and Equipment</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-indent:0in;text-autospace:ideograph-numeric ideograph-other'><b>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Property and Equipment</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Property and equipment are stated at cost, less accumulated depreciation and amortization.&#160; Depreciation and amortization are determined using the straight-line method over the estimated useful lives of the assets, which range between 3 and 7 years.&#160; Leasehold improvements are amortized over the shorter of the estimated useful lives of the assets or the terms of the lease.&#160; Expenditures for maintenance and repairs are expensed as incurred.&#160; Upon the sale or disposal of property and equipment, any gains or losses are included in operations.&#160; Property and equipment consisted of the following as of:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> June 30, 2017 </b></p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>&#160;</b><b>September 30, 2016 </b></p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Software</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>47,974</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>47,974</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Leasehold improvements</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>98,023</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>98,023</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Furniture</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>68,758</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>68,758</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Equipment</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>47,191</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>49,772</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total property and equipment</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>261,946</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>264,527</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Accumulated depreciation and amortization</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(205,501)</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(177,793)</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:13.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Property and equipment, net</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>56,445</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>86,734</p> </td> </tr> <tr style='height:6.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> </tr> </table> </div> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Assets to be disposed of are reported at the lower of the carrying amounts or fair values, less the estimated costs to sell or dispose.&#160; During the nine months ended June 30, 2016, the Company recorded a gain on the disposal of property and equipment of $245.&#160; Depreciation expense for the nine months ended June 30, 2017 and 2016, was $33,107 and $38,817, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909563712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">8. Accrued Expenses</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Accrued Expenses</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Accrued expenses consisted of the following as of: </p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;background:white;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> June 30, 2017 </b></p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>&#160;</b><b>September 30, 2016 </b></p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&#160;Interest </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,694,545</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>1,206,387</p> </td> </tr> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&#160;Liability to issue warrants for the purchase &#160;&#160; shares of common stock </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,081,254</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Liability to issue common stock </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,000,933</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>240,000</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Finance fees </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>333,000</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&#160;Payroll expense </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>329,615</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>207,052</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Other </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>141,394</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>89,828</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Deferred revenue </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>85,399</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>111,803</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Warranty liability </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>58,300</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>134,330</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&#160;Commissions and fees </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>40,997</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>52,311</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Severance </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>60,000</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:13.5pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total accrued expenses</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>7,765,437</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,101,711</p> </td> </tr> <tr style='height:6.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> </tr> </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909675824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Notes Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">9. Notes Payable</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Notes Payable </b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The Company had the following notes payable outstanding as of:&#160; &#160;&#160;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="451" valign="bottom" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>June 30,</b></p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>September 30,</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="bottom" style='width:338.0pt;padding:0;height:9.35pt'></td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>2017</b></p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>2016</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured notes payable with interest at 10% per annum, due November 2018.&#160; The notes may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; Some of the notes are currently in technical default. However, as of the time of this report, the lenders have informally agreed to work with the Company until such time as the note can be repaid.&#160; &#160;&#160;In February 2016, the Company redeemed all 5,361 shares of its Series F Convertible Preferred Stock (&quot;Series F preferred&quot;) plus accrued dividends of $673,948 for 20,005 shares of common stock with a fair value of $1,600,000 containing certain temporary restrictions, and $5,900,000 of notes payable. Payments on the notes are partially or fully convertible at the Company's option at the lesser of (i) 80% of the per share price of the common stock to be offered in the proposed offering that is described in the Form S-1 filed on July 19, 2016 (the &quot;Offering&quot;), (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering to a maximum of 39,334 shares of common stock.&#160; The conversion rate is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&#160; A note may only be converted if the holder owns less than 4.99% of the Company's common stock after conversion.&#160; The Company recorded a derivative liability of $2,461,899 related to the conversion feature of the notes.&#160; In connection with the redemption of the Series F preferred stock, the Company issued new warrants in exchange for warrants held by the Series F preferred stockholders for the purchase of 11,070 shares of common stock at an exercise price of the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering, adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&#160; The Company is also required to issue additional warrants for the purchase of up to 16,000 shares of common stock exercisable at $0.50 per share, also adjustable, that vest upon certain events of default.&#160; On December 11, 2017, the Company entered into Securities Purchase Agreements that adjusted the conversion rate to exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in a contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the &#147;Private Placement&#148;) (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment (see Note 18).&#160; The fair value of $1,344,608 related to the new warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value of the stock, conversion feature, warrants and $25,000 of fees, in excess of the carrying value of the Series F preferred stock were recorded as a deemed dividend of $6,484,236.&#160; During the three months ended March 31, 2017, the Company entered into letter agreements related to the note to convert the outstanding principal and interest into shares of common stock contingent upon the Offering, which also removes the maximum share limitation conversion, which have expired (see Note 17).&#160; Subsequent to June 30, 2017, the Company received letters related to the notes wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 (see Note 18).&#160; In December 2017, the Company entered into those certain forbearance and lock up letter agreements with four of the eight debtors, with principal balances in the aggregate amount of $1,134,658, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of Common Stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more.&#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&#160; In addition, two of the five debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity (see Note 18). On January 12, 2018, the Company received letters from four of the debtors where the debtors forbear against any historical and future events of default and remedies through February 15, 2018. Further, the maturity date was extended through February 15, 2018.&#160; As part of the letters, the Company agreed not to initiate any new financing arrangements without the consent of the debtors. (see Note 18).&#160; On December 11, 2017, the Company borrowed an aggregate additional $300,000 from two of the lenders under new note payable agreements (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;5,900,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;5,900,000 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured borrowings from a third party that purchased $3,257,600 of customer receivables for $2,100,000, with due dates ranging from January 2018 to October 2018, and payable in daily payments ranging from $5,000 to $13,000.&#160; The $1,157,600 difference between the customer receivables and cash received is being amortized to interest expense over the term of the respective notes.&#160; The secured borrowings are guaranteed by a former chief executive officer of the Company and are subordinated to other notes payable. On April 17, 2017, the Company entered into a factoring agreement which provides for an advance of $1,794,000, comprised of $1,000,000 in cash and the consolidation of $794,000 from four prior factoring agreements into the amounts owed under the factoring agreement (collectively, the &quot;Funds&quot;). In consideration for the Funds, the Company sold to the lender all future receipts until the total amount of $2,511,601 has been paid. The factoring agreement requires payment of the minimum daily amount of $12,999.99 for 193 days. The $2,511,601 can be reduced if repayment occurs more quickly. Repayment of the amounts owing is with recourse and secured by all accounts, chattel paper, documents, equipment, general intangibles, instruments, and inventory of the Company and subordinated to other notes payable.&#160; In June 2017, the lender verbally agreed to reduce the minimum daily amount to $5,000 and, in November 2017, verbally agreed to further reduce the minimum daily amount to $2,600 through January 7, 2018, after which the daily amount would return to $13,000.&#160; Subsequent to June 30, 2017, the Company entered into similar secured borrowings and related verbal or written reductions in the daily amounts.&#160; On January 5, 2018, the Company further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018 &#160;(see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 1,974,602 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 689,318 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="bottom" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Unsecured note payable with a vendor with interest at 0.65% per annum payable at the end of each calendar year, due January 2018, issued in March 2016 upon the conversion of $2,523,937 in accounts payable to the vendor.&#160; The note requires payments of $50,000 per month in April 2016 through December 2016, $100,000 per month in January 2017 through December 2017 and the remaining balance due in January 2018.&#160; In September 2017, the Company entered into agreements with the vendor which supersedes the unsecured note payable agreement and provides new terms (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 1,773,937 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 2,223,937 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with a third party with no interest, was due the earlier of November 2016 or the third business day after the closing of a proposed Offering. The note is currently in technical default. However, as of the time of this report, the lender has provided bridge capital since going in default and has informally agreed to work with the Company until such time as the note can be repaid. &#160;Pursuant to the note, the Company may borrow up to $1,500,000 upon meeting certain milestones and may be converted into shares of common stock upon default.&#160; The note required a payment of common stock on the 5th trading day after the pricing of the proposed Offering, but no later than December 15, 2016.&#160; The number of common shares will equal $200,000 divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the common shares or during the ten days prior to the date of the Purchase Agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price of the Offering, or (iv) the exercise price of any warrants issued in the Offering.&#160; The estimated fair value of $240,000 of the stock is included in accrued liabilities and is being amortized to interest expense over the life of the note.&#160; In connection with the issuance of the note, the Company also issued 20,000 warrants to purchase shares of common stock at an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock in the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering, or (iv) the exercise price of any warrants issued in the Offering and the number of shares will reset upon the closing of the Offering.&#160; The warrants may only be exercised to the extent the holder would own a maximum of 9.99% of the Company's common stock after exercise.&#160; The fair value of $493,590 related to the replacement warrants was recorded as a derivative (see Notes 12 and 15).&#160; Of this fair value amount, $220,000 was recorded as a debt discount and is being amortized over the life of the note and the remaining $273,590 was recorded as a loss on derivative liability.&#160; In the event of borrowing in excess of an initial $500,000, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to the initial warrants issued.&#160; In November 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $286,171 related to the November 2016 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; In November 2016, the Company amended the note to extend the maturity date to the earlier of January 31, 2017 or the third business day after the closing of the Offering.&#160; In addition, the amendment adjusted the origination shares to equal 20% of the note divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the shares or during the ten days prior to the date of the agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Offering.&#160; In December 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $349,819 related to the December 2016 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; On January 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $567,753 related to the January 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note. On January 30, 2017, the Company amended the note to extend the maturity date to the earlier of March 15, 2017 or the third business day after the closing of the Offering. Also on January 30, 2017. the Company borrowed the remaining $300,000 on the note and issued an additional warrant for the purchase of 12,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $899,598 related to the January 30, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; On March 3, 2017, the Company amended the note to increase the maximum sum from $1,500,000 to $2,000,000. Also on March 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $407,947 related to the March 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The Company recorded a loss on extinguishment of debt of $501,969 related to the March 3, 2017 amendment and additional borrowing. Effective March 27, 2017, the Company amended the note to extend the maturity date to the earlier of April 15, 2017 or the third business day after the closing of the Offering. Additionally, the lender agreed to enter into a lock up prohibiting the sale or other transfer of all securities of the Company owned by them for a period of 6 months. In consideration for entering into the lock-up agreement the Company has agreed to pay a $340,000 fee, payable in shares of common stock at a rate of the lowest of (i) 80% of the common stock Offering price of the Offering, (ii) 80% of the unit price Offering price of the Offering (if applicable), or (iii) 80% of the exercise price of any warrants issued in the Offering.&#160; The lock-up agreement was signed during April 2017, which has expired. Effective April 19, 2017, the Company amended the note to extend the maturity date to the earlier of May 20, 2017 or the third business day after the closing of the Offering. On December 11, 2017, the Company borrowed an additional $250,000 from the lender under a new note payable agreement (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;1,700,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 500,000 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured note payable to a third party with interest at 12.75% per annum, due February 2019, in default.&#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; The Company entered into the note payable agreement in conjunction with a line of credit.&#160; The Company initially borrowed $1,500,000 and may borrow additional amounts under the note payable agreement up to a total balance of $3,000,000 as the Company meets certain milestones.&#160; The interest rate may also reduce to 11.25% per annum as the Company meets certain milestones.&#160; In conjunction with the note and related line of credit, the Company issued warrants to the lender to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&#160; The Company has recorded discounts of $1,500,000, which are being amortized to interest expense over the term of the note.&#160; In April 2016, the Company borrowed an additional $500,000 on the note and incurred additional fees of $25,000, which are being amortized to interest expense over the remaining term of the note.&#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issue the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the &quot;November Forbearance Agreement&quot;). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the &quot;November Forbearance&quot;) with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company's Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company's Series G Preferred Stock to certain affiliates of the Company.&#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the &quot;December Forbearance&quot;). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $15,470 on the note payable. </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;1,152,778 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;1,652,778 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured line of credit with a third party with interest at 12.25% per annum, due February 2018, in default.&#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; The Company entered into the line of credit agreement in conjunction with a note payable.&#160; The Company may draw up to the lesser of 80% of certain accounts receivable or $1,500,000 and increase the maximum it may borrow under the agreement up to a total balance of $3,000,000 at $500,000 per increase as the Company meets certain milestones.&#160; The interest rate may also reduce to 10.75% per annum as the Company meets certain milestones.&#160; In conjunction with the line of credit and related note, the Company issued warrants to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&#160; The Company has recorded prepaid expenses of $44,665, which are being amortized to interest expense over the term of the line of credit.&#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issuance of the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the &quot;November Forbearance Agreement&quot;). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the &quot;November Forbearance&quot;) with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company's Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company's Series G Preferred Stock to certain affiliates of the Company.&#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the &quot;December Forbearance&quot;). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $16,997 on the note payable.</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;1,259,007 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;929,518 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 18% per annum, with no maturity date.&#160; The note payable is from a verbal agreement with the lender which converted $617,500 of advances into $1,100,000 of principal on the note payable.&#160; The additional $482,500 of principal plus agreed upon fees of $95,226 have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&#146;s common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,100,000</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 2.8% of total revenue per annum, with no maturity date.&#160; The note payable is from a verbal agreement with the lender which converted a $350,000 advance into the note payable.&#160; Agreed upon fees of $143,987 and a future payoff fee of 20%, or $70,000, have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to where the Company is required to pay any outstanding interest at the end of the first month following a quarter end, the lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and to become convertible into shares of the Company&#146;s common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>350,000</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Note payable previously secured by CareServices customer contracts.&#160; In January 2015, the note was amended to reduce the outstanding principal to $375,000, interest at 9% per annum, and payable in 15 monthly installments beginning in February 2015.&#160; The amendment released the collateralized customer contracts and the note payable is guaranteed by both a former Executive Chairman of the Board of Directors and a member of the Board of Directors.&#160; A gain on the extinguishment of the old note of $769,449 was recorded in other income.&#160; In December 2015, the note was amended to extend maturity to January 2018 payable in monthly installments beginning in July 2016, convert $31,252 from accrued interest into principal, interest at 10% per annum, and provide that the note is convertible into common stock at its fair value per share.&#160; The Company recorded a derivative in connection with the convertible feature of the note (see Note 12) and is amortizing the initial $302,690 fair value of the derivative liability over the life of the note.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016.&#160; In July 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or November 2016 and included additional default penalties and payment terms.&#160; In October 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or December 31, 2016 and included additional default penalties and payment terms.&#160; In December 2016, February 2017 and March 2017, the note was further amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or February 15, 2017, March 31, 2017, and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;334,464 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;334,464 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 12% per annum, due February 2016, convertible into common stock at $150 per share.&#160; In connection with the issuance of the note, the Company repriced previously issued warrants to purchase shares of common stock.&#160; The $22,397 increase in relative fair value of the warrants was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&#160; The note also required a payment of 6,000 shares of common stock.&#160; The fair value of $780,000 was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&#160; The maturity date was subsequently extended on two occasions for a total of 500 shares of common stock and the note was due May 2016.&#160; The $31,250 fair value of these shares was being amortized over the extension period.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company's common stock on the date of the amendment.&#160; The note may only be converted if the holder owns less than 9.99% of the Company's common stock after conversion.&#160; The Company recorded the value of the beneficial conversion feature of $381,299 to loss on termination of debt as a result of the modification.&#160; In May 2016, the note was amended to extend the maturity date to the earlier of an equity raise of $10,000,000 or October 2016 which required a payment of 600 shares of common stock.&#160; The $28,500 fair value of these shares has been included in accrued liabilities and was amortized over the extension period.&#160; In October 2016, the Company extended the maturity date of the note month-by-month through no later than April 30, 2017 for a fee of $5,000 per month extended.&#160; During September 2017, the Board of Directors granted 200 shares of Series H Preferred Stock for extension fees. In October 2017, the Company entered into a settlement agreement related to the note where the Company borrowed an additional $200,000 and modified the terms of the note payable to become secured by inventory owned by the Company, requires issuance of 3,000 shares of Series H Preferred Stock, which were authorized for grant by the Board of Directors on September 5, 2017 and are required to be able to convert the lender&#146;s shares into 300,000 shares of the Company&#146;s common stock, and requires payments of $8,600 for 72 consecutive weeks.&#160; If any payment is late, the Company is required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&#160; The fair value of the shares will be amortized over the life of the amended note.&#160; The note terms are adjustable for any terms subsequently provided to other investors (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;300,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;300,000 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured note payable with interest at 12.25% per annum, due May 2017, in default. The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note. The Company entered into the agreement in conjunction with a modification to another note payable and line of credit. The note requires payment of a $3,000 modification fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&#160; The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $4,050 on the note payable.</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;300,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;-&#160;&#160; </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 12.75% per annum, due June 2017, in default, subordinated to other notes payable. The note requires payment of a $3,000 closing fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&#160; The $3,000 closing fee is being amortized to interest expense over the remaining term of the note and the $50,000 fees are being accrued as incurred.&#160; On January 12, 2018, the lender forbore against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;300,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;-&#160;&#160; </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 12% per annum, due September 2016, in default, subordinated to other notes payable.&#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&#160; The $100,000 fair value of the stock was amortized to interest expense over the term of the note.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). On January 12, 2018, the lender forbore against9/ any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;250,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;250,000 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured cash advance with fees at $1,000 per day for the first 15 days and $1,500 per day thereafter, with no maturity date.&#160; The terms of the advance are verbal. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&#146;s common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>100,000</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured notes with interest at 18% per annum, due April 2013, in default.&#160; The Company issued 20,000 shares of Series D preferred stock as loan origination fees.&#160; The $195,000 fair value of the preferred stock was amortized over the original term of the note.&#160;&#160; Principal of $50,000 and accrued interest of $13,333 were converted to common stock in December 2013.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 64,261 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 64,261 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured note payable to a third party with interest at 18% per annum, due June 2017.&#160; The note was secured by shares of the Company's common stock held by, and other assets of an entity controlled by, a former Executive Chairman of the Board of Directors. &#160;The note was guaranteed by a former Executive Chairman of the Board of Directors and his related entity and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; Payments on the note were convertible at the holder's option into common stock at 75% of its fair value if not paid by its respective due date, which is subject to a 20 trading day true-up and is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of other certain raises.&#160; The Company recognized a derivative liability related to the conversion feature with a fair value of $181,670, which was recognized as a loss on termination of debt.&#160; In June 2016, $13,713 of principal and $11,287 of accrued interest converted into 953 shares of common stock, pursuant to the terms of the note.&#160; In August 2016, $64,654 of principal and $10,346 of accrued interest converted into 9,203 shares of common stock, pursuant to the terms of the note.&#160; This note was terminated by paying the remaining principal and accrued interest in cash with no additional consideration.</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;-&#160;&#160; </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;162,539 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160; Total notes payable before discount</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 16,859,049 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;13,006,815 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160;&#160;&#160;&#160; Less discount</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> (1,468,335)</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> (1,930,060) </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160; Total notes payable</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;15,390,714 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;11,076,755 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160;&#160;&#160;&#160; Less current portion</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> (9,501,544)</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> (3,722,899) </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160; Notes payable, net of current portion</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 5,889,170 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;7,353,856 </p> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6610254624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. Related Party Notes Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">10. Related Party Notes Payable</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Related-Party Notes Payable </b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The Company had the following related-party notes payable outstanding as of: </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="450" valign="bottom" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>June 30,</b></p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>September 30,</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="bottom" style='width:337.7pt;padding:0;height:9.35pt'></td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>2017</b></p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>2016</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'> Secured borrowings from entities controlled by an officer who purchased a $2,813,175 customer receivable for $1,710,500.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; The Company repurchased the receivable for $1,950,000 less cash received by the entities through March 2015.&#160; The $239,500 difference between the buyback and cash received plus $253,500 of loan origination fees was amortized to interest expense through March 2015.&#160; In September 2015, the note was modified to extend the maturity date to January 2017, with interest at 18% per annum.&#160; The Company added $81,600 of extension fees and issued 6,000 shares of common stock to a lender as part of the modification.&#160; The note is convertible into common stock at $150 per share.&#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lenders.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lenders, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,721,100</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,721,100</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'> Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due January 2017, convertible into common stock at $150 per share.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; The Company issued 6,000 shares of common stock to a lender as loan origination fees.&#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and reduced the conversion price to $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lender.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lender, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,303,135</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,303,135</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to an entity controlled by a former Executive Chairman of the Board of Directors with interest at 18% per annum, due January 2017.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In February 2016, notes payable to the same entity, with outstanding balances of $511,005 plus accrued interest of $30,999 combined into this note.&#160;&#160; The note is subordinated to notes payable to unrelated parties and is convertible into shares of common stock at $30 per share, which was below the fair value of the Company's stock on the date of the agreement.&#160; The conversion of the note is limited to a maximum of 18,500 common shares.&#160; The Company recorded the value of the beneficial conversion feature of $632,339 to loss on termination of debt.&#160; The note has a default penalty of 1,469 shares of common stock if not paid by maturity. The note may only be converted if the holder owns less than 4.99% of the Company's common stock after conversion.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>542,004</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>542,004</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to an entity controlled by an officer with interest at 12% per annum, due September 2016, subordinated to other third party notes payable.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&#160; The $70,000 fair value of the stock is being amortized to interest expense over the term of the note.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>250,000</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>250,000</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to a former officer with interest at 12% per annum, due September 2013.&#160; This note is in default and is convertible into common stock at $375 per share.</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>26,721</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>26,721</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due on demand.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In February 2016, the note was amended to subordinate the note to other notes payable also issued during February 2016.&#160; The note is convertible into shares of common stock at $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the entity.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the entity, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; In January 2017 and February 2017, the note was amended to extend the maturity date to February 15, 2017 and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>25,463</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>25,463</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to a former officer with interest at 15% per annum, due June 2012, in default.&#160; The note included a $3,000 loan origination fee added to the principal and is convertible into common stock at $250 per share.</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,260</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>17,227</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to a former officer with interest at 12% per annum, due on demand.</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>12,474</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&#160;&#160; Total notes payable, related-party</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>3,869,683</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>3,898,124</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&#160;&#160;&#160;&#160;&#160; Less current portion</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(3,869,683)</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(3,898,124)</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&#160;&#160; Notes payable, related-party, net of current portion</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6630657536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">11. Fair Value Measurements</a></td>
<td class="text"><!--egx--><p style='margin-top:12.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Fair Value Measurements</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>The Company measures the fair values of its assets and liabilities using the US GAAP hierarchy levels as follows: </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:12.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%;border-collapse:collapse'> <tr style='height:15.0pt'> <td width="14%" valign="top" style='width:14.94%;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Level 1</p> </td> <td width="85%" valign="top" style='width:85.06%;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>The Company does not have any Level 1 inputs available to measure its assets.</p> </td> </tr> <tr style='height:15.0pt'> <td width="14%" valign="top" style='width:14.94%;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Level 2 </p> </td> <td width="85%" valign="top" style='width:85.06%;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Certain of the Company&#146;s embedded derivative liabilities are measured on a recurring basis using Level 2 inputs.</p> </td> </tr> <tr style='height:15.0pt'> <td width="14%" valign="top" style='width:14.94%;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Level 3 </p> </td> <td width="85%" valign="top" style='width:85.06%;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:15.0pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Certain of the Company&#146;s embedded derivative liabilities are measured on a recurring basis using Level 3 inputs.</p> </td> </tr> </table> </div> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Items measured at fair value on a recurring basis include embedded derivatives related to the Company&#146;s warrants and notes payable. During the nine months ended June 30, 2017, the Company has not changed the manner in which it values liabilities that are measured at fair value using Level 3 inputs. The following fair value hierarchy table presents information about the Company's financial liabilities measured at fair value on a recurring basis:</p> <table border="0" cellspacing="0" cellpadding="0" width="100%" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;padding:0;height:9.35pt'></td> <td width="1%" valign="top" style='width:1.1%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>&#160;Quoted Prices in Active Markets for Identical Items (Level 1) </b></p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>&#160;Significant Other Observable Inputs (Level 2) </b></p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>&#160;Significant Unobservable Inputs (Level 3) </b></p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>&#160;Total </b></p> </td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>June 30, 2017</p> </td> <td width="1%" valign="top" style='width:1.1%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;background:#DBEEF3;padding:0;height:9.35pt'></td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:20.0pt'>Derivatives liability</p> </td> <td width="1%" valign="bottom" style='width:1.1%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="19%" valign="bottom" style='width:19.8%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>-</p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="18%" valign="bottom" style='width:18.74%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>269,427</p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="16%" valign="bottom" style='width:16.66%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>3,962,556</p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="11%" valign="bottom" style='width:11.88%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>4,231,983 </p> </td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="1%" valign="top" style='width:1.1%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;background:#DBEEF3;padding:0;height:9.35pt'></td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>September 30, 2016</p> </td> <td width="1%" valign="top" style='width:1.1%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;padding:0;height:9.35pt'></td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:20.0pt'>Derivatives liability</p> </td> <td width="1%" valign="bottom" style='width:1.1%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>-</p> </td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>281,613</p> </td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>1,772,458</p> </td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>2,054,071</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in'>The following is a reconciliation of the opening and closing balances for the derivatives liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended June 30, 2017:</p> <table border="0" cellspacing="0" cellpadding="0" width="98%" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;padding:0;height:9.35pt'></td> <td width="2%" valign="bottom" style='width:2.54%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;padding:0;height:9.35pt'></td> <td width="25%" valign="bottom" style='width:25.5%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Derivatives Liability</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Balance, September 30, 2016</p> </td> <td width="2%" valign="bottom" style='width:2.54%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="25%" valign="bottom" style='width:25.5%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,772,458 </p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>Issuance of warrants recorded as derivatives</p> </td> <td width="2%" valign="bottom" style='width:2.54%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;padding:0;height:9.35pt'></td> <td width="25%" valign="bottom" style='width:25.5%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>2,511,288</p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>Gain on termination of debt resulting from</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>&#160; payments on notes payable</p> </td> <td width="2%" valign="bottom" style='width:2.54%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="25%" valign="bottom" style='width:25.5%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(103,213) </p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>Loss on derivatives liability resulting</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>&#160; from changes in fair value</p> </td> <td width="2%" valign="bottom" style='width:2.54%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="25%" valign="bottom" style='width:25.5%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(217,997)</p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Balance, June 30, 2017</p> </td> <td width="2%" valign="bottom" style='width:2.54%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="25%" valign="bottom" style='width:25.5%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>3,962,556</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The Company&#146;s embedded derivative liabilities are re-measured to fair value as of each reporting date.&#160; See Note 12 for more information about the valuation methods of derivatives and the inputs used for calculating fair value.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909642016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Derivatives Liability<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">12. Derivatives Liability</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Derivatives Liability</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The derivatives liability as of June 30, 2017 and September 30, 2016, was<font style='display:none'> </font>$4,231,983 and $2,054,071, respectively. The derivatives liability as of June 30, 2017 and September 30, 2016 is related to a variable conversion price adjustment on outstanding notes payable and warrants.&#160; All of the derivatives outstanding as of September 30, 2015, were eliminated during February 2016, due to the conversion of notes payable into shares of common stock.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During the nine months ended June 30, 2017, the Company estimated the fair value of some of the embedded derivatives upon issuance at the end of each reporting period using a binomial option-pricing model with the following assumptions, according to the instrument: exercise price of $8 to $15 per share; risk free interest rate of 0.85% to 1.14%; expected life of 0.53 to 1.03 years; expected dividends of 0%; volatility factor of 260.57% to 282.07%; and stock price of $8 to $15.&#160; During the nine months ended June 30, 2017, the Company estimated the fair value of the remaining embedded derivatives upon issuance and at the end of each reporting period using a Monte Carlo valuation model with the following assumptions: exercise prices ranging from $2.50 to $25.00 per share; risk free interest rates ranging from 0.44% to 1.99%; expected lives ranging from 0.09 to 4.93 years; expected dividends of 0%; volatility factors of 128% - 194%; and stock prices ranging from $2.50 to $25.00.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During fiscal year 2016, the Company estimated the fair value of some of the embedded derivatives upon issuance, at the end of each reporting period and prior to their conversion and elimination using a binomial option-pricing model with the following assumptions, according to the instrument: exercise prices ranging from $14.50 to $46.75 per share; risk free interest rates ranging from 0.16% to 1.06%; expected lives ranging from 0.05 to 2.09 years; expected dividends of 0%; volatility factors ranging from 125.33% to 510.03%; and stock prices ranging from $15 to $70. During fiscal 2016, the Company estimated the fair value of the remaining embedded derivatives upon issuance and at the end of each reporting period using a Monte Carlo valuation model with the following assumptions: exercise prices ranging from $20 to $125 per share; risk free interest rates ranging from 0.18% to 1.44%; expected lives ranging from 0.04 to 6.40 years; expected dividends of 0%; volatility factors of 129% to 140%; and stock prices ranging from $20 to $475 per share.&#160; The expected lives of the instruments were equal to the average term of the conversion option or expected exercise period of the warrants.&#160; The expected volatility is based on the historical price volatility of the Company's common stock.&#160; The risk-free interest rate represents the US Treasury constant maturities rate for the expected life of the related conversion option. The dividend yield represents anticipated cash dividends to be paid over the expected life of the conversion option.&#160; The Company recognized a gain on derivatives liability for the three months ended June 30, 2017 of $64,145 and a gain on derivatives liability for the three months ended June 30, 2016 of $5,603,411.&#160; The Company recognized a gain on derivatives liability for the nine months ended June 30, 2017 of $230,163 and a gain on derivatives liability for the nine months ended June 30, 2016 of $2,796,542.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640668800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">13. Preferred Stock</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Preferred Stock</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The Company is authorized to issue 10,000,000 shares of preferred stock, with a par value of $0.00001 per share.&#160; Pursuant to the Company's Certificate of Incorporation, the Board of Directors has the authority to amend the Company's Certificate of Incorporation, without further stockholder approval, to designate and determine the preferences, limitations and relative rights of the preferred stock before any issuance of the preferred stock and to create one or more series of preferred stock, fix the number of shares of each such series, and determine the preferences, limitations and relative rights of each series of preferred stock, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, and liquidation preferences.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i><u>Series D Convertible Preferred Stock </u></i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The Board of Directors has designated 1,000,000 shares of preferred stock as Series D Convertible Preferred Stock (&quot;Series D Preferred &quot;).&#160; The Series D Preferred votes on an as-converted basis.&#160; The Series D Preferred has a dividend rate of 8%, payable quarterly.&#160; The Company may redeem the Series D Preferred at a redemption price equal to 120% of the original purchase price with 15 days' notice. During the nine months ended June 30, 2017 and 2016, the Company accrued $24,800 and $18,617 of dividends on Series D preferred stock, respectively, and settled $0 and $12,434 of accrued dividends, respectively, by issuing 0 and 455 shares of common stock, respectively.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i><u>Series E Convertible Preferred Stock </u></i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During fiscal year 2013, the Board of Directors designated shares of preferred stock as Series E Convertible Preferred Stock (&quot;Series E Preferred&quot;), convertible into common stock at $500 per share, adjustable if there are distributions of common stock or stock splits by the Company.&#160; The Series E Preferred is non-voting and receives a monthly dividend of 3.322% for 25 to 32 months.&#160; In addition, the convertibility and the redemption price of the Series E Preferred is gradually reduced by dividend payments over 25 to 32 months.&#160; After the dividend payment term, the redemption price of Series E Preferred is $0, the Series E Preferred has no convertibility to common stock and the holders are entitled to receive a pro-rata share of cumulative royalties totaling 4% of the Company's gross profits payable quarterly for a two-year period.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During the three months ended June 30, 2017 and 2016, the Company accrued dividends of $34,178 and $39,598, respectively, payable to Series E Preferred.&#160; During the nine months ended June 30, 2017 and 2016, the Company accrued dividends of $102,535 and $185,485, respectively, payable to Series E Preferred. &#160;As of June 30, 2017 and September 30, 2016, the aggregate redemption price for the Series E Preferred was $477,829.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i><u>Series F Convertible Preferred Stock </u></i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During fiscal year 2014, the Board of Directors designated 7,803 shares of preferred stock as Series F Convertible Preferred Stock (&quot;Series F Preferred&quot;).&#160; In April 2014, the Company increased the authorized shares of Series F Preferred &#160;to 10,000.&#160; Series F Preferred is non-voting, has a stated value of $1,000 per share and is convertible into common stock at $166.85 per share (see Note 12).&#160; Series F Preferred has a dividend rate, payable quarterly, of 8% until April 30, 2015, 16% from May 1, 2015 to July 31, 2015, 20% from August 1, 2015 to October 31, 2015, and 25% thereafter.&#160; In February 2016, the Company redeemed all 5,361 outstanding shares and $673,848 of accrued dividends for 20,005 shares of common stock, $5,900,000 of notes payable and exchanged warrants for the purchase of 11,070 shares of common stock held by Series F Preferred stockholders for new warrants with new terms for the purchase of the same number of shares (see Note 15).&#160; The Company recorded a deemed dividend of $6,484,236 as a result of the transactions.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During the three and nine months ended June 30, 2016, the Company accrued dividends of $0 and $495,148, respectively, payable to Series F Preferred stockholders.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i><u>Series G Convertible Preferred Stock </u></i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During January 2017, the Board of Directors designated 43,220 shares of preferred stock as Series G Convertible Preferred Stock (&quot;Series F Preferred&quot;).&#160; Series G Preferred votes on an as-converted basis, has a stated value of $500 per share. The Series G Preferred will automatically convert the stated value of such shares into fully paid and non-assessable shares of common stock (Series G Conversion Shares&#148;) of the Company upon (i) the Company&#146;s receipt of $50,000,000 or more in gross revenue in a single fiscal year, (ii) the sale of the Company via asset purchase, stock sale, merger or other business combination in which the Company and/or its stockholders receive aggregate gross proceeds of $25,000,000 or more, or (iii) the closing of an underwritten offering by the Company pursuant to which the Company receives aggregate gross proceeds of at least $10,000,000 in consideration of the purchase of shares of common stock and/or which results in the listing of the Company&#146;s common stock on the Nasdaq National Market, the Nasdaq Capital Market, the New York Stock Exchange, or the NYSE MKT. The number of Series G Conversion Shares issuable upon conversion shall equal the stated value divided by the conversion price then in effect. The conversion price of the Series G Preferred is $22.50. Upon the trigger of an automatic conversion, all of the shares of Series G Preferred owned by such holders will convert into common stock at the conversion price then in effect.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>On January 31, 2017, the Company issued 32,415 shares of Series G Preferred to an entity affiliated with one of the Company&#146;s former Chief Executive Officers and 10,805 shares of Series G Preferred to a different former Chief Executive Officer and consultant to the Company. The consideration for such issuance relates to services rendered to the Company. Each of the two recipients of the Series G Preferred stock have entered into lock-up agreements, as amended, prohibiting the sale or other transfer of the Common Shares issued pursuant to the conversion of the Series G Preferred securities of the Company owned by each of them for the longer of (i) 18 months or (ii) the date the Company first has annual gross revenues in an amount of at least $20,000,000. The lock-up agreements initially expired if the Offering was not completed by February 15, 2017, whose expirations were extended to March 31, 2017 with new agreements signed during February 2017.&#160; As of June 30, 2017, the agreements have expired.&#160; On September 5, 2017, the Board of Directors of the Company agreed to modify the terms of the Series G Convertible Preferred stock to remove the 18-month lock-up period, however, no such amendment to the Series G Preferred has not been filed with the State of Delaware as of the date of this filing.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i><u>Liquidation Preference</u></i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Upon any liquidation, dissolution or winding up of the Company, before any distribution or payment may be made to the holders of the common stock, the holders of the Series D Preferred, Series E Preferred, and Series F Preferred are entitled to be paid out of the assets an amount equal to $1.00 per share plus all accrued but unpaid dividends.&#160; If the assets of the Company are insufficient to make payment in full to all holders of preferred stock, then the assets shall be distributed among the holders of preferred stock ratably in proportion to the full amounts to which they would otherwise be entitled.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632910848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. Common Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">14. Common Stock</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:.5in;line-height:115%;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in;line-height:normal'><b>14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Common Stock</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>In April 2014, the Company amended its Certificate of Incorporation increasing the total number of authorized shares of common stock from 50,000,000 shares to 200,000,000 shares.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>On January 27, 2017, the Company effected a 1-for-500 reverse stock split of its outstanding common stock, which caused the then outstanding common stock to decrease from 115,112,802 to 232,100 while keeping the authorized capitalization unchanged.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During the nine months ended June 30, 2017, the Company issued 7,000 shares of common stock (post reverse stock split) for services provided by an independent consultant; the value on the date of grant was $70,000.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909659232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Common Stock Options and Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_Stockoptionsandwarrants0TextBlock', window );">15. Common Stock Options and Warrants</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Common Stock Options and Warrants</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The fair value of each stock option or warrant is estimated on the date of grant using a binomial option-pricing model or the Monte Carlo valuation model.&#160; The expected life of stock options or warrants represents the period of time that the stock options or warrants are expected to be outstanding, based on the simplified method.&#160; Expected volatilities are based on historical volatility of the Company's common stock, among other factors.&#160; The Company uses the simplified method within the binomial option-pricing valuation model due to the Company's short trading history.&#160; The risk-free rate related to the expected term of the stock options or warrants is based on the US Treasury yield curve in effect at the time of grant.&#160; The dividend yield is zero.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During fiscal 2016, the Company granted warrants to purchase 24,032 common shares with an exercise price of $32.50 per share in connection with the acquisition of a note payable and line of credit; warrants for the purchase of 14,786 shares vested immediately, 3,696 vested upon the disbursement of the second tranche of the related note payable, and 5,550 vest evenly in the event of three available increases on the related line of credit (see Note 9). The warrants expire in February 2023, may be exercised via cashless exercise and are puttable upon expiration or liquidation for the greater of $500,000 or up to 6.5% of the equity value of the Company, depending on the number of warrants vested. The fair value of the warrants upon grant of $3,731,969 was recorded as a derivative and the Company received cash of $2,967 upon issuance of the warrants. The Company recognized $1,419,541 as debt discount for the portion allocated to the note payable and the debt discount is being amortized over the life of the note payable to interest expense. During September 2016, the Company entered into a conditionally effective warrant cancellation agreement with the warrant holders, which has expired (see Note 17).</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During February 2016, the Company exchanged warrants held by the holders of its Series F Preferred for the purchase of 11,070 shares of common stock in connection with the redemption of Series F Preferred for new warrants for the purchase of the same number of shares on different terms. The new warrants were initially exercisable for $150 per share, adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises. During September 2016, the Company issued warrants for the purchase of common stock that adjusted the warrants to have an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering. On December 11, 2017, the Company entered into Securities Purchase Agreements that adjusted the conversion rate to exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in a contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the &#147;Private Placement&#148;) (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment (see Note 18). The new warrants expire in February 2021, and may be exercised via cashless exercise. Additional warrants for the purchase of 16,000 shares of common stock may be issued in the event of default on the related notes payable, exercisable at $0.50 per share, with 25% issuable upon the first event of default, 37.5% upon the second event, and 37.5% upon the third event. The warrants issuable upon default expire in February 2026 (if issued), may be exercised via cashless exercise, and are puttable upon expiration or liquidation with the primary warrants. The new warrants may only be exercised to the extent the respective holder would own a maximum of 4.99% of the Company&#146;s common stock after exercise, but the holders may elect to increase the maximum to 9.99%. The Company recognized a deemed dividend of $6,484,236 as a result of the exchange and related redemption of Series F Preferred.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>During September 2016, the Company granted warrants to purchase 20,000 shares in connection with the acquisition of a note payable at an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering. Upon the closing of the Offering, the number of shares issuable under the warrant will reset to an amount of shares equal to the aggregate exercise amount of the warrants (as defined therein) divided by the exercise price then in effect. The warrants expire in September 2021, and may be exercised via cashless exercise. The warrants may only be exercised to the extent the holder would own a maximum of 9.99% of the Company&#146;s common stock after exercise. The Company recognized $220,000 of the $493,590 fair value of the warrants as a debt discount, which is being amortized over the life of the borrowing, and recognized the remaining $273,590 as a loss on derivatives liability. In the event the Company borrows additional amounts above the initial $500,000 under the note payable, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to warrants issued as part of the initial borrowing. During the nine months ended June 30, 2017, the Company borrowed an additional $1,000,000 on the note and issued warrants for the purchase of 40,000 shares of common stock with the same terms as the initial warrants. The Company recognized the $2,103,341 fair value of the warrants as debt discounts, which are being amortized over the remaining life of the borrowing. &#160;Effective March 3, 2017, the note was amended to increase the maximum principal sum from $1,500,000 to $2,000,000 under which the Company borrowed an additional $200,000 in consideration and issued the lender a warrant to purchase up to 8,000 shares of common stock with the same terms as the warrants previously issued under the previous terms of the note.&#160; The Company recognized the $407,947 fair value of the warrants as part of the total on extinguishment of debt of $501,969.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>During the nine months ended June 30, 2017, the Company measured the fair value of warrants classified as liabilities on the date of issuance and on each re-measurement date using the Monte Carlo valuation model. For this liability, the Company and specialist developed their own assumptions that do not have observable inputs or available market data to support the fair value. This method of valuation involves using inputs such as the fair value of the Company&#146;s common stock, stock price volatility, the contractual term of the warrants, risk&#150;free interest rates and dividend yields. Due to the nature of these inputs, the valuation of the warrants uses Level 3 measurements. The following assumptions were used:</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="626" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'></td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Exercise price</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>$2.50 - $25.00</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Expected term (years)</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>0.21 - 4.93</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Volatility</p> </td> <td width="15" valign="top" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>128% - 194%</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Risk-free rate</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>0.49% - 1.99%</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Dividend rate</p> </td> <td width="15" valign="top" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>0%</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Common stock price</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>$2.50 - $25.00</p> </td> </tr> </table> </div> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>The following table summarizes information about stock options and warrants outstanding as of June 30, 2017:</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="93%" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;border:none;border-bottom:solid windowtext 1.0pt;background:white;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Options and Warrants</b></p> </td> <td width="2%" valign="top" style='width:2.44%;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Number of Options and Warrants</b></p> </td> <td width="2%" valign="top" style='width:2.44%;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Weighted-</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Average</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Exercise</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Price</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Outstanding as of October 1, 2016</p> </td> <td width="2%" valign="bottom" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>65,045</p> </td> <td width="2%" valign="bottom" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="16%" valign="bottom" style='width:16.86%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>35.06</p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Granted</p> </td> <td width="2%" valign="top" style='width:2.44%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>48,000</p> </td> <td width="2%" valign="bottom" style='width:2.44%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>25.00</p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Forfeited</p> </td> <td width="2%" valign="top" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(3,871)</p> </td> <td width="2%" valign="bottom" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>357.84</p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Outstanding as of June 30, 2017</p> </td> <td width="2%" valign="top" style='width:2.44%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>109,174</p> </td> <td width="2%" valign="bottom" style='width:2.44%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>37.12</p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Exercisable as of June 30, 2017</p> </td> <td width="2%" valign="top" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>102,225</p> </td> <td width="2%" valign="bottom" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>34.46</p> </td> </tr> </table> </div> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>As of June 30, 2017, the outstanding warrants have an aggregate intrinsic value of $0 and the weighted average remaining term of the warrants was 4.52 years. The total compensation cost related to unvested awards not yet recognized (warrants and shares) was $38,468.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_Stockoptionsandwarrants0TextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the textual narrative disclosure of 15. Common Stock Options and Warrants, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_Stockoptionsandwarrants0TextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619104144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. Related-party Transactions Not Otherwise Disclosed<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock', window );">16. Related-party Transactions Not Otherwise Disclosed</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Related-Party Transactions Not Otherwise Disclosed</b></p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>In February 2016, the Company amended a consulting agreement dated September 2015, with an entity controlled by a former Executive Chairman of the Board of Directors, effective January 2016.&#160; The amendment extended the agreement through December 2016, which automatically renews on a monthly basis until otherwise cancelled in accordance with the terms therein, changing the monthly compensation of $6,000 to an hourly rate of $250 per hour, and eliminated the previously included bonus structure.&#160; During May 2017, the Company granted 1,719 shares of common stock, with a value of $17,207 on the date of grant, to the consultant as a bonus for services performed.&#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&#160; On September 5, 2017, the Company granted 1,500 shares of the Company&#146;s Series H Preferred stock to an entity controlled by a former Executive Chairman of the Board of Directors for past services rendered in addition to amounts earned under an existing consulting agreement.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; On November 13, 2017, the former Executive Chairman of the Board of Directors terminated the consulting agreement.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>In July 2016, the Company entered into a Consulting Agreement with a former Executive Chairman and Chief Executive Officer of the Company.&#160; This Consulting Agreement is for an initial period of one year, and shall automatically renew for consecutive one month periods unless terminated by the Company or the former Executive Chairman and Chief Executive Officer. As consideration for the services to be performed thereunder, the Company shall pay the former Executive Chairman and Chief Executive Officer at the rate of $250 per hour, but such compensation may not exceed $20,000 during any calendar month. &#160;During May 2017, the Company granted 10,324 shares of common stock, with a value of $103,343 on the date of grant, to the consultant as a bonus for services performed.&#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&#160; On September 5, 2017, the agreement was replaced with a new agreement for an initial period of one year, and shall automatically renew for consecutive one month periods unless terminated by the Company or the former Executive Chairman and Chief Executive Officer.&#160; As consideration for the services, the Company shall pay the former Executive Chairman and Chief Executive Officer at the rate of $250 per hour, but such compensation may not exceed $20,000 during any calendar month, plus 1,500 shares of the Company&#146;s Series H Preferred stock.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>In August 2016, the Company received a cash advance for $135,000 from a former Executive Chairman and Chief Executive Officer of the Company.&#160; During the nine months ended June 30, 2017, the Company repaid the advance.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During May 2017, the Company granted 96,275 shares of common stock, with a value of $963,713 on the date of grant, to a former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, as a bonus for services performed.&#160; As of June 30, 2017, the shares have not been issued and the value has been included in accrued expenses.&#160; On September 5, 2017, the Board of Directors of the Company granted 963 shares of Series H Preferred stock to the former Executive Chairman and Chief Executive Officer of the Company in lieu of the 96,275 shares of previously granted common stock.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; The Series H Preferred shares have not yet been issued.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>In September 2017, the Company entered into an employment agreement with the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, for a period of two years for services as the Executive Chairman and Chief Executive Officer of the Company.&#160; The initial term of the agreement is for two years and shall automatically renew on a year to year basis, unless terminated sooner.&#160; The base compensation is $360,000 per year plus 1,500 shares of the Company&#146;s Series H Preferred stock.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; An additional cash or stock bonus may be awarded, subject to the attainment of such individual of certain objectives as the Board of Directors of the Company shall establish from time to time.&#160; Upon certain termination conditions contained in the agreement, the Company may be required to pay severance of twice the base compensation at its highest point during the five-year period prior to termination.&#160; Effective October 12, 2017, the former Executive Chairman and Chief Executive Officer has waived any constructive termination in relation to changes in title, working conditions or duties such that his powers are diminished, reduced or otherwise changed to include powers, duties, or working conditions which are note materially consistent with title, continuing after written notice and 10 days to cure.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the textual narrative disclosure of 16. Related-party Transactions Not Otherwise Disclosed, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RelatedPartyTransactionsNotOtherwiseDisclosed0TextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6751750560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">17. Commitments and Contingencies</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Commitments and Contingencies</b></p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During the nine months ended June 30, 2017, the Company leased office space under a non-cancelable operating lease.&#160; In February 2015, the Company entered into a sublease agreement for part of the office space under the non-cancelable operating lease through the end of the original lease period.&#160; Payments under the sublease were made by the sublessee directly to the Company's landlord.&#160; The non-cancelable operating lease was terminated during June 2015.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During June 2015, the Company entered into a new non-cancelable operating lease for its existing office space, excluding the previously subleased space, with payments beginning in July 2015.&#160; Future minimum rental payments under the non-cancelable operating lease as of June 30, 2017, were as follows:</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:white;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b><u>Years Ending September 30,</u></b></p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>2017</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>32,908</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>2018</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>111,340</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;border:none;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:79.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>144,248</p> </td> </tr> </table> </div> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The Company's rent expense under the new non-cancelable operating lease for nine months ended June 30, 2017 and 2016, was approximately $97,000 and $94,000, respectively.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During February 2016, the Company entered into an agreement with one if its vendors to purchase a minimum of $200,000 of inventory per quarter through January 2018.&#160; The agreement was cancelled subsequent to June 30, 2017.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During February 2016, the Company redeemed all of its Series F preferred stock in exchange for 20,005 shares of common stock and $5,900,000 of notes payable (see Note 9).&#160; As part of the redemption, the Company exchanged warrants held by the Series F Preferred stockholders for the purchase of 11,070 shares of common stock for new warrants to purchase the same number of shares with different terms.&#160; As part of the redemption, the Company may be required to issue additional warrants for the purchase of up to 16,000 shares of common stock upon three events of default on the notes payable (see Note 15).</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During February 2016, the Company converted notes payable and accrued interest payable to an entity controlled by a former Executive Chairman of the Board of Directors into a convertible note payable (see Note 10).&#160; The Company may be required to issue 1,469 shares of common stock if the note is not paid by maturity.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During February 2016, the Company amended notes payable to an entity controlled by an officer of the Company to subordinate to notes payable also issued during February 2016, reduced the conversion price per share to $30 per share and limited the shares into which it is convertible (see Note 10).&#160; The Company may be required to issue 8,407 shares of common stock if the note is not paid by maturity.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During September 2016, the Company issued a note payable to a third party for up to $1,500,000.&#160; The Company initially borrowed $500,000 under the note and may borrow up to $1,500,000 upon meeting certain milestones.&#160; The Company subsequently drew an additional $1,000,000 under the note and issued additional warrants for the purchase of 40,000 shares of common stock at similar terms to warrants issued as part of the initial borrowing.&#160; During March 2017, the note was amended to increase the maximum principal sum from $1,500,000 to $2,000,000 under which the Company borrowed an additional $200,000 in consideration and issued the lender a warrant to purchase up to 8,000 shares of common stock with the same terms as the warrants previously issued under the previous terms of the note.&#160; In the event the Company borrows any part of the remaining $300,000 available, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to warrants issued as part of the initial borrowing.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>During September 2016, the Company entered into a conditionally effective warrant cancellation agreement (the &quot;Warrant Cancellation Agreement&quot;) with certain warrant holders who were issued the warrants in connection with a secured note payable and line of credit. Pursuant to the terms of the Warrant Cancellation Agreement, upon the Company's consummation of an equity financing of at least $15,000,000, the warrant holders agree to terminate and cancel the warrants they currently hold. As an inducement to enter into the Warrant Cancellation Agreement, the warrant holders will receive upon termination and cancelation of the warrants an aggregate of 10,800 shares of the Company's common stock, which will be subject to a 6-month lock-up agreement. Additionally, if the warrant holders terminate and cancel the warrants, the Company will issue the related note holder a new unsecured promissory note with an initial principal amount of $180,000, no cash interest, and a three-year term. In lieu of cash interest, the principal of the note will increase in the amount $3,333 each month not to exceed a maximum of $300,000.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Effective November 1, 2016, the Board approved the 2016 Incentive Stock Option plan providing for the issuance of options to purchase up to 377,250 shares.&#160; No shares have been approved under the Plan as of June 30, 2017.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>On April 17, 2017 the Company entered into a Joint Venture Agreement, effective March 31, 2017 (the &quot;JV Agreement&quot;) with Colorado Choice Health Plans (&quot;CCHP&quot;), a customer. Under the JV Agreement: (i) CCHP is providing various services to the Company to improve the Company's diabetes programs, (ii) the Company loaned CCHP $500,000 under a debenture note (recorded as a note receivable in the accompanying consolidated condensed balance sheets), and (iii) the JV Agreement will terminate upon the later of (a) repayment of the debenture note or (b) the one year anniversary of the JV Agreement. The debenture note: (i) bears interest at the rate of five percent per annum, (ii) is subordinated to the rights of CCHP policyholders, claimants and beneficiary claims and all other classes of CCHP creditors other than subordinated debenture holders, (iii) does not become a liability of CCHP until and unless the Commissioner of the Colorado Department of Regulatory Agencies, Division of Insurance (&quot;Division of Insurance&quot;) authorizes repayment of the debenture agreement, and shall be treated by CCHP as surplus until the time of such approval, (iv) is only repayable from available funds in excess of CCHP's minimum net surplus required to be maintained by the Division of Insurance, and (v) is otherwise repayable on March 31, 2018, assuming approval by the Division of Insurance.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>On May 28, 2015, an investor of the Company filed a lawsuit claiming damages of $1,000,000 exclusive of interest and costs against the Company, a former Executive Chairman, an entity controlled by another former Executive Chairman, and 4G Biometrics, a wholly owned subsidiary of the Company, for breach of contract. The Company has engaged legal counsel regarding the matter.&#160; The Company has assessed a high probability of settling the matter for $750,000 in cash, equity, or a combination thereof.&#160; The Company has accrued a contingent liability of $750,000 and loss on settlement as of June 30, 2017.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>On November 4, 2015, the Company received a demand for payment of $275,000 from a former employee of the Company and former principal of 4G Biometrics whose employment was terminated for cause.&#160; On December 4, 2015, the Company filed a complaint against the former owners of 4G Biometrics, including this former employee, seeking damages in excess of $300,000 related to alleged misrepresentations made to induce the Company to acquire 4G Biometrics.&#160; Between February 4, 2016 and February 8, 2016, the Company settled the complaint with each of the former owners of 4G Biometrics and all parties released each other from all outstanding claims, including any current monetary obligations to each party, excluding one former owner of 4G Biometrics who continues to be employed by the Company.&#160; A Stipulation for Order of Dismissal with Prejudice of all Claims and Counterclaims has been filed and is in the process of being approved.&#160; The settlement resulted in the termination of $39,863 of related-party accounts payable.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6618734640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>18. Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">18. Subsequent Events</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph;text-indent:0in'><b>18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><b>Subsequent Events</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>Subsequent to June 30, 2017, the Company entered into the following agreements and transactions:</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(1)&nbsp;&nbsp;&nbsp; On August 2, 2017, the Company received a cash advance from a third party in the amount of $100,000, which incurs fees of $1,500 per day until repaid.&#160; During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&#146;s common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(2)&nbsp;&nbsp;&nbsp; On August 7, 2017, the Company received a cash advance from a third party in the amount of $50,000, which incurs fees of $750 per day until repaid. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&#146;s common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(3)&nbsp;&nbsp;&nbsp; During August 2017, the Company received letters related to unsecured notes payable with third parties with principal balances totaling $5,900,000 as of June 30, 2017 where the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017. </p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(4)&nbsp;&nbsp;&nbsp; During August 2017, the Company received a letter related to an unsecured note payable with a third party with a principal balance of $334,464 as of June 30, 2017 wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(5)&nbsp;&nbsp;&nbsp; During August 2017, the Company received a letter related to secured and unsecured notes payable with entities controlled by the Company&#146;s former chief executive officer and Executive Chairman of the Board of Directors, who was in office at the time, with principal balances of $1,721,100, $1,303,135, $250,000 and $25,463 as of June 30, 2017, wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017.&#160; On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through January 12, 2018 and extended maturity date was extended through January 12, 2018.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(6)&nbsp;&nbsp;&nbsp; During August 2017, the Company received a letter related to an unsecured note payable with a former Executive Chairman of the Board of Directors with a principal balance of $542,004 as of June 30, 2017 wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017. &#160;On December 18, 2017, another letter was received wherein the lender waived any historical and future events of default through January 12, 2018 and extended maturity date was extended through January 12, 2018.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(7)&nbsp;&nbsp;&nbsp; During July 2017, the Company granted 1,562 shares of common stock, with a value of $12,496 on the date of grant, to the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, as a bonus for services performed during the three months ended June 30, 2017.&#160; The value of the shares has been included in accrued expenses as of June 30, 2017. </p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(8)&nbsp;&nbsp;&nbsp; On August 16, 2017, the Company sold $248,500 of future customer receipts to a third party for $175,000 in cash.&#160; The $73,500 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company&#146;s former Executive Chairman and Chief Executive Officer, who was in office at the time.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(9)&nbsp;&nbsp;&nbsp; During July 2017, the Company granted 50,000 shares of common stock, with a value of $400,000 on the date of grant, to a third party as part of a one-year consulting agreement.&#160; The value of the shares will be amortized to selling, general and administrative expenses evenly over the service period.&#160; On September 5, 2017, the Board of Directors granted the issuance of 500 shares of Series H Preferred stock in lieu of the 50,000 shares of common stock, to which the third party has verbally agreed.&#160; The Series H Preferred shares have not yet been issued.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(10) During July 2017, the Company granted 3,937 shares of common stock to employees for bonuses.&#160; The $31,500 fair value of the shares has been included in accrued expenses as of June 30, 2017.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(11) On August 28, 2017, the Company sold $224,850 of future customer receipts to a third party for $150,000 in cash.&#160; The $74,850 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company&#146;s former Executive Chairman and Chief Executive Officer, who was in office at the time.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(12) On August 31, 2017, the Company sold $119,920 of future customer receipts to a third party for $80,000 in cash.&#160; The $39,920 difference between the future customer receipts and cash received by the Company is being amortized to interest expense over the term of the note. The note is subordinated to another note and is guaranteed by the Company&#146;s former Executive Chairman and Chief Executive Officer, who was in office at the time.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(13) On September 5, 2017, the Board of Directors of the Company modified the terms of the Series G Convertible Preferred stock to remove the 18-month lock-up period.&#160; The amendment has not been filed with the State of Delaware as of the date of this filing.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(14) On September 5, 2017, the Board of Directors of the Company ratified a change to the Series H Preferred stock, previously contemplated and approved by the Board of Directors, to where each share of the Series H Preferred stock is convertible into 100 shares of the Company&#146;s common stock, is limited to a total ownership of 4.99% of the outstanding common stock at the time of conversion, is to be non-voting stock, does not bear interest or dividends, and is transferable with the same terms.&#160; The Certificate of Designation for the Series H Preferred stock has not been filed with the State of Delaware as of the time of this filing and no shares had been issued prior to September 5, 2017.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(15) On September 5, 2017, the Company entered into a consulting agreement with a former Executive Chairman and Chief Executive Officer of the Company, which replaced and existing consulting agreement, for certain consulting services to the Company including, but not limited to (i) developing business plans, (ii) making introductions to potential customers and/or suppliers, (iii) identifying qualified employees and other service providers, (iv) sales, marketing, manufacturing and other operating activities, and (v) meeting with the Company's and its affiliates' respective managers, officers, employees, agents, and other service providers regarding the business, prospects and affairs of the Company and its affiliates. The former officer may not engage in and shall not be entitled to any fees or consideration for (i) negotiating the purchase and/or sale of Company securities, (ii) making recommendations regarding transactions involving Company securities, (iii) or any other matters involving transactions of Company securities.&#160; The agreement is for one year and includes compensation of $250.00 per hour, but such compensation may not exceed $20,000 during any calendar month, plus 1,500 shares of the Company&#146;s Series H Preferred stock.&#160; The shares of Series H Preferred stock have not been issued at the time of this filing.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(16) On September 5, 2017, the Company renewed an existing license and royalty agreement with an entity controlled by a former Executive Chairman and Chief Executive Officer of the Company (the &#147;licensee&#148;).&#160; Under the agreement, the licensee receives the right to make, sell and use products related to the Company&#146;s intellectual property regarding diabetics, cellular, GPS and CareCenter arena and generally characterized as the CareCenter Technology in a certain region.&#160; The Company shall receive a royalty of 15% of the licensee&#146;s gross sales price for the product.&#160; The initial term is for three years whereby the licensee must achieve a minimum royalty of $10,000 per month to maintain the agreement, whereby the agreement will be extended for one addition year unless terminated.&#160; If the minimum monthly royalty is not maintained, the licensee may pay a sum to bring the total payment up to $360,000 within 60 days of the end of the three-year term to extend the agreement for one additional year.&#160; The Company may terminate the agreement if the licensee does not commence to manufacture, distribute and sell product within a 6-month period after the execution of the agreement.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(17) On September 5, 2017, the Company granted 1,500 shares of the Company&#146;s Series H Preferred stock to an entity controlled by a former Executive Chairman of the Board of Directors for past services rendered in addition to amounts earned under an existing consulting agreement.&#160; The shares of Series H Preferred stock have not been issued at the time of this filing.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(18) On September 5, 2017, the Company entered into an employment agreement with the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, for a period of two years for services as the Executive Chairman and Chief Executive Officer of the Company.&#160; The initial term of the agreement is for two years and shall automatically renew on a year to year basis, unless terminated sooner.&#160; The base compensation is $360,000 per year plus 1,500 shares of the Company&#146;s Series H Preferred stock.&#160; The shares of Series H Preferred stock have not yet been issued.&#160; The terms of the Series H Preferred stock have been approved by the Board of Directors of the Company, but no Certificate of Designation has been filed with the appropriate authoritative body.&#160; An additional cash or stock bonus may be awarded, subject to the attainment of such individual and ActiveCare objectives as the Board of Directors of the Company shall establish from time to time as determined by the Board of Directors of the Company.&#160; Upon certain termination conditions upon termination of the agreement, the Company may be required to pay severance of twice the base compensation of the former Executive Chairman and Chief Executive Officer at its highest point during the five-year period prior to termination. In addition, the Board of Directors approved compensation at a level of $360,000 per year retroactive from July 2017, when the former Executive Chairman and Chief Executive Officer was appointed, until the employment agreement was signed. Effective October 12, 2017, the agreement was amended to waive any constructive termination in relation to changes in title, working conditions or duties such that his powers are diminished, reduced or otherwise changed to include powers, duties, or working conditions which are note materially consistent with title, continuing after written notice and 10 days to cure.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(19) On September 5, 2017, the Board of Directors granted 963 shares of Series H Preferred stock to the former Executive Chairman and Chief Executive Officer of the Company, who was in office at the time, in lieu of 96,275 shares of previously granted common stock as a bonus for services performed.&#160; The Series H Preferred shares have not yet been issued.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(20) On September 5, 2017, the Board of Directors granted 200 shares of Series H Preferred stock to the holder of an unsecured note payable with a balance of $300,000 as of June 30, 2017 for the extension of the note payable.&#160; The Series H Preferred shares have not yet been issued.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(21) From September 21, 2017 through December 1, 2017, the Company received cash advances totaling $230,000 from an entity controlled by the Company&#146;s former Executive Chairman and Chief Executive Officer, who was in office at the time, and repaid $10,000 plus the reimbursement of bank fees of $200.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(22) On September 25, 2017, the Company entered into agreements with its primary product vendor that supersedes all prior agreements with the vendor.&#160; Under the agreements, the vendor will provide all products and services to the Company&#146;s service members as they are assigned to the vendor.&#160; In return, the vendor will pay the Company a fee for services rendered to the vendor and to the members for monitoring and reporting.&#160; The Company also earns commissions on all members assigned under the agreement to be paid upon completion of certain milestones met with each individual member.&#160; The agreements also modify the terms of an existing note payable to the vendor.&#160; The note accrues interest at 0.65% per annum, is reduced by the amount of commissions earned by the Company under the agreements and matures on September 25, 2019.&#160; The agreements also add interest fees on existing accounts payable at 0.65% per annum and the accounts payable are reduced by the amount of commissions earned by the Company under the agreements for a minimum of 24 months.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(23) On September 27, 2017, the Company received a cash advance from a third party in the amount of $40,000, which incurs fees of $600 per day until repaid.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(24) In October 2017, the Company entered into a settlement agreement related to an unsecured note payable with a principal balance of $300,000 as of June 30, 2017.&#160; As part of the agreement, the lender lent the Company an additional $200,000 which has been added to the principal balance of the note payable.&#160; The agreement modified the terms of the note payable to become secured by inventory owned by the Company, requires issuance of 3,000 shares of Series H Preferred Stock, which were granted by the Board of Directors on September 5, 2017 and are required to be able to convert the lender&#146;s shares into 300,000 shares of the Company&#146;s common stock, and requires payments of $8,600 for 72 consecutive weeks.&#160; If any payment is late, the Company is required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&#160; The fair value of the shares will be amortized over the life of the amended note.&#160; The note terms are adjustable for any terms subsequently provided to other investors.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(25) On November 7, 2017, the Company entered into individual agreements related to secured borrowings from four different parties that each previously purchased customer receivables that require daily payments.&#160; The agreements modified each agreement to reduce the amount of the respective daily payment to approximately half of the amount previously drawn through January 7, 2018, whereafter the amount of the payment returns to the payment required under the respective agreement plus an additional amount equal to the amount shorted during the period of lower payments divided by the number of remaining payments remaining on the original term of the respective note payable.&#160; Three of the four agreements are verbal.&#160; On January 5, 2018, the Company further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018.&#160; Three of the four agreements are verbal.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(26) On November 13, 2017, an entity controlled by a former Executive Chairman of the Board of Directors, with whom we contracted for consulting, terminated the existing consulting arrangement.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(27) On November 13, 2017, the Company entered into a sales broker agreement with an entity controlled by a former Executive Chairman of the Board (the &#147;Sales Broker&#148;).&#160; Under the Sales Broker agreement, the Company will provide services to certain customers referred to the Company and the Sales Broker will receive administration fees in the amount of 15% of gross revenues, as defined by the Sales Broker agreement, as long as the Company services the respective customer even in the event the Sales Broker agreement is terminated.&#160; The Sales Broker will promote the Company, its services and products, and introduce potential customers to the Company as a sales representative.&#160; The initial term of the Sales Broker agreement is one year, which automatically renews for additional one-year periods until cancelled by either party.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(28) On November 30, 2017, the Company signed a letter of understanding with a former consultant where the Company agreed to convert $100,000 of past consulting fees owed into an equivalent value of equity in the Company upon a qualifying capital raise.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(29) On November 10, 2017, the Company signed a formal agreement replacing a former verbal agreement with an unsecured note holder, with principal due of $350,000 as of June 30, 2017.&#160; The new agreement memorialized previously agreed upon terms whereby the lender converted a $350,000 advance into an unsecured note payable, with interest at 2.8% of revenues, for $143,987 in fees and a future payoff fee of 20% of the principal, or $70,000, which are included in accrued liabilities and interest expense as of June 30, 2017.&#160; The written agreement adjusted the verbal agreement to where the Company is required to pay any outstanding interest at the end of the first month following a quarter end. The lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and the written agreement includes a most favored nations clause in relation to conversion features.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(30) On November 27, 2017, the Company signed a formal agreement memorializing previous agreements with the holder of an unsecured note and cash advance, with aggregate principal due of $1,200,000 as of June 30, 2017, as well as additional advances with aggregate principal of $190,000 that were received subsequent to June 30, 2017.&#160; The new agreement memorialized the terms of the note payable whereby the lender converted $617,500 in advances into a $1,100,000 unsecured note payable, with interest at 18% per annum for $95,226 in fees, which have been included in accrued liabilities and interest expense as of June 30, 2017.&#160; In addition, the new agreement allows for advances to incur fees at 1.5% of the advance principal per calendar day until paid in full.&#160; The written agreement adjusted the verbal agreements to where the note payable and advance balances and fees may be called by the lender at any time and are due by May 30, 2018, and the new agreement includes a most favored nations clause in relation to conversion features on the note payable and advances.&#160; The new agreement also assigned $2,000,000 of note payable principal held by an entity controlled by an officer of the Company to the lender.&#160; All interest accrued on the assigned balance is payable to the officer. </p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(31) On December 6, 2017 the Company entered into those certain forbearance and lock up letter agreements with three (3) debtors which held convertible debentures in the aggregate principal amount of $1,109,345 at the time of the agreements, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more.&#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&#160; In addition, two (2) of the debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(32) Effective December 11, 2017, the Company entered into a Securities Purchase Agreement (the &#147;Purchase Agreement&#148;) with four accredited investors, including the Company&#146;s new Chief Executive Officer in connection with the closing of a bridge financing (the &#147;Bridge Financing&#148;) in the gross amount of $600,000. The three remaining accredited investors hold notes payable with an aggregate principal balance of $3,865,865 as of June 30, 2017. Pursuant to the Purchase Agreements, the Investors purchased from the Company (i) Promissory Notes in the aggregate principal amount of $631,578.06 (the &#147;Notes&#148;) due and payable six months from the Effective Date and (ii) Common Stock Purchase Warrants (the &#147;Warrant&#148;), exercisable for five years from the date of issuance, to purchase up that certain amount of shares with an aggregate exercise amount equal to $600,000 at an exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in the companies contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the &#147;Private Placement&#148;) (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment hereunder (the &#147;Exercise Price&#148;). The Notes were issued in favor of the Investors with an original issue discount equal to five percent (5%). Additionally, pursuant to the Purchase Agreement, the Company will issue the investors common stock (the &#147;Origination Shares&#148;) worth 30% of the purchase price paid by each investor (the &#147;Origination Dollar Amount&#148;) on the 5th trading day after the pricing of the Private Placement, but in no event later than six months from the Effective Date. The Origination Dollar amount will divided by the lowest of (i) $3.00 (subject to adjustment for stock splits), (ii) 80% of the common stock offering price in the Private Placement, (iii) 80% of the offering price of the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement.&#160; At the closing of the Private Placement the Note shall automatically convert into a subscription into the Private Placement in an amount equal to 125% of the Note balance, subject to certain conditions as outlined therein. If the Company fails to repay the balance due under the Note on its Maturity the Investors have the right, at any time, at their election, to convert all or part of the outstanding and unpaid principal sum and accrued interest (and any other fees) into shares of fully paid and non-assessable shares of common stock of the Company pursuant to the following conversion formula: number of shares receivable upon conversion equals the dollar amount being converted divided by the Conversion Price. The Conversion Price is the lesser of $3.00 (subject to adjustment for stock splits) or 60% of the lowest trade price in the 25 trading days. Further, in the event of any default, the outstanding principal amount of the Notes, plus accrued but unpaid interest, liquidated damages, fees and other amounts owing in respect thereof through the date of acceleration (the &#147;Note Balance&#148;), shall become, at the Investor&#146;s election, immediately due and payable in cash at the Mandatory Default Amount. The Mandatory Default Amount means the investor&#146;s choice of (this choice may be made at any time without presentment, demand, or notice of any kind): (i) the Note Balance divided by the Conversion Price on the date of the default multiplied by the closing price on the date of the default; or (ii) the Note Balance divided by the Conversion Price on the date the Mandatory Default Amount is either (a) demanded or (b) paid in full, whichever has a lower Conversion Price, multiplied by the closing price on the date the Mandatory Default Amount is either (a) demanded or (b) paid in full, whichever has a higher closing price; or (iii) 150% of the Note Balance. If, at any time the Note is outstanding, the Company issues a Variable Security (as defined therein), then in such event the Investors shall have the right to convert all or any portion of the outstanding balance of the Notes into shares of Common Stock on the same terms as granted in any applicable Variable Security issued by the Company.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(33) On November 17, 2017, the Company received cash advances from third parties totaling $60,000.&#160; On January 5, 2018, the advances converted into agreements with the same terms as the Bridge Financing entered into on December 11, 2017.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(34) On December 11, 2017, Eric Robinson voluntarily resigned as Chief Financial Officer, Secretary and In-House Counsel, and all other positions with the Company to which he has been assigned regardless of whether he served in such capacity, effective immediately. On the same date, Jeffrey S. Peterson voluntarily resigned as Chairman of the Board of Directors, while acknowledging that he will continue to serve the Company as a Director and Executive Vice President.&#160; On the same date, Robert J. Welgos and Bradley Robinson voluntarily resigned as members of the Board of Directors and all other positions with the Company to which they may have been assigned, regardless of whether they served in such capacity, effective immediately.&#160; These resignations were not as a result of any disagreements with the Company.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(35) On December 11, 2017, Isaac Onn was appointed as a member of the Company&#146;s board of Directors and Mark J. Rosenblum was appointed as the Company&#146;s Chairman of the Board of Directors and Chief Executive Officer in connection with the Bridge Financing.&#160; In connection with Mr. Rosenblum&#146;s appointment as the Company&#146;s Chief Executive Officer, on December 11, 2017, the Company and Mr. Rosenblum finalized the terms of his employment and entered into an employment agreement (the &#147;Rosenblum Employment Agreement&#148;). Mr. Rosenblum shall have such duties, responsibilities and authority which shall include, but not be limited to the responsibility for the overall management, direction and strategy of the Company. The Company shall pay Mr. Rosenblum a salary at a rate of Three Hundred Thousand and 00/100 Dollars ($300,000) per year (the &#147;Initial Base Salary&#148;). The Initial Base Salary shall increase to an annual rate of Three Hundred and Sixty Thousand Dollars ($360,000) (the &#147;Base Salary&#148;) upon the Company closing a financing of at least Five Million Dollars ($5,000,000). Mr. Rosenblum shall be eligible for an annual performance-based cash bonus of up to 100% of the Base Salary (as further defined in the Rosenblum Employment Agreement&#148;). The Rosenblum Employment Agreement is for a term of three (3) years and will be automatically renewed for one year periods, unless otherwise terminated by the Company or Mr. Rosenblum. Upon execution of the Rosenblum Employment Agreement the Company agreed to issue restricted shares equal to $300,000 valued at the offering price of the next equity offering of the Company (&#147;RSU&#148;) and an option to purchase an aggregate $600,000 valued at the offering price of the next equity offering of the Company at an exercise price equal to the market price for the next equity offering of the Company (the &#147;Options&#148;). One-third of these Options shall vest immediately, another third on the first anniversary of the Rosenblum Employment Agreement, and the final third on the second anniversary of the Rosenblum Employment Agreement. The RSUs shall vest 50% immediately upon issuance and 25% on each of the first and second anniversaries of the Rosenblum Employment Agreement. If the Company terminates Mr. Rosenblum&#146;s employment without just cause or if Mr. Rosenblum&#146;s employment is terminated due to Disability (as defined therein), Mr. Rosenblum shall be entitled to receive, in addition to any accrued and unpaid Base Salary, plus any accrued but unused vacation time and unpaid expenses that have been earned as of the date of such termination, the following severance payments (the &#147;Severance Payments&#148;): (i) equal monthly installments at the applicable Base Salary rate then in effect, as determined on the first day of the calendar month immediately preceding the day of termination, to be paid beginning on the first day of the month following such termination and continuing until the later of (A) the expiration of the Term or (B) the expiration of (i) six (6) months following the effective termination date; provided, however, that if the Company terminates the Agreement without Just Cause (as defined in the Rosenblum Employment Agreement) within six (6) months of the effective date, then Mr. Rosenblum will only be entitled to three (3) months of severance instead of six (6) months; and (ii) during the Severance Period (as defined in the Rosenblum Employment Agreement), health and life insurance benefits substantially similar to those which Mr. Rosenblum was receiving or entitled to receive immediately prior to termination; provided, however, such insurance benefits shall be reduced to the extent comparable benefits during such period following Mr. Rosenblum&#146;s termination, and any benefits actually received shall be reported by Mr. Rosenblum to the Company.&#160; The Company will reimburse Mr. Rosenblum for any reasonably travel and relocation expenses.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(36) During December 2017, the Company entered into those certain forbearance and lock up letter agreements with a debtor which holds convertible debentures in the principal amount of $25,312 as of December 5, 2017, whereby the debtor agreed that, without prior written consent of the Company, the debtor will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more. Additionally, the debtor agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the convertible debentures. The forbearance and lock up letter agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(37) On January 12, 2018, the Company received letters from four (4) debtors which hold convertible debentures with principal balances totaling $3,162,955 as of June 30, 2017 where the debtors forbear against any historical and future events of default and remedies through February 15, 2018. Further, the maturity date was extended through February 15, 2018. &#160;As part of the letters, the Company agreed not to initiate any new financing arrangements without the consent of the debtors.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(38) On January 12, 2018, the Company received a letter from a lender who holds two unsecured notes payable with principal balances totaling $550,000 as of June 30, 2017 where the lender forbears against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock. </p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.7pt;margin-bottom:6.0pt;margin-left:.25in;text-indent:-.25in'>(39) &#160;On December 22, 2017, the Company entered into a Services Agreement (the &#147;Cleveland Clinic Agreement&#148;) with the Cleveland Clinic Foundation d.b.a. Cleveland Clinic, an Ohio nonprofit corporation (&#147;Cleveland Clinic&#148;). Pursuant to the Cleveland Clinic Agreement, the Company will be providing services to Cleveland Clinic as agreed to by the parties in any mutually agreed form pursuant to a &#147;Statement of Work&#148;. Pursuant to the Statement of Work included in the Cleveland Clinic Agreement, the Company will provide monitoring services to Cleveland Clinic&#146;s expected beneficiary diabetic population within the Cleveland Clinic Medicare ACO. The initial term of the Cleveland Clinic Agreement is for three years and shall automatically renew after the term for a successive twelve (12) month period from year to year unless sooner terminated by either party in accordance with the terms of the Cleveland Clinic Agreement. As consideration for the Company&#146;s Services, the Company is to receive a fixed monthly fee per Covered Diabetic Patient (as defined in the Cleveland Clinic Agreement). In addition, at such time the Cleveland Clinic Accountable Care Organization (&#147;CCACO&#148;) shall receive a shared savings payment from the Centers for Medicare and Medicaid Services, CCACO shall share such savings with the Company based on a formula defined in the Cleveland Clinic Agreement. Cleveland Clinic may, by written notice to the Company, terminate the Agreement, any purchase order or any portion of a purchase order if the Company (i) is in material breach of any of the terms and conditions of the Cleveland Clinic Agreement or any Purchase Order, which breach in not cured within thirty (30) days after notification of such breach, (ii) terminates or suspends its business, becomes insolvent, or becomes subject to any bankruptcy or insolvency proceeding under Federal or State law. Cleveland Clinic further may terminate the Cleveland Clinic Agreement, any Purchase Order or any portion of any Purchase Order for convenience upon ninety (90) days&#146; prior written notice to Company (&#147;Termination for Convenience&#148;). In connection with any Termination for Convenience, Cleveland Clinic will reimburse Company for the actual cost reasonably incurred for work in process up to the time of cancellation, as well as any non-cancellable contract of Company, or non-cancellable purchase order to a third party, entered into for the benefit of Cleveland Clinic. The Cleveland Clinic Agreement is nonexclusive, and Cleveland Clinic may contract with others to perform similar services. Accordingly, the Company may also perform similar services for others.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909569184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Nature of Operations: Going Concern (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Going Concern</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other'><i>Going Concern</i></p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in'>The Company continues to incur negative cash flows from operating activities and net losses.&#160; The Company had minimal cash, negative working capital and negative total equity as of June 30, 2017 and September 30, 2016.&#160; In addition, the Company is in technical default on certain notes payable although the lenders in each case are working with the Company to resolve the defaults.&#160; These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-autospace:none;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-autospace:ideograph-numeric ideograph-other'>In order for the Company to eliminate substantial doubt about its ability to continue as a going concern, it must achieve profitability, generate positive cash flows from operating activities and obtain the necessary debt or equity funding to meet its projected capital investment requirements.&#160; Management's plans with respect to this uncertainty consist of raising additional capital by issuing debt or equity securities and increasing the sales of the Company's services and products.&#160; There can be no assurance that the Company will be able to raise sufficient additional capital or that revenues will increase rapidly enough to achieve operating profits.&#160; If the Company is unable to increase revenues or obtain additional financing, it will be unable to continue the development of its products and services and may have to cease operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640744752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Nature of Operations: Use of Estimates in The Preparation of Financial Statements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates in The Preparation of Financial Statements</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i>Use of Estimates in the Preparation of Financial Statements</i></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the reporting periods. Actual results could differ from these estimates.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640712656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Nature of Operations: Fair Value of Financial Instruments (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i>Fair Value of Financial Instruments</i></p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>The Company measures the fair values of its assets and liabilities using the US GAAP hierarchy.&#160; The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts receivable, accounts payable, and accrued liabilities approximate fair values due to the short-term nature of these financial instruments. Derivative financial instruments are recorded at fair value based on current market pricing models. The carrying amounts reported for notes payable approximate fair values because the underlying instruments are at interest rates which approximate current market rates.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6618698528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Organization and Nature of Operations: Reclassifications (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Reclassifications', window );">Reclassifications</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'><i>Reclassifications</i></p> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>Certain prior year amounts have been reclassified to conform to the current period&#146;s presentation. The reclassifications had no effect on the previously reported net loss.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Reclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for classifying current financial statements, which may be different from classifications in the prior year's financial statements. Disclose any material changes in classification including an explanation of the reason for the change and the areas impacted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Reclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619104144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Recent Accounting Pronouncements: New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In May 2014, August 2015 and May 2016, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, <i>Revenue from Contracts with Customers</i>, ASU 2015-14 <i>Revenue from Contracts with Customers, Deferral of the Effective Date</i>, ASU 2016-12 <i>Revenue from Contracts with Customers, Narrow-Scope Improvements and Practical Expedients</i>, ASU 2017-13 <i>Revenue Recognition, Revenue from Contracts with Customers, Leases, and Leases: Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments</i>, and ASU 2017-14 <i>Income Statement&#151;Reporting Comprehensive Income, Revenue Recognition, and Revenue from Contracts with Customers</i>, respectively, which implement ASC Topic 606. ASC Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance under US GAAP, including industry-specific guidance. It also requires entities to disclose both quantitative and qualitative information that enable financial statements users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amendments in these ASUs are effective for annual periods beginning after December 15, 2017, and interim periods therein, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted for annual periods beginning after December 15, 2016. These ASUs may be applied retrospectively to all prior periods presented, or retrospectively with a cumulative adjustment to retained earnings in the year of adoption. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In August 2014, the FASB issued ASU 2014-15, <i>Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern</i>. This standard sets forth management's responsibility to evaluate, each reporting period, whether there is substantial doubt about the Company's ability to continue as a going concern, and if so, to provide related disclosures. ASU 2014-15 is effective for annual reporting periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its evaluation of going concern.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In July 2015, the FASB issued ASU 2015-11, <i>Inventory: Simplifying the Measurement of Inventory</i>. The purpose of ASU 2015-11 is to more closely align the measurement of inventory in US GAAP with the measurement of inventory in International Financial Reporting Standards. ASU 2015-11 requires entities to measure most inventory at the &quot;lower of cost or net realizable value.&quot; Additionally, some of the amendments are designed to more clearly articulate the requirements for the measurement and disclosure of inventory. ASU 2015-11 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In February 2016, the FASB issued ASU 2016-02, <i>Leases</i>.&#160; The purpose of ASU 2016-02 is to establish the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. This guidance results in a more faithful representation of the rights and obligations arising from operating and capital leases by requiring lessees to recognize the lease assets and lease liabilities that arise from leases in the statement of financial position and to disclose qualitative and quantitative information about lease transactions, such as information about variable lease payments and options to renew and terminate leases. ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In March 2016, the FASB issued ASU 2016-09, <i>Stock Compensation: Improvements to Employee Share-Based Payment Accounting</i>.&#160; The purpose of ASU 2016-09 is to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equities or liabilities, and classification of amounts in the statement of cash flows.&#160; ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016, which will be effective for the Company for the quarter ending December 31, 2017.&#160; The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In August 2016, the FASB issued ASU 2016-15, <i>Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments</i>. The amendments in this update provided guidance on eight specific cash flow issues. This update is to provide specific guidance on each of the eight issues, thereby reducing the diversity in practice in how certain transactions are classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In May 2017, the FASB issued ASU 2017-09, <i>Stock Compensation: Scope of Modification Accounting</i>. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. ASU 2017-09 is effective for fiscal years and interim periods beginning after December 15, 2017, which will be effective for the Company for the quarter ending December 31, 2018. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>In July 2017, the FASB issued ASU 2017-11, <i>Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivative and Hedging (Topic 815)</i>. The amendments in Part I of this update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down-round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down-round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&#146;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down-round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (&#147;EPS&#148;) in accordance with Topic 260 to recognize the effect of the down-round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down-round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt-Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Accounting Standards Codification, to a scope exception. Those amendments do not have an accounting effect. ASU 2017-11 is effective for fiscal years and interim periods beginning after December 15, 2018, which will be effective for the Company for the quarter ending December 31, 2019. Early adoption is permitted. The Company is assessing the impact, if any, of implementing this guidance on its consolidated financial position, results of operations and liquidity.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640554640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Net Loss per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><!--egx--> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="649" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="193" colspan="4" valign="bottom" style='width:144.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>Three Months Ended</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>June 30,</b></p> </td> <td width="18" valign="top" style='width:13.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="169" colspan="3" valign="bottom" style='width:126.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>Nine Months Ended</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>June 30,</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> 2017 </b></p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2016</b></p> </td> <td width="18" valign="top" style='width:13.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2017</b></p> </td> <td width="19" valign="bottom" style='width:14.45pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2016</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'><b>Numerator:</b></p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Net loss attributable to common stockholders</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(5,873,988)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>3,304,133</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(15,151,168)</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(14,924,907)</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>Effect of dilutive securities on net loss:</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt'>Common stock warrants</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(2,427,640)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt'>Convertible debt</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(1,860,373)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(1,790,407)</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total net loss for purpose of </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>&#160; calculating diluted net loss</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>&#160; per common share</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(5,873,988)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(983,880)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(15,151,168)</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(16,715,314)</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'><b>Number of shares used in per common share </b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'><b>&#160; calculations:</b></p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total shares for purposes of calculating basic</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>&#160; net loss per common share</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>237,100</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>217,595</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>233,767</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>182,979</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>Weighted-average effect of dilutive securities:</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt'>Common stock warrants</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>3,337</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:15.95pt'>Convertible debt</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>39,334</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>18,949</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total shares for purpose of calculating diluted </p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:10.0pt'>&#160; net loss per common share</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>237,100</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>260,266</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>233,767</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>201,928</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'><b>Net loss per common share:</b></p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Basic</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(24.77)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15.18</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(64.81)</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(81.57)</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Diluted</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(24.77)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(3.78)</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(64.81)</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(82.78)</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619311568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Net Loss per Common Share: Schedule of Common Stock Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfCommonStockEquivalents0TextBlock', window );">Schedule of Common Stock Equivalents</a></td>
<td class="text"><!--egx--> <p style='margin-top:0in;margin-right:.9pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="649" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="193" colspan="4" valign="bottom" style='width:144.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>Three Months Ended</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>June 30,</b></p> </td> <td width="18" valign="top" style='width:13.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="169" colspan="3" valign="bottom" style='width:126.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>Nine Months Ended</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>June 30,</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="bottom" style='width:2.8in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> 2017 </b></p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2016</b></p> </td> <td width="18" valign="top" style='width:13.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2017</b></p> </td> <td width="19" valign="bottom" style='width:14.45pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>2016</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Common stock warrants</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>109,174</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>18,346</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>109,174</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>42,378</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Series D convertible preferred stock</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>450</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>450</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>450</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>450</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Series E convertible preferred stock</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>961</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>961</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>961</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>961</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Convertible debt</p> </td> <td width="8" valign="bottom" style='width:6.35pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>158,798</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>95,799</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>158,798</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>95,799</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Restricted shares of common stock</p> </td> <td width="8" valign="bottom" style='width:6.35pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>15</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Liability to issue common stock and warrants</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>358,097</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,246</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>358,097</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,246</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="8" valign="bottom" style='width:6.35pt;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="18" valign="bottom" style='width:13.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="19" valign="bottom" style='width:14.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="269" valign="top" style='width:2.8in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:16.1pt'>Total common stock equivalents</p> </td> <td width="8" valign="bottom" style='width:6.35pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right;text-indent:10.0pt'>&nbsp;</p> </td> <td width="89" valign="bottom" style='width:66.55pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>627,495</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'></td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>117,817</p> </td> <td width="18" valign="bottom" style='width:13.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="72" valign="bottom" style='width:.75in;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>627,495</p> </td> <td width="19" valign="bottom" style='width:14.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="78" valign="bottom" style='width:58.5pt;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>141,849</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfCommonStockEquivalents0TextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the textual narrative disclosure of Schedule of Common Stock Equivalents, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ScheduleOfCommonStockEquivalents0TextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640803312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Inventory: Schedule of Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><!--egx--><div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> June 30, 2017 </b></p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>&#160;</b><b>September 30, 2016 </b></p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Finished goods </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>503,477</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>206,444</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Inventory reserve</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(1,708)</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(1,708)</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:13.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:7.95pt'>Net inventory</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>501,769</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>204,736</p> </td> </tr> <tr style='height:2.25pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:2.25pt'></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6621609104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Prepaid Expenses and Other Current Assets: Schedule of Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><!--egx--><div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;background:white;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> June 30, 2017 </b></p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>&#160;</b><b>September 30, 2016 </b></p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Prepaid information technology services </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>38,081</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>57,073</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Other </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>12,249</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>112,117</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Prepaid insurance </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>6,225</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>14,602</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Prepaid legal and professional fees </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>333,741</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Research and development </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>96,346</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;Line of credit acquisition fees </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>30,978</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:26.25pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:7.95pt'>Total prepaid expenses and &#160;&#160; other current assets</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>56,555</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:26.25pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>644,857</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637580960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. Property and Equipment: Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><!--egx--> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> June 30, 2017 </b></p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>&#160;</b><b>September 30, 2016 </b></p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Software</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>47,974</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>47,974</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Leasehold improvements</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>98,023</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>98,023</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Furniture</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>68,758</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>68,758</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Equipment</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>47,191</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>49,772</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total property and equipment</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>261,946</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>264,527</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>Accumulated depreciation and amortization</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(205,501)</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>(177,793)</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:13.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Property and equipment, net</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>56,445</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>86,734</p> </td> </tr> <tr style='height:6.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6618519760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Accrued Expenses: Schedule of Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><!--egx--><div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;background:white;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b> June 30, 2017 </b></p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:center'><b>&#160;</b><b>September 30, 2016 </b></p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&#160;Interest </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,694,545</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>1,206,387</p> </td> </tr> <tr style='height:25.5pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&#160;Liability to issue warrants for the purchase &#160;&#160; shares of common stock </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,081,254</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:25.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Liability to issue common stock </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,000,933</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>240,000</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Finance fees </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>333,000</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&#160;Payroll expense </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>329,615</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>207,052</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Other </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>141,394</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>89,828</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Deferred revenue </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>85,399</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>111,803</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Warranty liability </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>58,300</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>134,330</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&#160;Commissions and fees </p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>40,997</p> </td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>52,311</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'> Severance </p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>-</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>60,000</p> </td> </tr> <tr style='height:12.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-top:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:12.75pt'></td> </tr> <tr style='height:13.5pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-indent:7.95pt'>Total accrued expenses</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>7,765,437</p> </td> <td width="16" valign="bottom" style='width:11.8pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:1.1in;border:none;border-bottom:double windowtext 2.25pt;background:#DBEEF3;padding:0in 5.4pt 0in 5.4pt;height:13.5pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;text-align:right'>2,101,711</p> </td> </tr> <tr style='height:6.75pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="16" valign="bottom" style='width:11.8pt;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> <td width="106" valign="bottom" style='width:1.1in;padding:0in 5.4pt 0in 5.4pt;height:6.75pt'></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6631760576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Notes Payable: Schedule of Debt - Other (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt - Other</a></td>
<td class="text"><!--egx--><table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="451" valign="bottom" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>June 30,</b></p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>September 30,</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="bottom" style='width:338.0pt;padding:0;height:9.35pt'></td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>2017</b></p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>2016</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured notes payable with interest at 10% per annum, due November 2018.&#160; The notes may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; Some of the notes are currently in technical default. However, as of the time of this report, the lenders have informally agreed to work with the Company until such time as the note can be repaid.&#160; &#160;&#160;In February 2016, the Company redeemed all 5,361 shares of its Series F Convertible Preferred Stock (&quot;Series F preferred&quot;) plus accrued dividends of $673,948 for 20,005 shares of common stock with a fair value of $1,600,000 containing certain temporary restrictions, and $5,900,000 of notes payable. Payments on the notes are partially or fully convertible at the Company's option at the lesser of (i) 80% of the per share price of the common stock to be offered in the proposed offering that is described in the Form S-1 filed on July 19, 2016 (the &quot;Offering&quot;), (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering to a maximum of 39,334 shares of common stock.&#160; The conversion rate is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&#160; A note may only be converted if the holder owns less than 4.99% of the Company's common stock after conversion.&#160; The Company recorded a derivative liability of $2,461,899 related to the conversion feature of the notes.&#160; In connection with the redemption of the Series F preferred stock, the Company issued new warrants in exchange for warrants held by the Series F preferred stockholders for the purchase of 11,070 shares of common stock at an exercise price of the lesser of (i) 80% of the per share price of the common stock of the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering (if applicable), or (iv) the exercise price of any warrants issued in the Offering, adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of certain other raises.&#160; The Company is also required to issue additional warrants for the purchase of up to 16,000 shares of common stock exercisable at $0.50 per share, also adjustable, that vest upon certain events of default.&#160; On December 11, 2017, the Company entered into Securities Purchase Agreements that adjusted the conversion rate to exercise price per share equal to the lesser of (i) 80% of the per share price of common stock in a contemplated private placement of securities of up to $5,000,000, contemplated to take place within six months of the effective date (the &#147;Private Placement&#148;) (ii) $3.00 per share, (iii) 80% of the offering price in the Private Placement (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Private Placement, in each case subject to adjustment (see Note 18).&#160; The fair value of $1,344,608 related to the new warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value of the stock, conversion feature, warrants and $25,000 of fees, in excess of the carrying value of the Series F preferred stock were recorded as a deemed dividend of $6,484,236.&#160; During the three months ended March 31, 2017, the Company entered into letter agreements related to the note to convert the outstanding principal and interest into shares of common stock contingent upon the Offering, which also removes the maximum share limitation conversion, which have expired (see Note 17).&#160; Subsequent to June 30, 2017, the Company received letters related to the notes wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 (see Note 18).&#160; In December 2017, the Company entered into those certain forbearance and lock up letter agreements with four of the eight debtors, with principal balances in the aggregate amount of $1,134,658, whereby the debtors agreed that, without prior written consent of the Company, the debtors will not, directly or indirectly, (i) offer for sale, sell, pledge, or otherwise transfer or dispose of (or enter into any transaction that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) any shares of Common Stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock, (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction is to be settled by delivery of common stock or other securities, in cash or otherwise, (iii) except as provided for, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any other securities of the Company, or (iv) publicly disclose the intention to do any of the foregoing for a period of the earlier of (a) June 5, 2018 or (2) the consummation of a qualified offering, herein deemed as an offering by the Company of $3,000,000 or more.&#160; Additionally, the Debt Holders agreed that they will forbear from enforcing their rights and remedies against any defaults which may exist historically, currently or in the future through June 5, 2018 under the existing loan documents.&#160; The agreements automatically terminate upon the earlier of (i) inability to raise a minimum of $550,000 in capital on or before December 31, 2017; (ii) June 5, 2018; or (iii) the consummation of a qualified offering of at least $3,000,000 by the Company.&#160; In addition, two of the five debtor agreements waive their rights to default litigation only through December 31, 2017 and any new financing must receive their prior consent unless it is common equity (see Note 18). On January 12, 2018, the Company received letters from four of the debtors where the debtors forbear against any historical and future events of default and remedies through February 15, 2018. Further, the maturity date was extended through February 15, 2018.&#160; As part of the letters, the Company agreed not to initiate any new financing arrangements without the consent of the debtors. (see Note 18).&#160; On December 11, 2017, the Company borrowed an aggregate additional $300,000 from two of the lenders under new note payable agreements (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;5,900,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;5,900,000 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured borrowings from a third party that purchased $3,257,600 of customer receivables for $2,100,000, with due dates ranging from January 2018 to October 2018, and payable in daily payments ranging from $5,000 to $13,000.&#160; The $1,157,600 difference between the customer receivables and cash received is being amortized to interest expense over the term of the respective notes.&#160; The secured borrowings are guaranteed by a former chief executive officer of the Company and are subordinated to other notes payable. On April 17, 2017, the Company entered into a factoring agreement which provides for an advance of $1,794,000, comprised of $1,000,000 in cash and the consolidation of $794,000 from four prior factoring agreements into the amounts owed under the factoring agreement (collectively, the &quot;Funds&quot;). In consideration for the Funds, the Company sold to the lender all future receipts until the total amount of $2,511,601 has been paid. The factoring agreement requires payment of the minimum daily amount of $12,999.99 for 193 days. The $2,511,601 can be reduced if repayment occurs more quickly. Repayment of the amounts owing is with recourse and secured by all accounts, chattel paper, documents, equipment, general intangibles, instruments, and inventory of the Company and subordinated to other notes payable.&#160; In June 2017, the lender verbally agreed to reduce the minimum daily amount to $5,000 and, in November 2017, verbally agreed to further reduce the minimum daily amount to $2,600 through January 7, 2018, after which the daily amount would return to $13,000.&#160; Subsequent to June 30, 2017, the Company entered into similar secured borrowings and related verbal or written reductions in the daily amounts.&#160; On January 5, 2018, the Company further modified each agreement to keep the amount of the daily payments at approximately the same level as the agreement on November 7, 2017 through mid-March 2018, except one where the lower payments are only through February 5, 2018 &#160;(see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 1,974,602 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 689,318 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="bottom" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Unsecured note payable with a vendor with interest at 0.65% per annum payable at the end of each calendar year, due January 2018, issued in March 2016 upon the conversion of $2,523,937 in accounts payable to the vendor.&#160; The note requires payments of $50,000 per month in April 2016 through December 2016, $100,000 per month in January 2017 through December 2017 and the remaining balance due in January 2018.&#160; In September 2017, the Company entered into agreements with the vendor which supersedes the unsecured note payable agreement and provides new terms (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 1,773,937 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 2,223,937 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with a third party with no interest, was due the earlier of November 2016 or the third business day after the closing of a proposed Offering. The note is currently in technical default. However, as of the time of this report, the lender has provided bridge capital since going in default and has informally agreed to work with the Company until such time as the note can be repaid. &#160;Pursuant to the note, the Company may borrow up to $1,500,000 upon meeting certain milestones and may be converted into shares of common stock upon default.&#160; The note required a payment of common stock on the 5th trading day after the pricing of the proposed Offering, but no later than December 15, 2016.&#160; The number of common shares will equal $200,000 divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the common shares or during the ten days prior to the date of the Purchase Agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price of the Offering, or (iv) the exercise price of any warrants issued in the Offering.&#160; The estimated fair value of $240,000 of the stock is included in accrued liabilities and is being amortized to interest expense over the life of the note.&#160; In connection with the issuance of the note, the Company also issued 20,000 warrants to purchase shares of common stock at an exercise price per share equal to the lesser of (i) 80% of the per share price of the common stock in the Offering, (ii) $25 per share, (iii) 80% of the unit price in the Offering, or (iv) the exercise price of any warrants issued in the Offering and the number of shares will reset upon the closing of the Offering.&#160; The warrants may only be exercised to the extent the holder would own a maximum of 9.99% of the Company's common stock after exercise.&#160; The fair value of $493,590 related to the replacement warrants was recorded as a derivative (see Notes 12 and 15).&#160; Of this fair value amount, $220,000 was recorded as a debt discount and is being amortized over the life of the note and the remaining $273,590 was recorded as a loss on derivative liability.&#160; In the event of borrowing in excess of an initial $500,000, the Company will be required to issue additional warrants with an aggregate exercise amount equal to 100% of the additional amount borrowed with similar terms to the initial warrants issued.&#160; In November 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $286,171 related to the November 2016 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; In November 2016, the Company amended the note to extend the maturity date to the earlier of January 31, 2017 or the third business day after the closing of the Offering.&#160; In addition, the amendment adjusted the origination shares to equal 20% of the note divided by the lowest of (i) the lowest daily closing price of the common stock during the ten days prior to delivery of the shares or during the ten days prior to the date of the agreement, (ii) 80% of the common stock Offering price of the Offering, (iii) 80% of the unit price Offering price (if applicable), or (iv) 80% of the exercise price of any warrants issued in the Offering.&#160; In December 2016, the Company borrowed an addition $250,000 on the note and issued an additional warrant for the purchase of 10,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $349,819 related to the December 2016 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; On January 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $567,753 related to the January 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note. On January 30, 2017, the Company amended the note to extend the maturity date to the earlier of March 15, 2017 or the third business day after the closing of the Offering. Also on January 30, 2017. the Company borrowed the remaining $300,000 on the note and issued an additional warrant for the purchase of 12,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $899,598 related to the January 30, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The fair value was recorded as a debt discount and is being amortized over the remaining life of the note.&#160; On March 3, 2017, the Company amended the note to increase the maximum sum from $1,500,000 to $2,000,000. Also on March 3, 2017, the Company borrowed an additional $200,000 on the note and issued an additional warrant for the purchase of 8,000 shares of common stock with similar terms to the original warrants.&#160; The fair value of $407,947 related to the March 3, 2017 warrants was recorded as a derivative (see Notes 12 and 15).&#160; The Company recorded a loss on extinguishment of debt of $501,969 related to the March 3, 2017 amendment and additional borrowing. Effective March 27, 2017, the Company amended the note to extend the maturity date to the earlier of April 15, 2017 or the third business day after the closing of the Offering. Additionally, the lender agreed to enter into a lock up prohibiting the sale or other transfer of all securities of the Company owned by them for a period of 6 months. In consideration for entering into the lock-up agreement the Company has agreed to pay a $340,000 fee, payable in shares of common stock at a rate of the lowest of (i) 80% of the common stock Offering price of the Offering, (ii) 80% of the unit price Offering price of the Offering (if applicable), or (iii) 80% of the exercise price of any warrants issued in the Offering.&#160; The lock-up agreement was signed during April 2017, which has expired. Effective April 19, 2017, the Company amended the note to extend the maturity date to the earlier of May 20, 2017 or the third business day after the closing of the Offering. On December 11, 2017, the Company borrowed an additional $250,000 from the lender under a new note payable agreement (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;1,700,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 500,000 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured note payable to a third party with interest at 12.75% per annum, due February 2019, in default.&#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; The Company entered into the note payable agreement in conjunction with a line of credit.&#160; The Company initially borrowed $1,500,000 and may borrow additional amounts under the note payable agreement up to a total balance of $3,000,000 as the Company meets certain milestones.&#160; The interest rate may also reduce to 11.25% per annum as the Company meets certain milestones.&#160; In conjunction with the note and related line of credit, the Company issued warrants to the lender to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&#160; The Company has recorded discounts of $1,500,000, which are being amortized to interest expense over the term of the note.&#160; In April 2016, the Company borrowed an additional $500,000 on the note and incurred additional fees of $25,000, which are being amortized to interest expense over the remaining term of the note.&#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issue the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the &quot;November Forbearance Agreement&quot;). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the &quot;November Forbearance&quot;) with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company's Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company's Series G Preferred Stock to certain affiliates of the Company.&#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the &quot;December Forbearance&quot;). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $15,470 on the note payable. </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;1,152,778 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;1,652,778 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured line of credit with a third party with interest at 12.25% per annum, due February 2018, in default.&#160; The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; The Company entered into the line of credit agreement in conjunction with a note payable.&#160; The Company may draw up to the lesser of 80% of certain accounts receivable or $1,500,000 and increase the maximum it may borrow under the agreement up to a total balance of $3,000,000 at $500,000 per increase as the Company meets certain milestones.&#160; The interest rate may also reduce to 10.75% per annum as the Company meets certain milestones.&#160; In conjunction with the line of credit and related note, the Company issued warrants to purchase 24,032 shares of common stock at $32.50 per share with a fair market value of $3,732,100 (see Notes 12 and 15), which resulted in a loss on derivative of $2,309,461.&#160; The Company has recorded prepaid expenses of $44,665, which are being amortized to interest expense over the term of the line of credit.&#160; In September 2016, the Company entered into a forbearance agreement where the lender will forbear from exercising remedies with regard to certain breaches through October 31, 2016 and consented to the Company entering into a purchase agreement with another party and issuance of the note and the warrant thereunder. Effective November 1, 2016, the Company and a lender entered into a forbearance and consent under a loan and security agreement (the &quot;November Forbearance Agreement&quot;). Pursuant to the terms of the November Forbearance Agreement, the lender will forbear from exercising remedies (the &quot;November Forbearance&quot;) with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous forbearance agreement.&#160; Additionally, pursuant to the November Forbearance Agreement, the lender has provided the Company with the consent required under the existing agreements and previous forbearance agreement to make certain payments from the proceeds of the Offering. These payments include, but are not limited to (i) payments to holders of the Company's Series E Preferred, (ii) third party note and receivable payments and (iii) repayment of an unsecured note payable issued in September 2016. The lender also consented to the issuance of the Company's Series G Preferred Stock to certain affiliates of the Company.&#160; In consideration for the November Forbearance, the Company has agreed to issue the lender warrants to purchase 130,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering, which shall be subject to a 12-month lock-up agreement.&#160; The Company has included the $1,932,577 estimated fair value of the warrants in accrued expenses as of June 30, 2017. The Forbearance set forth in the November Forbearance Agreement was in effect through December 31, 2016.&#160; The Company recorded a loss on extinguishment of debt of $2,043,715 on the note and its related line of credit in relation to the forbearance agreement.&#160; Effective December 31, 2016, the Company and the lender entered into a forbearance and consent under loan and security agreement (the &quot;December Forbearance&quot;). Pursuant to the terms of the December Forbearance, the lender will forbear from exercising remedies with regard to certain breaches of agreements between the Company and the lender, including the existing agreements as well as the previous two forbearances.&#160; Additionally, pursuant to the December Forbearance, the lender has provided the Company with the consent required under the Existing Agreements and prior two forbearances to make certain payments from the proceeds of the Offering. In consideration for the December Forbearance, the Company has agreed to issue the lender warrants to purchase 10,000 shares of common stock at an exercise price equal to the per share price of the common stock in the Offering and $50,000 of common stock at 80% of the at the same issue price in of the Offering, which shall be subject to a lock-up agreement.&#160; The $148,677 estimated fair value of the warrants and $60,000 fair value of the stock has been included in accrued expenses as of June 30, 2017.&#160; $104,824 of the fair value of the warrants and common stock associated with the note is recorded as a discount and is being amortized to interest expense over the remaining life of the note. The forbearance set forth in the December Forbearance was in effect through February 15, 2017.&#160; On February 15, 2017, the lender extended the December Forbearance period through March 31, 2017.&#160; On March 28, 2017, the lender extended the December Forbearance period through April 10, 2017.&#160; In March 2017, the Company modified the line of credit to include an additional secured borrowing of a maximum of $300,000. The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $16,997 on the note payable.</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;1,259,007 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;929,518 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 18% per annum, with no maturity date.&#160; The note payable is from a verbal agreement with the lender which converted $617,500 of advances into $1,100,000 of principal on the note payable.&#160; The additional $482,500 of principal plus agreed upon fees of $95,226 have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&#146;s common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,100,000</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 2.8% of total revenue per annum, with no maturity date.&#160; The note payable is from a verbal agreement with the lender which converted a $350,000 advance into the note payable.&#160; Agreed upon fees of $143,987 and a future payoff fee of 20%, or $70,000, have been included in accrued liabilities and were booked to interest expense immediately. During November 2017, the Company amended the note to where the Company is required to pay any outstanding interest at the end of the first month following a quarter end, the lender may call all amounts due under the note payable as due and payable after February 28, 2018, given 15 calendar days notice, and to become convertible into shares of the Company&#146;s common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>350,000</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:white;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Note payable previously secured by CareServices customer contracts.&#160; In January 2015, the note was amended to reduce the outstanding principal to $375,000, interest at 9% per annum, and payable in 15 monthly installments beginning in February 2015.&#160; The amendment released the collateralized customer contracts and the note payable is guaranteed by both a former Executive Chairman of the Board of Directors and a member of the Board of Directors.&#160; A gain on the extinguishment of the old note of $769,449 was recorded in other income.&#160; In December 2015, the note was amended to extend maturity to January 2018 payable in monthly installments beginning in July 2016, convert $31,252 from accrued interest into principal, interest at 10% per annum, and provide that the note is convertible into common stock at its fair value per share.&#160; The Company recorded a derivative in connection with the convertible feature of the note (see Note 12) and is amortizing the initial $302,690 fair value of the derivative liability over the life of the note.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016.&#160; In July 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or November 2016 and included additional default penalties and payment terms.&#160; In October 2016, the note was amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or December 31, 2016 and included additional default penalties and payment terms.&#160; In December 2016, February 2017 and March 2017, the note was further amended to extend the maturity date to the earlier of an equity raise in excess of $10,000,000 or February 15, 2017, March 31, 2017, and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lender waived any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;334,464 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;334,464 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 12% per annum, due February 2016, convertible into common stock at $150 per share.&#160; In connection with the issuance of the note, the Company repriced previously issued warrants to purchase shares of common stock.&#160; The $22,397 increase in relative fair value of the warrants was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&#160; The note also required a payment of 6,000 shares of common stock.&#160; The fair value of $780,000 was included as a loss on the extinguishment of the old note in other expense in fiscal 2015.&#160; The maturity date was subsequently extended on two occasions for a total of 500 shares of common stock and the note was due May 2016.&#160; The $31,250 fair value of these shares was being amortized over the extension period.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company's common stock on the date of the amendment.&#160; The note may only be converted if the holder owns less than 9.99% of the Company's common stock after conversion.&#160; The Company recorded the value of the beneficial conversion feature of $381,299 to loss on termination of debt as a result of the modification.&#160; In May 2016, the note was amended to extend the maturity date to the earlier of an equity raise of $10,000,000 or October 2016 which required a payment of 600 shares of common stock.&#160; The $28,500 fair value of these shares has been included in accrued liabilities and was amortized over the extension period.&#160; In October 2016, the Company extended the maturity date of the note month-by-month through no later than April 30, 2017 for a fee of $5,000 per month extended.&#160; During September 2017, the Board of Directors granted 200 shares of Series H Preferred Stock for extension fees. In October 2017, the Company entered into a settlement agreement related to the note where the Company borrowed an additional $200,000 and modified the terms of the note payable to become secured by inventory owned by the Company, requires issuance of 3,000 shares of Series H Preferred Stock, which were authorized for grant by the Board of Directors on September 5, 2017 and are required to be able to convert the lender&#146;s shares into 300,000 shares of the Company&#146;s common stock, and requires payments of $8,600 for 72 consecutive weeks.&#160; If any payment is late, the Company is required to issue the lender an additional 86 shares of Series H Preferred Stock per late payment and an additional 172 shares of Series H Preferred stock if late payments are not cured within 30 days and for each subsequent 30-day period the note is in default.&#160; The amended note also requires payment of a key man life insurance policy on a former Executive Chairman of the Board of Directors naming the lender as the benefactor.&#160; The fair value of the shares will be amortized over the life of the amended note.&#160; The note terms are adjustable for any terms subsequently provided to other investors (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;300,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;300,000 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured note payable with interest at 12.25% per annum, due May 2017, in default. The note is secured by the assets of the Company and may go into default in the event other notes payable go into default subsequent to the effective date of the note. The Company entered into the agreement in conjunction with a modification to another note payable and line of credit. The note requires payment of a $3,000 modification fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&#160; The Company recorded a loss on extinguishment of debt of $56,741 related to the modification. The Company has accrued default interest of $4,050 on the note payable.</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;300,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;-&#160;&#160; </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 12.75% per annum, due June 2017, in default, subordinated to other notes payable. The note requires payment of a $3,000 closing fee and requires payment of a fee of $50,000 for each thirty days that the loan is outstanding.&#160; The $3,000 closing fee is being amortized to interest expense over the remaining term of the note and the $50,000 fees are being accrued as incurred.&#160; On January 12, 2018, the lender forbore against any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;300,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;-&#160;&#160; </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable with interest at 12% per annum, due September 2016, in default, subordinated to other notes payable.&#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&#160; The $100,000 fair value of the stock was amortized to interest expense over the term of the note.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). On January 12, 2018, the lender forbore against9/ any historical and future events of default through February 28, 2018 and extended the maturity date through February 28, 2018 in exchange for 12,000 shares of common stock (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;250,000 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;250,000 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured cash advance with fees at $1,000 per day for the first 15 days and $1,500 per day thereafter, with no maturity date.&#160; The terms of the advance are verbal. During November 2017, the Company amended the advance to be callable at any time, due May 30, 2018, and to become convertible into shares of the Company&#146;s common stock at the most favorable rate available as of the date of the agreement.&#160; The conversion rate may adjusted for any more favorable conversion terms provided to any other note holder at a future date (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>100,000</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured notes with interest at 18% per annum, due April 2013, in default.&#160; The Company issued 20,000 shares of Series D preferred stock as loan origination fees.&#160; The $195,000 fair value of the preferred stock was amortized over the original term of the note.&#160;&#160; Principal of $50,000 and accrued interest of $13,333 were converted to common stock in December 2013.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17).</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 64,261 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 64,261 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Secured note payable to a third party with interest at 18% per annum, due June 2017.&#160; The note was secured by shares of the Company's common stock held by, and other assets of an entity controlled by, a former Executive Chairman of the Board of Directors. &#160;The note was guaranteed by a former Executive Chairman of the Board of Directors and his related entity and may go into default in the event other notes payable go into default subsequent to the effective date of the note.&#160; Payments on the note were convertible at the holder's option into common stock at 75% of its fair value if not paid by its respective due date, which is subject to a 20 trading day true-up and is adjustable to any lower rates granted through equity sales or other conversion rates provided by issuances of other debt, warrants, options or other instruments, with the exception of other certain raises.&#160; The Company recognized a derivative liability related to the conversion feature with a fair value of $181,670, which was recognized as a loss on termination of debt.&#160; In June 2016, $13,713 of principal and $11,287 of accrued interest converted into 953 shares of common stock, pursuant to the terms of the note.&#160; In August 2016, $64,654 of principal and $10,346 of accrued interest converted into 9,203 shares of common stock, pursuant to the terms of the note.&#160; This note was terminated by paying the remaining principal and accrued interest in cash with no additional consideration.</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;-&#160;&#160; </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;162,539 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-top:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160; Total notes payable before discount</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 16,859,049 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;13,006,815 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160;&#160;&#160;&#160; Less discount</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> (1,468,335)</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> (1,930,060) </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160; Total notes payable</p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;15,390,714 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;11,076,755 </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160;&#160;&#160;&#160;&#160; Less current portion</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> (9,501,544)</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> (3,722,899) </p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:.95in;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.25pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="451" valign="top" style='width:338.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&#160; Notes payable, net of current portion</p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:.95in;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'> 5,889,170 </p> </td> <td width="7" valign="bottom" style='width:5.25pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&#160;7,353,856 </p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642125744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. Related Party Notes Payable: Schedule of Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text"><!--egx--> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-top:6.0pt;margin-right:.9pt;margin-bottom:6.0pt;margin-left:0in;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="450" valign="bottom" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>June 30,</b></p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>September 30,</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="bottom" style='width:337.7pt;padding:0;height:9.35pt'></td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>2017</b></p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>2016</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'> Secured borrowings from entities controlled by an officer who purchased a $2,813,175 customer receivable for $1,710,500.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; The Company repurchased the receivable for $1,950,000 less cash received by the entities through March 2015.&#160; The $239,500 difference between the buyback and cash received plus $253,500 of loan origination fees was amortized to interest expense through March 2015.&#160; In September 2015, the note was modified to extend the maturity date to January 2017, with interest at 18% per annum.&#160; The Company added $81,600 of extension fees and issued 6,000 shares of common stock to a lender as part of the modification.&#160; The note is convertible into common stock at $150 per share.&#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and the conversion price was reduced to $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lenders.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lenders, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lenders waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,721,100</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,721,100</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'> Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due January 2017, convertible into common stock at $150 per share.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; The Company issued 6,000 shares of common stock to a lender as loan origination fees.&#160; The $540,000 fair value of the common stock was recognized as a loss on extinguishment of debt in fiscal 2015.&#160; In February 2016, the note was amended to subordinate to other notes payable also issued during February 2016, and reduced the conversion price to $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the lender.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the lender, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,303,135</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,303,135</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to an entity controlled by a former Executive Chairman of the Board of Directors with interest at 18% per annum, due January 2017.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In February 2016, notes payable to the same entity, with outstanding balances of $511,005 plus accrued interest of $30,999 combined into this note.&#160;&#160; The note is subordinated to notes payable to unrelated parties and is convertible into shares of common stock at $30 per share, which was below the fair value of the Company's stock on the date of the agreement.&#160; The conversion of the note is limited to a maximum of 18,500 common shares.&#160; The Company recorded the value of the beneficial conversion feature of $632,339 to loss on termination of debt.&#160; The note has a default penalty of 1,469 shares of common stock if not paid by maturity. The note may only be converted if the holder owns less than 4.99% of the Company's common stock after conversion.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>542,004</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>542,004</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to an entity controlled by an officer with interest at 12% per annum, due September 2016, subordinated to other third party notes payable.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In connection with the issuance of the note, the Company issued 2,000 shares of common stock.&#160; The $70,000 fair value of the stock is being amortized to interest expense over the term of the note.&#160; During the three months ended March 31, 2017, the Company entered into a letter agreement related to the remainder of the note to convert the outstanding principal and interest into shares of common stock contingent upon the completion of the Offering, which has expired (see Note 17). Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>250,000</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>250,000</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to a former officer with interest at 12% per annum, due September 2013.&#160; This note is in default and is convertible into common stock at $375 per share.</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>26,721</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>26,721</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to an entity controlled by an officer with interest at 18% per annum, due on demand.&#160; The note is currently in technical default. However, as of the time of this report, the lender has informally agreed to work with the Company until such time as the note can be repaid.&#160; In February 2016, the note was amended to subordinate the note to other notes payable also issued during February 2016.&#160; The note is convertible into shares of common stock at $30 per share, which was below the fair value of the Company's stock on the date of the amendment.&#160; The conversion of the note is now limited to a maximum of 40,000 common shares in combination with other convertible notes payable held by the entity.&#160; The note has a default penalty of 8,407 shares of common stock, in combination with other convertible notes held by the entity, if not paid by maturity.&#160; The Company recorded the value of the combined beneficial conversion features of $1,400,000 to loss on termination of debt as a result of the amendment.&#160; In January 2017 and February 2017, the note was amended to extend the maturity date to February 15, 2017 and April 30, 2017, respectively. Subsequent to June 30, 2017, the Company received a letter related to the note wherein the lender waived any historical and future events of default through August 24, 2017 and extended the maturity date through August 24, 2017 and later sent an additional letter where the lenders waived any historical and future events of default through January 12, 2018 and extended the maturity date through January 12, 2018 (see Note 18).&#160; In November 2017, the officer assigned $2,000,000 of principal all of the notes payable held by the related-party entities to a third party who the Company owed aggregate principal of $1,200,000 as of June 30, 2017.&#160; Interest accrued on the $2,000,000 assigned principal will continue to be payable to the related-party entities (see Note 18).</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>25,463</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>25,463</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to a former officer with interest at 15% per annum, due June 2012, in default.&#160; The note included a $3,000 loan origination fee added to the principal and is convertible into common stock at $250 per share.</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,260</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>17,227</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>Unsecured note payable to a former officer with interest at 12% per annum, due on demand.</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>12,474</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&#160;&#160; Total notes payable, related-party</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>3,869,683</p> </td> <td width="7" valign="bottom" style='width:5.3pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>3,898,124</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&#160;&#160;&#160;&#160;&#160; Less current portion</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(3,869,683)</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(3,898,124)</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> <td width="7" valign="bottom" style='width:5.3pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="91" valign="bottom" style='width:68.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="450" valign="top" style='width:337.7pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:justify;text-justify:inter-ideograph'>&#160;&#160; Notes payable, related-party, net of current portion</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> <td width="7" valign="bottom" style='width:5.3pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="91" valign="bottom" style='width:68.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>-</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6636266960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis</a></td>
<td class="text"><!--egx--><table border="0" cellspacing="0" cellpadding="0" width="100%" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;padding:0;height:9.35pt'></td> <td width="1%" valign="top" style='width:1.1%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>&#160;Quoted Prices in Active Markets for Identical Items (Level 1) </b></p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>&#160;Significant Other Observable Inputs (Level 2) </b></p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>&#160;Significant Unobservable Inputs (Level 3) </b></p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>&#160;Total </b></p> </td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>June 30, 2017</p> </td> <td width="1%" valign="top" style='width:1.1%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;background:#DBEEF3;padding:0;height:9.35pt'></td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:20.0pt'>Derivatives liability</p> </td> <td width="1%" valign="bottom" style='width:1.1%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="19%" valign="bottom" style='width:19.8%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>-</p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="18%" valign="bottom" style='width:18.74%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>269,427</p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="16%" valign="bottom" style='width:16.66%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>3,962,556</p> </td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="11%" valign="bottom" style='width:11.88%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>4,231,983 </p> </td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="1%" valign="top" style='width:1.1%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;background:#DBEEF3;padding:0;height:9.35pt'></td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>September 30, 2016</p> </td> <td width="1%" valign="top" style='width:1.1%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.58%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;padding:0;height:9.35pt'></td> </tr> <tr style='height:9.35pt'> <td width="23%" valign="bottom" style='width:23.74%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:20.0pt'>Derivatives liability</p> </td> <td width="1%" valign="bottom" style='width:1.1%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="19%" valign="bottom" style='width:19.8%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>-</p> </td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="18%" valign="bottom" style='width:18.74%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>281,613</p> </td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.66%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>1,772,458</p> </td> <td width="1%" valign="bottom" style='width:1.58%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.12%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="11%" valign="bottom" style='width:11.88%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>2,054,071</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619174432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Fair Value Measurements: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><!--egx--><table border="0" cellspacing="0" cellpadding="0" width="98%" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;padding:0;height:9.35pt'></td> <td width="2%" valign="bottom" style='width:2.54%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;padding:0;height:9.35pt'></td> <td width="25%" valign="bottom" style='width:25.5%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Derivatives Liability</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Balance, September 30, 2016</p> </td> <td width="2%" valign="bottom" style='width:2.54%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="25%" valign="bottom" style='width:25.5%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>1,772,458 </p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>Issuance of warrants recorded as derivatives</p> </td> <td width="2%" valign="bottom" style='width:2.54%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;padding:0;height:9.35pt'></td> <td width="25%" valign="bottom" style='width:25.5%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>2,511,288</p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>Gain on termination of debt resulting from</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>&#160; payments on notes payable</p> </td> <td width="2%" valign="bottom" style='width:2.54%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="25%" valign="bottom" style='width:25.5%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(103,213) </p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>Loss on derivatives liability resulting</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-indent:10.0pt'>&#160; from changes in fair value</p> </td> <td width="2%" valign="bottom" style='width:2.54%;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'></td> <td width="25%" valign="bottom" style='width:25.5%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(217,997)</p> </td> </tr> <tr style='height:9.35pt'> <td width="70%" valign="bottom" style='width:70.16%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Balance, June 30, 2017</p> </td> <td width="2%" valign="bottom" style='width:2.54%;background:#DBEEF3;padding:0;height:9.35pt'></td> <td width="1%" valign="bottom" style='width:1.8%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="25%" valign="bottom" style='width:25.5%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>3,962,556</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637598240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Common Stock Options and Warrants: Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3 (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock', window );">Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3</a></td>
<td class="text"><!--egx--><div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="626" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:white;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'></td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Exercise price</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>$2.50 - $25.00</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Expected term (years)</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>0.21 - 4.93</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Volatility</p> </td> <td width="15" valign="top" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>128% - 194%</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Risk-free rate</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>0.49% - 1.99%</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Dividend rate</p> </td> <td width="15" valign="top" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>0%</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Common stock price</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="top" style='width:11.5pt;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:1.1in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>$2.50 - $25.00</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the textual narrative disclosure of Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel0TextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642190352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Common Stock Options and Warrants: Schedule of Share-based Compensation, Activity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share-based Compensation, Activity</a></td>
<td class="text"><!--egx--> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="93%" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;border:none;border-bottom:solid windowtext 1.0pt;background:white;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Options and Warrants</b></p> </td> <td width="2%" valign="top" style='width:2.44%;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Number of Options and Warrants</b></p> </td> <td width="2%" valign="top" style='width:2.44%;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Weighted-</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Average</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Exercise</b></p> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b>Price</b></p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Outstanding as of October 1, 2016</p> </td> <td width="2%" valign="bottom" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>65,045</p> </td> <td width="2%" valign="bottom" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="16%" valign="bottom" style='width:16.86%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>35.06</p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Granted</p> </td> <td width="2%" valign="top" style='width:2.44%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>48,000</p> </td> <td width="2%" valign="bottom" style='width:2.44%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>25.00</p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Forfeited</p> </td> <td width="2%" valign="top" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>(3,871)</p> </td> <td width="2%" valign="bottom" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>357.84</p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Outstanding as of June 30, 2017</p> </td> <td width="2%" valign="top" style='width:2.44%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:double windowtext 1.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>109,174</p> </td> <td width="2%" valign="bottom" style='width:2.44%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>37.12</p> </td> </tr> <tr style='height:9.35pt'> <td width="61%" valign="bottom" style='width:61.38%;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>Exercisable as of June 30, 2017</p> </td> <td width="2%" valign="top" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>102,225</p> </td> <td width="2%" valign="bottom" style='width:2.44%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="16%" valign="bottom" style='width:16.86%;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>34.46</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for share-based compensation plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909640528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases</a></td>
<td class="text"><!--egx--><div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:white;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'><b><u>Years Ending September 30,</u></b></p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>2017</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>32,908</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:center'>2018</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;border:none;border-bottom:solid windowtext 1.0pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>111,340</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;border:none;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>&nbsp;</p> </td> </tr> <tr style='height:9.35pt'> <td width="384" valign="bottom" style='width:4.0in;background:#DBEEF3;padding:0;height:9.35pt'> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="106" valign="bottom" style='width:79.45pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>&nbsp;</p> </td> <td width="15" valign="bottom" style='width:11.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.9pt;text-align:right'>$</p> </td> <td width="106" valign="bottom" style='width:79.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#DBEEF3;padding:0;height:9.35pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-autospace:ideograph-numeric ideograph-other;margin-right:.7pt;text-align:right'>144,248</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755596160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Net Loss per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net income (loss), excluding discontinued operations</a></td>
<td class="num">$ (5,873,988)<span></span>
</td>
<td class="nump">$ 3,304,133<span></span>
</td>
<td class="num">$ (15,151,168)<span></span>
</td>
<td class="num">$ (14,924,907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther', window );">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</a></td>
<td class="num">$ (5,873,988)<span></span>
</td>
<td class="num">$ (983,880)<span></span>
</td>
<td class="num">$ (15,151,168)<span></span>
</td>
<td class="num">$ (16,715,314)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="nump">237,100<span></span>
</td>
<td class="nump">217,595<span></span>
</td>
<td class="nump">233,767<span></span>
</td>
<td class="nump">182,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="nump">237,100<span></span>
</td>
<td class="nump">260,266<span></span>
</td>
<td class="nump">233,767<span></span>
</td>
<td class="nump">201,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income (Loss) from Continuing Operations, Per Basic Share</a></td>
<td class="num">$ (24.77)<span></span>
</td>
<td class="nump">$ 15.18<span></span>
</td>
<td class="num">$ (64.81)<span></span>
</td>
<td class="num">$ (81.57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income (Loss) from Continuing Operations, Per Diluted Share</a></td>
<td class="num">$ (24.77)<span></span>
</td>
<td class="num">$ (3.78)<span></span>
</td>
<td class="num">$ (64.81)<span></span>
</td>
<td class="num">$ (82.78)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=fil_CommonStockOptionsAndWarrantsMember', window );">CommonStockOptionsAndWarrantsMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther', window );">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,427,640)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount', window );">Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=fil_ConvertibleDebt1Member', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther', window );">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,860,373)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,790,407)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount', window );">Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,949<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic net Income or Loss per outstanding limited partnership unit in the future and that were not included in the computation of diluted net income per limited partnership unit, because to do so would increase net income per unit amounts or decrease loss per unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1533-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1536-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=fil_CommonStockOptionsAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=fil_CommonStockOptionsAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=fil_ConvertibleDebt1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=fil_ConvertibleDebt1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755592800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Net Loss per Common Share: Schedule of Common Stock Equivalents (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants', window );">Exercise of outstanding common stock warrants</a></td>
<td class="nump">109,174<span></span>
</td>
<td class="nump">18,346<span></span>
</td>
<td class="nump">109,174<span></span>
</td>
<td class="nump">42,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConversionOfSeriesDPreferredStock', window );">Conversion of Series D preferred stock</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConversionOfSeriesEPreferredStock', window );">Conversion of Series E preferred stock</a></td>
<td class="nump">961<span></span>
</td>
<td class="nump">961<span></span>
</td>
<td class="nump">961<span></span>
</td>
<td class="nump">961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConversionOfDebt', window );">Conversion of debt</a></td>
<td class="nump">158,798<span></span>
</td>
<td class="nump">95,799<span></span>
</td>
<td class="nump">158,798<span></span>
</td>
<td class="nump">95,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IssuanceOfEmployeeRestrictedShares', window );">Issuance of employee restricted shares</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LiabilityToIssueCommonStock', window );">Liability to issue common stock</a></td>
<td class="nump">358,097<span></span>
</td>
<td class="nump">2,246<span></span>
</td>
<td class="nump">358,097<span></span>
</td>
<td class="nump">2,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockEquivalents', window );">Common stock equivalents</a></td>
<td class="nump">627,495<span></span>
</td>
<td class="nump">117,817<span></span>
</td>
<td class="nump">627,495<span></span>
</td>
<td class="nump">141,849<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Common stock equivalents (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonStockEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConversionOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Conversion of debt (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConversionOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConversionOfSeriesDPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Conversion of Series D preferred stock (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConversionOfSeriesDPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConversionOfSeriesEPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Conversion of Series E preferred stock (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConversionOfSeriesEPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Exercise of outstanding common stock warrants (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ExerciseOfOutstandingCommonStockOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IssuanceOfEmployeeRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Issuance of employee restricted shares (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IssuanceOfEmployeeRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LiabilityToIssueCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Liability to issue common stock (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LiabilityToIssueCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6618904016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>4. Accounts Receivable (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for Doubtful Accounts Receivable</a></td>
<td class="nump">$ 25,468<span></span>
</td>
<td class="nump">$ 75,161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6744842784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>5. Inventory: Schedule of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Inventory, Finished Goods, Gross</a></td>
<td class="nump">$ 503,477<span></span>
</td>
<td class="nump">$ 206,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory Valuation Reserves</a></td>
<td class="num">(1,708)<span></span>
</td>
<td class="num">(1,708)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 501,769<span></span>
</td>
<td class="nump">$ 204,736<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754423840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>6. Prepaid Expenses and Other Current Assets: Schedule of Other Current Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">$ 56,555<span></span>
</td>
<td class="nump">$ 644,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=fil_PrepaidInformationTechnologyServicesMember', window );">Prepaid information technology services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">38,081<span></span>
</td>
<td class="nump">57,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=fil_OtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">12,249<span></span>
</td>
<td class="nump">112,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=fil_PrepaidInsurance1Member', window );">Prepaid insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">$ 6,225<span></span>
</td>
<td class="nump">14,602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=fil_PrepaidProfessionalFeesMember', window );">Prepaid professional fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=fil_ResearchAndDevelopmentMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=fil_LineOfCreditAcquisitionFeesMember', window );">Line of credit acquisition fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,978<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=fil_PrepaidInformationTechnologyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=fil_PrepaidInformationTechnologyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=fil_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=fil_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=fil_PrepaidInsurance1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=fil_PrepaidInsurance1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=fil_PrepaidProfessionalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=fil_PrepaidProfessionalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=fil_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=fil_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=fil_LineOfCreditAcquisitionFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=fil_LineOfCreditAcquisitionFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6743678384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>7. Property and Equipment: Property, Plant and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 56,445<span></span>
</td>
<td class="nump">$ 86,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">261,946<span></span>
</td>
<td class="nump">264,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(205,501)<span></span>
</td>
<td class="num">(177,793)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer Software, Intangible Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">47,974<span></span>
</td>
<td class="nump">47,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember', window );">Leaseholds and Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">98,023<span></span>
</td>
<td class="nump">98,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">68,758<span></span>
</td>
<td class="nump">68,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 47,191<span></span>
</td>
<td class="nump">$ 49,772<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619193632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfProperty', window );">Gain on disposal of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation, Amortization and Accretion, Net</a></td>
<td class="nump">$ 33,107<span></span>
</td>
<td class="nump">$ 38,817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of oil and gas property or timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753362944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>8. Accrued Expenses: Schedule of Accrued Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 7,765,437<span></span>
</td>
<td class="nump">$ 2,101,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,694,545<span></span>
</td>
<td class="nump">1,206,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_LiabilityToIssueWarrantsMember', window );">LiabilityToIssueWarrantsMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,081,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_LiabilityToIssueCommonStockMember', window );">Liability To Issue Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,000,933<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_FinanceFeesMember', window );">Finance Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">333,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_PayrollExpenseMember', window );">Payroll Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">329,615<span></span>
</td>
<td class="nump">207,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_OtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">141,394<span></span>
</td>
<td class="nump">89,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_DeferredRevenueMember', window );">DeferredRevenueMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">85,399<span></span>
</td>
<td class="nump">111,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_WarrantyLiabilityMember', window );">Warranty Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">58,300<span></span>
</td>
<td class="nump">134,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_CommissionsAndFeesMember', window );">CommissionsAndFeesMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 40,997<span></span>
</td>
<td class="nump">52,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=fil_SeveranceMember', window );">Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_LiabilityToIssueWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_LiabilityToIssueWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_LiabilityToIssueCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_LiabilityToIssueCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_FinanceFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_FinanceFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_PayrollExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_PayrollExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_DeferredRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_DeferredRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_WarrantyLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_WarrantyLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_CommissionsAndFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_CommissionsAndFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=fil_SeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=fil_SeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754238928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>9. Notes Payable: Schedule of Debt - Other (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">$ 16,859,049<span></span>
</td>
<td class="nump">$ 13,006,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DiscountOnNotesPayable', window );">Discount on notes payable</a></td>
<td class="num">(1,468,335)<span></span>
</td>
<td class="num">(1,930,060)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NotesPayableCurrentAndNoncurrent', window );">Notes payable current and noncurrent</a></td>
<td class="nump">15,390,714<span></span>
</td>
<td class="nump">11,076,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="num">(9,501,544)<span></span>
</td>
<td class="num">(3,722,899)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">5,889,170<span></span>
</td>
<td class="nump">7,353,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note1Member', window );">Note 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">5,900,000<span></span>
</td>
<td class="nump">5,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note2Member', window );">Note 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">1,974,602<span></span>
</td>
<td class="nump">689,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note3Member', window );">Note 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">1,773,937<span></span>
</td>
<td class="nump">2,223,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note4Member', window );">Note 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note5Member', window );">Note 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">1,152,778<span></span>
</td>
<td class="nump">1,652,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note6Member', window );">Note 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">1,259,007<span></span>
</td>
<td class="nump">929,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note7Member', window );">Note 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note8Member', window );">Note 8</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note9Member', window );">Note 9</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">334,464<span></span>
</td>
<td class="nump">334,464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note10Member', window );">Note 10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note11Member', window );">Note 11</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note12Member', window );">Note12Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note13Member', window );">Note13Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note14Member', window );">Note14Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note15Member', window );">Note15Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="nump">$ 64,261<span></span>
</td>
<td class="nump">64,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_Note16Member', window );">Note16Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossNotesPayableBeforeDiscount', window );">Gross notes payable before discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,539<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DiscountOnNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Discount on notes payable, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DiscountOnNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GrossNotesPayableBeforeDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Gross notes payable before discount, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_GrossNotesPayableBeforeDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NotesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Notes payable current and noncurrent, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NotesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note11Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note11Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note12Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note12Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note13Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note13Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note14Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note14Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note15Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note15Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_Note16Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_Note16Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754445344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>10. Related Party Notes Payable: Schedule of Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="nump">$ 3,869,683<span></span>
</td>
<td class="nump">$ 3,898,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Notes payable, related party</a></td>
<td class="num">(3,869,683)<span></span>
</td>
<td class="num">(3,898,124)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote1Member', window );">RelatedPartyNote1Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="nump">1,721,100<span></span>
</td>
<td class="nump">1,721,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote2Member', window );">RelatedPartyNote2Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="nump">1,303,135<span></span>
</td>
<td class="nump">1,303,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote3Member', window );">RelatedPartyNote3Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="nump">542,004<span></span>
</td>
<td class="nump">542,004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote4Member', window );">RelatedPartyNote4Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote5Member', window );">RelatedPartyNote5Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="nump">26,721<span></span>
</td>
<td class="nump">26,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote6Member', window );">RelatedPartyNote6Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="nump">25,463<span></span>
</td>
<td class="nump">25,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote7Member', window );">RelatedPartyNote7Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="nump">$ 1,260<span></span>
</td>
<td class="nump">17,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote8Member', window );">RelatedPartyNote8Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Notes Payable, Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_RelatedPartyNote8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6889200672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>11. Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives liability</a></td>
<td class="nump">$ 4,231,983<span></span>
</td>
<td class="nump">$ 2,054,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives liability</a></td>
<td class="nump">269,427<span></span>
</td>
<td class="nump">281,613<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives liability</a></td>
<td class="nump">$ 3,962,556<span></span>
</td>
<td class="nump">$ 1,772,458<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=82849420&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13495-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909560704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Fair Value Measurements: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives liability</a></td>
<td class="nump">$ 4,231,983<span></span>
</td>
<td class="nump">$ 2,054,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives liability</a></td>
<td class="nump">3,962,556<span></span>
</td>
<td class="nump">$ 1,772,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues', window );">Issuance of warrants recorded as derivative</a></td>
<td class="nump">2,511,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Issuance of embedded derivatives related to notes payable</a></td>
<td class="num">(103,213)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Loss (gain) on derivative liability resulting from changes in fair value</a></td>
<td class="num">$ (217,997)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=82849420&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13495-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified in shareholders' equity measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (loss) for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6743927104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Derivatives Liability (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives liability</a></td>
<td class="nump">$ 4,231,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,231,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,054,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivatives liability</a></td>
<td class="nump">$ 64,145<span></span>
</td>
<td class="nump">$ 5,603,411<span></span>
</td>
<td class="nump">$ 230,163<span></span>
</td>
<td class="nump">$ 2,796,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5618551-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a),(c),(d),(e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=82849420&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13495-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753858704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Preferred Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertiblePreferredStockSharesDesignated', window );">Convertible Preferred Stock Shares Designated</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncreaseDecreaseInDividendsPayable', window );">IncreaseDecreaseInDividendsPayable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,800<span></span>
</td>
<td class="nump">$ 18,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncreaseDecreaseInDividendsPayable', window );">IncreaseDecreaseInDividendsPayable</a></td>
<td class="nump">$ 34,178<span></span>
</td>
<td class="nump">$ 39,598<span></span>
</td>
<td class="nump">102,535<span></span>
</td>
<td class="nump">185,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RedemptionPriceOfSeriesEPreferredStock', window );">Redemption Price of Series E preferred stock</a></td>
<td class="nump">$ 477,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 477,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 477,829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesFPreferredStockMember', window );">Series F Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertiblePreferredStockSharesDesignated', window );">Convertible Preferred Stock Shares Designated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncreaseDecreaseInDividendsPayable', window );">IncreaseDecreaseInDividendsPayable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesGPreferredStockMember', window );">Series G Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConvertiblePreferredStockSharesDesignated', window );">Convertible Preferred Stock Shares Designated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConvertiblePreferredStockSharesDesignated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Convertible Preferred Stock Shares Designated (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ConvertiblePreferredStockSharesDesignated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IncreaseDecreaseInDividendsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of IncreaseDecreaseInDividendsPayable, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_IncreaseDecreaseInDividendsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RedemptionPriceOfSeriesEPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Redemption Price of Series E preferred stock, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RedemptionPriceOfSeriesEPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesFPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesFPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesGPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_SeriesGPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6658960816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
<td class="text">On January 27, 2017, the Company effected a 1-for-500 reverse stock split of its outstanding common stock, which caused the then outstanding common stock to decrease from 115,112,802 to 232,100 while keeping the authorized capitalization unchanged.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619602976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Common Stock Options and Warrants (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DeemedDividendsOnRedemptionOfPreferredStock', window );">Deemed dividends on redemption of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,484,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageRemainingTermOfTheWarrants', window );">Weighted average remaining term of the warrants</a></td>
<td class="nump">4.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</a></td>
<td class="nump">$ 38,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DeemedDividendsOnRedemptionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Deemed dividends on redemption of preferred stock, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DeemedDividendsOnRedemptionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageRemainingTermOfTheWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Weighted average remaining term of the warrants, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageRemainingTermOfTheWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized and expensed compensation cost from equity-based compensation arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6743233200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Common Stock Options and Warrants: Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3 (Details) - Fair Value, Inputs, Level 3<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2017 </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Fair Value Assumptions, Exercise Price</a></td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Fair Value Assumptions, Expected Term</a></td>
<td class="text">2 months 16 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">128.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">0.49%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueAssumptionsCommonStockPrice', window );">Fair Value Assumptions Common Stock Price</a></td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Fair Value Assumptions, Exercise Price</a></td>
<td class="nump">$ 25.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Fair Value Assumptions, Expected Term</a></td>
<td class="text">4 years 11 months 5 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">194.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">1.99%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueAssumptionsCommonStockPrice', window );">Fair Value Assumptions Common Stock Price</a></td>
<td class="nump">$ 25.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueAssumptionsCommonStockPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the per-share monetary value of Fair Value Assumptions Common Stock Price, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_FairValueAssumptionsCommonStockPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed upon price for the exchange of the underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6743968304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Common Stock Options and Warrants: Schedule of Share-based Compensation, Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">109,174<span></span>
</td>
<td class="nump">65,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 37.12<span></span>
</td>
<td class="nump">$ 35.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based compensation arrangement by share-based payment award, Options, Grants in period</a></td>
<td class="nump">48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 25.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</a></td>
<td class="num">(3,871)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 357.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</a></td>
<td class="nump">102,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 34.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6736674976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. Related-party Transactions Not Otherwise Disclosed (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,325,427<span></span>
</td>
<td class="nump">$ 3,175,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember', window );">FormerExecutiveChairmanOfTheBoardOfDirectorsMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RelatedPartyCompensationHourlyRate', window );">Related Party Compensation, Hourly Rate</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember', window );">FormerExecutiveChairmanAndChiefExecutiveOfficerMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RelatedPartyCompensationHourlyRate', window );">Related Party Compensation, Hourly Rate</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RelatedPartyCompensationHourlyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Related Party Compensation, Hourly Rate, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RelatedPartyCompensationHourlyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_FormerExecutiveChairmanOfTheBoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_FormerExecutiveChairmanAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6744922208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>17. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths', window );">Operating Leases, Future Minimum Payments, Next Rolling Twelve Months</a></td>
<td class="nump">$ 32,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Operating Leases, Future Minimum Payments, Due in Two Years</a></td>
<td class="nump">111,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Operating Leases, Future Minimum Payments Due</a></td>
<td class="nump">$ 144,248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909565376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating Leases, Rent Expense, Net</a></td>
<td class="nump">$ 97,000<span></span>
</td>
<td class="nump">$ 94,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M<: ,HA; NGEB/$Y]"Q? #"-,/G\7T*[$I?HG=ND .R6G[-;4.([U*)=<V4'
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MZ>S&-H2H@P.#3-3S1(,"J3R4 7$#2V7F8TJR1XK+[! I5X5GJDA#R"O?V&8
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M?ZZ/3YZ.7]KJ,#Q5FY\>[=W]#U!+ P04    " #HBS],!'KTYQ4"  "<!0
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MQ7A\V=C_QA@/F$IR@R/4X0=;# F-#\<[/-MIS";#FW[^06SYQN5O4$L#!!0
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M^M]8&P"E[&YPA#K\8(NAH GQ>(]G-XW99 3;SS^(+=^X_ U02P,$%     @
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M'VPV%-0^'@_A;,<Q&PV/W?2#V/R-B]]02P,$%     @ Z(L_3!&9P):V 0
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M_.+/9ARST7#833^(S=\X_P=02P,$%     @ Z(L_3/++S>2S 0  T@,  !D
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MB_'XLK'_E3$>4,KJ!D>HP0\V&1(J'XY[/-MAS ;#FW;\06SZQOE?4$L#!!0
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MLTK%)2C+M4(&ZAS?IH?C-N CX)G#8!=G%"HY:_T:C!]5CI.0$ @H75!@?KO
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MDB959%MJ6E6;M$E1IVV?B7U^48'S ,?=OQ]@UW,[[PMPQSW//7<<Z8#FQ38
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MVXYK-CK>=-,+8O,SSO\ 4$L#!!0    ( .B+/TS^'OTJMP$  -(#   9
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M?[-Q_HW6#GPIR8U?H<X_L,41T+A@?O*VF=9L<ISNYQ=$EF=<_@-02P,$%
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M@IJS>U4"0"FH$/X! G W5$+(A..88@:KC$&5\4 E1OY>MIBXYXI0CI$7^P*
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MK*W61MGHT<A>?WO;U5\FN=H:-^1V7+6M;3LQ^M"U[='EO\/L/U!+ P04
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MG8.0!=-F*H^>JB1G^[JHR#U*2.05+"O=S:I>>Y2;E3CK/"OYHW34N2B8_/?
M<W%=N^"^+SQEQY.V"]YF5;$C_\7U<_4HS<SK6/99P4N5B=*1_+!V/\/]%E);
M4"-^9_RJ>F/'6GD1XM5.ON_7+K&*>,YWVE(P<[GP+<]SRV1T_&U)W>Z9MK _
M?F?_6ILW9EZ8XEN1_\GV^K1V$]?9\P,[Y_I)7+_QUE#H.JW['_S"<P.W2LPS
M=B)7]:^S.RLMBI;%2"G86W/-ROIZ;?G?R_ "VA;0K@""#PO\ML ?%7B-LMKJ
M%Z;99B7%U9'-OU4Q>RC@WC>;N;.+]=[5]XQ;958O&Y\D*^]BB5K,0X.A/0P=
M(K93A$\ZB&<$="HHJH+6]<&@/AVI:#!QC2D;3!*E4>*/M&"X- $:X()\5) _
M$12,=Z6!A+WG?,(%H< /% 6HHF"Z13"SQR%*$"[8XW B%6(*0,C(TFW<0%"$
M"HH01X 3Q"A!O,!1/%7J$Q_\<.3H-FX@*$$%)8@CBA.D*$&ZP%$Z41H&)K:#
MD:&;L($<('@Z$,21/T,Q$S"PP%,+ZJNE(2&3<W<;-Y2$IPT@<0-S&X/G TP#
M G$U??-I9-Z3L:E;L*$@/!X RX>9PPMX0,"2A(#IJT_#(!IGWDW84! >$( E
M1#1#@4<$+,F(%M3_9 "-)F</B8B8TGA&#YX0@$7$' 6>$; @)+8M:&@IB,>'
MW.NU";9O^\GD,2N5\R*TZ3CJON @A.:&DMP9YR?3*G:3G!^T'<9F+)M^J9EH
M4;6]H-<UI)O_4$L#!!0    ( .B+/TR7$'2^\P$  #8%   9    >&PO=V]R
M:W-H965T<R]S:&5E=#4S+GAM;(54[6Z;,!1]%<0#U&#SD42 U*::-FF3HD[K
M?CMP":@&,]L)W=O/-@0Q8.L?['LYY_@<8YST7+S)"D Y[PUK9>I62G4'A&1>
M04/E ^^@U6]*+AJJ="DN2'8":&%)#4/8\R+4T+IUL\3V3B)+^%6QNH63<.2U
M::CX_02,]ZGKN_?&2WVIE&F@+.GH!;Z#^M&=A*[0I%+4#;2RYJTCH$S=1_]P
MC S> EYKZ.5L[I@D9\[?3/&E2%W/& (&N3(*5 \W. )C1DC;^#5JNM.2ACB?
MW]4_V>PZRYE*.'+VLRY4E;H[URF@I%>F7GC_&<8\H>N,X;_"#9B&&R=ZC9PS
M:9].?I6*-Z.*MM+0]V&L6SOVH_Z=MDW (P%/!#_X+X&,!+(@H,&9C?I,%<T2
MP7M'#!^KH^9,^ >B-S,W3;MW]IU.*W7WEA%_EZ";$1HQ3P,&SS#X;\1QC2#>
M!$':P.0";[K EA_,^*&W,#% 8@MI+23 Q-_OR,+*&H>],/!B?]L/V?1#5G[T
M4ML"P:9 \'&@ 1+.C4;[ ,>+/!NPG1_Y9-M-N.DF7,?!__@^T:9 ]'&<:+7O
M9!_A,(P6>=8X/XYQ$.X6?M#L!)L;Y1L5E[J5SIDK_3/8(UMRKD!K>@\Z8*4O
ML:E@4"HSC?5<#+_R4"C>C;<4FJ[*[ ]02P,$%     @ Z(L_3%RQZS$P @
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M;NU<A0L< B.'Z6WB^0=1?0!02P,$%     @ Z(L_3/H%71O? 0  9@0  !D
M  !X;"]W;W)K<VAE971S+W-H965T-C,N>&UL?53;;IPP$/T5RQ\0LT!"L@*D
M+%752JVT2M7VV0O#1?&%VMXE_?OZ0@C=T+Y@S_B<,S/V#/DDU;/N 0QZX4SH
M O?&C'M"=-T#I_I&CB#L22L5I\::JB-Z5$ ;3^*,Q%%T1S@=!"YS[SNJ,I=G
MPP8!1X7TF7.J?A^ R:G ._SJ>!JZWC@'*?.1=O -S/?QJ*Q%%I5FX"#T( 52
MT!;X<;>O4H?W@!\#3'JU1ZZ2DY3/SOC<%#AR"0&#VC@%:I<+5,"8$[)I_)HU
M\1+2$=?[5_6/OG9;RXEJJ"3[.32F+_ ]1@VT],S,DYP^P5S/+49S\5_@ LS"
M728V1BV9]E]4G[61?%:QJ7#Z$M9!^'4*)[?I3-LFQ#,A7@@V]O\(R4Q(W@@^
M @F9^5(_4$/+7,D)J?!8(W4]L=LG]C)KY_1WY\]LM=IZ+V62/>3DXH1FS"%@
MXA5FMR"(55]"Q%LA#O$[>OQW@.H](OM'A&2SB,3SDW6$NVA;(-T42+U NKZ%
M^^CJ%@(F\QCA,0]9%%VAJ@U4ND:%9,CJ>3BHSG>R1K4\"^,N8N5=AN4Q=L][
MY3_8(0H]_R83)O K5=T@-#I)8YO'/W$KI0&;9'1CV[JW0[\8#%KCMIG=J]#Z
MP3!RG*>:++^6\@]02P,$%     @ Z(L_3*MVWY%,G@  :P<# !0   !X;"]S
M:&%R9613=')I;F=S+GAM;.R]:7/CUK4V^OF]OP+55WDC54$RYZ&=DZIV#T[G
MQ'8?JYW<\Q$D00EIDF  4K+RZ^\:]X0-DE++29STJ9.R6@(V]K#V&I^UUN_J
M>I?L-\7?]OGK<K_9_=>+_J3[(OEYO=K4__7B=K?;OOSJJWI^FZ^S^JK<YAOX
MR[*LUMD._EG=?%5OJSQ;U+=YOENOONIU.J.OUEFQ>?'[W]7%[W^W^_V;<KY?
MYYM=DFT6R=O-KM@]).\W/$)1;I++I+[-JKS^W5>[W__N*WR'WYLFWY6;W6T-
M[RSR1?C7/^XW5TF_DR:]3G?<^&-F_S@)_WAD/B_#Y^61'_.;HMY5&;SX?;;.
MPZ=>O?[X_L]O7[_Z\6V:O/_^]57K5S\^;!LO=SN7_]/ZPH>\*DJ<Z2)YD^T:
M[^I&_#__Y__$MN)CE2V*S4UR_;">E:OPK]D\JQHK@:\NZ,OO5ME-^-=EMJH;
M<Y M>@TO5=D*=G.1_YS\=_X0/O=Z7U4T<%'/X;G_S;.J=5V7EYWI9;_3]JER
MO0;:N=Z5\T]I<DT$E/RPW]4[.%58;\MK[XI57B6OX7,W9=68WO4Z6^'??\RW
M9;7#78//;+--XT&=A"S'/G^]RW;[!B7_;Y.X980_ERNX<5DE,VL\]GW9\N)?
M\M7J\M.FO(<]R+.ZW.2+Y'U=[_/&<1HZ<C?]'?RR\;'P22&\Z+/_TV^<;0FG
MOJEA'O!37:Z*!>SR(ODF6V6;>0Y'!/RAALO^T_6;Y/SLHK'W^=9<V5$;W61U
M#8,T;NCKK+YM4/%\CLRL3JI\GA=WV6R5I\DFWX7/O=_<P<@18OB^W.7.R^&?
M/U3Y-BL62?[S%E==$S<I=[?- _A8[F SY]X2FJ,!8ZW@7'&4_&_[8HL'$9WP
M&R"VNM@Y'VP9\TV);#C9 +.*#L3SBK^K&[XJLEFQ*G9%WMQUL\/;["&V0^'?
M4]C-%='$-H.E1AZO]KG=T A]X14+9M4V<;J0P"#*9;*!@VR=Y/?N'X_,\$UQ
M5P")+UH'>P,7Y@Z$R!T,J7-LC.*3PX&E!%.#$\35S/T%QD<_,"IQS-MRM0!N
M\]MDD2^+>;%KG"U0]S*'#RV2FCGLV54'_J^+&Y/<9:M]_C+I=E+X%?Y/!'B2
M[7>W957\/5]\G0R&[E]@XM>P.?#3FZ^3,;PTCOSI[==$TX-^VNMUZ,?(0]\F
M!;*Y!9._9?AX=O4VG^/NKYJ"A\5%^V)ZG8.KZ?6G:;?#D^KU>_2S3NW4.;Q:
M+ H\,C@?Y!R7<#?GV;: \TJ3.<\/A]_JUD<NR'Z]9_J4<XN??AT[XJ.$0A\_
MZ=73./V'#.GT-M\5*$LND[/DJQ9%[PGC':%7>[+''FR<]8DOE.VJADMK[1/Q
MGCHZB]C3!Z<0W5'43G(4+'2A?@")0QKO :G</UD';\CL'W,0K/N(W'A]6Y6;
M8IX4J]4FK^L$%E:  $;UJ=YOMRNDQ4I>?L2[RSQO?8V)_<#+K=\K:^*ZU><L
M9AX,\LA%'7O]Z.*.#?!M5<(+VZI<-N^Z$ F,HG*YL077H(H2\P/9G*/ZCXPD
M6ZR+#=E+R R3\V(S7^W)$#GKIH,1_&\X3O'G3F>0]KI=^!FY*OR[/Z8!SD *
MP".C[L#GJBFNA.[!Y2Q#"@?6B1,C2F[0[X]Y#>KN_):&7,#Z5R5I5O$]+!N+
M#9_[$^[4LBK7^BS<GL:6D4X&"R[7L' 9Z:*Q;>\WNQP6MM-O174T^AY>_'RW
M6^6QF7^+.AX\L3A%]]#A\I]QE?NBOB5]'W9TD<_:ARYJ4#EQ?Y9()1%%M>U-
M,Q%G ?$]A8>+S6(_IP,%E;RJB3&US,S=XI:CC!Y"0\4"G4J?6<$T&@^\R6'.
M0#E&\X-Y@BS(UUO5+K>^?&C7&>'Q(\_B;' 62;;;5<5LOT/%+]F5JAVXPKGU
M73@=\SS*">#M<$^*^6->6!2K_:[)[O^2%S>W*$<R.)_L)O=>\^11VT<?-4++
M+!XKVT(]I$72?=:P$7%M>)+>;U+Z@-I$B)=@MJU1A_][IJ0D?]CR!_""W6<5
M.IQ.U9C\R:)5G+Q;E?<'Y#L]LZ1G7*X&^Y\AOXT;?DHZ307WK_MZQ]\'J@7;
MN=S,"R#AC=(:_!9_GN-7]SA]9!.G?/)5L%7(%) OL849M7$BXD&/(OJ\M^&N
MD9&)8;J$(ZOSZJZ8-^7"^\V\RN%[N""T-]5L@RL/_*78 N7A=E0+'!-&#W@_
M7W)D>SO\G&<VX\/E82-6YN_,,_Q Q(D \REX5VB1S@8W]9,,[.XZ."SR&]"[
MAYP$_"Z^FC4=,NT/%VU>&?O(]F0'3&0.+1OI/4F;><@^/X62CUTX7&A]C/H_
M5.4\SQ?R"DCB_'11_&$/ZD]6LPU]VBOO:4ZD&:"-:OTNF\,NL<:&Q!9W;$.6
MQ0:LOD=M"-Y5LA1#9T]4I6I_5YP_E^3\^:R1+!NA_=N@\@H7[;[8W1Z^R1\,
MNX 'A)-O#DWLM $.N\#TV( Z4%E9)+.'Z#'$7ESDEO'-(VY8/-XTF>4WQ6:#
MH\'FP!5%I:,HFZ*='L[Q'A]Z[!H-*Y)S:/>HE#L8PZ&GB%VXW+'I<=M<TI/O
M+>'"9-Z9O7C53I+O8\</C'LK]\_Q9+GJ',UG56; /:H"-HDY,IA]3>F*'(F5
M\,Q1K.$3)*N>]E'X808&$DW\*1_]I1?UN?,/]'>\"TA7!U5X3^A;S1^_&? $
M;T[$4G^>LP1QB""BNXEY0ZL.I;W[<=<[=TP'>%77Q<U&S;D#' -'@IW;;]37
MO;LMJA:/MTO4!XX"6%R]7]%]:5.0?A'J/49=KW'NJY75<JJ\.+JBP^?E;^QC
M3N\13/S$;?='C.W($P>FH?*?=Z!7_5(7-S-!YMCH)\[37,YGG%T; 7>ODA^J
MFVRC1@B>]/?9;E_EOF$8C>)$!OL&[&.:P0>8"8HR&O4C,*?])MLOBAVI4""G
MBC7>+S'WYJZY)S*://ZNX4=2*G\-2TQ!DLVODG/D>?_W_^T.QE]+0!O_,?D:
MC5#^M7V%_W*1W(*)#G([%T6[8HT.";Y:T-&0,O,*C(8YT/T$O_MC?K.7RW9]
M^?^EJ$^L]ZL;FBNH%#B)ZWR^KVRXX:WR2_1OP]' JU?):]!0,](>+4:$W'=@
M[H$5N<>3V^!?5JN'A/V*/+GH?AR:_4_7ZK-<T5W.M^2;X$N-W$RLMQ5\\9PW
M"E[Y]M6K#\U=LF<$FUJNBQV%$?<5$O(.*:_>SV^3:K^2I5=FL^HK."7:G7);
M;(3/K+--=I-S$!C_A).BD\-I/84N4(W'786U)IDUU%-ZM6!EI]S /I 2C;N+
MFOZ^(@^R]P)HLWE=(V8!>353;[+,BFK%9^R0V.CKVID-Q:WI-(E,_[C?Y ;!
M0WMRC0>PGN65"2JD]'L6V2ABZ$4,?EOW*]U:?&)W6^7,@4'3S-$!CH&+' ,7
MD6_AZ/0#CC9WC! 9[=0QKO#.@JR*;GI]6^Y70/PX_6PAUL!?]QO''*##W6R0
M6QT_1%H<20ZT<W/8_]UMMDO0:^=>A,@IO.)/,%(%U:!W<,9)MW/YWV;%#P@,
MX:4V#X*6Z1["9QW .B,)B!M3;!;%G(,$HO3K1W38Y1Y(=LF0%)TC86W"28ZO
MDF]+1NW %:^8F\H^B!F[9UD,F[4';2Z_X0_/3_""\;K$D9775][@MW"X&._
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MU$\9,_V X!A@I8W\ZP,G*CDGAH?#K[PJJ<XI'3\BZN;&;@[MX''61U6L)Q)
MN*C?N,-0CT\Q04=&IX)8HF6R;<VMD#6$MQ_].HX59$S-4UJ)%?$J.^XW([W#
MW!O;NU ;2:PC=6.8"B']#K8ZC1F#\9YF!VL"19HLQH[>*4:)_XR%DMTZ09+]
MY TNQ2I7QS[UB,RFS)2?YM+?7E&5,_8Q:&EUOSJ'1(%99CN:L!H/()&SE9'<
MZO(FCDSK<*H!_^.7TO 4?O9R@@(,[KFQ1A3:D&:U6L_REU]UQ X/FPGA3-D
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MGK\PC]D_82\4G$KD3W?DHB%]&+YQ:6'@Y,EJ?4T0$>[6$Q[B-ZEQ]TB5Y56
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MZJ[(@J[(A)I@0Q!XZ:( =G+8;3Q(QY.13N\NIP;#3COI-.FGH^E(_V)*#X$
MGX']DKO-TVI,_%F0\3._;0#DW'FR-C1,A[#B.ZKF!!:%%!"YE1QX?I\<NB:1
M5,,HIHN;#NZOV7$\3\7O;#:!%?3$[_3;ZZ>J"MHT1G2P(3"/<BS-@1%:#%6M
M_6YG'276^$ B=7$KNNF<Z%BI)U0=9*"V$CQT:**=TB8K5M$#E%\2&.1<X@VP
MFH)9(1]5K#7>SMT(FC=S8B*_=(R98:.@YZ\4WS!I.AKO;11P( @CP]^FHW$
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MAP*H"UV^EPWQGW ;?ITDGS+&_S,$]Q<YR)4:I)U/)/7?M"0B3%NVN",MF!%
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M6EM/J<,CU4GF/,B.LCTRV[ML+OA6A=+*"*9'!VOZ1M65,@_-4OJ,M+(EJ]+
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MBLL3'D).]@L/I*,."8G"]:L#0.T!>SD U&.G^B Z#0P&N51<::41='1^6G#
MD8J^<'$7:,INC_X++G!W-YI6IUE0A:C3Q8WS"9OR#8Y@*")D%/U+A8H:UYL!
MX)TJ)X-=NDXLYB(P9S,[D04C1+KA(1PNS3%,4N5;#5+YU%6!O[!YRZ1.*ZQ'
M.#U _J"0FG.+CBK1:8\=/=4O?;;[2C^FU=U7>RZ4!8,/S"^E("'>7?.:N$:*
MQZ+HXQ>J[(53^VLGB576#+I !6#.E"N_@26>L(Y&VC*>4+;H[!1QXV)3:VH9
M&<O68NYM.B60<U#@4M!6;"5_XD?72-+/1%7&&XY2QDX\._2/HM(HR-.X^5
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MESL QA!H++5.TCB%]B-96$#Y]D:2OCS7R+A7TR5\SI?&J\5LQAR? $^7! Z
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MR39.D&0_.8T+6.7LOJX>D-DTT?#3#/WM@*KLL(U!0:N[Z!SB!6:9;6G"ZO(
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M5M/^:.1'M#4L-/G_;!84V;R<,CA)=* +/_Z&J+080'MRB4<"V=H):+\PR+?
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M;"*XN/KK80NYI8$>T@"BW=QLV'9ZV,()OYB*B@=_B9.8#+?L39?OO)YBMZO
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M(-RK6.@R5M_B9?>TYS*VK1G%9N]O99"EVY"%__K_WLSU0:UZ",9^INR[W^O
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MN?_BMMC)[TW7>ROJE9@3R!F G/%"RK&X#TW?U6TK&NO#]=QL NO#VGA+",\
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .B+/TQ0CG8I[0   "L"   1
M          "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .B+
M/TR97)PC$ 8  )PG   3              "  ;4"  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ Z(L_3%'%S@R$ @  10D  !@
M ( !]@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .B+
M/TS*PCE%,P0  -02   8              "  ; +  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " #HBS],&V8A0QL"  "?!@  &
M        @ $9$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ Z(L_3+IIPF'B!0  YAL  !@              ( !:A(  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( .B+/TP$>O3G%0(  )P%   8
M              "  8(8  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " #HBS],F O%L.X%   M'@  &               @ '-&@  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ Z(L_3)E2\F&U 0
MT@,  !@              ( !\2   'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( .B+/TR\IGRUM $  -(#   8              "  =PB
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #HBS],#:3X
MB+4!  #2 P  &               @ '&)   >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ Z(L_3#U 8^VT 0  T@,  !D
M ( !L28  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #H
MBS],YT[BA+0!  #2 P  &0              @ &<*   >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( .B+/TQ/0G*QM0$  -(#   9
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M970Q-BYX;6Q02P$"% ,4    " #HBS],$9G EK8!  #2 P  &0
M    @ $?-   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M .B+/TPP_4A<M $  -(#   9              "  0PV  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ Z(L_3/++S>2S 0  T@,  !D
M             ( !]S<  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " #HBS],S[9:V[0!  #2 P  &0              @ 'A.0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( .B+/TS)30Z?M0$
M -(#   9              "  <P[  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ Z(L_3!_LDW6V 0  T@,  !D              ( !
MN#T  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " #HBS],
MA]5-,;0!  #2 P  &0              @ &E/P  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( .B+/TQQ<!>7M $  -(#   9
M      "  9!!  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ Z(L_3 @/G?ZW 0  T@,  !D              ( !>T,  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #HBS],2/%A8+(!  #2 P
M&0              @ %I10  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( .B+/TR3$6%GLP$  -(#   9              "  5)'  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ Z(L_3*[:\..X
M 0  T@,  !D              ( !/$D  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " #HBS],4W9Z5+@!  #2 P  &0
M@ $K2P  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( .B+
M/TQ6NYQWL@$  -(#   9              "  1I-  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ Z(L_3#\BR9:W 0  T@,  !D
M         ( ! T\  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " #HBS],P=W/+;@!  #2 P  &0              @ 'Q4   >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( .B+/TRG+%?6L@$  -(#
M   9              "  >!2  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ Z(L_3/X>_2JW 0  T@,  !D              ( !R50
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " #HBS],)$N(
M:+<!  #2 P  &0              @ &W5@  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( .B+/TR_<X"HM0$  -(#   9
M  "  :58  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
MZ(L_3.O.#N6R 0  T@,  !D              ( !D5H  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " #HBS],*9.<;+,!  #2 P  &0
M            @ %Z7   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( .B+/TS*#YMOL@$  -(#   9              "  61>  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ Z(L_3$%C("&R 0
MT@,  !D              ( !36   'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " #HBS],PI0RU;,!  #2 P  &0              @ $V
M8@  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( .B+/TR<
ML+"^M@$  -(#   9              "  2!D  !X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ Z(L_3'-S1/ L P  1PP  !D
M     ( !#68  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
M" #HBS],[/KC1<,"  "="@  &0              @ %P:0  >&PO=V]R:W-H
M965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( .B+/TSIW@!"LP$  -0#   9
M              "  6IL  !X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L!
M A0#%     @ Z(L_3+@EADOJ 0  \00  !D              ( !5&X  'AL
M+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #HBS],?>MQ^U4"
M  #^!P  &0              @ %U<   >&PO=V]R:W-H965T<R]S:&5E=#0W
M+GAM;%!+ 0(4 Q0    ( .B+/TRVUE%T50(  /$'   9              "
M 0%S  !X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ Z(L_
M3!&+8;3P 0  R@0  !D              ( !C74  'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " #HBS],\XG_I-0"  !<"P  &0
M        @ &T=P  >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( .B+/TR".V0GQ@,  $D2   9              "  ;]Z  !X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ Z(L_3+A@G[&C @  G H
M !D              ( !O'X  'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " #HBS],EQ!TOO,!   V!0  &0              @ &6@0
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( .B+/TQ<L>LQ
M, (  !T&   9              "  <"#  !X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ Z(L_3/TH@[Y" @  I 8  !D
M ( !)X8  'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " #H
MBS],A!Q8I0,#  "J"P  &0              @ &@B   >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( .B+/TP6TH8%! (  (<%   9
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M970V,2YX;6Q02P$"% ,4    " #HBS],K(U^%\4!   L!   &0
M    @ &WEP  >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M .B+/TSZ!5T;WP$  &8$   9              "  ;.9  !X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ Z(L_3*MVWY%,G@  :P<# !0
M             ( !R9L  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%
M  @ Z(L_3&C"D&E5 @  )PP   T              ( !1SH! 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " #HBS],Y'.O;90$  !U*0  #P
M@ ''/ $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ Z(L_3+CU PXC @
M$B8  !H              ( !B$$! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ Z(L_3'4>*[_O 0  ?24  !,              ( !
MXT,! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $@ 2 "J$P   T8!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.8.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>112</ContextCount>
  <ElementCount>205</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>56</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000030 - Statement - Condensed Consolidated Balance Sheets Parenthetical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets Parenthetical</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000040 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000050 - Statement - Condensed Consolidated Statements of Operations Parenthetical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfOperationsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Operations Parenthetical</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000060 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>000070 - Disclosure - 1. Organization and Nature of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperations</Role>
      <ShortName>1. Organization and Nature of Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000080 - Disclosure - 2. Net Loss per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShare</Role>
      <ShortName>2. Net Loss per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000090 - Disclosure - 3. Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements</Role>
      <ShortName>3. Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000100 - Disclosure - 4. Accounts Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivable</Role>
      <ShortName>4. Accounts Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000110 - Disclosure - 5. Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure5Inventory</Role>
      <ShortName>5. Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000120 - Disclosure - 6. Prepaid Expenses and Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssets</Role>
      <ShortName>6. Prepaid Expenses and Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000130 - Disclosure - 7. Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipment</Role>
      <ShortName>7. Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000140 - Disclosure - 8. Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure8AccruedExpenses</Role>
      <ShortName>8. Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000150 - Disclosure - 9. Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure9NotesPayable</Role>
      <ShortName>9. Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000160 - Disclosure - 10. Related Party Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayable</Role>
      <ShortName>10. Related Party Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000170 - Disclosure - 11. Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurements</Role>
      <ShortName>11. Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000180 - Disclosure - 12. Derivatives Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiability</Role>
      <ShortName>12. Derivatives Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000190 - Disclosure - 13. Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure13PreferredStock</Role>
      <ShortName>13. Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000200 - Disclosure - 14. Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure14CommonStock</Role>
      <ShortName>14. Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000210 - Disclosure - 15. Common Stock Options and Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrants</Role>
      <ShortName>15. Common Stock Options and Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000220 - Disclosure - 16. Related-party Transactions Not Otherwise Disclosed</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed</Role>
      <ShortName>16. Related-party Transactions Not Otherwise Disclosed</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000230 - Disclosure - 17. Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingencies</Role>
      <ShortName>17. Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>000240 - Disclosure - 18. Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure18SubsequentEvents</Role>
      <ShortName>18. Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>000250 - Disclosure - 1. Organization and Nature of Operations: Going Concern (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsGoingConcernPolicies</Role>
      <ShortName>1. Organization and Nature of Operations: Going Concern (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>000260 - Disclosure - 1. Organization and Nature of Operations: Use of Estimates in The Preparation of Financial Statements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsUseOfEstimatesInThePreparationOfFinancialStatementsPolicies</Role>
      <ShortName>1. Organization and Nature of Operations: Use of Estimates in The Preparation of Financial Statements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>000270 - Disclosure - 1. Organization and Nature of Operations: Fair Value of Financial Instruments (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsFairValueOfFinancialInstrumentsPolicies</Role>
      <ShortName>1. Organization and Nature of Operations: Fair Value of Financial Instruments (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>000280 - Disclosure - 1. Organization and Nature of Operations: Reclassifications (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure1OrganizationAndNatureOfOperationsReclassificationsPolicies</Role>
      <ShortName>1. Organization and Nature of Operations: Reclassifications (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>000290 - Disclosure - 3. Recent Accounting Pronouncements: New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncementsNewAccountingPronouncementsPolicies</Role>
      <ShortName>3. Recent Accounting Pronouncements: New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure3RecentAccountingPronouncements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>000300 - Disclosure - 2. Net Loss per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables</Role>
      <ShortName>2. Net Loss per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>000310 - Disclosure - 2. Net Loss per Common Share: Schedule of Common Stock Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables</Role>
      <ShortName>2. Net Loss per Common Share: Schedule of Common Stock Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>000320 - Disclosure - 5. Inventory: Schedule of Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryTables</Role>
      <ShortName>5. Inventory: Schedule of Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>000330 - Disclosure - 6. Prepaid Expenses and Other Current Assets: Schedule of Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables</Role>
      <ShortName>6. Prepaid Expenses and Other Current Assets: Schedule of Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>000340 - Disclosure - 7. Property and Equipment: Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables</Role>
      <ShortName>7. Property and Equipment: Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>000350 - Disclosure - 8. Accrued Expenses: Schedule of Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables</Role>
      <ShortName>8. Accrued Expenses: Schedule of Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>000360 - Disclosure - 9. Notes Payable: Schedule of Debt - Other (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherTables</Role>
      <ShortName>9. Notes Payable: Schedule of Debt - Other (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>000370 - Disclosure - 10. Related Party Notes Payable: Schedule of Related Party Transactions (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables</Role>
      <ShortName>10. Related Party Notes Payable: Schedule of Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>000380 - Disclosure - 11. Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables</Role>
      <ShortName>11. Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>000390 - Disclosure - 11. Fair Value Measurements: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables</Role>
      <ShortName>11. Fair Value Measurements: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>000400 - Disclosure - 15. Common Stock Options and Warrants: Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3 (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables</Role>
      <ShortName>15. Common Stock Options and Warrants: Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3 (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>000410 - Disclosure - 15. Common Stock Options and Warrants: Schedule of Share-based Compensation, Activity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables</Role>
      <ShortName>15. Common Stock Options and Warrants: Schedule of Share-based Compensation, Activity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>000420 - Disclosure - 17. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables</Role>
      <ShortName>17. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>000430 - Disclosure - 2. Net Loss per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedDetails</Role>
      <ShortName>2. Net Loss per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfEarningsPerShareBasicAndDilutedTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>000440 - Disclosure - 2. Net Loss per Common Share: Schedule of Common Stock Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsDetails</Role>
      <ShortName>2. Net Loss per Common Share: Schedule of Common Stock Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure2NetLossPerCommonShareScheduleOfCommonStockEquivalentsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>000450 - Disclosure - 4. Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivableDetails</Role>
      <ShortName>4. Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure4AccountsReceivable</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>000460 - Disclosure - 5. Inventory: Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryDetails</Role>
      <ShortName>5. Inventory: Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure5InventoryScheduleOfInventoryTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>000470 - Disclosure - 6. Prepaid Expenses and Other Current Assets: Schedule of Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsDetails</Role>
      <ShortName>6. Prepaid Expenses and Other Current Assets: Schedule of Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure6PrepaidExpensesAndOtherCurrentAssetsScheduleOfOtherCurrentAssetsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>000480 - Disclosure - 7. Property and Equipment: Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentDetails</Role>
      <ShortName>7. Property and Equipment: Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>000490 - Disclosure - 7. Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentDetails</Role>
      <ShortName>7. Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure7PropertyAndEquipmentPropertyPlantAndEquipmentTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>000500 - Disclosure - 8. Accrued Expenses: Schedule of Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesDetails</Role>
      <ShortName>8. Accrued Expenses: Schedule of Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure8AccruedExpensesScheduleOfAccruedLiabilitiesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>000510 - Disclosure - 9. Notes Payable: Schedule of Debt - Other (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherDetails</Role>
      <ShortName>9. Notes Payable: Schedule of Debt - Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure9NotesPayableScheduleOfDebtOtherTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>000520 - Disclosure - 10. Related Party Notes Payable: Schedule of Related Party Transactions (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsDetails</Role>
      <ShortName>10. Related Party Notes Payable: Schedule of Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure10RelatedPartyNotesPayableScheduleOfRelatedPartyTransactionsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>000530 - Disclosure - 11. Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>11. Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueLiabilitiesMeasuredOnRecurringBasisTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>000540 - Disclosure - 11. Fair Value Measurements: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationDetails</Role>
      <ShortName>11. Fair Value Measurements: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure11FairValueMeasurementsFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>000550 - Disclosure - 12. Derivatives Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiabilityDetails</Role>
      <ShortName>12. Derivatives Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure12DerivativesLiability</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>000560 - Disclosure - 13. Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure13PreferredStockDetails</Role>
      <ShortName>13. Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure13PreferredStock</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>000570 - Disclosure - 14. Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure14CommonStockDetails</Role>
      <ShortName>14. Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure14CommonStock</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>000580 - Disclosure - 15. Common Stock Options and Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsDetails</Role>
      <ShortName>15. Common Stock Options and Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>000590 - Disclosure - 15. Common Stock Options and Warrants: Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Details</Role>
      <ShortName>15. Common Stock Options and Warrants: Schedule of Share Based Payment Award Stock Options Valuation Assumptions, Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsLevel3Tables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>000600 - Disclosure - 15. Common Stock Options and Warrants: Schedule of Share-based Compensation, Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityDetails</Role>
      <ShortName>15. Common Stock Options and Warrants: Schedule of Share-based Compensation, Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure15CommonStockOptionsAndWarrantsScheduleOfShareBasedCompensationActivityTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>000610 - Disclosure - 16. Related-party Transactions Not Otherwise Disclosed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosedDetails</Role>
      <ShortName>16. Related-party Transactions Not Otherwise Disclosed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure16RelatedPartyTransactionsNotOtherwiseDisclosed</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>000620 - Disclosure - 17. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails</Role>
      <ShortName>17. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="acar-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>000630 - Disclosure - 17. Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesDetails</Role>
      <ShortName>17. Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://activecare.com/20170630/role/idr_Disclosure17CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>acar-20170630.xml</File>
    <File>acar-20170630.xsd</File>
    <File>acar-20170630_cal.xml</File>
    <File>acar-20170630_def.xml</File>
    <File>acar-20170630_lab.xml</File>
    <File>acar-20170630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2014-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001096906-18-000055-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001096906-18-000055-xbrl.zip
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MKRK>91>S&_<>M#K_M*>&9^\_:%5&8L_IV>/-@TI?.U99.2J,$,NHC0H>E<+
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M/R5">@?IE3TB\LW!_B=,%5;I]7Q*E)AU/2+M*_&@GSGK^8!<9V,D6J/7(47
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ML4R0&'&C82XFM%_9E/81OL#=EROE.RGQ!<MV8V"D1 'X.)QUV'XX"O!& !P
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M5J%HI^V"%,).)%X,F\][NJTJ=]^D-BS4M0-? $8:B]KWO)4-;]&=-P%3I]M
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M&B#@G7WP]]BX0UCP&"] "-PMJ%%.\FC$KL^HR0_G7:5A8]PF)/V9,7FD=6#
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M:<W(OB5\=SD^$N1?CYS5;'IMXP'\I/#]+222+,"(R:0)2+,)<WE6$P)%$2O
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M!TM$]]5A-"-O%H%<$==*SI*WJ\CS#32_M]R280CD%#T=B QI1 M7GO ]<VI
MBWUV3S<8_$9K..[)D(,ES,8#!O$'Z:62#FZ$7?H3,  ]<WF]$$,HOAKN'ZH
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M0 -6E%,I>R,P550)\2BF7G(W2#^AA%C*&2U2 ];E$-3 _RS1@PEDE" E8@
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MD-.]@=_S4HSYI?+F_B62>Z]I<;'*8EWC=X;=/ )^-^L%<2K*/H:^-T59>6#
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M8=B5<H!V"72QBXT6M'[=,I[7<FQN*P1K#W2>@J;)1M'DT+3M89/%\M7)8*V
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M;@U'OEWF^D]"S"U$SSL6):X7K-7-)J=';_!];&!Y6RKP SS7NW>Q9'%!^KI
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MSL#M#3M63INX76+8PU'/'??'I18;*VYXP=6&V:N!.Q%^@T)2&Z4-?.=J-)V
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MD]Z&V$B;9ZF(%LG4YS"F/W?!9IG^$S8LA86795X0R3GN9- $$4V;QI'5J ?
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MO(O)9!++&_5:7J)9+0B!>8 Y$=$\=26SI PZ@($9HS=[<13*&! VP/@4F:2
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M2UG'!F!27S6K_U4/UK387#-/2%N'0Z!ZE8(:F<BTC>P^$!TKBC1A-X_8DQT
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M?.]/LVO\?R+I3[]'B8I$SF*LRI7I(Y+9"0 *O1]<03/X:M9;X+V  0!H4"R
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M%2X9<";@O&E- ,8VY(UG0G^1;;T; O4_UVD6+![X5^(?;P+8=G*M+F@']S8
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ML.YEH:C81]R7QZO_$N?B3+P[8B>4;!VP],KK+%R(0%CC(R,0X#V^3K79$N$
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M LQ)UES=<[P]D%Q1%5SZVW3-[RBC5A;>"L)K_X'I>[O [FV_+W *@RB=\9>
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M:D=3-6?MA8'8"X(/_!YG*,4*#<((:$&8FR"=]J5Z4O'^-8X>L66[@& ^ N'
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M1?$BB!K>U48O?UGER1^_SXELF-''%9\*?]$2_T\3&ZBT_O3G_P-02P,$%
M  @ Z(L_3""_Y)V1$0  &LP  !$   !A8V%R+3(P,3<P-C,P+GAS9.U=ZT_D
M.!+_O/M7^.8+NQ+]HH$!-,R*&6"NM0R-@-E=Z71:A<3=;5W:[K$3'O?77]EY
MO]Q).M"94S[1Q';Y5RZ[7%4N)Q]^>U[:Z!%S01@]W1GUASL(4Y-9A,Y/=XA@
MO:.C@^/>:.>WCS]_^$>OAVXXLUP36^CA!=TQUUEP8LTQNL/\D9A8(%= 2W1Q
M_N7L5KC$P4BPF?-D<+R+SJQ'@\JFG]ERY3J8HPFE[-%PH&NQ"_^8_5TH6[UP
M,E\XZ)?/OZ*]X?"HMS<<':%_W=S\]?OA:'1]?/'[GW]<G5]=[UW\_N\^>GIZ
MZF-K;G#56]]D2]3K 59A+O#20, =%2>44>HN3W<6CK,Z&0QDF^<';O<9GP\L
MAP^<EQ4>0*4>U,*<F#M>NT2#I[&J#HA&@[^^7MTI^G[%$U?TYH:Q"AO,#/&@
MJOL%T&STOC<<]<:CH(D$8#EABQ /=' P\ K#JC:A_\D#,SH^/AZHTJ"JA4F2
MI,!F?\X>!U @0>PG0<R('58W3(<\8A-$)4=1(1X>CF$^. :?8^?:6&*Q,DR\
MOH$_Z.M'/#':)QDNXV,R'LCB!T/@^  237U"A2/GVPXR'(>3!YAQEXPOS_',
M<&T8>)=^=PV;S BV8,[;>(FIDZ@0%7_\^:</!LQ51\U5^ _^7:T(G3'Y^Z</
M$MI)@.\6SY"2R8ED\O2=(,N5C=_YSQ8<ST[?&3!JO6# _E[!" )/017.;&A6
MR)<L'D 3 7@5GJNHXX"$P<T,E<R< 2)LA;E#L @']]V@$8XL/*O*$30AE+24
M']MXJ,H/-,%V"UDQ#;LJ*]#$=.W7G6N2Q#VP@.2/;[>3D%R!EO&0$8O_?4Z$
M:3/A<CPZ@)UER>B=P\S_3%=J7SFCUI\&YP9UQ#M$K--WU9HHA#[$:(9^' Z'
M>Z,AZJ&($OPS.N@CCQQ2])!/$!G40@')#X,TL5@7KL#6E'Y4O]-+W&_H5REH
ME%Q%I9JDI)MMXS\))-2TT$:7!N%_&+:+OV)#/I&*.%]8!56+A03=9H0TZB-)
M!BDZ*$ZH$XT<[\^,6IA"'_!#,)M8AH.M.V#6&Z3I; H+V3/:(B%5:50LKN&^
M%%?8#'Z'=%&<<%1%(#9#$>U.@LD5\_[&4[LOH-,NOKMD)<?L'#L&L7-7F+9^
ML=SVCS/+['T?!;24^@NIH5]\>K]VPDH._MXU=JZ8$#>8^YO2 II)1\-R;3R=
M71B<@G,ERU7))T,0$P1U3FRP;:U[X\'&N5)MAG"Q^,?#C/CW^@@Z1;)7!),@
MW!8E^1,4="T7;] Y@MZ]\EVD *AIXT- OW@@NCE3S>2)9!P(5FKHY0I4JH)\
M)GLBSDOQW&FV XT*J6E.)2>3 M&3QJ4790A@[*( 2#>3:FJ?V#20NOS1L.7V
MJ]E+-B.HF2G[&VB;Q'R*==OM2H4:9GB+;6ETW1BPEU\S!XL;XT6NH4B4\1KW
ML"R%I \K5:-6-J>JV8]RK/YA'_GTD"*(5)_([S0Y29(5XUUWVJ.*H1D\N[%!
M4\<+BN=%+3J:F9#5%86&Z4GX?!>IGM)V:R?Z*E[B9T,L+FWV5,5)C-IH?,3#
M6CZB)(T4[4Y^I:(JX<,K8CP0F\C0G5\.N&ZQZ7(.=KLTU7560(/4B^?$P;A*
MF.<D5K"+8@""6A8"$R'$H+R1SD HG#_[9Z;)7!A7&#$,]A0H2<U\T-36F'P'
M&?GN]U% "46D.BD5KO*]<\R)/&Q]Q"*8\R^Y*S:_IB;(>I1=?6"1QZB$B^RE
M$TO%:"G8H/!H@1T"2&O%6Y,4-!OKP8;!5Y3HJ9/TQH$4<$[D,)\]&=R*-Y,[
MEQ==$<)=>L^N\".VQ[J-^"W[UVS5V5!QW3@/4B"1CQ(IF"D*(5(4@PI[O@2+
MQMUN4<F=*^VOZ?:*K*56Z)!U0DFMX/=RE1!'J5X8;U#*#MBGF)I@N^I6?IEV
MQ2([S#&NWWLKUJ>IQ):@VJVLNMX6Z"GL%+I"WRA[$)@K6W="5ZX#Q0Q&W":*
M(4V\[0VZU81A<I1^6?_,0Z9SS791'!]2 %$281>\:33J7_^H44M/,X&RIT--
MQ/R[25%A4I07M\[)R/J*.D%VDJEDQ-<W_TL8[CE>?AG#O3,%:MESD<J\=!VH
M_!686[K+6SDNMN_RB$O&??>;SJ]@@\2Z$[?7ZTT3N-NK;CLFE;>'!_F D(<H
M\/D$FC&.0E#(0]7I]8()=WC#\<H@UL6S3(S <A9,G06H;K"FI)^O+*UH*F3+
M-/JE,=J:R90]UCV4OJ/J%P4=JPFER".?OF]")N=57HU.56TU>-5H$E+M[C7S
M+YOFML705:?C&DA$J)H*NY:09O9D[:?ZJ0B=GBK04_LQ1:&SAO/J:6S?G(2B
M_=3*[V12.8&L6F*8+JI\6#7AJQ-2<MB/\U/PSO&#HRPES5HJVU2SO++1G>.^
M+D%/TH9*G@W7+;RBA3<&VWB&P<*UUNK#@JH:F>4LN;&RQCTRG5:LL%.MW:)T
M]Q!SK-+4WM2-_1L>AFR0"]=(OYHEFTV&?>M3F$X;K$T#^F38\JT%=PL, UXE
M^T?34!./'Y=,^O&I(X]\E^J3HU^8Z2I7T/\KW4/J$.=E0F>,+Q6:F%8H4ULC
M-\]D\AO'?RI/45%",5*=B)*J^&!"'X%-QG-3(&.E&J<C:[4>]%'8LAOQ"N</
ME0\L= 91C7R53EAZ?Z",SZ!;*CGY'UEGH1-":H"/[EPPJ+Z[P.N%U"KYRR1;
M2[,V<DS HSZ**""/1">*U"!/^=R@Y+_>R0&UK@UY*AG/L@9+US:$(#,PB-2#
M&S"="E7;!N0TPLTYH>^C>%=*\7F=)5.W3U"F0_1+T&5GK:=GPV'1U=1KYL6\
MGHC ?GULZ3S">I2*Y\!ASC7ZPS 2VEME;[1"1RCL"85==;Y:?5WP3<B7:@B'
M@.V-Q83>+[ ZI?:*I[-+0L&7(H8=W:383%MLTJ%&G^2$^$KK$X"DWNX1@$*$
M(H"%8KA4>D> +'ZKI-,\;YDR5#=S?,/N-#IL.TE#G;ZKJ^_" &9,TTRH<+C;
M@&XK2URCQW).;TOKL5AT-*&N8A Z??6:=\OKWVDH3[QX[HQS;.K&;Y9WJ3RY
MDV<L[W53Q[_F#>-UPQF%GZ8WV-?XJ:A(IW$:H*I1-=E Q[B/O!Y11!<E"9\@
MZ+6XN-,O37EB#;A@.N'GV"VU?*].RI66;(U5KCM9J;6$.Y$EQ_\(1HJ[.$P'
MCYP%OR"V.6H<D#ID- ?@V52)(_4:$4DI3"!/NA)!:7PS[UR%VJY"/1] MUSK
M&_>=].HOMF*KO 85C?F=??%/O17;F=BO^?K89E\[HNM!$S5J[G;&FA?(=MI_
M74Y%)-7P4;'"*--,HR&R1G<\"R,IW?!QIQ JO29,M[ZU#32V6%:S%[XTK%MR
M]0VN+PR<E<\,_!1.-PO$YE+2>,,Y BX==55](;^S+OY13^5J5FVI=L6RW<^>
M#)92NMTR;OX=VSK=W !9C0;/"7<U]9;M;J*\T@W^8C.L*=(:4RV;F-GT_?W.
MJBO[BMZ2[^;5)75F':[\E_)VTM!<F%Q[HU(G@:R)E;XWV8U]M<NJQ?JQ9$N-
M^LL:355NN7:J[34^FK7!]VM*4M98T=G]L/'/9G6&U :&5&TS2:>SLU9S%2.H
MDV.Y^X]5[DKJ3I?V:EV/[*2D/Q,J<VZD6T/96RPYIT+_%T+X,(@^- Z_X]\@
M_T"6*\8=Y'WI_HIY]S8T'T27__6"KZ+WY*/>:*\W'O6?A;6#:.;[[II/J@\J
M]I_^Y+OL_5CV/CHLU7OFD_'U 3!ZO2D&1GMU<4"?!TH0EB/[/RCJ.:]!HK-L
MDYDA'E035_3FAK%2*[(W'(&$=XJPJ6YR&PZP[8C@22\BY0'6(U%4!3;[<_8X
ML#"1!/?+($FWD3]Z4>-8W]CV%++Q(!P.FNATQX'%#R-);%L:RL'_4F"G.Y(X
M.8&:8#%-0)7+U05(7&A,'%?B^,*9NPHJ$JBR@[S?8(419MTK,I;K!:AWI/K:
MF1'[;]WM[3,?FB?>TYUR=1/<Y7,#\P^FWXG%E@:AC;(CG9'15[Q\P#Q G7BT
M=7![67![K0$WSH(;MP;<?A;<?FO '63!'50 YW4#CA(X._RE$71>V8-GU4$!
M?B!.A#F>&>";&S=@OD_\+ =^M@3%Z)]R36<%J0\!MPT1V[H0#[-"/&S-#'N?
M!?>^W3.,/F(NE,CC1S1!>-4/&,$,R,FJ8D7'/M&4>QWJ6Q6SOQ1>PK2!I,@+
MB[<*.D1SSR9"N#B6+)6$7Z+B5AF!.0!^B^TKL"3V_+*MPCWWWSQQBQ\Q=5-X
M"PJW"EC=?A3"5_N76-YIBF,N+M^Z[CW*ZMZCUH [SH([;@VXT3#'&!^V!UZ>
MK] .9^&*4/FU&5C$Q#DSO[M$J%A-=MV4J+A=O>I%AF.^XCTV%Y39;/YRA_DC
M,=,<56G1!M9N.)MAI;D,.RN?-97:P,"$"B@"*VY4((AT\59!JU.%)-#$HZV"
MNX,=5XU5$F#F\59!WF*!#6XNY%F??!L_4R]E3R+6UVFCQZ$L?<.>SL[2IF;@
M8]ZS&Q=8,@16YXTB\36O2\:OF$'ASP,P+GN0RS08CE<B_F.-8X.C]H./T3D&
M.-8Y>206II:0M_(M['WB8CI+OE4NLLDK--FR>DBZQZ.T9B@H;A7H/3WH=@1=
MTZC&>M#M",:F4>WK0;<C2)M&=: '725X^W:@#_6@VQ&L3*-ZKP==)8CY=J"/
M]*#;X?W#3KG$_.(9FZY,9/B\, CX2[";W"_P)V9P:SH[)QR;#N,IGZ1.RS:R
M*M_HM2!X%A9,9S/P#GDI;M<U;E58-; R]3'5=*WMRDR]:@IG/>*<@C;:>#*'
M<4HGU')-E7OE'S@(+V4V%,&:6FWD[ N(>DK#R7.''<<#&!KNNAIMY.B&,Q-C
M2UQRMI0K05::SH+E,*$@&(K5W9P_B;/(.U':A$(;1R3I;DSE&S6+'8[HG"ST
M3T!IQIF,^6DR_>,9'%TZCPU0OI?S!MVV<>SCIY/E3B37G7'6H=+&D3D3@LRI
M1)0\MXTCOV=G]!OE7NG]@G"O2AA3V(1$*\>DD=#2E),Y[*M!Z+_9N%6&>!O'
M\;-\:MO!_>];3$(UGL-9N,HJMFHCYU7#;,$A2MTP7=2^C:,QT0D0T(=[3<!^
MA0;;/[',22 <M2.8I:#DI!".VA&VTK[%)YN*L+;JEIF1MH%#H$OI9HS2^/-+
MVY1XG'NK)7J%>OR]'8E/=:63DC>GTT8=%EB\H?\AE;$5F7TY2KQ2D_;R'(*=
M4 >#,G;\I*LDF\6UVLA9UI\$Y/(3!W6MN@8)MGN\\AF12]VUY4M,TXN@3LL?
M<03BCD]6K&5'8QV5'W%D)!\7SPXH@\(U4[IA&_FO<Z1^!@Q8DHE-S^93A$J/
MCU 4&[4?+IXQ-XG\;,S4=>2E/DN]W$MCN 6,UVFY34[C<2#06O)%P?D9!B4J
MMHN/B[)\9"JVA8_X24#V^3911NKN8KFRV0O&MUB:\:8TCU5W6<587'.;G&@N
M#I2X6[#MN1("N?CNDD?#QLF+4[FE;[GO>#>BG<RV8ZJ$XMB9$6="Q&.LG_",
M<?59 1F9#@^.UE5K V_IHQ(?W)3FA>&+2MO 2%I(B:,3_WT>U+IFU/3^B8=E
M]/6VKV!5^"*I]SUM=([E 8 T7'/B'>L:M,*D2XMM0N$)N&WGV/L[H6'(,349
MR]1LX\2,S@!O8&/!:PR LK7+A.#<I02L)D*SV0W!1YK.8,/QP(J8/E? PX2'
M4G5+R\W")ED:=A-B"Z\>8C)?P (YDVGJ<S  9,02S.)[S)<J*RAM1%=HT(HE
MEU+Y<<\W?GWYG\SE]LLME.6E?A75;".'7EY*E+B1S%>)/V\C^CK.:>43T&:C
M9*]\L)+S^H-1.U)K%92<%R",VI%$JZ#D7.T?U4B7=?"S\\F&>=+LG2$Y\YBW
M+1C4>O(UY_ ^Z"T1^]97W#8OE3Y%EN6P=O-M\QV]53'?J<L19H46[>$N^LB)
M_S':,YB%5CQN)@T=+YLB,G:NY TRW1 T1!;&Z</ >S_3QY__!U!+ P04
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M*W!+59$N#@%PN;I,\^0 ,)>:=AY">O\*-9NF)=/4@6@+"DN#PONO2M)![I2
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M_C?>VOZN*HV8'L1/GF&7_0HQ?_,,JIC7^LXJ+YKJ!G  DC VJ/!FVR;5C<8
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MF0A"L1C[.X9Y9//[SGO;AH,TFK?Q!I0;$*2MV,]\:5SRB3UNC-CBQ0OKI&)
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MI!S,\A31R^7'A 8L._9_V;"4 84S2E/%\J3[!K<\&7*$6YXB*MZ5!!GB;>G
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M+:"G!X\VH,2VY$A6T3,)F9@)6#WDTX&RODJ<,B4RQ%G&R?,9/S^G*QI\BN-
M9F&5-,8G1%;Q@,H@5/:\(&7?1'2^("*EN2,X,Q-$._^Q5AM3I]:&+$!G?$AY
MG;H-B^ZWR::O:'+"0KX]!ZJW\/[]V$G'/8!S'#"!*/D6R'Z75TC94JYEZ%Y
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M/=\C6.2SM1<".@%W >3P9XVX49+%$/P.:0BW<"Z[X(WCW1W$>7@KI&P8$*\
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M*!T(Z_H5380SAP3;AA_C0T'Z\(B+!MG-I%D]P3@&V'X2:8>!]%;;A"&4V\V
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M2LN7]NOVZM;[<YL)$DSXM!1W6Z.V($"/ $%24B37[BR10R6E2EA@K-()_2_
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M_N?_!U!+ 0(4 Q0    ( .B+/TR^W_ Q;BT! &(7#P 1              "
M 0    !A8V%R+3(P,3<P-C,P+GAM;%!+ 0(4 Q0    ( .B+/TP@O^2=D1$
M !K,   1              "  9TM 0!A8V%R+3(P,3<P-C,P+GAS9%!+ 0(4
M Q0    ( .B+/TQA?V%WB0D  +:#   5              "  5T_ 0!A8V%R
M+3(P,3<P-C,P7V-A;"YX;6Q02P$"% ,4    " #HBS],0^%S\R,4  !$5P$
M%0              @ $920$ 86-A<BTR,#$W,#8S,%]D968N>&UL4$L! A0#
M%     @ Z(L_3(=KZJ)R0@  XUX# !4              ( !;UT! &%C87(M
M,C Q-S V,S!?;&%B+GAM;%!+ 0(4 Q0    ( .B+/TQO_\]T:R@  /[X @ 5
M              "  12@ 0!A8V%R+3(P,3<P-C,P7W!R92YX;6Q02P4&
/  8 !@"* 0  LL@!

end
</TEXT>
</DOCUMENT>
</SUBMISSION>
